Sentence,class,file
3 753–771 https://doi.org/10.1084/jem.20162089 The Journal of Experimental Medicine753IntroductIon Myeloproliferative neoplasms (MPNs) are a group of related  but heterogeneous clonal hematopoietic malignancies that can be classified by the presence of the Philadelphia chro-mosome (Ph).,Non-OADS,/arxiv_data1/oa_pdf/10/21/JEM_20162089.PMC5339683.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/4.0/ rThe Author(s) 2017 Supplementary Information accompanies the paper on Hyp ertension Research website (http://www.nature.com/hr)T80/A5/H12.5 vs. T80/A5 therapy for hypertension JH i g a k i et al 258 Hypertension Research",Non-OADS,/arxiv_data1/oa_pdf/2f/18/hr2016124a.PMC5339800.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017",Non-OADS,/arxiv_data1/oa_pdf/57/6b/cr2016159a.PMC5339831.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/6c/63/cr2016146a.PMC5339848.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/9e/f2/cr2016147a.PMC5339849.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case ObservationsEditor: S. A. Enam,  MD  Aga Khan University; Karachi,  Sindh, PakistanCase Report Post‑irradiation lumbosacral radiculopathy associated with  multiple cavernous malformations of the cauda equina: Case  report and review of the literature Doniel Drazin, Ari Kappel1, Stefan Withrow, Tiffany Perry, Ray Chu, Surasak Phuphanich2 Departments of Neurosurgery, 2Neurology, Cedars‑Sinai Medical Center, Los Angeles, California, 1School of Medicine, Stony Brook University, New York, USA E‑mail: *Doniel Drazin ‑ Doniel.drazin@cshs.org; Ari Kappel ‑ ari.kappel@stonybrookmedicine.edu; Stefan Withrow ‑ swithrow@umich.edu;   Tiffany Perry ‑ Tiffany.perry@cshs.org; Ray Chu ‑ ray.chu@cshs.org; Surasak Phuphanich ‑ Surasak.Phuphanich@cshs.org   *Corresponding author Received: 25 May 16  Accepted: 23 December 16  Published: 20 February 17 Abstract Background:  Multiple radiation‑induced cavernous malformations of the  cauda equina are extremely rare.",Non-OADS,/arxiv_data1/oa_pdf/37/ac/SNI-8-26.PMC5339903.pdf
"Surg Neurol Int 2017;8:26. http://surgicalneurologyint.com/Post-irradiation-lumbosacral-radiculopathy- associated-with-multiple-cavernous-malformations-of-the-cauda-equina:-Case- report-and-review-of-the-literature/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/37/ac/SNI-8-26.PMC5339903.pdf
"Surgical Neurology International 2017, 8:26  http://www.surgicalneurologyint.com/content/8/1/26demonstrated nodular enhancements in the cauda equina  on MRI, and only 5 provided histological evidence of  cavernous malformation.",Non-OADS,/arxiv_data1/oa_pdf/37/ac/SNI-8-26.PMC5339903.pdf
"Surgical Neurology International 2017, 8:26  http://www.surgicalneurologyint.com/content/8/1/26 Table 1: Reported cases of radiation‑induced cavernous malformations of the cauda equina First Author  (Year)Age at  Presentation  (Sex)Interval  (years)Initial  cancerPresentation Clinical  CourseCSF MRI MRI Findings  LocalizationHistology Bowen[3] (1996) 61 (M) 11 Testicular  SeminomaAsymmetric distal leg  weakness.Progressive Protein 400 mg/dL,  acellularFocal enhancement of the  lumbosacral rootsCauda equina Clusters of dilated vascular  channels with thick  hyalinized walls Bowen[3] (1996) 47 (M) 10 Testicular  teratomaInitially monomelic  distal leg weakness.",Non-OADS,/arxiv_data1/oa_pdf/37/ac/SNI-8-26.PMC5339903.pdf
"Surgical Neurology International 2017, 8:26  http://www.surgicalneurologyint.com/content/8/1/26Intradural spinal cavernous malformations are  uncommon lesions that account for only 3–13%  of all space occupying spinal lesions.",Non-OADS,/arxiv_data1/oa_pdf/37/ac/SNI-8-26.PMC5339903.pdf
"Surgical Neurology International 2017, 8:26  http://www.surgicalneurologyint.com/content/8/1/26with gadolinium enhancement of the cauda equina.",Non-OADS,/arxiv_data1/oa_pdf/37/ac/SNI-8-26.PMC5339903.pdf
"Surgical Neurology International 2017, 8:26  http://www.surgicalneurologyint.com/content/8/1/26radiation-induced telangiectasia in children after cranial irradiation:  Frequency, latency, and dose relation.",Non-OADS,/arxiv_data1/oa_pdf/37/ac/SNI-8-26.PMC5339903.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comErratum Erratum: Metabolic syndrome and the hepatorenal reflex In the article titled, “Metabolic syndrome and the hepatorenal reflex” published as elocation ID 83, in vol.",Non-OADS,/arxiv_data1/oa_pdf/df/55/SNI-8-21.PMC5339908.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: General NeurosurgeryEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOriginal Article Management strategies for neoplastic and vascular brain lesions  presenting during pregnancy: A  series of 29 patients Celestino Esteves Pereira, Jose Carlos Lynch Neurosurgical and Obstetrics Departments of Servidores do Estado Hospital, RJ, Brazil E‑mail:  Celestino Pereira ‑ celestino.pereira@br.inter.net; *Jose Carlos Lynch ‑ Jclynch@globo.com   *Corresponding author Received: 27 May 16  Accepted: 12 December 16  Published: 20 February 17 Abstract Background:  The occurrence of a brain tumor or intracranial vascular lesion during  pregnancy is a rare event, but when it happens, it jeopardizes the lives of both  the mother and infant.",Non-OADS,/arxiv_data1/oa_pdf/63/79/SNI-8-27.PMC5339909.pdf
"Surg Neurol Int 2017;8:27. http://surgicalneurologyint.com/Management-strategies-for-neoplastic-and-vascular- brain-lesions-presenting-during-pregnancy:-A series-of-29 patients/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/63/79/SNI-8-27.PMC5339909.pdf
"Surgical Neurology International 2017, 8:27  http://www.surgicalneurologyint.com/content/8/1/27at identifying the best medical and surgical procedures  to be followed for a pregnant patient harboring a brain  tumor or an intracranial vascular lesion.",Non-OADS,/arxiv_data1/oa_pdf/63/79/SNI-8-27.PMC5339909.pdf
"Surgical Neurology International 2017, 8:27  http://www.surgicalneurologyint.com/content/8/1/276 harbored AVMs, and 1 patient presented cerebral  cavernous malformation (CCM) [Figures 2‑4].",Non-OADS,/arxiv_data1/oa_pdf/63/79/SNI-8-27.PMC5339909.pdf
"Surgical Neurology International 2017, 8:27  http://www.surgicalneurologyint.com/content/8/1/27aforementioned factors, we could establish five different  clinical scenarios: •	 If	the	patient	presents	stable	neurological	 conditions,	 the neurosurgery may be deferred until gestational  period reaches the 30th week.",Non-OADS,/arxiv_data1/oa_pdf/63/79/SNI-8-27.PMC5339909.pdf
"Surgical Neurology International 2017, 8:27  http://www.surgicalneurologyint.com/content/8/1/27Vascular lesions SAH is rare among pregnant women and the  occurrence rate varies from 0.002 to 0.05% of all  pregnancies.",Non-OADS,/arxiv_data1/oa_pdf/63/79/SNI-8-27.PMC5339909.pdf
"Surgical Neurology International 2017, 8:27  http://www.surgicalneurologyint.com/content/8/1/27Conflicts of interest There are no conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/63/79/SNI-8-27.PMC5339909.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case ObservationsEditor: S. A. Enam,  MD  Aga Khan University; Karachi,  Sindh, PakistanCase Report A case of acute subdural hematoma due to bleeding from  metastatic chondrosarcoma of the skull Kenzo Kosugi, Satoshi Takahashi, Hikaru Sasaki, Ryota Tamura, Kentaro Ohara1, Kazunari Y oshida Departments of Neurosurgery, 1Pathology, Keio University School of Medicine, Shinjuku, T okyo, Japan E‑mail:  *Kenzo Kosugi ‑ kensan03977@yahoo.co.jp; Satoshi Takahashi ‑ satoshi710@mac.com; Hikaru Sasaki ‑ hsasaki@a5.keio.jp;   Ryota Tamura ‑ moltobello‑r‑610@hotmail.co.jp; Kentaro Ohara ‑ k‑ohara@a5.keio.jp; Kazunari Yoshida ‑ kazrmky@z3.keio.jp   *Corresponding author Received: 31 October 16  Accepted: 15 December 16  Published: 20 February 17 Abstract Background:  Intra or peritumoral hemorrhage of brain and skull tumors  sometimes presents as stroke.",Non-OADS,/arxiv_data1/oa_pdf/f6/aa/SNI-8-23.PMC5339913.pdf
"Surg Neurol Int 2017;8:23. http://surgicalneurologyint.com/A-case-of-acute-subdural-hematoma-due-to- bleeding-from-metastatic-chondrosarcoma-of-the-skull/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/f6/aa/SNI-8-23.PMC5339913.pdf
"Surgical Neurology International 2017, 8:23  http://www.surgicalneurologyint.com/content/8/1/23CASE DESCRIPTION A 73‑year‑old man underwent right lower leg amputation  16 years earlier because of chondrosarcoma.",Non-OADS,/arxiv_data1/oa_pdf/f6/aa/SNI-8-23.PMC5339913.pdf
"Surgical Neurology International 2017, 8:23  http://www.surgicalneurologyint.com/content/8/1/23a chest wall chondrosarcoma suffered a hemothorax.",Non-OADS,/arxiv_data1/oa_pdf/f6/aa/SNI-8-23.PMC5339913.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: NeurovascularCase Report Mixed aneurysm: A  new proposed nomenclature for a rare  condition Cassiano U. Crusius1, Paulo Henrique P .",Non-OADS,/arxiv_data1/oa_pdf/ae/93/SNI-8-29.PMC5339914.pdf
"Surg Neurol Int 2017;8:29. http://surgicalneurologyint.com/Mixed-aneurysm:-A-new-proposed-nomenclature- for-a-rare-condition/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/ae/93/SNI-8-29.PMC5339914.pdf
"Surgical Neurology International 2017, 8:29  http://www.surgicalneurologyint.com/content/8/1/29resonance imaging (MRI) study, on suspicion of multiple  intracranial aneurysms, the patient was referred to  the neurosurgery service for further investigation and  treatment of possibly vascular aneurysmal malformations.",Non-OADS,/arxiv_data1/oa_pdf/ae/93/SNI-8-29.PMC5339914.pdf
"Surgical Neurology International 2017, 8:29  http://www.surgicalneurologyint.com/content/8/1/29new angiography was performed which showed evidence  of mixed aneurysmal lesion with obvious radiological  characteristics.",Non-OADS,/arxiv_data1/oa_pdf/ae/93/SNI-8-29.PMC5339914.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: NeurovascularOriginal Article Surgical strategy to minimize ischemia during trapping/resection  of giant extracranial carotid artery aneurysm stratified by  collateral evaluation Hiroki Hongo, Tomohiro Inoue, Akira Tamura, Isamu Saito Department of Neurosurgery, Fuji Brain Institute and Hospital, Fujinomiya‑shi, Shizuoka, Japan E‑mail:  Hiroki Hongo ‑ hhongo@hotmail.co.jp; *T omohiro Inoue ‑ t.inoue‑fujinsu@beige.plala.or.jp; Akira Tamura ‑ tamura‑nsu@umin.ac.jp;   Isamu Saito ‑ saito‑kyr@umin.ac.jp   *Corresponding author Received: 09 June 16  Accepted: 30 December 16  Published: 20 February 17 Abstract Background: Extracranial carotid artery aneurysm (ECAA) is a rare clinical entity,  and no standard treatment strategy has been established for this condition.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/SNI-8-28.PMC5339915.pdf
"Surg Neurol Int 2017;8:28. http://surgicalneurologyint.com/Surgical-strategy-to-minimize-ischemia-during- trapping/resection-of-giant-extracranial-carotid-artery-aneurysm-stratified-by- collateral-evaluation/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/SNI-8-28.PMC5339915.pdf
"Surgical Neurology International 2017, 8:28  http://www.surgicalneurologyint.com/content/8/1/28However, a standard treatment strategy has not yet been  established.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/SNI-8-28.PMC5339915.pdf
"Surgical Neurology International 2017, 8:28  http://www.surgicalneurologyint.com/content/8/1/28by cervical skin incision along the anterior edge  of the sternocleidomastoid muscle.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/SNI-8-28.PMC5339915.pdf
"Surgical Neurology International 2017, 8:28  http://www.surgicalneurologyint.com/content/8/1/28related to the surgical procedure in any of the patients.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/SNI-8-28.PMC5339915.pdf
"Surgical Neurology International 2017, 8:28  http://www.surgicalneurologyint.com/content/8/1/28include aneurysm rupture, paralysis of the cranial nerves  due to compression by the giant aneurysm, and enlarging  pulsatile or nonpulsatile neck mass.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/SNI-8-28.PMC5339915.pdf
"Surgical Neurology International 2017, 8:28  http://www.surgicalneurologyint.com/content/8/1/28 Figure 3: Intraoperative photo of Case 2.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/SNI-8-28.PMC5339915.pdf
"Surgical Neurology International 2017, 8:28  http://www.surgicalneurologyint.com/content/8/1/28intraoperative SSEP monitoring, and did not have new  ischemic lesion as detected by DWI that was performed  on postoperative day 0 to 1.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/SNI-8-28.PMC5339915.pdf
"Surgical Neurology International 2017, 8:28  http://www.surgicalneurologyint.com/content/8/1/28The surgical treatment strategy of ECAA based on the  preoperative collateral evaluation has not been previously  investigated in a case series.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/SNI-8-28.PMC5339915.pdf
"Surg Neurol Int 2017;8:24. http://surgicalneurologyint.com/Removal-of-a-malignant-cystic-brain-tumor-utilizing- pyoktanin-blue-and-fibrin-glue:-T echnical-note/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/6b/e8/SNI-8-24.PMC5339916.pdf
"For reprints contact:  reprints@medknow.comAccess this article online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.200578 Quick Response Code: Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology",Non-OADS,/arxiv_data1/oa_pdf/6b/e8/SNI-8-24.PMC5339916.pdf
"Surgical Neurology International 2017, 8:24  http://www.surgicalneurologyint.com/content/8/1/24fluid to reduce the volume of the cystic contents.",Non-OADS,/arxiv_data1/oa_pdf/6b/e8/SNI-8-24.PMC5339916.pdf
"Surgical Neurology International 2017, 8:24  http://www.surgicalneurologyint.com/content/8/1/24The advantage of using pyoktanin blue[7] is that it  is a simple and inexpensive technique that allows  visualization of the cyst inner wall without damage to  the brain tissue.",Non-OADS,/arxiv_data1/oa_pdf/6b/e8/SNI-8-24.PMC5339916.pdf
"Surgical Neurology International 2017, 8:24  http://www.surgicalneurologyint.com/content/8/1/24removal of the cyst wall; this simple method may be a  useful technique.",Non-OADS,/arxiv_data1/oa_pdf/6b/e8/SNI-8-24.PMC5339916.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: NeurovascularCase Report Aneurysm of azygos anterior cerebral artery associated with  falcine meningioma: Case Report and review of the literature Lucas C. Meguins, Raquel C. T .",Non-OADS,/arxiv_data1/oa_pdf/2e/25/SNI-8-25.PMC5339917.pdf
"Surg Neurol Int 2017;8:25. http://surgicalneurologyint.com/Aneurysm-of-azygos-anterior-cerebral-artery- associated-with-falcine-meningioma:-Case-Report-and-review-of-the-literature/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/2e/25/SNI-8-25.PMC5339917.pdf
"Surgical Neurology International 2017, 8:25  http://www.surgicalneurologyint.com/content/8/1/25such as agenesis of corpus callosum, hydranencephaly  and arteriovenous malformations (AVMs).",Non-OADS,/arxiv_data1/oa_pdf/2e/25/SNI-8-25.PMC5339917.pdf
"Surgical Neurology International 2017, 8:25  http://www.surgicalneurologyint.com/content/8/1/25In contrast, Le May and Gooding reported four cases  of azygos ACA (3.73%) in 107 consecutive carotid  angiograms.",Non-OADS,/arxiv_data1/oa_pdf/2e/25/SNI-8-25.PMC5339917.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor Antonio A. F. DeSalles,  MD University of California,  Los Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: StereotacticReview Article Stereotactic spine radiosurgery: Review of safety and efficacy  with respect to dose and fractionation Michael Huo1,2, Arjun Sahgal3,4, David Pryor1,2, Kristin Redmond5, Simon Lo6, Matthew Foote1,2 1Department of Radiation Oncology, Princess Alexandra Hospital, 2School of Medicine, University of Queensland, Brisbane, Australia, 3Department of Radiation  Oncology, Sunnybrook Health Sciences Centre, 4Department of Radiation Oncology, University of T oronto, T oronto, Canada, 5Department of Radiation Oncology,  Johns Hopkins University, Baltimore, 6Department of Radiation Oncology, University of Washington School of Medicine, Seattle, USA E‑mail: *Michael Huo ‑ michaelhuo@live.com.au; Arjun Sahgal ‑ arjun.sahgal@sunnybrook.ca; David Pryor ‑ david.pryor@health.qld.gov.au;  Simon Lo ‑ simonslo@uw .edu; Kristin Redmond ‑ kjanson3@jhmi.edu; Matthew Foote ‑ matthew .foote@health.qld.gov.au   *Corresponding author Received: 27 October 16  Accepted: 30 December 16  Published: 20 February 17 Abstract Background: Stereotactic body radiotherapy (SBRT) is an emerging treatment  option for spinal metastases with demonstrated efficacy in the upfront, postoperative,  and re‑treatment settings, as well as for tumor histologies considered radioresistant.",Non-OADS,/arxiv_data1/oa_pdf/41/fd/SNI-8-30.PMC5339918.pdf
"Surg Neurol Int 2017;8:30. http://surgicalneurologyint.com/Stereotactic-spine-radiosurgery:-Review-of-safety-and-efficacy-with-respect-to-dose-and-fractionation/This is an open access article distributed under the terms of the Creative Commons Attribution‑NonCommercial‑ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non‑commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/41/fd/SNI-8-30.PMC5339918.pdf
"Surgical Neurology International 2017, 8:30  http://www.surgicalneurologyint.com/content/8/1/30INTRODUCTION Spinal metastases are relatively common, with their  incidence projected to increase as modern systemic  therapies prolong patients’ overall survival.",Non-OADS,/arxiv_data1/oa_pdf/41/fd/SNI-8-30.PMC5339918.pdf
"Surgical Neurology International 2017, 8:30  http://www.surgicalneurologyint.com/content/8/1/30treatment planning/delivery and risk of under‑dosing  tumor immediately adjacent to the spinal cord.",Non-OADS,/arxiv_data1/oa_pdf/41/fd/SNI-8-30.PMC5339918.pdf
"Surgical Neurology International 2017, 8:30  http://www.surgicalneurologyint.com/content/8/1/30outcomes from 12 studies reporting on 426 patients  treated postoperatively, demonstrated in Figure  2.",Non-OADS,/arxiv_data1/oa_pdf/41/fd/SNI-8-30.PMC5339918.pdf
"Surgical Neurology International 2017, 8:30  http://www.surgicalneurologyint.com/content/8/1/30Histology T umor histologies such as renal cell carcinoma,  melanoma, and sarcoma have traditionally been regarded  as radioresistant.",Non-OADS,/arxiv_data1/oa_pdf/41/fd/SNI-8-30.PMC5339918.pdf
"Surgical Neurology International 2017, 8:30  http://www.surgicalneurologyint.com/content/8/1/30Chang et al .",Non-OADS,/arxiv_data1/oa_pdf/41/fd/SNI-8-30.PMC5339918.pdf
"Surgical Neurology International 2017, 8:30  http://www.surgicalneurologyint.com/content/8/1/30bevazicumab contributed to esophageal toxicity.",Non-OADS,/arxiv_data1/oa_pdf/41/fd/SNI-8-30.PMC5339918.pdf
"Surgical Neurology International 2017, 8:30  http://www.surgicalneurologyint.com/content/8/1/30with respect to pain palliation, via regimens of 24 Gy  in 2 fractions for SBRT and 20 Gy in 5 fractions for  conventional radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/41/fd/SNI-8-30.PMC5339918.pdf
"Surgical Neurology International 2017, 8:30  http://www.surgicalneurologyint.com/content/8/1/3021.",Non-OADS,/arxiv_data1/oa_pdf/41/fd/SNI-8-30.PMC5339918.pdf
2010; Available from: http://www.cancerresearchuk.,Non-OADS,/arxiv_data1/oa_pdf/41/fd/SNI-8-30.PMC5339918.pdf
"Surgical Neurology International 2017, 8:30  http://www.surgicalneurologyint.com/content/8/1/30of radiation myelopathy specific to stereotactic body radiation therapy to  guide safe practice.",Non-OADS,/arxiv_data1/oa_pdf/41/fd/SNI-8-30.PMC5339918.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor Antonio A. F. DeSalles,  MD University of California,  Los Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: StereotacticCase Report Effects of deep brain stimulation on vocal fold immobility in  Parkinson’s disease Elsa V .",Non-OADS,/arxiv_data1/oa_pdf/dc/17/SNI-8-22.PMC5339919.pdf
"Surg  Neurol Int 2017;8:22. http://surgicalneurologyint.com/Effects-of-deep-brain-stimulation-on-vocal-fold- immobility-in-Parkinson’s-disease/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/dc/17/SNI-8-22.PMC5339919.pdf
"Surgical Neurology International 2017, 8:22  http://www.surgicalneurologyint.com/content/8/1/22secondary to bilateral VF immobility ultimately requiring  a tracheostomy.",Non-OADS,/arxiv_data1/oa_pdf/dc/17/SNI-8-22.PMC5339919.pdf
"Surgical Neurology International 2017, 8:22  http://www.surgicalneurologyint.com/content/8/1/22had improved to 3 mm, and maximal airway opening  had increased to 6 mm.",Non-OADS,/arxiv_data1/oa_pdf/dc/17/SNI-8-22.PMC5339919.pdf
"Surgical Neurology International 2017, 8:22  http://www.surgicalneurologyint.com/content/8/1/22for airway protection.",Non-OADS,/arxiv_data1/oa_pdf/dc/17/SNI-8-22.PMC5339919.pdf
"Surgical Neurology International 2017, 8:22  http://www.surgicalneurologyint.com/content/8/1/22Acknowledgements Christopher J. Sheridan, RN: Involved in organization  of clinic appointments, DBS programming sessions, and  clinical examinations.",Non-OADS,/arxiv_data1/oa_pdf/dc/17/SNI-8-22.PMC5339919.pdf
Available from:  https://www.elso.org/Registry/Statistics/InternationalSummary.aspx.,OADS,/arxiv_data1/oa_pdf/c2/14/CMJ-130-505.PMC5339921.pdf
Available from: https://www.elso.org/Guidelinesforadultrespiratory  falure.aspx.,Non-OADS,/arxiv_data1/oa_pdf/c2/14/CMJ-130-505.PMC5339921.pdf
"Functional analysis of differentially expressed  microRNAs To discover the patterns and rules of the differentially  expressed miRNAs, functional enrichment analysis was  performed using tool for annotations of microRNAs (TAM)  software (http://www.cuilab.cn/tam).",OADS,/arxiv_data1/oa_pdf/1a/fe/CMJ-130-566.PMC5339930.pdf
"To improve the quality of prediction, the regulatory  relationships were predicted by combining four existing  algorithms: TargetScan, miRanda, Pictar, and DIANA,  which were implemented with a Bioconductor package  (http://bioconductor.org/), miRNAtap, in the R software  environment (http://www.r -project.org).",OADS,/arxiv_data1/oa_pdf/1a/fe/CMJ-130-566.PMC5339930.pdf
"Bioinformatical and structural analysis of wild type,  mutant NOD‑like receptor family pyrin domain‑containing  protein 3 pyrin domain and apoptosis‑associated  speck‑like protein pyrin domain The structural -based alignment result was modified by  online ESPript program software (http://espript.ibcp.fr/ ESPript/cgi‑bin/ESPript.cgi).",OADS,/arxiv_data1/oa_pdf/6c/e5/CMJ-130-586.PMC5339933.pdf
"[12] Instead of those common mutations found in exon 3 of  NLRP3 gene which encodes the central nucleotide‑biding  site (NOD) domain,[1] we identified a novel mutation of c.92A>T in exon 1 of NLRP3 gene in our patient, which were  verified by three authoritative databases: Exome Aggregation  Consortium Browser (http://exac.broadinstitute.org/),  1000genomes Browser (http://www.internationalgenome.",OADS,/arxiv_data1/oa_pdf/6c/e5/CMJ-130-586.PMC5339933.pdf
"org/), and Exome Variant Server (http://evs.gs.washington.",OADS,/arxiv_data1/oa_pdf/6c/e5/CMJ-130-586.PMC5339933.pdf
Available from: http://www.fmf.igh.cnrs.fr/ infevers.,Non-OADS,/arxiv_data1/oa_pdf/6c/e5/CMJ-130-586.PMC5339933.pdf
"[46] Based  on LMB‑1, its derivative, LMB‑9, yet was developed by  combining scdsFv of mAb B3 and PE38, which was utilized  to treat several different types of advanced solid tumors  including recurrent nonsmall cell lung cancer (NSCLC) expressing the Ley antigen  (https://clinicaltrials.gov/ct2/ show/NCT00019435).",Non-OADS,/arxiv_data1/oa_pdf/cb/cf/CMJ-130-607.PMC5339936.pdf
Available from: http://www.seer.cancer.gov/statfacts/html/ lungb.html.,Non-OADS,/arxiv_data1/oa_pdf/cb/cf/CMJ-130-607.PMC5339936.pdf
Available from: https://www.clinicaltrials.gov/ct2/show/ NCT01362790.,Non-OADS,/arxiv_data1/oa_pdf/cb/cf/CMJ-130-607.PMC5339936.pdf
Available from: http://www.who.int/ tb/publications/global_report/en/.,Non-OADS,/arxiv_data1/oa_pdf/01/05/JOVR-12-30.PMC5340061.pdf
Available from: http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/01/05/JOVR-12-30.PMC5340061.pdf
Available from: http://www.cdc.gov/ mmwr/preview/mmwrhtml/rr5905a1.htm?s_cid=rr5905a1_e.,OADS,/arxiv_data1/oa_pdf/01/05/JOVR-12-30.PMC5340061.pdf
Available at: https://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/18/b3/JOVR-12-65.PMC5340066.pdf
Findings suggest that one mechanism by which 5-HTTLPR  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/8f/nihms837525.PMC5340078.pdf
"Biophysical Journal 112, 767–779, February 28, 2017 767http://dx.doi.org/10.1016/j.bpj.2016.11.3194 /C2112016 Biophysical Society.",Non-OADS,/arxiv_data1/oa_pdf/92/9c/main.PMC5340097.pdf
"724 Biophysical Journal 112, 724–735, February 28, 2017http://dx.doi.org/10.1016/j.bpj.2016.12.032 /C2112016 Biophysical Society.",Non-OADS,/arxiv_data1/oa_pdf/7b/2c/main.PMC5340129.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/cd/cvw251.PMC5340141.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which per- mits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/e6/cvw222.PMC5340142.pdf
"780 Biophysical Journal 112, 780–794, February 28, 2017http://dx.doi.org/10.1016/j.bpj.2016.12.035 This is an open access article under the CC BY-NC-ND license ( http:// creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/c3/12/main.PMC5340160.pdf
"Biophysical Journal 112, 703–713, February 28, 2017 703http://dx.doi.org/10.1016/j.bpj.2016.12.047 /C2112017 Biophysical Society.",Non-OADS,/arxiv_data1/oa_pdf/a3/d0/main.PMC5340176.pdf
MATERIALS AND METHODS All calculations were performed using a home-written code (using the soft- ware Python; https://www.python.org/ ).,OADS,/arxiv_data1/oa_pdf/a3/d0/main.PMC5340176.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ff/05/jmdh-10-065.PMC5340182.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ff/05/jmdh-10-065.PMC5340182.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2017:10 65–74Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 65 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S129085Residents’ experiences of relationships with  nurses in community-based supported housing –  a qualitative study based on Giorgi’s method of  analysis and self psychology Solrun Brenk Rønning   Stål Bjørkly Faculty of Health Sciences and Social  Care, Molde University College,  Molde, NorwayAbstract:  One of the prioritizations in the World Health Organization’ s (WHO) Mental Health  Action Plan 2013–2020 is the provision of community mental health and social care services,  such as supported housing.",Non-OADS,/arxiv_data1/oa_pdf/ff/05/jmdh-10-065.PMC5340182.pdf
"It emphasizes the self as the crucial part of the personality and its dependence on Correspondence: Solrun Brenk Rønning   Faculty of Health Sciences and Social  Care, Molde University College, PO Box 2110, NO-6402 Molde, Norway   Tel +47 7121 4040 Email solrun.b.ronning@himolde.noJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Rønning and BjørklyRunning head recto: Helping relationships in supported housingDOI: http://dx.doi.org/10.2147/JMDH.S129085",Non-OADS,/arxiv_data1/oa_pdf/ff/05/jmdh-10-065.PMC5340182.pdf
Available from: http://apps.who.int/iris/bitstream/10665/89966/1/9789241506021_eng.pdf.,OADS,/arxiv_data1/oa_pdf/ff/05/jmdh-10-065.PMC5340182.pdf
Available from: http://brukererfaring.no/PDF%20BsB%20rapporter%20ISBN/Bruker%20Sp%C3%B8r%20Bruker%20%C3%85lesund%202010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ff/05/jmdh-10-065.PMC5340182.pdf
Avail-able from: http://brukererfaring.no/PDF%20BsB%20rapporter%20ISBN/Bruker%20Sp%C3%B8r%20Bruker%20Namsos%202007.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ff/05/jmdh-10-065.PMC5340182.pdf
"Journal of Multidisciplinary Healthcare 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/ff/05/jmdh-10-065.PMC5340182.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 74 Rønning and Bjørkly,Non-OADS,/arxiv_data1/oa_pdf/ff/05/jmdh-10-065.PMC5340182.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4a/9d/jmdh-10-075.PMC5340183.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4a/9d/jmdh-10-075.PMC5340183.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2017:10 75–85Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 75 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S123905Regional variation in post-stroke multidisciplinary  rehabilitation care among veteran residents in  community nursing homes Huanguang Jia1 Qinglin Pei1 Charles T Sullivan1 Diane C Cowper Ripley1 Samuel S Wu1 W Bruce Vogel1 Xinping Wang1 Douglas E Bidelspach2 Jennifer L Hale-Gallardo1 Barbara E Bates3 1Center of Innovation on Disability  and Rehabilitation Research, North  Florida/South Georgia Veterans Health System, Gainesville, FL,  2Physical  Medicine and Rehabilitation Service,  Department of Veterans Affairs,  Washington, DC,  3Aleda E. Lutz VA  Medical Center, Saginaw, MI, USAIntroduction: Effective post-acute multidisciplinary rehabilitation therapy improves stroke  survivors’ functional recovery and daily living activities.",Non-OADS,/arxiv_data1/oa_pdf/4a/9d/jmdh-10-075.PMC5340183.pdf
"Correspondence: Huanguang Jia Center of Innovation on Disability and Rehabilitation Research, North Florida/South Georgia Veterans Health System, 1601 SW Archer Road (151B), Gainesville, FL 32608, USATel +1 352 376 1611ext4926Fax +1 352 271 4540Email Huanguang.Jia@va.govJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Jia et alRunning head recto: Veterans’ post-stroke care in community nursing homesDOI: http://dx.doi.org/10.2147/JMDH.S123905",Non-OADS,/arxiv_data1/oa_pdf/4a/9d/jmdh-10-075.PMC5340183.pdf
A map of the districts can be found at http://www.blogs.va.gov/V An-tage/16786/.,Non-OADS,/arxiv_data1/oa_pdf/4a/9d/jmdh-10-075.PMC5340183.pdf
Available from: http://www.Cms.Gov/ research-statistics-data-and-systems/files-for-order/identifiabledatafiles/longtermcareminimumdatasetmds.Html.,OADS,/arxiv_data1/oa_pdf/4a/9d/jmdh-10-075.PMC5340183.pdf
Available at: http://www.blogs.va.gov/V Antage/16786/.,Non-OADS,/arxiv_data1/oa_pdf/4a/9d/jmdh-10-075.PMC5340183.pdf
Available from: http://www.Cms.,Non-OADS,/arxiv_data1/oa_pdf/4a/9d/jmdh-10-075.PMC5340183.pdf
Available at: https://academyhealth.confex.com/academyhealth/2016arm/meetingapp.cgi/Paper/8329.,Non-OADS,/arxiv_data1/oa_pdf/4a/9d/jmdh-10-075.PMC5340183.pdf
Available at:  https://www.researchgate.net/publication/304817374_Regional_Variation_in_Post-Stroke_Rehabilitation_Care_Among_Veteran_Residents_in_Commu-nity_Nursing_Homes.,Non-OADS,/arxiv_data1/oa_pdf/4a/9d/jmdh-10-075.PMC5340183.pdf
"Journal of Multidisciplinary Healthcare 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/4a/9d/jmdh-10-075.PMC5340183.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 85 Veterans’ post-stroke care in community nursing homes,Non-OADS,/arxiv_data1/oa_pdf/4a/9d/jmdh-10-075.PMC5340183.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: Erin E Longbrake Erin Longbrake, PO Box 208018, New Haven, CT06473, USA.",Non-OADS,/arxiv_data1/oa_pdf/9d/86/10.1177_2055217316677868.PMC5340186.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/ad/kfw207.PMC5340205.pdf
"In recent years, ac- tivities in the international community, coordinated through theOECD, have focused on providing a single, harmonized, point ofaccess to summary descriptions of AOPs, including associated weight of evidence assemblies and evaluations via an AOP knowledge base (AOP-KB; https://aopkb.org; last accessed October24, 2016).",OADS,/arxiv_data1/oa_pdf/ad/ad/kfw207.PMC5340205.pdf
"The biological description of the KEs presented in the AOP-WIKI module of the AOP-KB(https://aopwiki.org/; last accessed October 25, 2016; the first infor-mation field on each KE page) provides the entry point or gatewaythat can introduce the modeler to the biology encompassed by the AOP and its events.",OADS,/arxiv_data1/oa_pdf/ad/ad/kfw207.PMC5340205.pdf
",2 0 1 2 ), association of the KE with an assay identifies a database (Actor/iCSS dash- board; http://actor.epa.gov/dashboard/; last accessed October 24,2016) of relevant data that may be useful for model development.Depending on the experimental me thod(s) used, additional in- formation might be required to translate the raw output of themethod to in vivo relevant data.",Non-OADS,/arxiv_data1/oa_pdf/ad/ad/kfw207.PMC5340205.pdf
"Case Example 2: Skin Sensitization in Mammals Another well-characterized AOP in volves a MIE of covalent modifi- cation of cellular proteins in the skin by electrophilic chemicals,which results in an AO of sensitization of the skin to allergens(https://aopwiki.org/wiki/index.",Non-OADS,/arxiv_data1/oa_pdf/ad/ad/kfw207.PMC5340205.pdf
"Indeed, the connection between alterations in serum TH and adverse effects at the individual or population level are supported by the remainder of the AOP description (eg, https://aopwiki.org/wiki/index.php/Aop:134; last accessed October 25, 2016).",Non-OADS,/arxiv_data1/oa_pdf/ad/ad/kfw207.PMC5340205.pdf
"In order to stimulate development of quantitative prediction models aligned with AOPs, and attract greater involvement ofthe broader modeling community, we recommend initiating a program of AOP challenges to develop real-world applications based on established AOP practices ( OECD, 2013 ; https://aop wiki.org/; last accessed October 25, 2016), such as the recentannouncement of the AOP Wiki Data Challenge (http://www.piscltd.org.uk/aop-prize/; last accessed October 25, 2016).",Non-OADS,/arxiv_data1/oa_pdf/ad/ad/kfw207.PMC5340205.pdf
Availableat: http://www.who.int/ipcs/publications/new_issues/endo crine_disruptors/en/.,OADS,/arxiv_data1/oa_pdf/ad/ad/kfw207.PMC5340205.pdf
"233 , Organisation for Economic Cooperation and Development, Paris, France.Available at: http://aopkb.org/common/AOP_Handbook.pdf;Accessed October 25, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ad/ad/kfw207.PMC5340205.pdf
"Available at: http://www.regulations.gov/#!documentDetail;D ¼EPA-HQ- OPP-2014-0614-0003; Accessed October 25, 2016. van der Veen, J. W., Rorije, E., Emter, R., Natsch, A., van Loveren, H., and Ezendam, J.",OADS,/arxiv_data1/oa_pdf/ad/ad/kfw207.PMC5340205.pdf
"Available at: http://www.who.int/ipcs/publications/new_issues/ endocrine_disruptors/en; Accessed October 25, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ad/ad/kfw207.PMC5340205.pdf
"A WMH lesion load of at least 5.25 cm  3   Received: August 25, 2016   Accepted after revision: October 10, 2016   Published online: January 27, 2017 EXTRA  Fabrizio Vernieri, MD   Headache and Neurosonology Unit, Neurology   Policlinico Universitario Campus Bio-Medico di Roma   Via Alvaro del Portillo 200, IT–00128 Rome (Italy)   E-Mail f.vernieri   @   unicampus.it www.karger.com/cee DOI: 10.1159/000452717  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/5f/d6/cee-0007-0001.PMC5340215.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/eb/ec/bctt-9-059.PMC5340239.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/eb/ec/bctt-9-059.PMC5340239.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 59–60Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 59 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S132959 Comment on “Gastric and colon metastasis  from breast cancer: case report, review of the  literature, and possible underlying mechanisms” Amin Talebi Bezmin Abadi Department of Bacteriology, Faculty  of Medical Sciences, Tarbiat Modares University, T ehran, IranDear editor I have read the interesting case report by Villa Guzmán et al recently published in  Breast Cancer (Dove Med Press).1 A female heavy smoker was diagnosed with lobular  breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/eb/ec/bctt-9-059.PMC5340239.pdf
"Box 14115-111, Tehran, IranTel +98 21 8288 4883Fax +98 21 8288 4883Email Amin.talebi@modares.ac.irJournal name: Breast Cancer - Targets and Therapy Article Designation: LETTERY ear: 2017V olume: 9Running head verso: Talebi Bezmin AbadiRunning head recto: Short TitleDOI: http://dx.doi.org/10.2147/BCTT.S132959",Non-OADS,/arxiv_data1/oa_pdf/eb/ec/bctt-9-059.PMC5340239.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/eb/ec/bctt-9-059.PMC5340239.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 60 Talebi Bezmin Abadi Dove Medical Press encourages responsible, free and frank academic debate.",Non-OADS,/arxiv_data1/oa_pdf/eb/ec/bctt-9-059.PMC5340239.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/fd/ijn-12-1747.PMC5340240.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1747–1755International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1747OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12417 4 Evaluation of a novel fluorescent nanobeacon  for targeted imaging of Thomsen-Friedenreich  associated colorectal cancer hiroshi Nakase,1,2 shinji sakuma,3  Takumi Fukuchi,4 Takuya  Y oshino,1,5 Kohta Mohri,3 Kohei  Miyata,3,6 hironori Kumagai,6  Ken-Ichiro hiwatari,6 Kazufumi  Tsubaki,6 T etsuya Ikejima,6 etsuo  T obita,6 Meiying Zhu,7 Kevin J  Wilson,7 Kay Washington,8 John c  gore,7,9–13 Wellington Pham7,9–12,14 1Division of endoscopy, Kyoto University  hospital, Kyoto, Japan; 2Department of  gastroenterology and hepatology, sapporo  Medical University school of Medicine,  sapporo, hokkaido, Japan; 3Faculty of  Pharmaceutical sciences, setsunan University,  hirakata, Osaka, Japan; 4gastroenterology  and hepatology, Osakafu saiseikai Nakatsu  hospital, Osaka, Japan; 5Division of  Inflammatory Bowel Disease, Digestive  Disease center, Kitano hospital, Osaka,  Japan; 6Advanced Materials R&D Laboratory,  aDeK a corp., T okyo, Japan; 7Department of  Radiology, Vanderbilt University Institute of  Imaging science, 8Division of gastrointestinal  and Hepatic Pathology, Vanderbilt School  of Medicine, 9Department of radiology  and radiological sciences, 10Department  of Biomedical engineering, 11Vanderbilt  Ingram Cancer Center, Vanderbilt School  of Medicine, 12Vanderbilt Brain Institute,  13Molecular Physiology and Biophysics,  14Vanderbilt Institute of Chemical Biology,  Vanderbilt University, Nashville, TN, USAAbstract:  The Thomsen–Friedenreich (TF) antigen represents a prognostic biomarker of  colorectal carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/34/fd/ijn-12-1747.PMC5340240.pdf
"In epithelial cells, TF antigen is carried by MUC-1 on the apical surface, while in  tumor cells, MUC-1 is posttranslationally modified, resulting in aberrant O-glycosylation,  such as TF antigen, a well-defined antigen with a proven link to CRC.6 Its expression is  also found to correlate with poor prognosis in CRC7 and with a significantly higher risk  of developing metastasis.8 In keeping with this observation, developing a fundamental correspondence: Wellington Pham Vanderbilt University Institute of Imaging  science, 1161, 21st avenue south, aaa 3117,  Nashville, TN 37232, Usa Tel +1 615 936 7621 Fax +1 615 322 0734 email wellington.pham@vanderbilt.ed u  shinji sakuma Faculty of Pharmaceutical sciences, setsunan  University, 45-1 Nagaotoge-cho, hirakata,  Osaka 573-0101, Japan Tel +81 72 866 3124 Fax +81 72 866 3126 email sakuma@pharm.setsunan.ac.j p  hiroshi Nakase Department of gastroenterology and  hepatology, sapporo Medical University school  of Medicine, s-1, W-16, chuo-ku, sapporo,  hokkaido 060-8543, Japan Tel +81 11 611 2111 Fax +81 11 613 1241 email hiro_nakase@sapmed.ac.j p Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Nakase et al Running head recto: Fluorescent nanobeacon for targeted imaging of Thomsen-Friedenreich antigen DOI: http://dx.doi.org/10.2147/IJN.S124174",Non-OADS,/arxiv_data1/oa_pdf/34/fd/ijn-12-1747.PMC5340240.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/34/fd/ijn-12-1747.PMC5340240.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/fd/ijn-12-1747.PMC5340240.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/81/f9/bctt-9-061.PMC5340241.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/81/f9/bctt-9-061.PMC5340241.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 61–65Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 61 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S128777 Nanomolar concentration of blood-soluble  drag-reducing polymer inhibits experimental  metastasis of human breast cancer cells Zhijie Ding1,* Marion Joy1,* Marina V Kameneva1-3 Partha Roy1,3-6 1Department of Bioengineering,   2Department of Surgery, 3McGowan  Institute of Regenerative  Medicine,4Department of Pathology,   5Department of Cell Biology,   6Magee Women’s Research Institute,   University of Pittsburgh, Pittsburgh,  PA, USA *These authors contributed equally to  this workAbstract:  Metastasis is the leading cause of cancer mortality.",Non-OADS,/arxiv_data1/oa_pdf/81/f9/bctt-9-061.PMC5340241.pdf
"3–5 Shear stress also impacts surface expression  of adhesion molecules in VEC.6,7 Given the importance of hemodynamic parameters  in regulating cell–cell adhesion, we speculated that hemodynamic-alteration strategy could be a novel way to restrain tumor cell extravasation and subsequent development of metastasis.Correspondence: Partha Roy Department of Bioengineering, University of Pittsburgh, 306 Center for Biotechnology and Bioengineering, 300 Technology Drive, Pittsburgh, PA 15219, USATel +1 412 624 7867Fax +1 412 383 8788Email par19@pitt.eduJournal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Ding et alRunning head recto: Inhibition of human breast cancer cell metastasisDOI: http://dx.doi.org/10.2147/BCTT.S128777",Non-OADS,/arxiv_data1/oa_pdf/81/f9/bctt-9-061.PMC5340241.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/81/f9/bctt-9-061.PMC5340241.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 65 Inhibition of human breast cancer cell metastasis 12.,Non-OADS,/arxiv_data1/oa_pdf/81/f9/bctt-9-061.PMC5340241.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ee/13/cia-12-445.PMC5340242.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 445–452Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  445OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S13069 0 serum uric acid is associated with lumbar spine  bone mineral density in healthy Chinese males  older than 50 years Jing Xiao Weijun Chen Xinhui Feng Wenyi liu Zhenxing Zhang li he Zhibin Ye Department of nephrology, huadong  hospital Affiliated to Fudan University,   shanghai, People’s republic of ChinaObjectives:  We aimed to investigate the association of serum uric acid (UA) levels with bone  mineral density (BMD) at all skeletal sites in healthy Chinese males .50 years of age.",Non-OADS,/arxiv_data1/oa_pdf/ee/13/cia-12-445.PMC5340242.pdf
"The Fujiwara-kyo Osteoporosis Risk in Correspondence: Zhibin Ye Department of nephrology,  Huadong Hospital Affiliated to Fudan  University, shanghai 200040, People’s  republic of China Tel +86 133 8605 6905 Fax +86 21 6248 2308 email yezhibin3@126.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Xiao et al Running head recto: Uric acid association with lumbar spine BMD in Chinese males aged .50 years  DOI: http://dx.doi.org/10.2147/CIA.S130690",Non-OADS,/arxiv_data1/oa_pdf/ee/13/cia-12-445.PMC5340242.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/ee/13/cia-12-445.PMC5340242.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ee/13/cia-12-445.PMC5340242.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e2/0c/ijn-12-1775.PMC5340243.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1775–1789International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1775OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12029 0 a facile method to prepare superparamagnetic  iron oxide and hydrophobic drug-encapsulated  biodegradable polyurethane nanoparticles Kuo-Wei cheng shan-hui hsu Institute of Polymer science and  engineering, college of engineering,   National Taiwan University, Taipei,   Taiwan, republic of chinaAbstract:  Superparamagnetic iron oxide nanoparticles (SPIO NPs) have a wide range of  biomedical applications such as in magnetic resonance imaging, targeting, and hyperthermia  therapy.",Non-OADS,/arxiv_data1/oa_pdf/e2/0c/ijn-12-1775.PMC5340243.pdf
"correspondence: shan-hui hsu Institute of Polymer science and  engineering, National Taiwan University,  No 1, sec 4 roosevelt road, Taipei  10617, Taiwan, republic of china Tel +886 2 3366 5313 Fax +886 2 3366 5237 email shhsu@ntu.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Cheng and Hsu Running head recto: SPIO and hydrophobic drug-encapsulated biodegradable PU NPs DOI: http://dx.doi.org/10.2147/IJN.S120290",Non-OADS,/arxiv_data1/oa_pdf/e2/0c/ijn-12-1775.PMC5340243.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e2/0c/ijn-12-1775.PMC5340243.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/0c/ijn-12-1775.PMC5340243.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/48/15/ijn-12-1757.PMC5340244.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1757–1774International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1757OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12839 6 Wheat germ agglutinin-conjugated liposomes  incorporated with cardiolipin to improve  neuronal survival in alzheimer’s disease treatment Yung-chih Kuo1 che-Yu lin1 Jay-shake li2 Yung-I lou3 1Department of chemical engineering,   2Department of Psychology,   National chung cheng University,   chia-Yi, 3Department of accounting,   Providence University, Taichung,   Taiwan, republic of chinaAbstract:  Curcumin (CRM) and nerve growth factor (NGF) were entrapped in liposomes (LIP)  with surface wheat germ agglutinin (WGA) to downregulate the phosphorylation of kinases in  Alzheimer’s disease (AD) therapy.",Non-OADS,/arxiv_data1/oa_pdf/48/15/ijn-12-1757.PMC5340244.pdf
"Keywords:  liposome, Alzheimer’s disease, β-amyloid, neurodegeneration, blood–brain barrier,  wheat germ agglutinin Introduction Alzheimer’s disease (AD) is a commonly encountered neurodegenerative disorder of  the brain with progressive memory impairment, loss of cognitive function, and per - sonality change, leading to irreversible dementia.1,2 The AD pathology originates from  the temporal lobes and spreads gradually over the hippocampus and amygdala of the  partial lobes, revealing its main characteristics of abnormal aggregation of β-amyloid  peptide (A β), abundant senile plaques around neurons, and neurofibrillary tangles  through extensive phosphorylation of tau protein.3–6 In the neurodegeneration pathway,  mitogen-activated protein kinase (MAPK) is a typical enzyme family comprising  various kinases, which are capable of conjugating covalently with serine, threonine,  and tyrosine by phosphate linkage.7 In fact, MAPK-catalyzed phosphorylation plays  a central role in regulating the function of protein kinase, phospholipase, transcription  factor, and cytoskeleton via the capture of phosphoryl groups.8 This phosphorylation is  also regarded as one of the most crucial stages during the alteration of cellular activity,  including gene expression, mitosis, metabolism, and apoptosis.9 Thus, an understanding  of the kinase pathway is critical to disclosing AD progression and can be of great help  in developing an innovative medicinal strategy to avoid AD deterioration.correspondence: Yung-chih Kuo Department of chemical engineering,  National chung cheng University,  168 University road, Min-hsiung,  chia-Yi, Taiwan 62102, republic of china Tel +886 5 272 0411 ext 33459 Fax +886 5 272 1206 email chmyck@ccu.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Kuo et al Running head recto: Wheat germ agglutinin-conjugated liposomes DOI: http://dx.doi.org/10.2147/IJN.S128396",Non-OADS,/arxiv_data1/oa_pdf/48/15/ijn-12-1757.PMC5340244.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/48/15/ijn-12-1757.PMC5340244.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/15/ijn-12-1757.PMC5340244.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/86/72/ijn-12-1731.PMC5340245.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1731–1745International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1731OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12274 7 a novel ion-exchange carrier based upon  liposome-encapsulated montmorillonite for  ophthalmic delivery of betaxolol hydrochloride Yi huang1 Qi Tao2 Dongzhi hou1 sheng hu1 shuangyan Tian1 Yanzhong chen3 ruyi gui1 lingling Yang4 Yao Wang5 1college of Pharmacy, guangdong  Pharmaceutical University, 2Key  laboratory of Mineralogy and  Metallogeny, chinese academy of  sciences, guangdong Provincial Key  laboratory of Mineral Physics and  Materials, 3guangdong Provincial  Key laboratory of advanced Drug  Delivery systems, guangdong  Pharmaceutical University, guangzhou,   4state Key laboratory cultivation  Base, shandong Provincial Key  laboratory of Ophthalmology,   shandong eye Institute, shandong  academy of Medical sciences,   5Qingdao eye hospital, shandong  eye Institute, shandong academy  of Medical sciences, Qingdao, chinaAbstract:  As a novel ion-exchange carrier with high surface area and excellent exchangeability,  montmorillonite (Mt) was intercalated with betaxolol hydrochloride (BH) to form a nanocompos - ite and then encapsulated by liposomes (Mt-BH-LPs) for an ophthalmic drug-delivery system.",Non-OADS,/arxiv_data1/oa_pdf/86/72/ijn-12-1731.PMC5340245.pdf
"Therefore, a novel local ocular delivery system for  BH needs to develop to improve preocular retention and drug absorption.5correspondence: Dongzhi hou college of Pharmacy, guangdong  Pharmaceutical University, Middle  ring road east, higher education  Mega center, Panyu Qu, guangzhou,  guangdong 510006, china Tel/fax +86 20 3935 2117 email houdongzhi406@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Huang et al Running head recto: Mt-BH liposomes for ophthalmic drug delivery DOI: http://dx.doi.org/10.2147/IJN.S122747",Non-OADS,/arxiv_data1/oa_pdf/86/72/ijn-12-1731.PMC5340245.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/86/72/ijn-12-1731.PMC5340245.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/72/ijn-12-1731.PMC5340245.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a9/32/ijn-12-1699.PMC5340246.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1699–1715International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1699OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12126 2 T umor-targeted polymeric nanostructured  lipid carriers with precise ratiometric control  over dual-drug loading for combination therapy  in non-small-cell lung cancer Yan liang1 Baocheng Tian1 Jing Zhang1 Keke li1 lele Wang1 Jingtian han1,* Zimei Wu2,* 1school of Pharmacy, Binzhou Medical  University, 2school of Pharmacy, Yantai  University, Yantai, china *These authors contributed equally  to this workAbstract:  Gemcitabine (GEM) and paclitaxel (PTX) are effective combination anticancer  agents against non-small-cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/a9/32/ijn-12-1699.PMC5340246.pdf
"Keywords:  polymer–drug conjugate, nanostructured lipid carriers, combination treatment,  ratiometric drug loading, cancer targeting Introduction Recently, nanoparticles (NPs) have attracted much research, due to their ability to  reduce nonspecific uptake, prolong drug half-life, and preferentially accumulate in  tumors through the enhanced permeation and retention effect.1–3 Nanostructured lipid  carriers (NLCs) contain solid lipids and liquid lipids,4 and present superiority com - pared to the solid lipid NPs.5–9 The addition of spatially incompatible liquid lipids will  change the high crystallization from solid lipids.10 Obviously, apart from improved  bioavailability, loading capacity, and stability, NLCs can still load drugs with different  physical and chemical properties, as well as control release.11–13correspondence: Jingtian han   346 guanhai road, Yantai, shandong  264003, china Tel +86 535 691 3317 Fax +86 535 691 3718 email hanjingtian002@163.co m Zimei Wu 30 Qingquan road, Yantai, shandong  264003, china Tel +86 535 670 6060 Fax +86 535 670 6060 email z.wu@auckland.ac.n zJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Liang et al Running head recto: Precise ratiometric control dual-drug tumor-targeted NLCs DOI: http://dx.doi.org/10.2147/IJN.S121262",Non-OADS,/arxiv_data1/oa_pdf/a9/32/ijn-12-1699.PMC5340246.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a9/32/ijn-12-1699.PMC5340246.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/32/ijn-12-1699.PMC5340246.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9f/8e/bctt-9-085.PMC5340247.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9f/8e/bctt-9-085.PMC5340247.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 85–93Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 85 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S130838 Alternative therapies for metastatic breast  cancer: multimodal approach targeting tumor  cell heterogeneity Manpreet Sambi1 Sabah Haq1 Vanessa Samuel1 Bessi Qorri1 Fiona Haxho1 Kelli Hill1,2 William Harless2 Myron R Szewczuk1 1Department of Biomedical and  Medical Sciences, Queen’s University,   Kingston, ON, Canada; 2ENCYT  T echnologies, Inc., Membertou, NS,  CanadaAbstract: One of the primary challenges in developing effective therapies for malignant  tumors is the specific targeting of a heterogeneous cancer cell population within the tumor.",Non-OADS,/arxiv_data1/oa_pdf/9f/8e/bctt-9-085.PMC5340247.pdf
"It is now important Correspondence: Myron R Szewczuk Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON K7L 3N6, CanadaTel +1 613 533 2457Fax +1 613 533 6796Email szewczuk@queensu.ca William Harless ENCYT Technologies, Inc., 201 Churchill Dr, Suite 205, Membertou, NS B1S 0H1, CanadaTel +1 902 539 3365Fax +1 902 539 3363Email williamharless@ymail.comJournal name: Breast Cancer - Targets and Therapy Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Sambi et alRunning head recto: Alternative therapies for metastatic breast cancerDOI: http://dx.doi.org/10.2147/BCTT.S130838",Non-OADS,/arxiv_data1/oa_pdf/9f/8e/bctt-9-085.PMC5340247.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/9f/8e/bctt-9-085.PMC5340247.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 93 Alternative therapies for metastatic breast cancer 45.,Non-OADS,/arxiv_data1/oa_pdf/9f/8e/bctt-9-085.PMC5340247.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/11/31/cia-12-437.PMC5340248.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 437–444Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  437OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12937 7 The impact of hypomagnesemia on erectile  dysfunction in elderly, non-diabetic, stage 3 and 4  chronic kidney disease patients: a prospective  cross-sectional study Omer T oprak1 Yasin Sarı2 Akif Koç3 Erhan Sarı3 Ali Kırık2 1Division of nephrology, 2Division  of Internal Medicine, 3Division of  Urology, Department of Medicine,   Balikesir University school of  Medicine, Balikesir, T urkeyBackground:  Erectile dysfunction (ED) is common in older men with chronic kidney disease.",Non-OADS,/arxiv_data1/oa_pdf/11/31/cia-12-437.PMC5340248.pdf
"Epidemiologic studies clearly show  an increasing age-related prevalence and severity of erectile dysfunction (ED) among  elderly men.1–4 ED is a condition in which a man is persistently unable to attain and/or  maintain penile erection sufficient for sexual intercourse and is the most common sexual  dysfunction among men worldwide.2,5 Increasing comorbidities and pathological changes  in the erectile tissue and the supplying vessels result in a high prevalence of ED in geriatric  population.2,3 ED affects only 4% of men in their 50s but almost 50% over the age of 75,  and up to 90% of elderly men with chronic kidney disease (CKD) have ED.2,6–8Correspondence: Omer Toprak Division of nephrology, Department  of Medicine, Balikesir University school  of Medicine, Çagış Yerleşkesi, Balikesir  10145, Turkey Tel +90 266 258 9585 Fax +90 266 612 1023 email omertoprak@balikesir.edu.t r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Toprak et al Running head recto: Magnesium and erectile dysfunction DOI: http://dx.doi.org/10.2147/CIA.S129377 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/11/31/cia-12-437.PMC5340248.pdf
Or use: http://youtu.be/-6IKiZMk6T kVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/11/31/cia-12-437.PMC5340248.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/11/31/cia-12-437.PMC5340248.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/11/31/cia-12-437.PMC5340248.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/51/c3/ijn-12-1717.PMC5340249.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1717–1729International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1717OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12884 8 Nerve growth factor delivery by ultrasound- mediated nanobubble destruction as a treatment  for acute spinal cord injury in rats Zhaojun song1 Zhigang Wang2 Jieliang shen1 shengxi Xu1 Zhenming hu1 1Department of Orthopedics, The  First affiliated hospital, 2Institution  of Ultrasound Imaging, The second  affiliated hospital, chongqing Medical  University, chongqing, People’s  republic of chinaBackground:  Spinal cord injuries (SCIs) can cause severe disability or death.",Non-OADS,/arxiv_data1/oa_pdf/51/c3/ijn-12-1717.PMC5340249.pdf
"Physiotherapy and neurotrophic rehabilitation attenuate further damage, relieve spinal correspondence: Zhenming hu Department of Orthopedics, The First  Affiliated Hospital of Chongqing Medical  University, No 1 Medical college road,  Yuzhong District, 400016, chongqing,  People’s republic of china email spinecenterhu@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Song et al Running head recto: NGF delivery by US-mediated NB destruction treatment for ASI in rats DOI: http://dx.doi.org/10.2147/IJN.S128848",Non-OADS,/arxiv_data1/oa_pdf/51/c3/ijn-12-1717.PMC5340249.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/51/c3/ijn-12-1717.PMC5340249.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/c3/ijn-12-1717.PMC5340249.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/34/66/bctt-9-067.PMC5340250.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/34/66/bctt-9-067.PMC5340250.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 67–83Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 67 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S125165 Ulva lactuca polysaccharides prevent Wistar rat  breast carcinogenesis through the augmentation  of apoptosis, enhancement of antioxidant defense  system, and suppression of inflammation Gamal-Eldein F Abd-Ellatef1 Osama M Ahmed2 Eman S Abdel-Reheim2 Abdel-Hamid Z  Abdel-Hamid1 1Pharmaceutical and Drug Industries  Research Division, Therapeutic  Chemistry Department, National Research Centre, Cairo, Egypt;   2Division of Physiology, Department  of Zoology, Faculty of Science, Beni-Suef University, Beni-Suef, EgyptBackground: Recently, several research studies have been focused on the isolation and function  of the polysaccharides derived from different algal species, which revealed multiple biological  activities such as antioxidant and antitumor activities.",Non-OADS,/arxiv_data1/oa_pdf/34/66/bctt-9-067.PMC5340250.pdf
"2 The multistep process including initiation, promotion, Correspondence: Gamal-Eldein F  Abd-EllatefPharmaceutical and Drug Industries Research Division, Therapeutic Chemistry Department, National Research Centre, 33 El-Buhouth Street, Dokki, Giza, Cairo 12622, EgyptEmail gamalology@yahoo.comJournal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Abd-Ellatef et alRunning head recto: Ulva lactuca polysaccharides prevent breast carcinogenesisDOI: http://dx.doi.org/10.2147/BCTT.S125165 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/34/66/bctt-9-067.PMC5340250.pdf
Or use: http://youtu.be/ZhQ3twQun9o,Non-OADS,/arxiv_data1/oa_pdf/34/66/bctt-9-067.PMC5340250.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/34/66/bctt-9-067.PMC5340250.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 83 Ulva lactuca polysaccharides prevent breast carcinogenesis 95.,Non-OADS,/arxiv_data1/oa_pdf/34/66/bctt-9-067.PMC5340250.pdf
"merrbys.org website under CreativeCommons License CC-BY-NC, QuikSCATsatellite data from the NASA Jet Propulsion Laboratory PO.DAAC, MODIS satellite data form MODIS Web http://modis.gsfc.nasa.gov/data/, river gaugedata from U.S. Geological Survey http:// waterdata.usgs.gov/nwis, digital eleva- tion model data from http://www2.jpl.nasa.gov/srtm/, and land cover and landuse data from Institut Cartogrà ﬁci Geològic de Catalunya http://www.icc.",Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
"[Available at http://www.encyclopediaofarkansas.net/encyclopedia/entry-detail.aspx?entryID=2418, accessed March 2016.]",Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
"[Available at http://www.fws.gov/biglake/, accessed March 2016.]",Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
"[Available at http://www.fws.gov/wetlands/ data/mapper.HTML, accessed Jan.",Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
"[Available at http://unstats.un.org/unsd/statcom/47th-session/documents/2016-2-SDGs-Rev1-E.pdf, accessed June 2016].",Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
"[Available at http://www.icc.cat/vissir3/, accessed Aug.",Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
"[Available at http://cures.lmu.edu/blog/the-ballona-wetlands-natures-water-treatment-system/, accessed Oct.",Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
"[Available at http://www.merrbys.org/, accessed Mar.",Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
"[Available at http://www.ramsar.org/, accessed Feb.",Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
"[Available at http://www.ramsar.org/sites/default/ ﬁles/ documents/library/cop12_res05_new_strp_e_0.pdf, accessed June 2016.]",Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
"[Available at http://www.ramsar.org/ sites-countries/ramsar-fact-sheets, accessed Feb.",Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
"Ramsar STRP 19 (2015), Convention on Wetlands (Ramsar, Iran, 1971) 19th Meeting of the Scienti ﬁc and Technical Review Panel (STRP), Gland, Switzerland, 2 –6 Nov. [Available at http://www.ramsar.org/sites/default/ ﬁles/documents/library/211202_strp19_report.pdf, accessed June 2016.",Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
[Available at http://www2.jpl.,Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
[Available at http://edna.usgs.gov/watersheds/html_index.,Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
[Available at https://www.youtube.com/watch?,Non-OADS,/arxiv_data1/oa_pdf/58/dc/ESS2-4-16.PMC5340282.pdf
Medicine (2017) 96:9(e5795)Received: 2 August 2016 / Received in ﬁnal form: 1 December 2016 / Accepted: 7 December 2016 http://dx.doi.org/10.1097/MD.0000000000005795Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3a/80/medi-96-e5795.PMC5340423.pdf
Medicine (2017) 96:9(e5884)Received: 8 September 2016 / Received in ﬁnal form: 16 December 2016 / Accepted: 18 December 2016 http://dx.doi.org/10.1097/MD.0000000000005884Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e8/77/medi-96-e5884.PMC5340425.pdf
Available at: https://www.cdc.gov/vaccines/pubs/pinkbook/hepa.html.,Non-OADS,/arxiv_data1/oa_pdf/e8/77/medi-96-e5884.PMC5340425.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs328/en/.,Non-OADS,/arxiv_data1/oa_pdf/e8/77/medi-96-e5884.PMC5340425.pdf
Available at: http://apps.who.int/iris/bitstream/10665/70180/1/WHO_IVB_10.01_eng.pdf.Web.,OADS,/arxiv_data1/oa_pdf/e8/77/medi-96-e5884.PMC5340425.pdf
Available at: http://demo.istat.it/.,Non-OADS,/arxiv_data1/oa_pdf/e8/77/medi-96-e5884.PMC5340425.pdf
Medicine (2017) 96:9(e5912)Received: 9 June 2016 / Received in ﬁnal form: 25 December 2016 / Accepted: 27 December 2016 http://dx.doi.org/10.1097/MD.0000000000005912Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2a/ae/medi-96-e5912.PMC5340427.pdf
Medicine (2017) 96:9(e5981)Received: 23 September 2016 / Received in ﬁnal form: 21 December 2016 / Accepted: 2 January 2017 http://dx.doi.org/10.1097/MD.0000000000005981Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/79/3f/medi-96-e5981.PMC5340428.pdf
"Study selection and case inclusion A total of 54 PBL eligible patients in 36 studies were included in this study, including 45 cases in 27 Chinese studies, and 9 cases in 9 English studies (Supplemental Table 1, http://links.lww.com/MD/B544).",Non-OADS,/arxiv_data1/oa_pdf/79/3f/medi-96-e5981.PMC5340428.pdf
"Moreover, 6 additional PBL cases from PUMCH that have not yet been published were also included (Supplement Table 2, http://links.lww.com/MD/B544).",Non-OADS,/arxiv_data1/oa_pdf/79/3f/medi-96-e5981.PMC5340428.pdf
Medicine (2017) 96:9(e5990)Received: 18 May 2016 / Received in ﬁnal form: 31 August 2016 / Accepted: 2 January 2017 http://dx.doi.org/10.1097/MD.0000000000005990Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/97/b8/medi-96-e5990.PMC5340429.pdf
"The 5 consecutive measure- ments of Cc norm and T s(Supplementary ﬁle 1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/97/b8/medi-96-e5990.PMC5340429.pdf
Medicine (2017) 96:9(e6018)Received: 29 November 2016 / Received in ﬁnal form: 2 January 2017 / Accepted: 8 January 2017 http://dx.doi.org/10.1097/MD.0000000000006018Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/21/51/medi-96-e6018.PMC5340432.pdf
Medicine (2017) 96:9(e6034)Received: 17 September 2016 / Received in ﬁnal form: 27 December 2016 / Accepted: 6 January 2017 http://dx.doi.org/10.1097/MD.0000000000006034Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a0/ac/medi-96-e6034.PMC5340433.pdf
Medicine (2017) 96:9(e6059)Received: 16 September 2016 / Received in ﬁnal form: 15 December 2016 / Accepted: 13 January 2017 http://dx.doi.org/10.1097/MD.0000000000006059Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/bc/a0/medi-96-e6059.PMC5340434.pdf
Medicine (2017) 96:9(e6064)Received: 14 October 2016 / Received in ﬁnal form: 27 December 2016 / Accepted: 9 January 2017 http://dx.doi.org/10.1097/MD.0000000000006064Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/23/b9/medi-96-e6064.PMC5340435.pdf
"The study was internationally subscribed: NCT01311297 (registered 08/03/2011, https://clinicaltrials.gov/).The authors have no con ﬂicts of interest to disclose.",Non-OADS,/arxiv_data1/oa_pdf/fc/56/medi-96-e6066.PMC5340436.pdf
Medicine (2017) 96:9(e6066)Received: 19 November 2016 / Received in ﬁnal form: 12 January 2017 / Accepted: 13 January 2017 http://dx.doi.org/10.1097/MD.0000000000006066Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fc/56/medi-96-e6066.PMC5340436.pdf
Medicine (2017) 96:9(e6094)Received: 2 December 2016 / Received in ﬁnal form: 17 January 2017 / Accepted: 18 January 2017 http://dx.doi.org/10.1097/MD.0000000000006094Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/bf/23/medi-96-e6094.PMC5340437.pdf
Medicine (2017) 96:9(e6139)Received: 1 April 2016 / Received in ﬁnal form: 7 January 2017 / Accepted: 23 January 2017 http://dx.doi.org/10.1097/MD.0000000000006139Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d4/2c/medi-96-e6139.PMC5340440.pdf
All detected regions were then looked up in the normalized human brain by referring to the a utomated anatomical labeling (AAL) system (http://www.cyceron.fr /index.php/en/plateforme-en/ freeware [in the public domain]).Table 1 Baseline clinical characteristics.,OADS,/arxiv_data1/oa_pdf/d4/2c/medi-96-e6139.PMC5340440.pdf
Medicine (2017) 96:9(e6142)Received: 18 September 2016 / Received in ﬁnal form: 20 January 2017 / Accepted: 24 January 2017 http://dx.doi.org/10.1097/MD.0000000000006142Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/25/ad/medi-96-e6142.PMC5340441.pdf
Medicine (2017) 96:9(e6149)Received: 25 November 2016 / Received in ﬁnal form: 19 January 2017 / Accepted: 24 January 2017 http://dx.doi.org/10.1097/MD.0000000000006149Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ff/88/medi-96-e6149.PMC5340442.pdf
Available from: https://www.nice.org.uk/guidance/cg177.,Non-OADS,/arxiv_data1/oa_pdf/ff/88/medi-96-e6149.PMC5340442.pdf
Medicine (2017) 96:9(e6164)Received: 5 August 2016 / Received in ﬁnal form: 24 January 2017 / Accepted: 27 January 2017 http://dx.doi.org/10.1097/MD.0000000000006164Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9a/b3/medi-96-e6164.PMC5340443.pdf
2011; https://www.iofbonehealth.org/sites/default/ ﬁles/PDFs/Vertebral%20Fracture%20Initiative/IOF_VFI- Part_I-Manuscript.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9a/b3/medi-96-e6164.PMC5340443.pdf
Medicine (2017) 96:9(e6168)Received: 28 December 2015 / Received in ﬁnal form: 24 January 2017 / Accepted: 30 January 2017 http://dx.doi.org/10.1097/MD.0000000000006168Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ff/18/medi-96-e6168.PMC5340444.pdf
Available at: http://ip.ssaa.ir/Patent/SearchResult.aspx?DecNo= 139350140003013610&RN=86035.,OADS,/arxiv_data1/oa_pdf/ff/18/medi-96-e6168.PMC5340444.pdf
Medicine (2017) 96:9(e6182)Received: 25 August 2016 / Received in ﬁnal form: 12 January 2017 / Accepted: 1 February 2017 http://dx.doi.org/10.1097/MD.0000000000006182Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/70/e7/medi-96-e6182.PMC5340445.pdf
Medicine (2017) 96:9(e6202)Received: 28 March 2016 / Received in ﬁnal form: 13 January 2017 / Accepted: 30 January 2017 http://dx.doi.org/10.1097/MD.0000000000006202Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8a/c8/medi-96-e6202.PMC5340448.pdf
Medicine (2017) 96:9(e6203)Received: 23 September 2016 / Received in ﬁnal form: 2 February 2017 / Accepted: 3 February 2017 http://dx.doi.org/10.1097/MD.0000000000006203Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8e/10/medi-96-e6203.PMC5340449.pdf
Medicine (2017) 96:9(e6224)Received: 11 October 2016 / Received in ﬁnal form: 28 January 2017 / Accepted: 31 January 2017 http://dx.doi.org/10.1097/MD.0000000000006224Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fa/02/medi-96-e6224.PMC5340453.pdf
Medicine (2017) 96:9(e6226)Received: 16 March 2016 / Received in ﬁnal form: 31 January 2017 / Accepted: 2 February 2017 http://dx.doi.org/10.1097/MD.0000000000006226Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/da/5a/medi-96-e6226.PMC5340455.pdf
Medicine (2017) 96:9(e6227)Received: 12 September 2016 / Received in ﬁnal form: 25 January 2017 / Accepted: 26 January 2017 http://dx.doi.org/10.1097/MD.0000000000006227Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/62/c2/medi-96-e6227.PMC5340456.pdf
Medicine (2017) 96:9(e6228)Received: 2 September 2016 / Received in ﬁnal form: 30 January 2017 / Accepted: 31 January 2017 http://dx.doi.org/10.1097/MD.0000000000006228Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/72/a7/medi-96-e6228.PMC5340457.pdf
Medicine (2017) 96:9(e6232)Received: 19 September 2016 / Received in ﬁnal form: 14 January 2017 / Accepted: 26 January 2017 http://dx.doi.org/10.1097/MD.0000000000006232Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/18/a8/medi-96-e6232.PMC5340458.pdf
Medicine (2017) 96:9(e6233)Received: 14 October 2016 / Received in ﬁnal form: 1 February 2017 / Accepted: 2 February 2017 http://dx.doi.org/10.1097/MD.0000000000006233Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/da/d1/medi-96-e6233.PMC5340459.pdf
Medicine (2017) 96:9(e6236)Received: 31 December 2016 / Received in ﬁnal form: 26 January 2017 / Accepted: 27 January 2017 http://dx.doi.org/10.1097/MD.0000000000006236Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d2/02/medi-96-e6236.PMC5340461.pdf
Medicine (2017) 96:9(e6238)Received: 4 August 2016 / Received in ﬁnal form: 4 February 2017 / Accepted: 6 February 2017 http://dx.doi.org/10.1097/MD.0000000000006238Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/bf/5c/medi-96-e6238.PMC5340462.pdf
Medicine (2017) 96:9(e6239)Received: 12 July 2016 / Received in ﬁnal form: 19 January 2017 / Accepted: 6 February 2017 http://dx.doi.org/10.1097/MD.0000000000006239Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f9/4d/medi-96-e6239.PMC5340463.pdf
Medicine (2017) 96:9(e6241)Received: 11 October 2016 / Received in ﬁnal form: 5 February 2017 / Accepted: 6 February 2017 http://dx.doi.org/10.1097/MD.0000000000006241Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d7/27/medi-96-e6241.PMC5340464.pdf
Medicine (2017) 96:9(e6245)Received: 1 November 2016 / Received in ﬁnal form: 3 February 2017 / Accepted: 6 February 2017 http://dx.doi.org/10.1097/MD.0000000000006245Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b9/48/medi-96-e6245.PMC5340465.pdf
"For practitioners who do wish to connect with research-ers, the Massage Therapy Foundation provides a free e-book with helpful information on the topic (http://mtf.amtamassage.org/wp-content/uploads/ mtf-researcher-ebook.pdf).",Non-OADS,/arxiv_data1/oa_pdf/09/8d/ijtmb-10-1.PMC5340467.pdf
"If you are interested in being a writing mentor, please fill out the survey at https://goo.gl/forms/vN2DBxpYMCQuMeDK2.",Non-OADS,/arxiv_data1/oa_pdf/09/8d/ijtmb-10-1.PMC5340467.pdf
Available from: http://www.qualisys.com/software/qualisys- track-manager/  16.,OADS,/arxiv_data1/oa_pdf/88/58/ijtmb-10-3.PMC5340468.pdf
Available from: http://www.qualisys.com  4.,Non-OADS,/arxiv_data1/oa_pdf/88/58/ijtmb-10-3.PMC5340468.pdf
Available from: http://www.treadmetrix.com  5.,Non-OADS,/arxiv_data1/oa_pdf/88/58/ijtmb-10-3.PMC5340468.pdf
"A 60-year-old woman presented for bilateral delayed  breast reconstruction after undergoing right nipple sparing  mastectomy and left modified radical mastectomy, axillary  lymph node dissection and radiation, and suboptimal im- plant-based reconstruction (see figure, Supplemental Digital  Content 1, http://links.lww.com/PRSGO/A351).",Non-OADS,/arxiv_data1/oa_pdf/00/67/gox-5-e1189.PMC5340472.pdf
"At 6-month follow-up, the patient was satis- fied and pleased with the outcome (see figures, Supplemen- tal Digital Content 2–4, http://links.lww.com/PRSGO/A352,  http://links.lww.com/PRSGO/A353, http://links.lww.com/PRS- GO/A354).",Non-OADS,/arxiv_data1/oa_pdf/00/67/gox-5-e1189.PMC5340472.pdf
Available at: http://oig.hhs.gov.,Non-OADS,/arxiv_data1/oa_pdf/89/4a/gox-5-e1211.PMC5340473.pdf
3. http://www.transparancymarketresearch.com.,Non-OADS,/arxiv_data1/oa_pdf/89/4a/gox-5-e1211.PMC5340473.pdf
"3F24048/2018-06; see table, Supplemental Digital Content 2, http://links.lww.com/PRSGO/A376).",Non-OADS,/arxiv_data1/oa_pdf/5d/54/gox-5-e1222.PMC5340479.pdf
"Day 0 Histologic Examination Tissue samples taken shortly after bolus injection of  CPM showed small homogeneous pools of HA in the sub-cutis (see figure, Supplemental Digital Content 3, http://links.lww.com/PRSGO/A377).",Non-OADS,/arxiv_data1/oa_pdf/5d/54/gox-5-e1222.PMC5340479.pdf
"After retrograde fanning injection, CPM gel was visible  as small pools and thin rows of gel (see figure, Supplemen- tal Digital Content 4, http://links.lww.com/PRSGO/A378).",Non-OADS,/arxiv_data1/oa_pdf/5d/54/gox-5-e1222.PMC5340479.pdf
"Vycross gel was visible as small pools in the hypodermis  and along the injection tract (Fig., Supplemental Digital  Content 4, http://links.lww.com/PRSGO/A378).",Non-OADS,/arxiv_data1/oa_pdf/5d/54/gox-5-e1222.PMC5340479.pdf
"After retrograde fanning injection, a granulomatous  reaction to a foreign body and birefringent particles in polarized light were observed in tissue from both gel in- jection sites on day 0, probably due to threads from a pre- vious abdominoplasty (see figure, Supplemental Digital Content 5, http://links.lww.com/PRSGO/A388).",Non-OADS,/arxiv_data1/oa_pdf/5d/54/gox-5-e1222.PMC5340479.pdf
This video is available in the “Related Videos” section of the Full-Text article  on PRSGlobalOpen.com or available at http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/df/32/gox-5-e1225.PMC5340482.pdf
This video is available in  the “Related Videos” section of the Full-Text article on  PRSGlobalOpen.com or available at http://links.lww.com/ PRSGO/A373.),Non-OADS,/arxiv_data1/oa_pdf/df/32/gox-5-e1225.PMC5340482.pdf
com or available at http://links.lww.com/PRSGO/A372.,Non-OADS,/arxiv_data1/oa_pdf/df/32/gox-5-e1225.PMC5340482.pdf
com or available at http://links.lww.com/PRSGO/A373.,Non-OADS,/arxiv_data1/oa_pdf/df/32/gox-5-e1225.PMC5340482.pdf
Available  at: http://stateofobesity.org/states/ar/.,Non-OADS,/arxiv_data1/oa_pdf/65/db/gox-5-e1231.PMC5340487.pdf
This video is available in  the “Related Videos” section of the Full-Text article on  PRSGlobalOpen.com or available at http://links.lww.com/ PRSGO/A371.),Non-OADS,/arxiv_data1/oa_pdf/6e/96/gox-5-e1233.PMC5340489.pdf
this video is available in the “Related videos” section of the Full- text article on PRsGlobalopen.com or available at http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/6e/96/gox-5-e1233.PMC5340489.pdf
"Vienna, Austria: R Foundation for Statistical  Computing; 2015. https://www.R-project.org/  8.",Non-OADS,/arxiv_data1/oa_pdf/61/39/gox-5-e1240.PMC5340491.pdf
"For steps 1–4, see video, Supplemental Digital Content 1,   which displays the design of skin incision, subcutaneous  undermining, design of SMAS, and malar SMAS dissec- tion, http://links.lww.com/PRSGO/A385.",Non-OADS,/arxiv_data1/oa_pdf/cd/e7/gox-5-e1244.PMC5340494.pdf
This video is available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com or available at http://links.lww.com/ PRSGO/A385.,Non-OADS,/arxiv_data1/oa_pdf/cd/e7/gox-5-e1244.PMC5340494.pdf
This video is available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A389.,Non-OADS,/arxiv_data1/oa_pdf/cd/e7/gox-5-e1244.PMC5340494.pdf
"For step 6, see video, Supplemental Digital Content 3,  which displays the release of the major retaining ligaments and deep fascia covering the buccal fat pad in sub-SMAS  dissection, http://links.lww.com/PRSGO/A386.",Non-OADS,/arxiv_data1/oa_pdf/cd/e7/gox-5-e1244.PMC5340494.pdf
"For step 7, see video, Supplemental Digital Content 4 ,   which displays the vertical repositioning and suture fixa- tion of the SMAS flap, http://links.lww.com/PRSGO/A387.",Non-OADS,/arxiv_data1/oa_pdf/cd/e7/gox-5-e1244.PMC5340494.pdf
This video is available in the “Related Videos” section of the Full-Text ar - ticle on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A386.,Non-OADS,/arxiv_data1/oa_pdf/cd/e7/gox-5-e1244.PMC5340494.pdf
"4) (see figures, Supplemental Digital Content 1–4, which show pre- and postoperative clinical  photographs and CT scans, http://links.lww.com/PRSGO/ A379).",Non-OADS,/arxiv_data1/oa_pdf/8f/66/gox-5-e1245.PMC5340495.pdf
"This video is  available in the “Related Videos” section of the Full-Text  article on PRSGlobalOpen.com, http://links.lww.com/PRS-GO/A384.)",Non-OADS,/arxiv_data1/oa_pdf/25/2e/gox-5-e1248.PMC5340497.pdf
"(See video, Supplemental Digital Content 1 , available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/25/2e/gox-5-e1248.PMC5340497.pdf
"this video is available in the “Related Videos” section of the  Full- text article on pRsGlobalopen.com, http://links.lww.com/ PRSGO/A384.",Non-OADS,/arxiv_data1/oa_pdf/25/2e/gox-5-e1248.PMC5340497.pdf
"(See video, Supplemen-tal Digital Content 1, available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com, http://links.lww.com/PRSGO/A384.)",Non-OADS,/arxiv_data1/oa_pdf/25/2e/gox-5-e1248.PMC5340497.pdf
"(See video, Supplemental Digital Content  1, available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com, http://links.lww.com/ PRSGO/A384.)",Non-OADS,/arxiv_data1/oa_pdf/25/2e/gox-5-e1248.PMC5340497.pdf
1 http://repository.edm-forum.org/egems/vol5/iss1/1 DOI: 10.13063/2327-9214.1263,Non-OADS,/arxiv_data1/oa_pdf/e8/a7/egems1263.PMC5340503.pdf
1 http://repository.edm-forum.org/egems/vol5/iss1/1 DOI: 10.13063/2327-9214.1263,Non-OADS,/arxiv_data1/oa_pdf/e8/a7/egems1263.PMC5340503.pdf
1 http://repository.edm-forum.org/egems/vol5/iss1/1 DOI: 10.13063/2327-9214.1263,Non-OADS,/arxiv_data1/oa_pdf/e8/a7/egems1263.PMC5340503.pdf
1 http://repository.edm-forum.org/egems/vol5/iss1/1 DOI: 10.13063/2327-9214.1263,Non-OADS,/arxiv_data1/oa_pdf/e8/a7/egems1263.PMC5340503.pdf
1 http://repository.edm-forum.org/egems/vol5/iss1/1 DOI: 10.13063/2327-9214.1263,Non-OADS,/arxiv_data1/oa_pdf/e8/a7/egems1263.PMC5340503.pdf
32 http://repository.edm-forum.org/egems/vol4/iss1/32 DOI: 10.13063/2327-9214.1202,Non-OADS,/arxiv_data1/oa_pdf/fb/51/egems1202.PMC5340517.pdf
32 http://repository.edm-forum.org/egems/vol4/iss1/32 DOI: 10.13063/2327-9214.1202,Non-OADS,/arxiv_data1/oa_pdf/fb/51/egems1202.PMC5340517.pdf
32 http://repository.edm-forum.org/egems/vol4/iss1/32 DOI: 10.13063/2327-9214.1202,Non-OADS,/arxiv_data1/oa_pdf/fb/51/egems1202.PMC5340517.pdf
32 http://repository.edm-forum.org/egems/vol4/iss1/32 DOI: 10.13063/2327-9214.1202,Non-OADS,/arxiv_data1/oa_pdf/fb/51/egems1202.PMC5340517.pdf
32 http://repository.edm-forum.org/egems/vol4/iss1/32 DOI: 10.13063/2327-9214.1202,Non-OADS,/arxiv_data1/oa_pdf/fb/51/egems1202.PMC5340517.pdf
32 http://repository.edm-forum.org/egems/vol4/iss1/32 DOI: 10.13063/2327-9214.1202,Non-OADS,/arxiv_data1/oa_pdf/fb/51/egems1202.PMC5340517.pdf
32 http://repository.edm-forum.org/egems/vol4/iss1/32 DOI: 10.13063/2327-9214.1202,Non-OADS,/arxiv_data1/oa_pdf/fb/51/egems1202.PMC5340517.pdf
32 http://repository.edm-forum.org/egems/vol4/iss1/32 DOI: 10.13063/2327-9214.1202,Non-OADS,/arxiv_data1/oa_pdf/fb/51/egems1202.PMC5340517.pdf
32 http://repository.edm-forum.org/egems/vol4/iss1/32 DOI: 10.13063/2327-9214.1202,Non-OADS,/arxiv_data1/oa_pdf/fb/51/egems1202.PMC5340517.pdf
Email: pangsc@queensu.ca doi: https://doi.org/10.14740/cr523w,Non-OADS,/arxiv_data1/oa_pdf/3e/99/cr-08-001.PMC5340518.pdf
Email: ansgar.adams@bad-gmbh.de doi: https://doi.org/10.14740/cr516w,Non-OADS,/arxiv_data1/oa_pdf/44/82/cr-08-007.PMC5340519.pdf
Email: ahm35799@hotmail.com doi: https://doi.org/10.14740/cr445w,Non-OADS,/arxiv_data1/oa_pdf/82/53/cr-08-013.PMC5340520.pdf
Email: burn_hp@yahoo.com doi: https://doi.org/10.14740/cr512w,Non-OADS,/arxiv_data1/oa_pdf/9a/8b/cr-08-020.PMC5340521.pdf
Email: glenmore_md@yahoo.com doi: https://doi.org/10.14740/cr522w,Non-OADS,/arxiv_data1/oa_pdf/d9/e5/cr-08-026.PMC5340522.pdf
http://emedicine.med - scape.com/article/156863-overview/.,Non-OADS,/arxiv_data1/oa_pdf/d9/e5/cr-08-026.PMC5340522.pdf
"Key Words:  Medicinal plant, Lung inflammation, COPD, Constituent, FlavonoidAbstractReview Biomol  Ther 25(2), 91-104 (2017) *Corresponding Author E-mail: hpkim@kangwon.ac.kr Tel: +82-33-250-6915, Fax: +82-33-255-7865Received  Aug 18, 2016  Revised  Sep 21, 2016  Accepted  Oct 4, 2016 Published Online  Dec 16, 2016 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.187 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/39/bt-25-091.PMC5340533.pdf
"92 https://doi.org/10.4062/biomolther.2016.187trophils, macrophages and T lymphocytes.",Non-OADS,/arxiv_data1/oa_pdf/88/39/bt-25-091.PMC5340533.pdf
94 https://doi.org/10.4062/biomolther.2016.187Many medicinal plants have shown regulatory effects on  lung inflammation at doses of approximately 100-300 mg/kg  as summarized in Table  1.,Non-OADS,/arxiv_data1/oa_pdf/88/39/bt-25-091.PMC5340533.pdf
"96 https://doi.org/10.4062/biomolther.2016.187anti-allergic and anti-inflammatory activity (Dai et al., 2002; Ha  et al., 2008).",Non-OADS,/arxiv_data1/oa_pdf/88/39/bt-25-091.PMC5340533.pdf
98 https://doi.org/10.4062/biomolther.2016.187duced the inflammatory response of cigarette smoke-induced  COPD model in mice.,Non-OADS,/arxiv_data1/oa_pdf/88/39/bt-25-091.PMC5340533.pdf
"100 https://doi.org/10.4062/biomolther.2016.187(2014) Benralizumab for chronic obstructive pulmonary disease  and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.",Non-OADS,/arxiv_data1/oa_pdf/88/39/bt-25-091.PMC5340533.pdf
102 https://doi.org/10.4062/biomolther.2016.187inflammation in acute lung injury by suppressing PI3K/Akt/mTOR  signaling pathway.,Non-OADS,/arxiv_data1/oa_pdf/88/39/bt-25-091.PMC5340533.pdf
104 https://doi.org/10.4062/biomolther.2016.187κB and MAPKs signaling pathways.,OADS,/arxiv_data1/oa_pdf/88/39/bt-25-091.PMC5340533.pdf
"Key Words:  Rosmarinic acid, Electroencephalogram, γ-Aminobutyric acid A receptors subunits, Glutamic acid decarboxylase,  Pentobarbital-induced sleep, Insomnia AbstractOriginal Article Biomol  Ther 25(2), 105-111 (2017) *Corresponding Author E-mail: kiwan@chungbuk.ac.kr Tel: +82-43-261-2827, Fax: +82-43-268-2732Received  Feb 18, 2016  Revised  Mar 16, 2016  Accepted  May 11, 2016 Published Online  Aug 1, 2016http://dx.doi.org/10.4062/biomolther.2016.035 Copyright © 2017 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/8a/bt-25-105.PMC5340534.pdf
"106 https://doi.org/10.4062/biomolther.2016.035increased, and then the cells become hyperpolarized state  which leads to anti-anxiety or sleep (Gottesmann, 2002).",Non-OADS,/arxiv_data1/oa_pdf/35/8a/bt-25-105.PMC5340534.pdf
"108 https://doi.org/10.4062/biomolther.2016.035RESUL TS Decreased locomotor activity by RA When compared to the control group and the group treated  with RA, RA (0.5 mg/kg) reduced about 19.4%, RA (1.0 mg/ kg) reduced about 39.6% and RA (2.0 mg/kg) reduced about  49.8% of the locomotor activity (Fig.",Non-OADS,/arxiv_data1/oa_pdf/35/8a/bt-25-105.PMC5340534.pdf
110 https://doi.org/10.4062/biomolther.2016.035mus of rat orally treated RA (0.5 and 1.0 mg/kg).,Non-OADS,/arxiv_data1/oa_pdf/35/8a/bt-25-105.PMC5340534.pdf
"Key Words:  Acetaminophen, Hepatotoxicity, Toxicogenomics, GABA-A receptor subunit alpha 3, Lipoprotein lipaseAbstractOriginal Article Biomol  Ther 25(2), 112-121 (2017) Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.076 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/df/bt-25-112.PMC5340535.pdf
"114 https://doi.org/10.4062/biomolther.2016.076tive humidity, 12/12 h dark-light cycle) with ad libitum access  to laboratory normal diets (Purina Co., Seoul, Korea) and tab  water.",Non-OADS,/arxiv_data1/oa_pdf/8f/df/bt-25-112.PMC5340535.pdf
"116 https://doi.org/10.4062/biomolther.2016.076target gene in the sample with the lowest level of the normal - ized gene expression of the target genes, expressed as 2-ΔΔCt.",Non-OADS,/arxiv_data1/oa_pdf/8f/df/bt-25-112.PMC5340535.pdf
"118 https://doi.org/10.4062/biomolther.2016.076Gene expression analysis with microarray to identify  genes associated with susceptibility to APAP-induced hepatotoxicity To determine the genetic factors associated with these  inter-individual variations to APAP-induced hepatotoxicity, mi- croarray analysis was performed with the liver samples of 5  susceptible and 5 resistant animals pre-obtained before APAP  treatment as described in scheme (Fig.",OADS,/arxiv_data1/oa_pdf/8f/df/bt-25-112.PMC5340535.pdf
"Available from: http://content.time.com/time/health/article/0,8599,1572012,00.html.",Non-OADS,/arxiv_data1/oa_pdf/8f/df/bt-25-112.PMC5340535.pdf
"Key Words:  Synthetic cathinones, Conditioned place preference, Self-administration, Locomotor sensitization, Abuse potentialAbstractOriginal Article Biomol  Ther 25(2), 122-129 (2017) Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.241 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/2b/bt-25-122.PMC5340536.pdf
124 https://doi.org/10.4062/biomolther.2016.241Conditioned place preference test The CPP apparatus was composed of two large compart- ments (17.4×12.7×12.7 cm).,Non-OADS,/arxiv_data1/oa_pdf/51/2b/bt-25-122.PMC5340536.pdf
126 https://doi.org/10.4062/biomolther.2016.241pre- and post-conditioning phases.,Non-OADS,/arxiv_data1/oa_pdf/51/2b/bt-25-122.PMC5340536.pdf
128 https://doi.org/10.4062/biomolther.2016.241and that these two behavioral procedures represent different  aspects of reward.,Non-OADS,/arxiv_data1/oa_pdf/51/2b/bt-25-122.PMC5340536.pdf
Available from: http://www.emcdda.europa.eu/topics/pods/synthetic-cathinones-injection/.,Non-OADS,/arxiv_data1/oa_pdf/51/2b/bt-25-122.PMC5340536.pdf
"Key Words:  CXCR5, Retroviral transduction, Treg cell, Tfh cell, Tfr cell, Germinal center reactions AbstractOriginal Article Biomol  Ther 25(2), 130-139 (2017) *Corresponding Author E-mail: yeonseok@snu.ac.kr Tel: +82-2-880-7874, Fax: +82-2-872-1795 †The first two authors contributed equally to this work.Received  Apr 5, 2016  Revised  May 25, 2016  Accepted  Jun 7, 2016 Published Online  Oct 17, 2016 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.075 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/2a/bt-25-130.PMC5340537.pdf
"132 https://doi.org/10.4062/biomolther.2016.075toethanol, 2 mM L-glutamine, 100 units penicillin-streptomycin  (all from Gibco, Carlsbad, CA, USA), and 10 μg/ml gentamicin  (Sigma-Aldrich, St. Louis, MO, USA).",Non-OADS,/arxiv_data1/oa_pdf/e7/2a/bt-25-130.PMC5340537.pdf
"134 https://doi.org/10.4062/biomolther.2016.075Treg cells is essential for the regulation of germinal center for- mation, we adoptively transferred naïve CD4+ T cells together  with WT or CXCR5-deficient Treg cells into Tcrb-deficient mice.",Non-OADS,/arxiv_data1/oa_pdf/e7/2a/bt-25-130.PMC5340537.pdf
136 https://doi.org/10.4062/biomolther.2016.075tion.,Non-OADS,/arxiv_data1/oa_pdf/e7/2a/bt-25-130.PMC5340537.pdf
138 https://doi.org/10.4062/biomolther.2016.0752014).,Non-OADS,/arxiv_data1/oa_pdf/e7/2a/bt-25-130.PMC5340537.pdf
"Key Words:  Rubus occidentalis , Hyperlipidemia, Immune restoration, In vivo CTL assayAbstractOriginal Article Biomol  Ther 25(2), 140-148 (2017) *Corresponding Author E-mail: kimkj@syu.ac.kr Tel: +82-2-3399-1601, Fax: +82-2-3399-1617Received  Mar 1, 2016  Revised  May 17, 2016  Accepted  Jun 14, 2016 Published Online  Oct 17, 2016 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.052 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/5f/bt-25-140.PMC5340538.pdf
142 https://doi.org/10.4062/biomolther.2016.052ELISA.,OADS,/arxiv_data1/oa_pdf/02/5f/bt-25-140.PMC5340538.pdf
"144 https://doi.org/10.4062/biomolther.2016.052Effect of aqueous extract of immature RO on lymphocyte  proliferation  To confirm the viability and proliferative activity of the lym- phocytes, we performed an ex vivo proliferation assay using  mice splenocytes from each group.",Non-OADS,/arxiv_data1/oa_pdf/02/5f/bt-25-140.PMC5340538.pdf
"146 https://doi.org/10.4062/biomolther.2016.052of the entire array of immune cells, undergo changes in size  based on the host immune status (Pope, 1991), and their  weights can be used as a quantitative immunological index.",OADS,/arxiv_data1/oa_pdf/02/5f/bt-25-140.PMC5340538.pdf
"148 https://doi.org/10.4062/biomolther.2016.052Glassford, A., Caimol, M., Kenkel, J.",OADS,/arxiv_data1/oa_pdf/02/5f/bt-25-140.PMC5340538.pdf
"Key Words:  Cerebral ischemia, Interleukin-1 receptor antagonist, Intranasal administration, NeuroinflammationAbstractOriginal Article Biomol  Ther 25(2), 149-157 (2017) *Corresponding Author E-mail: koobn@yuhs.ac Tel: +82-2-2228-2420, Fax: +82-2-312-7185Received  Feb 29, 2016  Revised  May 6, 2016  Accepted  May 24, 2016 Published Online  Aug 19, 2016https://doi.org/10.4062/biomolther.2016.050 Copyright © 2017 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/41/bt-25-149.PMC5340539.pdf
150 https://doi.org/10.4062/biomolther.2016.050rier against the delivery of pharmacologically relevant quanti - ties of therapeutic proteins to the brain.,Non-OADS,/arxiv_data1/oa_pdf/55/41/bt-25-149.PMC5340539.pdf
152 https://doi.org/10.4062/biomolther.2016.050with Bonferroni post hoc tests was used for comparisons be- tween the 3 groups.,OADS,/arxiv_data1/oa_pdf/55/41/bt-25-149.PMC5340539.pdf
154 https://doi.org/10.4062/biomolther.2016.050 Contralateral Ipsilateral abA EC striatum EC cortex IN striatum IN cortexB DAPI NeuN IL-1RA Merge EC striatum EC cortex IN striatum IN cortexC DAPI Iba1 IL-1RA Merge Fig.,OADS,/arxiv_data1/oa_pdf/55/41/bt-25-149.PMC5340539.pdf
156 https://doi.org/10.4062/biomolther.2016.050results show that IL-1RA was already detected in the cortex  and striatum 1 h after intranasal administration and that the  IL-1RA level reached the peak at about 1 h after intranasal  administration in the striatum and 3 h after intranasal adminis - tration in the cortex.,OADS,/arxiv_data1/oa_pdf/55/41/bt-25-149.PMC5340539.pdf
"We performed in vitro cell screening to determine the pro- *Corresponding Author E-mail: sunnykim@gachon.ac.kr Tel: +82-32-899-6411, Fax: +82-32-899-8962Received  Feb 18, 2016  Revised  Apr 19, 2016  Accepted  Apr 22, 2016 Published Online  June 13, 2016https://doi.org/10.4062/biomolther.2016.034 Copyright © 2017 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/43/bt-25-158.PMC5340540.pdf
"160 https://doi.org/10.4062/biomolther.2016.034Biomol  Ther 25(2), 158-164 (2017)  A  B % ofcontrol120 100 80 60 40 20 0*** MGO (400 M) Hypericin (/c109 /c109 /c109M) Aminoguanidine (M)0.01 0.1 0.5 1### ## D % ofcontrol400 300 200 100 0*** MGO (400 M) Hypericin (/c109 /c109 /c109M) Aminoguanidine (M)0.5 1### ### CE Bcl-2 Bax p53 /c97-tubulinF Bcl-2 % ofcontrol150 100 50 0*** MGO (400 M) Hypericin (0.5/c109 /c109M)### G Bax % ofcontrol150 100 50 0 MGO (400 M) Hypericin (0.5/c109 /c109M)**## H p53 % ofcontrol200 100 50 0*** MGO (400 M) Hypericin (0.5/c109 /c109M)### 150 Fig.",Non-OADS,/arxiv_data1/oa_pdf/1c/43/bt-25-158.PMC5340540.pdf
"162 https://doi.org/10.4062/biomolther.2016.034jury and apoptosis in endothelial cells (Figarola et al., 2014).",OADS,/arxiv_data1/oa_pdf/1c/43/bt-25-158.PMC5340540.pdf
164 https://doi.org/10.4062/biomolther.2016.034valerianoides inhibit the formation of advanced glycation end prod- ucts and rat lens aldose reductase in vitro.,Non-OADS,/arxiv_data1/oa_pdf/1c/43/bt-25-158.PMC5340540.pdf
"Key Words:  Cordyceps bassiana, Phytochemical study, 1,9-dimethylguanine, NF-κB, AP-1, Anti-inflammatory activityAbstractOriginal Article Biomol  Ther 25(2), 165-170 (2017) Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.063 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/97/bt-25-165.PMC5340541.pdf
"166 https://doi.org/10.4062/biomolther.2016.063of its valuable pharmacological activities, no reports on the  chemical constituents of C. bassiana  have been published to  date.",Non-OADS,/arxiv_data1/oa_pdf/54/97/bt-25-165.PMC5340541.pdf
168 https://doi.org/10.4062/biomolther.2016.063Statistical analysis  All data are presented as the mean ± SEM of 3 different  experiments performed with 4 samples (Fig.,OADS,/arxiv_data1/oa_pdf/54/97/bt-25-165.PMC5340541.pdf
"170 https://doi.org/10.4062/biomolther.2016.063Wong, P., Bachki, A., Banerjee, K. and Leyland-Jones, B.",Non-OADS,/arxiv_data1/oa_pdf/54/97/bt-25-165.PMC5340541.pdf
"To date, more than 21,000 P450 genes have been reported across all classes of organism (http://drnelson.uthsc.",OADS,/arxiv_data1/oa_pdf/86/4b/bt-25-171.PMC5340542.pdf
"Key Words:  P450, Streptomyces avermitilis, CYP158A3, Flaviolin, 2-HydroxynaphthoquinoneAbstractOriginal Article Biomol  Ther 25(2), 171-176 (2017) *Corresponding Author E-mail: donghak@konkuk.ac.kr  Tel: +82-2-450-3366, Fax: +82-2-3436-5432Received  Aug 16, 2016  Revised  Sep 22, 2016  Accepted  Sep 22, 2016 Published Online  Dec 13, 2016 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.182 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/4b/bt-25-171.PMC5340542.pdf
172 https://doi.org/10.4062/biomolther.2016.182protect the bacterium in the soil from the deleterious effects  of UV irradiation.,Non-OADS,/arxiv_data1/oa_pdf/86/4b/bt-25-171.PMC5340542.pdf
Homology modeling of CYP158A3 protein  Homology modeling was performed on the Swiss-Model  server (https://swissmodel.expasy.org/).,OADS,/arxiv_data1/oa_pdf/86/4b/bt-25-171.PMC5340542.pdf
The result- ing threedimensional protein model was visualized in PyMOL  (http://www.pymol.org/).,OADS,/arxiv_data1/oa_pdf/86/4b/bt-25-171.PMC5340542.pdf
"CYP158A3 from Streptomyces avermitilis 173RESUL TS Amino acid sequence alignments for CYP158A3 The SAV_7130 gene from S. avermitilis  encodes a 404  amino acid enzyme, named CYP158A3 (http://drnelson.uth- sc.edu/cytochromeP450.html/).",Non-OADS,/arxiv_data1/oa_pdf/86/4b/bt-25-171.PMC5340542.pdf
174 https://doi.org/10.4062/biomolther.2016.182identify putative substrates.,Non-OADS,/arxiv_data1/oa_pdf/86/4b/bt-25-171.PMC5340542.pdf
"176 https://doi.org/10.4062/biomolther.2016.182Han, S., Pham, T. V., Kim, J. H., Lim, Y. R., Park, H. G., Cha, G. S.,  Yun, C. H., Chun, Y. J., Kang, L. W. and Kim, D. (2015) Functional  characterization of CYP107W1 from Streptomyces avermitilis and biosynthesis of macrolide oligomycin A. Arch.",OADS,/arxiv_data1/oa_pdf/86/4b/bt-25-171.PMC5340542.pdf
"Key Words:  Annexin A5, Apoptosis, Auranofin, Plasminogen activator inhibitor-2AbstractOriginal Article Biomol  Ther 25(2), 177-185 (2017) *Corresponding Author E-mail: yjchun@cau.ac.kr Tel: +82-2-820-5616, Fax: +82-2-825-5616Received  Sep 30, 2016  Revised  Oct 4, 2016  Accepted  Oct 17 , 2016 Published Online  Dec 13, 2016 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.223 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/1a/bt-25-177.PMC5340543.pdf
"178 https://doi.org/10.4062/biomolther.2016.223However, the role of annexin A5 itself has not yet been clari- fied.",Non-OADS,/arxiv_data1/oa_pdf/ad/1a/bt-25-177.PMC5340543.pdf
180 https://doi.org/10.4062/biomolther.2016.223tosis in PC-3 cells.,Non-OADS,/arxiv_data1/oa_pdf/ad/1a/bt-25-177.PMC5340543.pdf
182 https://doi.org/10.4062/biomolther.2016.223Fig.,Non-OADS,/arxiv_data1/oa_pdf/ad/1a/bt-25-177.PMC5340543.pdf
"184 https://doi.org/10.4062/biomolther.2016.223PAI-2 promoter activity in many cells (Stringer et al., 2012).",Non-OADS,/arxiv_data1/oa_pdf/ad/1a/bt-25-177.PMC5340543.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01419691/.,Non-OADS,/arxiv_data1/oa_pdf/ad/1a/bt-25-177.PMC5340543.pdf
"Key Words:  Tetrandrine, Glioma, Radiosensitization, Proliferation, ERKAbstractOriginal Article Biomol  Ther 25(2), 186-193 (2017) *Corresponding Author E-mail: tzxy@jnu.edu.cn  Tel: +86-20-85228363, Fax: +86-20-85228343 †The first three authors contributed equally to this work.Received  Feb 25, 2016  Revised  May 21, 2016  Accepted  Jul 28, 2016 Published Online  Nov 8, 2016 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.044 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/3e/bt-25-186.PMC5340544.pdf
"188 https://doi.org/10.4062/biomolther.2016.044ter, CA, USA).",Non-OADS,/arxiv_data1/oa_pdf/e7/3e/bt-25-186.PMC5340544.pdf
190 https://doi.org/10.4062/biomolther.2016.044(DSBs) by calculating the number of p-H2AX foci.,Non-OADS,/arxiv_data1/oa_pdf/e7/3e/bt-25-186.PMC5340544.pdf
192 https://doi.org/10.4062/biomolther.2016.044U0126+RT group displayed decreased p-ERK expression  compared with the group that received only RT.,OADS,/arxiv_data1/oa_pdf/e7/3e/bt-25-186.PMC5340544.pdf
"*Corresponding Author E-mail: imds@pusan.ac.kr Tel: +82-51-510-2817, Fax: +82-51-513-6754Received  Feb 25, 2016  Revised  Apr 11, 2016  Accepted  Apr 22, 2016 Published Online  June 17, 2016https://doi.org/10.4062/biomolther.2016.046 Copyright © 2017 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/1a/bt-25-194.PMC5340545.pdf
"196 https://doi.org/10.4062/biomolther.2016.046GT-3’), LPA 5 (sense 5’-TCT CCC GTG TCC TGA CTA CC-3’,  antisense 5’-TGA GCA TCA GGA AGA TGC AG-3’), and LPA 6  (sense 5’-TGC TCA GTA GTG GCA GCA GT-3’, antisense 5’-  CAG GCA GCA GAT TCA TTG TC-3’), and GAPDH (sense 5’-  GAG TCA ACG GAT TTG GTC GT-3’, antisense 5’-TTG ATT  TTG GAG GGA TCT CG-3’).",Non-OADS,/arxiv_data1/oa_pdf/9a/1a/bt-25-194.PMC5340545.pdf
"198 https://doi.org/10.4062/biomolther.2016.046partially inhibited LPE- and LPA-induced [Ca2+]i increases,  suggesting that Ca2+ influx across the plasma membrane con- tributed to observed [Ca2+]i increases.",Non-OADS,/arxiv_data1/oa_pdf/9a/1a/bt-25-194.PMC5340545.pdf
"200 https://doi.org/10.4062/biomolther.2016.046Therefore, in SH-SY5Y cells, LPE was found to act on LPA 1  to induce [Ca2+]i increase via G i/o proteins, phospholipase C,  and IP 3R, and LPA was found to use LPA 1 and LPA 2 to mobilize  Ca2+ (Fig.",OADS,/arxiv_data1/oa_pdf/9a/1a/bt-25-194.PMC5340545.pdf
"Key Words:  Ginsenoside Rb1, Doxorubicin, apoptosis, AhR, CYP1AAbstractOriginal Article Biomol  Ther 25(2), 202-212 (2017) Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.066 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/6d/bt-25-202.PMC5340546.pdf
204 https://doi.org/10.4062/biomolther.2016.066as enrichment factor and calculated using the following formu- la: enrichment factor=the ratio of absorbance of the sample:  absorbance of the negative control group.,OADS,/arxiv_data1/oa_pdf/e5/6d/bt-25-202.PMC5340546.pdf
"206 https://doi.org/10.4062/biomolther.2016.066Bcl-2 expression in H9C2 cells, which were not restored to  normal levels by Rb1 pretreatment (Fig.",Non-OADS,/arxiv_data1/oa_pdf/e5/6d/bt-25-202.PMC5340546.pdf
208 https://doi.org/10.4062/biomolther.2016.066DISCUSSION DOX-induced cardiomyopathy is a major obstacle that  limits the clinical application of doxorubicin in cancer chemo- therapy.,Non-OADS,/arxiv_data1/oa_pdf/e5/6d/bt-25-202.PMC5340546.pdf
210 https://doi.org/10.4062/biomolther.2016.066suggested that TCDD can induce apoptosis.,Non-OADS,/arxiv_data1/oa_pdf/e5/6d/bt-25-202.PMC5340546.pdf
"212 https://doi.org/10.4062/biomolther.2016.066Maayah, Z. H., Ansari, M. A., El Gendy, M. A., Al-Arifi, M. N. and Ko- rashy, H. M. (2014) Development of cardiac hypertrophy by suni- tinib in vivo and in vitro rat cardiomyocytes is influenced by the  aryl hydrocarbon receptor signaling pathway.",Non-OADS,/arxiv_data1/oa_pdf/e5/6d/bt-25-202.PMC5340546.pdf
"Key Words:  Baicalein, Migration, Invasion, PI3K/Akt, B16F10 Mouse Melanoma CellsAbstractOriginal Article Biomol  Ther 25(2), 213-221 (2017) Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.094 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/b4/bt-25-213.PMC5340547.pdf
214 https://doi.org/10.4062/biomolther.2016.094of cancer-related mortality.,Non-OADS,/arxiv_data1/oa_pdf/62/b4/bt-25-213.PMC5340547.pdf
"216 https://doi.org/10.4062/biomolther.2016.094Western blot analysis Following treatment with various concentrations of baica - lein, the cells were washed with ice-cold PBS and harvested  and lysed with a lysis buffer (20 mM sucrose, 1 mM ethylendi - aminetetraacetic acid, 20 μM Tris-Cl, pH 7.2, 1 mM dithioth - reitol, 10 mM KCl, 1.5 mM MgCl 2, 5 μg/ml pepstatin A, 10 μg/ml leupeptin, and 2 μg/ml aprotinin) for 30 min at 4°C.",Non-OADS,/arxiv_data1/oa_pdf/62/b4/bt-25-213.PMC5340547.pdf
218 https://doi.org/10.4062/biomolther.2016.094compared with the control group (Fig.,Non-OADS,/arxiv_data1/oa_pdf/62/b4/bt-25-213.PMC5340547.pdf
"220 https://doi.org/10.4062/biomolther.2016.094protein; however, the those levels of both TIMP-1 and -2 ex- hibit concentration-dependent upregulation in response to ba- icalein treatment (Fig.",Non-OADS,/arxiv_data1/oa_pdf/62/b4/bt-25-213.PMC5340547.pdf
"Also, the authors request to correct all term 'liver  index' from 'fatty liver index' on the 21th, 27th, 30th line of left column of page 654 and the 8th line of right column of page 656.Erratum Biomol  Ther 25(2), 222 (2017) Copyright  © 2017 The Korean Society of Applied Pharmacology*Corresponding Author E-mail: sychoung@khu.ac.kr Tel: +82-2-961-0372, Fax: +82-2-961-0372DOI of original article : https://doi.org/10.4062/biomolther.2016.176 https://doi.org/10.4062/biomolther.2017.222 Open  Access www.biomolther.org  This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Erratum to ""Protective Effects of Ecklonia stolonifera Extract on   Ethanol-Induced Fatty Liver in Rats""   [Biomol.Ther.",Non-OADS,/arxiv_data1/oa_pdf/18/0d/bt-25-222.PMC5340548.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/66/73/CG-CGCR160171.PMC5340651.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/a4/fa/CG-CGCR160131.PMC5340652.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/7c/fb/CG-CGCR160161.PMC5340653.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/d7/03/CG-CGCR160156.PMC5340654.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/e6/b2/CG-CGCR160155.PMC5340655.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/50/e2/CG-CGCR160167.PMC5340656.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/dd/ed/CG-CGCR160154.PMC5340658.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/00/07/CG-CGCR160169.PMC5340659.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/b6/43/CG-CGCR160135.PMC5340660.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/4a/a3/CG-CGCR160165.PMC5340718.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/cc/37/CG-CGCR160159.PMC5340719.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/d8/5b/CG-CGCR170001.PMC5340720.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/26/06/CG-CGCR160164.PMC5340723.pdf
"Correspondence to: Atul F. Kamath, MD   Department of Orthopaedic Surgery, Pennsylvania Hospital, 800 Spruce  Street, Philadelphia, PA 19107, USA Tel: +1-215-687-8169, Fax: +1-215-829-7492E-mail: akamath@post.harvard.edu https://doi.org/10.4055/cios.2017.9.1.128",Non-OADS,/arxiv_data1/oa_pdf/fe/a7/cios-9-128.PMC5340724.pdf
biomax.us/) and Super Bio Chips Laboratories (http://www.tissue-array.com/).,Non-OADS,/arxiv_data1/oa_pdf/e2/73/onc2016293a.PMC5340799.pdf
"Tumor-initiating frequency was calcu- lated using the ELDA software (http://bioinf.wehi.edu.au/software/elda/ index.html), provided by the Water and Eliza Hall Institute (Parkville, VIC, Australia).51 Study approval All human breast carcinoma specimens were obtained from the Universityof Tokyo Hospital, Minami-Machida Hospital and Showa General Hospital.The addiction circuits for cancer stem-like cells K Tominaga et al 1284 Oncogene (2017) 1276 –1286",OADS,/arxiv_data1/oa_pdf/e2/73/onc2016293a.PMC5340799.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)The addiction circuits for cancer stem-like cells K Tominaga et al 1286 Oncogene (2017) 1276 –1286",Non-OADS,/arxiv_data1/oa_pdf/e2/73/onc2016293a.PMC5340799.pdf
"For each condition, the sample size calculation was performed using ‘InvivoStat ’ software (http://invivostat.co.uk).",OADS,/arxiv_data1/oa_pdf/83/bc/onc2016284a.PMC5340801.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Inhibition of CXCL12/CXCR4 axis in breast cancers S Lefort et al 1222 Oncogene (2017) 1211 –1222",Non-OADS,/arxiv_data1/oa_pdf/83/bc/onc2016284a.PMC5340801.pdf
"In	this	Editorial, 	I	 highlight 	what	we	need	to	know	about 	this	transporter 	Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1513 1513 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1513-1520  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) EDITORIAL P-glycoprotein multidrug transporter in inflammatory bowel  diseases: More questions than answers Elke	Cario",Non-OADS,/arxiv_data1/oa_pdf/4f/d3/WJG-23-1513.PMC5340804.pdf
"World J  Gastroenterol  2017; 23(9): 1513-1520  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i9/1513.htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i9.1513 INTRODUCTION The gastrointestinal (GI) barrier is constantly exposed  to numerous environmental substrates that are  foreign and potentially harmful, so-called xenobiotics.",Non-OADS,/arxiv_data1/oa_pdf/4f/d3/WJG-23-1513.PMC5340804.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/4f/d3/WJG-23-1513.PMC5340804.pdf
"Therefore, H. pylori  infection  should always be considered a pro-cancerous factor.Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1521 1521 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1521-1540  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) FRONTIER Host pathogen interactions in Helicobacter pylori  related  gastric cancer Magdalena Chmiela, Zuzanna Karwowska, Weronika Gonciarz, Bujana Allushi, Paweł Stączek",Non-OADS,/arxiv_data1/oa_pdf/cd/98/WJG-23-1521.PMC5340805.pdf
World J Gastroenterol 2017; 23(9): 1521-1540  Available  from: URL: http://www.wjgnet.com/1007-9327/full/v23/i9/1521.,Non-OADS,/arxiv_data1/oa_pdf/cd/98/WJG-23-1521.PMC5340805.pdf
"htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1521 BIOGRAPHY With a master degree on biology, microbiology as  specialty, upon her PhD on Immunology in 1991,  Magdalena Chmiela (Figure 1) was nominated in 2005  on the position of permanent Professor (medical  microbiology, immunology) at the Faculty of Biology  and Environmental Protection, University of Lodz,  Poland.",Non-OADS,/arxiv_data1/oa_pdf/cd/98/WJG-23-1521.PMC5340805.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/cd/98/WJG-23-1521.PMC5340805.pdf
"Core tip: In	inflammatory 	bowel 	disease 	patients, 	 pseudopolyps 	are	formed 	at	the	bowel 	wall	during 	the	Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1541 1541 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1541-1551  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) REVIEW Pseudopolyps in inflammatory bowel diseases: Have we  learned enough?",Non-OADS,/arxiv_data1/oa_pdf/d7/4d/WJG-23-1541.PMC5340806.pdf
"World J Gastroenterol  2017; 23(9): 1541-1551   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i9/1541.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1541 INTRODUCTION The word pseudopolyp  (PP) derives from the com - pound pseudo, a prefix with Greek origin meaning  “fake”, and a second compound, polyp, which means  “any projection into the intestinal lumen above the  layer of mucosa”[1].",Non-OADS,/arxiv_data1/oa_pdf/d7/4d/WJG-23-1541.PMC5340806.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/d7/4d/WJG-23-1541.PMC5340806.pdf
"We	review 	the	options 	for	the	Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1552 1552 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1552-1567  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) REVIEW Current knowledge on the laboratory diagnosis of  Clostridium difficile  infection Adrián	Martínez-Meléndez,	Adrián	Camacho-Ortiz,	Rayo	Morfin-Otero,	Héctor	Jesús	Maldonado-Garza,	 Licet	Villarreal-Treviño,	Elvira	Garza-González",Non-OADS,/arxiv_data1/oa_pdf/6a/b7/WJG-23-1552.PMC5340807.pdf
World J Gastroenterol 2017; 23(9): 1552-1567   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i9/1552.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1552 INTRODUCTION Clostridium difficile  (C. difficile ) is a Gram-positive  and strictly anaerobic bacterium that may exist in  a vegetative form that is very sensitive to oxygen.,Non-OADS,/arxiv_data1/oa_pdf/6a/b7/WJG-23-1552.PMC5340807.pdf
Available from: URL: http://www.fast- trackdiagnostics.com/products/ 133 Genomica .,OADS,/arxiv_data1/oa_pdf/6a/b7/WJG-23-1552.PMC5340807.pdf
Available from: URL: http://genomica.es/en/in_vitro_diagnostics_ clart_enterobac.cfm 134 AusDiagnostics .,OADS,/arxiv_data1/oa_pdf/6a/b7/WJG-23-1552.PMC5340807.pdf
Available from: URL: http://www.ausdiagnostics.com/faecal- pathogens.html 135 Seegene .,Non-OADS,/arxiv_data1/oa_pdf/6a/b7/WJG-23-1552.PMC5340807.pdf
"Available from: URL: http://www.seegene.com/neo/en/products/ Gastrointestinal/seeplex_DIARRHEA.php P- Reviewer : Lightner AL    S- Editor : Yu J     L- Editor : A    E- Editor : Liu WX 1567 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comMartínez-Meléndez	A	 et	al.",Non-OADS,/arxiv_data1/oa_pdf/6a/b7/WJG-23-1552.PMC5340807.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/6a/b7/WJG-23-1552.PMC5340807.pdf
"Confirmation 	using 	individual 	 quantitative 	real-time 	PCR	(qRT-PCR) 	assays 	was	then	Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1568 1568 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1568-1575  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE hsa-mir-183  is frequently methylated and related to poor  survival in human hepatocellular carcinomaBasic Study Sumadi	Lukman	Anwar,	Till	Krech,	Britta	Hasemeier,	Elisa	Schipper,	Nora	Schweitzer,	Arndt	Vogel,	 Hans	Kreipe,	Reena	Buurman,	Britta	Skawran,	Ulrich	Lehmann",Non-OADS,/arxiv_data1/oa_pdf/86/05/WJG-23-1568.PMC5340808.pdf
wjgnet.com/1007-9327/full/v23/i9/1568.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/05/WJG-23-1568.PMC5340808.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/86/05/WJG-23-1568.PMC5340808.pdf
"christian.thiel@med.uni-tuebingen.de Telephone:  +49-7071-2982968 Fax:	+49-7071-294943 Received: 	December 9, 2016 Peer-review 	started: 	December 9, 2016 First	decision: 	January 10, 2017Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1576 1576 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1576-1585  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Porcine model characterizing various parameters assessing  the outcome after acetaminophen intoxication induced  acute liver failureBasic Study Karolin	Thiel,	Wilfried	Klingert,	Kathrin	Klingert,	Matthias	H	Morgalla,	Martin	U	Schuhmann,	 Pamela	Leckie,	Yalda	Sharifi,	Nathan	A	Davies,	Rajiv	Jalan,	Andreas	Peter,	Christian	Grasshoff,	Alfred	Königsrainer,	Martin	Schenk,	Christian	Thiel",Non-OADS,/arxiv_data1/oa_pdf/3f/1e/WJG-23-1576.PMC5340809.pdf
wjgnet.com/1007-9327/full/v23/i9/1576.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/1e/WJG-23-1576.PMC5340809.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/3f/1e/WJG-23-1576.PMC5340809.pdf
"Increase 	of	type	Ⅲ	collagen 	was	more 	pronounced 	 in	PPI-associated 	collagenous 	colitis 	than	in	non-PPI-Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1586 1586 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1586-1593  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Proton pump inhibitor induced collagen expression in  colonocytes is associated with collagenous colitisBasic Study Shiori	Mori,	Yui	Kadochi,	Yi	Luo,	Rina	Fujiwara-Tani,	Yukiko	Nishiguchi,	Shingo	Kishi,	Kiyomu	Fujii,	 Hitoshi	Ohmori,	Hiroki	Kuniyasu",Non-OADS,/arxiv_data1/oa_pdf/dd/50/WJG-23-1586.PMC5340810.pdf
"htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1586 INTRODUCTION Collagenous colitis is one type of microscopic colitis  and is the most common cause of non-bloody, watery  diarrhea[1,2].",Non-OADS,/arxiv_data1/oa_pdf/dd/50/WJG-23-1586.PMC5340810.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/dd/50/WJG-23-1586.PMC5340810.pdf
"Notably, 	Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1594 1594 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1594-1601  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE miR-1181 inhibits invasion and proliferation via STAT3 in  pancreatic cancerBasic Study Jie	Wang,	Xing-Jun	Guo,	You-Ming	Ding,	Jian-Xin	Jiang",Non-OADS,/arxiv_data1/oa_pdf/a3/0e/WJG-23-1594.PMC5340811.pdf
"World J  Gastroenterol  2017; 23(9): 1594-1601  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i9/ 1594 .htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i9.1594 INTRODUCTION Pancreatic cancer is a highly lethal disease, with a  mortality that closely parallels incidence.",Non-OADS,/arxiv_data1/oa_pdf/a3/0e/WJG-23-1594.PMC5340811.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/a3/0e/WJG-23-1594.PMC5340811.pdf
"Low	copy	number 	Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1602 1602 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1602-1607  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Association between TLR7  copy number variations and  hepatitis B virus infection outcome in ChineseCase Control Study Fang	Li,	Xu	Li,	Gui-Zhou	Zou,	Yu-Feng	Gao,	Jun	Ye",Non-OADS,/arxiv_data1/oa_pdf/76/a6/WJG-23-1602.PMC5340812.pdf
World J Gastroenterol  2017; 23(9): 1602-1607   Available from: URL: h ttp://www.wjgnet.com/1007-9327/ full/v23/i9/1602.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/76/a6/WJG-23-1602.PMC5340812.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/76/a6/WJG-23-1602.PMC5340812.pdf
"When considering Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1608 1608 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1608-1617  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Mortality associated with gastrointestinal bleeding in  children: A retrospective cohort studyRetrospective Cohort Study Thomas M Attard, Mikaela Miller, Chaitanya Pant, Ashwath Kumar, Mike Thomson",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
World J Gastroenterol 2017;  23(9): 1608-1617  Available from: UR L: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"2008:  1-56 Available from: URL: http://www.sign.ac.uk/guidelines/full - text/105/index.htm  15 Valkhoff VE , Coloma PM, Masclee GM, Gini R, Innocenti F,  Lapi F, Molokhia M, Mosseveld M, Nielsson MS, Schuemie M,  Thiessard F, van der Lei J, Sturkenboom MC, Trifirò G. Validation  study in four health-care databases: upper gastrointestinal bleeding  misclassification affects precision but not magnitude of drug-related  upper gastrointestinal bleeding risk.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"jennifer.kiser@ucdenver.edu Telephone: +1-303-7246131 Fax: +1-303-7246135 Received: October 21, 2016 Peer-review started: October 24, 2016 First decision: December 28, 2016 Revised: January 12, 2017 Accepted: February 6, 2017 Article in press: February 8, 2017 Published online: March 7, 2017 Abstract AIM To quantify drug-drug-interactions (DDIs) encountered  in patients prescribed hepatitis C virus (HCV) treatment,  the interventions made, and the time spent in this  process.Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1618 1618 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1618-1626  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Optimizing hepatitis C virus treatment through pharmacist  interventions: Identification and management of drug-drug  interactionsRetrospective Study Jacob A Langness, Matthew Nguyen, Amanda Wieland, Gregory T Everson, Jennifer J Kiser",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"World J Gastroenterol 2017; 23(9): 1618-1626   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i9/1618.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1618 INTRODUCTION Approximately 4.6 million Americans are estimated  to have been exposed to the hepatitis C virus (HCV),  and 3.5 million of those have active chronic infection[1].",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"RESULTS Among the 244 patients included, the underlying  diagnosis was cholangiocarcinoma in 118 patients, Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1627 1627 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1627-1636  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Efficacy and safety of limited endoscopic sphincterotomy  before self-expandable metal stent insertion for malignant  biliary obstructionRetrospective Study Hyeong Seok Nam, Dae Hwan Kang, Hyung Wook Kim, Cheol Woong Choi, Su Bum Park, Su Jin Kim,  Dae Gon Ryu",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"World J Gastroenterol 2017; 23(9): 1627-1636   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i9/1627.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1627 INTRODUCTION Malignant biliary obstruction is mainly caused by  cholangiocarcinoma, pancreatic cancer, gallbladder  cancer , and metastatic disease.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Twelve had a Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1637 1637 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1637-1644  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Fibrin sealant for closure of mucosal penetration at the  cardia during peroral endoscopic myotomy: A retrospective  study at a single centerRetrospective Study Wen-Gang Zhang, En-Qiang Linghu, Hui-Kai Li",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"World J  Gastroenterol 2017; 23(9): 1637-1644  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i9/1637.htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i9.1637 INTRODUCTION Peroral endoscopic myotomy (POEM) is an effective  and safe procedure for achalasia, and is becoming  one of the first-line therapies to treat achalasia[1-4].",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"kobara@med.kagawa-u.ac.jp Telephone: +81-87-8912156 Fax: +81-87-8912158 Received: November 30, 2016 Peer-review started: December 2, 2016 First decision: December 28, 2016 Revised: January 12, 2017 Accepted: February 7, 2017 Article in press: February 8, 2017 Published online: March 7, 2017Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1645 1645 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1645-1656  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Outcomes of gastrointestinal defect closure with an over- the-scope clip system in a multicenter experience: An  analysis of a successful suction methodClinical Trials Study Hideki Kobara, Hirohito Mori, Shintaro Fujihara, Noriko Nishiyama, Taiga Chiyo, Takayoshi Yamada,  Masao Fujiwara, Keiichi Okano, Yasuyuki Suzuki, Masayuki Murota, Yoshitaka Ikeda, Makoto Oryu,  Mohamed AboEllail, Tsutomu Masaki",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
World  J Gastroenterol 2017; 23(9): 1645-1656  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i9/1645.htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i9.1645 INTRODUCTION Conventional endoscopic therapy-resistant gastroin - testina diseases have traditionally required invasive  surgery.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1657 1657 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1657-1665  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Usefulness of a novel slim type FlushKnife-BT over  conventional FlushKnife-BT in esophageal endoscopic  submucosal dissectionObservational Study Yoshiko Ohara, Takashi Toyonaga, Namiko Hoshi, Shinwa Tanaka, Shinichi Baba, Hiroshi Takihara,  Fumiaki Kawara, Tsukasa Ishida, Yoshinori Morita, Eiji Umegaki, Takeshi Azuma",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
World J Gastroenterol  2017; 23(9): 1657-1665  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i9/1657.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1657INTRODUCTION Endoscopic submucosal dissection (ESD) is a standard  treatment for early-stage tumors in the digestive  tract[1-6].,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Jian-Bo Gao,  Professor, Department of  Radiology, The First Affiliated Hospital of Zhengzhou University,  No.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Correlations of nIC with MVD,  VEGF, and clinical-pathological features were analyzed.Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1666 1666 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1666-1675  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Spectral computed tomography in advanced gastric  cancer: Can iodine concentration non-invasively assess  angiogenesis?Prospective Study Xiao-Hua Chen, Ke Ren, Pan Liang, Ya-Ru Chai, Kui-Sheng Chen, Jian-Bo Gao",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"World J  Gastroenterol  2017; 23(9): 1666-1675  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i9/1666.htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i9.1666 INTRODUCTION Despite a recent decrease, gastric cancer (GC) remains  the most common cancer and is the third leading  cause of cancer-related death globally[1].",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"The creators of  these websites were: universities and research centers  (n = 25, 30%), foundations and associations ( n = 15,  18%), commercial and pharmaceutical companies ( n = Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1676 1676 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1676-1696  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) EVIDENCE-BASED MEDICINE Inflammatory bowel disease: An evaluation of health  information on the internet Samy A Azer, Thekra I AlOlayan, Malak A AlGhamdi, Malak A AlSanea",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"World J Gastroenterol  2017; 23(9): 1676-1696   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i9/1676.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1676 INTRODUCTION Inflammatory bowel disease (IBD) refers to two  chronic inflammatory disorders, Crohn’s disease and  ulcerative colitis.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
This information about each website  was collected using the following online meter:  http://whois.domaintools.com/.,OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
In this research  we have used the electronic system available at:  http://www.readabilityformulas.com/free-readability- formula-tests.php.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Website title,  OrganisationURL Authority/ownership,  state, countryYear  createdLast  updatedNumber  of pagesNumber of  tablesNumber  of imagesNumber of  illustrations 1 Inflammatory  Bowel Disease  (IBD), Mayo Clinichttp://www.mayoclinic.org/ diseases-conditions/inflammatory- bowel-disease/basics/definition/ con-20034908Mayo Foundation for  Medical Education  and Research,  Arizona, United  States1997 04 Feb 2014 11 0 0 0 2 Inflammatory  Bowel Disease  Health Center,  WebMdhttp://www.webmd.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/ibd-crohns-disease/WebMD, Inc.,  Georgia, United  States.1998 06 Sep 2013 2 0 3 0 3 Inflammatory  Bowel Disease  (IBD), Center for  Disease Control and  Prevention (CDC)http://www.cdc.gov/ibd/ Centers for Disease  Control and  Prevention (CDC),  Georgia, United  States.1999 04 Sep 2014 3 0 1 1 4 Inflammatory  Bowel Disease,  NHS Choiceshttp://www.nhs.uk/conditions/ inflammatory-bowel-disease/ pages/introduction.aspxNHS England,  Wakefield, United  Kingdom.1996 29 Apr 2013 2 0 0 0 5 What are Crohn's  and Colitis?",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Crohn's and Colitis  Foundation http://www.ccfa.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/what-are-crohns-and-colitis/Crohns  and  Colitis  Foundation of  America, New York,  United States.1996 14 Apr 2014 1 0 1 0 6 Inflammatory  Bowel Disease,  KidsHealthhttp://kidshealth.org/parent/ medical/digestive/ibd.htmlKids Health  Organisaion,  The Nemours  Foundation, Orlando,  United States.1995 27 Jan 2015 4 0 1 0 7 Inflammatory  Bowel  Disease (IBD).",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"FamilyDoctorhttp://familydoctor.org/ familydoctor/en/diseases- conditions/inflammatory-bowel- disease.htmlAmerican Academy  of Family Physicians,  New Jersey, United  States.1998 22 Jan 2015 7 0 0 0 8 Inflammatory  Bowel Disease,  Healthlinehttp://www.healthline.com/ health/inflammatory-bowel- disease#Overview1Healthline,  California, United  States.2004 29 Nov  20116 0 0 0 9 Crohn's and Colitis,  Australiahttps://www.crohnsandcolitis.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com.au/about-crohns-colitis/ inflammatory-bowel-disease/Crohn's  and  Colitis  Australia, Victoria,  Australia.2009 24 Jul 2014 3 0 1 0 10 Crohn's and Colitis  UKhttp://www.crohnsandcolitis.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"2010 13 Nov  20142 0 1 0 11 Inflammatory  Bowel Disease  (IBD) (Intestinal  Problems of IBD),  MedicineNethttp://www.medicinenet.com/infla mmatory_bowel_disease_intestinal_ problems/article.htmMedicine.Net.com,  WebMed Network,  New York, United  States.1995 6 Sep 2013 12 0 27 0 12 Inflammatory  Bowel Disease  Center,  Cedars-Sinaihttp://www.cedars-sinai.edu/ Patients/Programs-and-Services/ Inflammatory-Bowel-Disease- Center/Cedars-Sinai Medical  Center, California,  United States.1992 5 Jul 2013 2 0 0 0 13 Inflammatory  Bowel Diseases  Symptoms and  Treatment:  Livesciencehttp://www.livescience.com/39880- inflammatory-bowel-disease.htmlTanya Lewis,  LiveScience  Contributor, New  York, United States.2001 10 Apr 2014 11 0 1 0 14 Inflammatory  Bowel Diseases  Program, Penn  Medicine.orghttp://www.pennmedicine.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/gastroenterology/patient-care/ gi-diseases/inflammatory-bowel- disease-ibd/Penn Medicine,  Pennsylvania,  United Stats.2003 6 Nov 2014 4 0 0 0 15 Inflammatory  Bowel Diseases  Support Groups,  IBDsupport.orghttp://www.ibdsupport.org/ IBD support.org,  Utah, United States.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"2011 30 May  20142 0 0 0 16 Inflammatory  Bowel Disease  (IBD), ABC Health  and wellbeinghttp://www.abc.net.au/health/ library/stories/2012/02/22/343568 8.htmAustralian  Broadcasting  Corporation, NSW,  Australia.2001 3 Dec 2014 4 0 1 0Azer SA et al.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"1682 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.com17 Inflammatory  Bowel Disease  (IBD), GIKidshttp://www.gikids.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"2009 11 Jun 2013 2 0 1 0 18 Inflammatory  Bowel Disease,  Vitamin D Councilhttps://www.vitamindcouncil.org/ health-conditions/inflammatory- bowel-disease/The Vitamin D  Council, California,  United States.2007 17 Jun 2011 6 0 0 0 19 Inflammatory  Bowel Disease  Symptoms and  Diagnosis, Seattle  children'shttp://www.seattlechildrens.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Ctr, Washington,  United States.1993 23 Apr 2014 2 0 0 0 20 Crohn's Disease,  Patient.co.ukhttp://www.patient.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"co.uk/health/crohns-disease-leafletPatient, Patient  information  Publications, Leeds,  United Kingdom.1997 05 Mar  20138 0 0 1 21 Patient Information  Crohn Disease  (Beyond and the  Basics), Uptodatehttp://www.uptodate.com/ contents/crohn-disease-beyond-the- basicsUpToDate, Wolters  Kluwer Health,  Illinois, United  States.1998 29 Jul 2014 5 0 0 0 22 Crohn's Disease,  Centre for digestive  diseaseshttp://www.cdd.com.au/pages/ disease_info/crohns_disease.htmlThe Centre for  Digestive Diseases,  NSW, Australia.08 Jul 2013 4 0 0 0 23 Crohn's Disease,  Patients: British  Society for  Gastroenterology http://www.bsg.org.uk/patients/ general/crohn-s-disease.htmlBritish Society of  Gastroenterology,  London, United  Kingdom.1996 05 Aug  20146 0 0 0 24 Crohn's Disease,  Bupahttp://www.bupa.co.uk/health- information/directory/c/crohns- diseaseThe British  United Provident  Association Ltd,  London, United  Kingdom1996 16 Jun 2014 6 0 0 1 25 Crohn's Disease,  University of  Maryland Medical  Centerhttp://umm.edu/health/medical/ reports/articles/crohns-diseaseUniversity of  Maryland Medical  Center, Maryland,  United States1996 19 Sep 2013 20 0 0 0 26 Crohn's Disease,  Symptoms,  Diagnosis,  Treatment,  Southern Crosshttps://www.southerncross.co.nz/ AboutTheGroup/HealthResources/ MedicalLibrary/tabid/178/vw/1/ ItemID/523/Crohns-disease- symptoms-diagnosis-treatment.aspxSouthern Cross  Healthcare Group;  Auckland, New  Zealand.1998 01 Feb 2015 5 0 0 0 27 Crohn's Disease,  American family  physician http://www.aafp.org/ afp/2011/1215/p1379.htmlAmerican Academy  of Family Physicians,  Kansas, United States1995 02 Jul 2014 2 0 0 0 28 What is Crohn's   Disease?",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
MNThttp://www.medicalnewstoday.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/articles/151620.phpChristian Nordquist,  MNT, Sussex, United  Kingdom.2003 02 Jan 2014 7 0 0 0 29 Crohn's Disease,  Netdoctorhttp://www.netdoctor.co.uk/ diseases/facts/crohnsdisease.htmNetDoctor.co.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Ltd,  London, United  Kingdom.1998 24 Aug  20147 0 1 0 30 Crohn's Disease,  UCSF medical  centerhttp://www.ucsfhealth.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/conditions/crohns_disease/University of  California San  Francisco Medical  Center, California,  United States.2000 04 Jan 2012 2 0 0 0 31 Crohn's Disease  Symptoms and  Treatment, US.news  Wellnesshttp://health.usnews.com/ health-news/health-wellness/ articles/2013/08/03/crohns- disease-symptoms-and-treatmentGuido Zanni, US  News, New York,  United States,1995 22 Jan 2015 3 0 0 0 32 What are the  treatments for  Crohn's disease?",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Beth Israel  Deaconess Medical  Center http://www.bidmc.org/Centers- and-Departments/Departments/ Digestive-Disease-Center/ Inflammatory-Bowel-Disease- Program/Crohns-Disease/What- are-the-treatments-for-Crohns- disease.aspxBeth Israel Deaconess  Medical Center,  Massachusetts,  United States.2002 16 Mar  200615 0 4 1Azer SA et al.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"http://www.crohnsandme.com/ crohns-information/crohns-disease- diagnosis.aspxUCB Multinational  Biopharmaceutical  Company, Brussels,  Belgium2005 29 Apr 2014 9 1 1 1 34 Understanding  Crohn's Disease,  Crohn's and Colitis.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
http://www.crohnsandcolitisinfo.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/Crohns/What-is-Crohns- DiseaseCrohn's  and  Colitis,  Illinois, United States2011 02 Oct 2014 8 0 1 1 35 Learning About  Crohn's Disease,  National Human  Genome Research  Institutehttp://www.genome.gov/25521854 National Human  Genome Research  Institute,  Massachusetts,  United States27 Sep 2011 2 0 0 0 36 Crohn's Disease,  UPMC Life  Changing Medicine http://www.upmc.com/services/ digestive-disorders-center/services/ ibd/conditions/pages/crohns- disease.aspxUPMC Digestive  Disorders Center,  UPMC Presbyterian,  Pennsylvania, United  States1999 04 Mar  20143 0 0 0 37 Crohn's Disease,  Cincinnati  Children'shttp://www.cincinnatichildrens.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/health/c/crohns/Cincinnati Children's  Hospital Medical  Center, Ohio, United  States1998 15 may  20124 0 1 0 38 Crohn's Disease,  Cleveland clinichttp://my.clevelandclinic.org/ health/diseases_conditions/hic_Infl ammatory_Bowel_Disease_IBD_Qan dA/hic_Crohns_DiseaseThe Cleveland Clinic  Foundation, Ohio,  United States1998 02 Jan 2015 2 0 0 0 39 Treatment  of Crohn's  Disease, UNC  Multidisciplinary  Center for IBD  Research and  Treatment http://www.med.unc.edu/ gi/specialties/ibd/about-ibd/ treatment-of-ibd-1/treatment-of- crohns-diseaseUNC, School of  Medicine, North  Carolina, United  States1986 07 Mar  20139 0 9 10 40 Crohn's Disease,  Emedicine healthhttp://www.emedicinehealth.com/ crohn_disease/article_em.htmEMedicine.com Inc,  WebMD Network,  Georgia, United  States2003 06 Sep 2013 10 0 0 1 41 Understanding  Crohn's Disease  and Ulcerative  Colitis.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Australian  Gastroenterology  Institute.http://www.nevdgp.org.au/info/ gastro/crohns.htmAustralian  Gastroenterology  Institute, Digestive  Health Foundation,  New South Wales,  Australia02 Jun 2014 3 0 0 0 42 Crohn's Disease,  Health Centershttp://www.drweil.com/drw/u/ ART00339/Crohns-Disease.htmlWeil's Foundation,  Arizona, United  States1999 16 Jan 2012 3 0 1 0 43 Crohn's Disease-  An Overview, the  Royal Children's  Hospital Melbourne http://www.rch.org.au/kidsinfo/ fact_sheets/Crohns_Disease_an_ove rview/The Royal Children's  Hospital Melbourne,  Victoria, Australia19 Jun 2014 3 0 0 0 44 Fighting  Inflammatory  Bowel Disease  Together, the  Irish Society for  Colitis and Crohn's  Disease http://www.iscc.ie/page.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"php?id=18&title=What%20is%20IBDThe Irish Society for  Colitis  and  Crohn's   Disease, Dublin,  United Kingdom2000 05 Jan 2014 4 0 10 1 45 Crohn's Disease  Diagnosis, New  health guidehttp://www.newhealthguide.org/ Crohn%27s-Disease-Diagnosis.htmlNew Health Guide,  United States2013 10 Feb 15.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"3 0 1 0 46 Crohn's Disease,  HealthDay.http://consumer.healthday.com/ encyclopedia/digestive-health-14/ digestion-health-news-200/crohn-s- disease-644392.htmlHealthDay, New  York, United States2002 15 Apr 2014 4 0 0 0 47 Ulcerative Colitis,  Wikipediahttp://en.wikipedia.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/wiki/Ulcerative_colitisWikimedia  Foundation, Inc,  California, United  States2001 08 May  201214 6 6 1 48 Living with UC, Do  You Know Your  Treatment Options?http://www.livingwithuc.ca/ Janssen Inc., Canada 2010, May 2014 8 4 0 2Azer SA et al.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Everyday  Healthhttp://www.everydayhealth.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
News  Medicalhttp://www.news-medical.net/ health/What-is-Ulcerative-Colitis.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"aspxThe AZO Network,  New South Wales,  Australia2004 26 Feb 2015 2 0 0 0 51 Crohn's Disease and  Ulcerative Colitis,  Better Health  Channelhttp://www.betterhealth.vic.gov.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/diseases/ulcerative-colitis/Jackson  Gastroenterology  Ltd, Central  Pennsylvania,  Pennsylvania, United  States1997 07 April  20143 0 0 3 53 Ulcerative Colitis,  Crohn's and Colitis  Canadahttp://www.crohnsandcolitis.ca/ site/c.dtJRL9NUJmL4H/b.9012449/ k.C223/Ulcerative_Colitis.htmCrohn's  and  Colitis,  Canada2008 19 Dec 2013 12 0 0 1 54 Ulcerative Colitis,  Healthgradeshttp://www.healthgrades.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/conditions/ulcerative-colitisHealthGrades, Inc,  Colorado, United  States1999 08 May  20144 0 0 0 55 Information  for Those with  Ulcerative Colitis,  Colitis UKhttp://www.ulcerativecolitis.org.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"uk/Colitis UK,  Buckinghamshire,  United Kingdom2005 20 Oct 2013 10 0 0 0 56 Colitis and Chronic  Ulcerative Colitis,  Virginia Masonhttps://www.virginiamason.org/ ColitisandChronicUlcerativeColitisVirginia Mason  Medical Center,  Washington, United  States1998 07 May  20083 0 0 0 57 Ulcerative Colitis,  GastroNethttp://www.gastro.net.au/ diseases/ulcerativecolitis.htmlGastroNet Australia  Pty Ltd, Canberra,  Australia2009 12 May  20145 2 4 5 58 Ulcerative Colitis,  Ulcerative Colitis  Net.http://www.ulcerativecolitis.net/ Serovera, Florida,  United States2000 28 Feb 2014 9 3 1 0 59 Inflammatory  Bowel Disease, Lab  Tests Onlinehttp://labtestsonline.org/ understanding/conditions/ inflammatory-bowelAmerican  Association  for Clinical  Chemistry (AACC),  Washington, DC,  United States2001 08 Nov  20103 3 0 2 60 Inflammatory  Bowel Disease  Fact Sheet,  Womenshealth.govhttp://www.womenshealth.gov/ publications/our-publications/fact- sheet/inflammatory-bowel-disease.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"htmlWomenshealth.gov,  the US Department of  Health and Human  Services1995 29 Nov  20143 0 0 3 61 Inflammatory  Bowel Disease  (IBD), Innerbodyhttp://www.innerbody.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/diseases-conditions/ibdInnerBody,  California, United  States1996 02 Oct 2012 5 2 3 4 62 Inflammatory  Bowel  Disease (IBD),  Rightdiagnosishttp://www.rightdiagnosis.com/i/ inflammatory_bowel_disease/intro.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com,  United States2005 11 Jul 2013 2 1 5 0 63 Inflammatory  Bowel Disease,  Lifescript.comhttp://www.lifescript.com/ health/centers/digestive/ related_conditions/inflammatory_b owel_disease.aspxLifeScript, California,  United States1999 05 May  20141 5 2 1 64 Inflammatory  Bowel Disease  (IBD), MUSC  Healthhttp://www.ddc.musc.edu/public/ symptomsDiseases/diseases/ smallBowel/IBD.htmlDigestive Disease  Center, The Medical  University of South  Carolina, South  Carolina, United  States1990 21 May  20131 1 1 0 65 Inflammatory  Bowel Disease  (IBD): Ulcerative  Colitis, Crohn's   Disease, New  York-Presbyterian  Digestive Diseases.http://nyp.org/services/digestive/ ibd.htmlNewYork- Presbyterian  Hospital, New York,  United States1998 24 Aug  20071 2 0 0Azer SA et al.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"http://www.humanillnesses.com/ original/Her-Kid/Inflammatory- Bowel-Disease.htmlHuman Diseases  and   Conditions Forum,  United States2006 16 Oct 2013 2 3 1 0 67 Facts About Crohn's   Disease, US.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Food and Drug  Administration http://www.fda.gov/ ForConsumers/ConsumerUpdates/ ucm107358.htmUS Food and Drug  Administration, The  US Department of  Health  and  Human  Services, Maryland,  United States1997 14 Oct 2014 1 3 2 1 68 Crohn's Disease  Symptoms and  warning Signs,  SymptomFindhttp://www.symptomfind.com/ diseases-conditions/crohns-disease- symptoms-warning-signs/Symptom.Find.Com.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"United States2008 21 Jun 2014 3 2 1 2 69 Crohn's Disease- At a Glance,  SixPartsWater.Orghttp://www.sixpartswater.org/ knowledge-centre/crohns-disease/ glanceSixPartsWater.Org,  United Kingdom2007 02 Oct 2012 2 1 3 0 70 Ulcerative Colitis,  eMedTVhttp://colitis.emedtv.com/ ulcerative-colitis/ulcerative-colitis.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"htmleMedTV,  Washington, United  States2005 07 May  20143 0 5 2 71 Crohn's Disease,  Department of  Surgery, University  of California.http://colorectal.surgery.ucsf.edu/ conditions--procedures/crohns- disease.aspxDepartment of  Surgery, University  of California,  California, United  States1986 10 Oct 2013 1 1 4 1 72 Crohn's Disease, the  National Institute  of Diabetes and  Digestive and  Kidney Diseases http://www.niddk.nih.gov/ health-information/health-topics/ digestive-diseases/crohns-disease/ Pages/facts.aspx The National  Institutes of Diabetes  and Digestive and  Kidney Diseases,  NIDDK, Maryland,  United States2002 20 Jul 2014 1 1 2 0 73 Crohn's Disease,  Patient Education  Centerhttp://www.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/articles/crohns-disease/Patient Education  Center, Harvard  Medical School,  Harvard Medical  Publications,  Massachusetts,  United States2003 20 Jun 2014 2 0 3 0 74 Crohn's Disease  Information, alot  healthhttp://health.alot.com/conditions/ crohns-disease-information--163Alot Health.Com,  Arkansas, United  States1994 15 Aug  20143 1 1 1 75 Crohn's Disease,  Diagnose-me.Comhttp://www.diagnose-me.com/ symptoms-of/crohns-disease.htmlDiagnose-me.Com,  Hawaii, United States2002 21 Jan 2014 1 3 4 1 76 Crohns Disease  Information: Is  Colon Cleansing  the Answer,  Colon Cleanse  Informationhttp://www.colon-cleanse- information.com/crohns-disease- information.htmlColon-Cleanse- Information.Com,  MKR Concepts,  Oregon, United  States2007 11 Nov  20143 0 5 0 77 Crohn's Disease or  Regional Enteritis,  MD India.http://www.medindia.net/ patients/patientinfo/Crohns- Disease.htmMedindia4u.com Pvt.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Ltd, Chennai, India2000 21 Nov  20145 0 1 0 78 Crohn's Disease  Information,  Digestive Disordershttp://www.articleinsider.com/ health-and-fitness/digestive- disorders/crohns-disease- informationDigestive Disorders,  United States2003 03 Sep 2014 2 1 2 1 79 Inflammatory  Bowel Disease,  Patient Center,  American College  of Gastroenterologyhttp://patients.gi.org/topics/ inflammatory-bowel-disease/Patient Center,  American College of  Gastroenterology,  Maryland, United  States1996 16 May  20134 3 1 2 80 Crohn's Disease: Symptoms,  Diagnosis and  Treatment,  Disabled World.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Com http://www.disabled-world.com/ health/digestive/crohns-disease/Disabled World.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Com, New York,  United States2004 29 Oct 2012 1 3 4 1 81 Crohn's Disease,  Nutritionist  Resourcehttp://www.nutritionist-resource.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"1686 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.com82 Crohn's Disease:  Symptoms,  Diagnosis and  Treatment,  verywell.comhttp://seniorhealth.about.com/cs/ digestivetract/a/crohns_2.htmVerywell.com part  of about.com, Inc.,  United States1999 10 Feb 14 6 0 4 0 83 Ulcerative Colitis,  Halyard Surgical.http://www.ulcerative-colitis.org/ Halyard Surgical,  New South Wales,  Australia2003 7 Nov 14 2 0 6 1 84 Ulcerative Colitis  Overview, Health  Communities.com http://www.healthcommunities.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Website title,  OrganisationURL Accuracy scores Readability scores The DISCERN Score  (mean ± SD)The HONcode score  (Out of 100)*The Flesch-Kincaid  Grade Level IndexThe Coleman-Liau  Readability Index 1 Inflammatory Bowel  Disease (IBD), Mayo  Clinichttp://www.mayoclinic.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/diseases-conditions/ inflammatory-bowel-disease/ basics/definition/con-2003490865.0 ± 1.0   0.86* 13.1 ± 0.0 15.0 ± 0.0 2 Inflammatory Bowel  Disease Health Center,  WebMdhttp://www.webmd.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/ibd-crohns-disease/41.3 ± 1.1   0.70* 10.5 ± 3.2 13.3 ± 2.5 3 Inflammatory Bowel  Disease (IBD), Center  for Disease Control and  Prevention (CDC)http://www.cdc.gov/ibd/ 28.7 ± 0.6 0.90 10.9 ± 2.7 13.3 ± 0.6 4 Inflammatory Bowel  Disease, NHS Choiceshttp://www.nhs.uk/conditions/ inflammatory-bowel-disease/ pages/introduction.aspx53.7 ± 0.6 0.63 12.2 ± 1.6 12.3 ± 1.5 5 What are Crohn's and  Colitis?",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Crohn's and  Colitis Foundationhttp://www.ccfa.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/what-are-crohns-and-colitis/50.3 ± 0.6 0.81 16.2 ± 9.3 13.7 ± 0.6 6 Inflammatory Bowel  Disease, KidsHealthhttp://kidshealth.org/parent/ medical/digestive/ibd.html50.7 ± 0.6 0.45 12.0 ± 0.7 11.7 ± 0.6 7 Inflammatory Bowel  Disease (IBD).",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"FamilyDoctorhttp://familydoctor.org/ familydoctor/en/diseases- conditions/inflammatory-bowel- disease.html45.0 ± 1.0   0.63*   9.6 ± 1.4 10.7 ± 0.6 8 Inflammatory Bowel  Disease, Healthlinehttp://www.healthline.com/ health/inflammatory-bowel- disease#Overview141.0 ± 1.0   0.59*   8.7 ± 0.6 11.7 ± 0.6 9 Crohn's and Colitis,  Australiahttps://www.crohnsandcolitis.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
com.au/about-crohns-colitis/ inflammatory-bowel-disease/41.7 ± 0.6 0.34 13.6 ± 3.2 13.0 ± 1.0 10 Crohn's and Colitis UK http://www.crohnsandcolitis.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org.uk/information-and-support/ information-about-ibd/what-is- IBD60.7 ± 0.6 0.45 10.4 ± 1.6 10.3 ± 3.1 11 Inflammatory  Bowel Disease (IBD)  (Intestinal Problems of  IBD), MedicineNethttp://www.medicinenet.com/ inflammatory_bowel_disease_inte stinal_problems/article.htm57.3 ± 1.5   0.75* 13.3 ± 1.5 14.3 ± 1.5 12 Inflammatory Bowel  Disease Center,  Cedars-Sinaihttp://www.cedars-sinai.edu/ Patients/Programs-and-Services/ Inflammatory-Bowel-Disease- Center/25.7 ± 1.1 0.27 13.1 ± 2.9 14.0 ± 3.6 13 Inflammatory Bowel  Diseases Symptoms and  Treatment: Livesciencehttp://www.livescience.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/39880-inflammatory-bowel- disease.html39.3 ± 0.6 0.27 11.1 ± 1.4 11.3 ± 1.5 14 Inflammatory Bowel  Diseases Program, Penn  Medicine.orghttp://www.pennmedicine.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"orghttp://www.ibdsupport.org/ 52.0 ± 1.7   0.61* 12.8 ± 3.7 13.0 ± 3.6 16 Inflammatory Bowel  Disease (IBD), ABC  Health and wellbeinghttp://www.abc.net.au/health/ library/stories/2012/02/22/3435 688.htm34.0 ± 0.0 0.45 11.1 ± 0.3 11.3 ± 0.6 17 Inflammatory Bowel  Disease (IBD), GIKidshttp://www.gikids.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/content/7/en/IBD31.0 ± 0.0 0.52 12.5 ± 0.3 12.7 ± 0.6 18 Inflammatory Bowel  Disease, Vitamin D  Councilhttps://www.vitamindcouncil.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/health-conditions/ inflammatory-bowel-disease/31.3 ± 1.1 0.43   11.0 ± 10.4 10.7 ± 1.5 19 Inflammatory Bowel  Disease Symptoms  and Diagnosis, Seattle  children'shttp://www.seattlechildrens.org/ medical-conditions/digestive- gastrointestinal-conditions/ibd- symptoms/37.3 ± 0.6 0.43  8.9 ± 1.0 11.0 ± 1.0 20 Crohn's Disease,  Patient.co.ukhttp://www.patient.co.uk/ health/crohns-disease-leaflet55.7 ± 1.5   0.59*   8.5 ± 2.0 10.0 ± 1.7 21 Patient Information  Crohn's Disease  (Beyond and the  Basics), Uptodatehttp://www.uptodate.com/ contents/crohn-disease-beyond- the-basics36.7 ± 1.1 0.70 11.2 ± 1.9 12.3 ± 0.6 22 Crohn's Disease, Centre  for digestive diseaseshttp://www.cdd.com.au/pages/ disease_info/crohns_disease.html34.7 ± 0.6 0.52 12.0 ± 0.6 14.3 ± 1.1 23 Crohn's Disease,  Patients: British Society  for Gastroenterologyhttp://www.bsg.org.uk/ patients/general/crohn-s-disease.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"html49.7 ± 0.6 0.56 11.3 ± 1.7 10.7 ± 1.1 24 Crohn's Disease, Bupa http://www.bupa.co.uk/health- information/directory/c/crohns- disease52.0 ± 0.0   0.77*   8.2 ± 0.5   9.0 ± 1.7 25 Crohn's Disease,  University of Maryland  Medical Centerhttp://umm.edu/health/ medical/reports/articles/crohns- disease64.7 ± 1.5 0.81 15.3 ± 4.8 15.0 ± 1.0 26 Crohn's Disease,  Symptoms, Diagnosis,  Treatment, Southern  Crosshttps://www.southerncross.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"co.nz/AboutTheGroup/ HealthResources/ MedicalLibrary/tabid/178/ vw/1/ItemID/523/Crohns- disease-symptoms-diagnosis- treatment.aspx42.7 ± 0.6 0.40 13.8 ± 0.3 13.7 ± 0.6 27 Crohn's Disease,  American family  physicianhttp://www.aafp.org/ afp/2011/1215/p1379.html42.3 ± 1.1 0.18   9.0 ± 2.9 12.3 ± 4.2 28 What is Crohn's  Disease?",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
MNThttp://www.medicalnewstoday.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/articles/151620.php45.7 ± 1.5   0.50* 11.2 ± 2.1 10.7 ± 1.5 29 Crohn's Disease,  Netdoctorhttp://www.netdoctor.co.uk/ diseases/facts/crohnsdisease.htm43.0 ± 0.0 0.59 10.0 ± 1.6 12.3 ± 1.5 30 Crohn's Disease, UCSF  medical centerhttp://www.ucsfhealth.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/conditions/crohns_disease/41.0 ± 1.0 0.40 11.4 ± 0.5 11.3 ± 0.6 31 Crohn's Disease  Symptoms and  Treatment, US.news  Wellnesshttp://health.usnews.com/ health-news/health-wellness/ articles/2013/08/03/crohns- disease-symptoms-and-treatment48.3 ± 0.6 0.50   6.7 ± 0.8 12.3 ± 2.5 32 What are the treatments  for Crohn's disease?",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Beth Israel Deaconess  Medical Centerhttp://www.bidmc.org/ Centers-and-Departments/ Departments/Digestive-Disease- Center/Inflammatory-Bowel- Disease-Program/Crohns- Disease/What-are-the-treatments- for-Crohns-disease.aspx41.7 ± 1.5 0.59 14.3 ± 2.2 14.3 ± 1.1 33 Diagnosing Crohn's,  Crohn's and Me.http://www.crohnsandme.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/crohns-information/crohns- disease-diagnosis.aspx43.3 ± 1.1 0.27 13.6 ± 1.1 12.7 ± 2.5 34 Understanding Crohn's   Disease, Crohn' and  Colitis.http://www.crohnsandcolitisinfo.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/Crohns/What-is-Crohns- Disease41.7 ± 0.6 0.45 12.4 ± 2.0 12.0 ± 2.6 35 Learning About  Crohn's Disease,  National Human Genome  Research Institutehttp://www.genome.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"1688 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.com36 Crohn's Disease,  UPMC Life Changing  Medicinehttp://www.upmc.com/ services/digestive-disorders- center/services/ibd/conditions/ pages/crohns-disease.aspx44.3 ± 0.6 0.27 20.3 ± 9.5 15.0 ± 2.0 37 Crohn's Disease,  Cincinnati Children'shttp://www.cincinnatichildrens.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/health/c/crohns/44.7 ± 0.6 0.40   9.3 ± 1.1 10.7 ± 0.6 38 Crohn's Disease,  Cleveland clinichttp://my.clevelandclinic.org/ health/diseases_conditions/hic_I nflammatory_Bowel_Disease_IBD _QandA/hic_Crohns_Disease26.3 ± 1.1   0.50* 12.9 ± 1.2 12.3 ± 2.3 39 Treatment of Crohn's   Disease, UNC  Multidisciplinary  Center for IBD Research  and Treatmenthttp://www.med.unc.edu/ gi/specialties/ibd/about-ibd/ treatment-of-ibd-1/treatment-of- crohns-disease42.3 ± 0.6 0.45 12.3 ± 0.5 13.3 ± 0.6 40 Crohn's Disease,  Emedicine healthhttp://www.emedicinehealth.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Australian  Gastroenterology  Institute.http://www.nevdgp.org.au/ info/gastro/crohns.htm42.3 ± 1.1 0.27 10.4 ± 0.7 11.3 ± 0.6 42 Crohn's Disease, Health  Centershttp://www.drweil.com/drw/u/ ART00339/Crohns-Disease.html37.0 ± 0.0 0.50 11.9 ± 1.1 12.7 ± 1.5 43 Crohn's Disease- An  Overview, the Royal  Children's Hospital  Melbournehttp://www.rch.org.au/ kidsinfo/fact_sheets/Crohns_Dise ase_an_overview/33.7 ± 1.1 0.50 7.7 ± 2.0 11.3 ± 1.5 44 Fighting Inflammatory  Bowel Disease  Together, the Irish  Society for Colitis and  Crohn's Diseasehttp://www.iscc.ie/page.php?i d=18&title=What%20is%20IBD37.7 ± 0.6 0.40 11.6 ± 1.4 10.7 ± 0.6 45 Crohn's Disease  Diagnosis, New health  guidehttp://www.newhealthguide.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/Crohn%27s-Disease- Diagnosis.html18.3 ± 0.6 0.65 13.5 ± 0.7 13.7 ± 1.1 46 Crohn's Disease,  HealthDay.http://consumer.healthday.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"html61.0 ± 1.0   0.86* 10.9 ± 1.4 12.0 ± 0.0 47 Ulcerative Colitis,  Wikipediahttp://en.wikipedia.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/wiki/Ulcerative_colitis54.0 ± 0.0 0.63 15.2 ± 2.1 14.0 ± 2.6 48 Living with UC, Do  You Know Your  Treatment Options?http://www.livingwithuc.ca/ 44.3 ± 1.1 0.68 12.2 ± 1.6 11.3 ± 2.3 49 What Is Ulcerative  Colitis?",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Everyday  Healthhttp://www.everydayhealth.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
News Medicalhttp://www.news-medical.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"net/health/What-is-Ulcerative- Colitis.aspx46.0 ± 1.0 0.59 11.9 ± 0.2 13.0 ± 1.0 51 Crohn's Disease and  Ulcerative Colitis,  Better Health Channelhttp://www.betterhealth.vic.gov.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/diseases/ulcerative-colitis/52.3 ± 0.6 0.36 10.6 ± 1.4 11.7 ± 2.1 53 Ulcerative Colitis,  Crohn's and Colitis  Canadahttp://www.crohnsandcolitis.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"ca/site/c.dtJRL9NUJmL4H/ b.9012449/k.C223/ Ulcerative_Colitis.htm19.7 ± 0.6 0.31   9.2 ± 1.8 10.0 ± 1.0 54 Ulcerative Colitis,  Healthgradeshttp://www.healthgrades.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/conditions/ulcerative-colitis52.7 ± 1.1 0.68 14.5 ± 3.5 14.0 ± 1.0 55 Information for Those  with Ulcerative Colitis,  Colitis UKhttp://www.ulcerativecolitis.org.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"1689 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.com56 Colitis and Chronic  Ulcerative Colitis,  Virginia Masonhttps://www.virginiamason.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/ColitisandChronicUlcerative Colitis40.7 ± 0.6 0.31 16.7 ± 3.9 15.0 ± 2.0 57 Ulcerative Colitis,  GastroNethttp://www.gastro.net.au/ diseases/ulcerativecolitis.html26.7 ± 0.6 0.60 13.1 ± 1.1 13.3 ± 2.3 58 Ulcerative Colitis,  Ulcerative Colitis Net.http://www.ulcerativecolitis.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"net/41.3 ± 0.6 0.30 11.4 ± 3.3 12.0 ± 2.0 59 Inflammatory Bowel  Disease, Lab Tests  Onlinehttp://labtestsonline.org/ understanding/conditions/ inflammatory-bowel38.3 ± 0.6   0.32* 13.0 ± 0.7 12.0 ± 1.0 60 Inflammatory Bowel  Disease Fact Sheet,  Womenshealth.govhttp://www.womenshealth.gov/ publications/our-publications/ fact-sheet/inflammatory-bowel- disease.html55.7 ± 1.5 0.40   8.8 ± 0.7 10.0 ± 1.0 61 Inflammatory Bowel  Disease (IBD),  Innerbodyhttp://www.innerbody.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/diseases-conditions/ibd39.0 ± 1.0 0.25 17.2 ± 5.7 16.7 ± 1.5 62 Inflammatory Bowel  Disease (IBD),  Rightdiagnosishttp://www.rightdiagnosis.com/ i/inflammatory_bowel_disease/ intro.htm38.0 ± 1.0 0.33 15.9 ± 4.1 15.7 ± 2.1 63 Inflammatory Bowel  Disease, Lifescript.comhttp://www.lifescript.com/ health/centers/digestive/ related_conditions/inflammatory _bowel_disease.aspx32.0 ± 1.0 0.50 15.1 ± 2.8 12.7 ± 1.5 64 Inflammatory Bowel  Disease (IBD), MUSC  Healthhttp://www.ddc.musc.edu/ public/symptomsDiseases/ diseases/smallBowel/IBD.html22.7 ± 1.1 0.27 14.2 ± 2.2 15.7 ± 2.9 65 Inflammatory Bowel  Disease (IBD):  Ulcerative Colitis,  Crohn's Disease, New  York-Presbyterian  Digestive Diseaseshttp://nyp.org/services/ digestive/ibd.html32.3 ± 0.6 0.27 13.2 ± 0.5 12.7 ± 0.6 66 Inflammatory Bowel  Disease, Human  Diseases and  Conditions Forum.http://www.humanillnesses.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Food and  Drug Administrationhttp://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"htm34.7 ± 2.1 0.36 10.6 ± 2.6 13.7 ± 2.1 68 Crohn's Disease  Symptoms and warning  Signs, SymptomFindhttp://www.symptomfind.com/ diseases-conditions/crohns- disease-symptoms-warning- signs/26.0 ± 1.0   0.26* 10.0 ± 1.9 13.7 ± 2.3 69 Crohn's Disease-At a  Glance, SixPartsWater.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Orghttp://www.sixpartswater.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/knowledge-centre/crohns- disease/glance39.7 ± 0.6 0.15 18.3 ± 3.4 12.7 ± 0.6 70 Ulcerative Colitis,  eMedTVhttp://colitis.emedtv.com/ ulcerative-colitis/ulcerative- colitis.html55.3 ± 0.6   0.32* 12.1 ± 0.8 11.0 ± 2.0 71 Crohn's Disease,  Department of  Surgery, University of  California.http://colorectal.surgery.ucsf.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"edu/conditions--procedures/ ulcerative-colitis.aspx51.0 ± 1.0 0.73 12.4 ± 0.8 12.3 ± 2.5 72 Crohn's Disease, the  National Institute of  Diabetes and Digestive  and Kidney Diseaseshttp://www.niddk.nih.gov/ health-information/health-topics/ digestive-diseases/crohns- disease/Pages/facts.aspx68.3 ± 1.2 0.95 13.6 ± 3.9 13.7 ± 5.5 73 Crohn's Disease, Patient  Education Centerhttp://www.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/articles/crohns-disease/38.0 ± 1.0 0.30 8.9 ± 0.8 12.3 ± 1.5 74 Crohn's Disease  Information, alot healthhttp://health.alot.com/ conditions/crohns-disease- information--16332.3 ± 0.6 0.22 10.4 ± 1.5 12.0 ± 2.6 75 Crohn's Disease,  Diagnose-me.Comhttp://www.diagnose-me.com/ symptoms-of/crohns-disease.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Further analysis revealed that there was no  1690 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.com76 Crohns Disease  Information: Is  Colon Cleansing the  Answer, Colon Cleanse  Informationhttp://www.colon-cleanse- information.com/crohns-disease- information.html35.7 ± 2.5 0.36 13.2 ± 0.5 14.7 ± 1.5 77 Crohn's Disease or  Regional Enteritis, MD  India.http://www.medindia.net/ patients/patientinfo/Crohns- Disease.htm46.3 ± 1.1 0.54 11.8 ± 1.3 14.0 ± 2.6 78 Crohn's Disease  Information, Digestive  Disordershttp://www.articleinsider.com/ health-and-fitness/digestive- disorders/crohns-disease- information33.3 ± 0.6 0.60 10.2 ± 0.6 12.3 ± 0.6 79 Inflammatory Bowel  Disease, Patient Center,  American College of  Gastroenterologyhttp://patients.gi.org/topics/ inflammatory-bowel-disease/58.3 ± 1.2 0.80 12.7 ± 1.3 13.0 ± 1.0 80 Crohn's Disease: Symptoms, Diagnosis  and Treatment,  Disabled World.Comhttp://www.disabled-world.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"com/health/digestive/crohns- disease/26.3 ± 2.3 0.19 8.6 ± 0.6 12.00 ± 1.73 81 Crohn's Disease,  Nutritionist Resourcehttp://www.nutritionist-resource.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"html39.3 ± 0.6 0.57 10.2 ± 2.6 11.3 ± 1.1 82 Crohn's Disease:  Symptoms, Diagnosis  and Treatment,  verywell.comhttp://seniorhealth.about.com/ cs/digestivetract/a/crohns_2.htm44.3 ± 1.5 0.37 12.6 ± 0.7 11.0 ± 1.0 83 Ulcerative Colitis,  Halyard Surgical.http://www.ulcerative-colitis.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"org/51.7 ± 1.5 0.25 12.1 ± 0.6 12.7 ± 2.5 84 Ulcerative Colitis  Overview, Health  Communities.comhttp://www.healthcommunities.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Available from: URL:  http://www.pewinternet.org/2005/05/17/health-information-online/ 8 Azer SA .,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Available from: URL:  https://www.ebizmba.com/articles/search-engines 10 Schreuders EH , Grobbee EJ, Kuipers EJ, Spaander MC,  Veldhuyzen van Zanten SJ.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Available from: URL:  http://www.discern.org.uk/discern.pdf 15 Health on the net foundation (HON) .,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Available from: URL: https://www.healthonnet.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Available from: URL:  https://www.hon.ch/HONcode/Webmasters/HON_CCE_en.htm 17 Certificate of compliance.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Available  from: URL: http://www.healthonnet.org/HONcode/Conduct.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Available from:  URL: http://www.nlm.nih.gov/medlineplus/etr.html 23 Kutner M , Greenberg E, Jin Y , Paulsen C. The health literacy of  America’s adults: results from the 2003 National Assessment of  Adult Literacy.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Available from: URL: http://nces.ed.gov/pubsearch/pubsinfo.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
Available from: URL: http://www.pifonline.org.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"The efficacy  of antidiabetic treatment in improving the response to Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1697 1697 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1697-1711  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) SYSTEMATIC REVIEWS Diabetes mellitus, insulin resistance and hepatitis C virus  infection: A contemporary review Anne-Claire Desbois, Patrice Cacoub",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
World  J Gastroenterol 2017; 23(9): 1697-1711  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i9/1697.htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i9.1697 INTRODUCTION Hepatitis C virus (HCV) infection is a major health  problem.,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Core tip: This is a review of 58 published articles on  presacral venous plexus injury during the mobilization  Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1712 1712 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1712-1719  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) SYSTEMATIC REVIEWS Presacral venous bleeding during mobilization in rectal  cancer Jose Enrique Casal Núñez, Vincenzo Vigorita, Alejandro Ruano Poblador, Ana María Gay Fernández,  Maria Ángeles Toscano Novella, Nieves Cáceres Alvarado, Lucinda Pérez Dominguez",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
World J Gastroenterol  2017; 23(9): 1712-1719   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i9/1712.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1712 INTRODUCTION Presacral venous plexus injury during the mobiliza - tion of the rectum is one of the most frequent intra-   operative complications during rectal cancer surgery[1].,Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Based on our findings, Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1720 1720 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1720-1724  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) CASE REPORT Gastrointestinal stromal tumor of the stomach with axillary  lymph node metastasis: A case report Naoki Kubo, Nobumichi Takeuchi",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"World J Gastroenterol 2017; 23(9): 1720-1724  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i9/1720.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1720 INTRODUCTION Gastrointestinal stromal tumors (GISTs) are the most  common type of gastrointestinal mesenchymal tumor ,  although GIST only accounts for approximately 1% of  gastric malignancies[1].",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"Key words: Leiomyosarcoma; Chemotherapy; Multiple  liver tumors; Liver metastasis; AdenocarcinomaSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1725 1725 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1725-1734  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) CASE REPORT Synchronous coexistence of liver metastases from cecal  leiomyosarcoma and rectal adenocarcinoma: A case report Hideki Aoki, Takashi Arata, Masashi Utsumi, Yutaka Mushiake, Tomoyoshi Kunitomo, Isao Yasuhara,  Fumitaka Taniguchi, Koh Katsuda, Kohji Tanakaya, Hitoshi Takeuchi, Rie Yamasaki",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"World  J Gastroenterol  2017; 23(9): 1725-1734  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i9/1725.htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i9.1725 INTRODUCTION Since the appearance of gastrointestinal stromal tumor  as a distinctly defined entity, the diagnosis of intestinal  leiomyosarcoma has not been common.",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/45/1b/WJG-23-1608.PMC5340813.pdf
"jennifer.kiser@ucdenver.edu Telephone: 	+1-303-7246131 Fax:	+1-303-7246135 Received: 	October 21, 2016 Peer-review 	started: 	October 24, 2016 First	decision: 	December 28, 2016 Revised: 	January 12, 2017 Accepted: 	February 6, 2017 Article 	in	press: 	February 8, 2017 Published 	online: 	March 7, 2017 Abstract AIM To	quantify 	drug-drug-interactions 	(DDIs) 	encountered 	 in	patients 	prescribed 	hepatitis 	C	virus	(HCV) 	treatment, 	 the	interventions 	made, 	and	the	time	spent 	in	this	 process.Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1618 1618 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1618-1626  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Optimizing hepatitis C virus treatment through pharmacist  interventions: Identification and management of drug-drug  interactionsRetrospective Study Jacob	A	Langness,	Matthew	Nguyen,	Amanda	Wieland,	Gregory	T	Everson,	Jennifer	J	Kiser",Non-OADS,/arxiv_data1/oa_pdf/96/bd/WJG-23-1618.PMC5340814.pdf
"World J Gastroenterol 2017; 23(9): 1618-1626   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i9/1618.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1618 INTRODUCTION Approximately 4.6 million Americans are estimated  to have been exposed to the hepatitis C virus (HCV),  and 3.5 million of those have active chronic infection[1].",Non-OADS,/arxiv_data1/oa_pdf/96/bd/WJG-23-1618.PMC5340814.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/96/bd/WJG-23-1618.PMC5340814.pdf
"RESULTSAmong 	the	244	patients 	included, 	the	underlying 	 diagnosis 	was	cholangiocarcinoma 	in	118	patients, 	Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1627 1627 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1627-1636  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Efficacy and safety of limited endoscopic sphincterotomy  before self-expandable metal stent insertion for malignant  biliary obstructionRetrospective Study Hyeong	Seok	Nam,	Dae	Hwan	Kang,	Hyung	Wook	Kim,	Cheol	Woong	Choi,	Su	Bum	Park,	Su	Jin	Kim,	 Dae	Gon	Ryu",Non-OADS,/arxiv_data1/oa_pdf/f3/0a/WJG-23-1627.PMC5340815.pdf
"World J Gastroenterol 2017; 23(9): 1627-1636   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i9/1627.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1627 INTRODUCTION Malignant biliary obstruction is mainly caused by  cholangiocarcinoma, pancreatic cancer, gallbladder  cancer , and metastatic disease.",Non-OADS,/arxiv_data1/oa_pdf/f3/0a/WJG-23-1627.PMC5340815.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/f3/0a/WJG-23-1627.PMC5340815.pdf
"Twelve 	had	a	Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1637 1637 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1637-1644  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Fibrin sealant for closure of mucosal penetration at the  cardia during peroral endoscopic myotomy: A retrospective  study at a single centerRetrospective Study Wen-Gang	Zhang,	En-Qiang	Linghu,	Hui-Kai	Li",Non-OADS,/arxiv_data1/oa_pdf/7f/33/WJG-23-1637.PMC5340816.pdf
"World J  Gastroenterol 2017; 23(9): 1637-1644  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i9/1637.htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i9.1637 INTRODUCTION Peroral endoscopic myotomy (POEM) is an effective  and safe procedure for achalasia, and is becoming  one of the first-line therapies to treat achalasia[1-4].",Non-OADS,/arxiv_data1/oa_pdf/7f/33/WJG-23-1637.PMC5340816.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/7f/33/WJG-23-1637.PMC5340816.pdf
"kobara@med.kagawa-u.ac.jp Telephone: 	+81-87-8912156 Fax:	+81-87-8912158 Received: 	November 30, 2016 Peer-review 	started: 	December 2, 2016 First	decision: 	December 28, 2016 Revised: 	January 12, 2017 Accepted: 	February 7, 2017 Article 	in	press: 	February 8, 2017 Published 	online: 	March 7, 2017Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1645 1645 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1645-1656  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Outcomes of gastrointestinal defect closure with an over- the-scope clip system in a multicenter experience: An  analysis of a successful suction methodClinical Trials Study Hideki	Kobara,	Hirohito	Mori,	Shintaro	Fujihara,	Noriko	Nishiyama,	Taiga	Chiyo,	Takayoshi	Yamada,	 Masao	Fujiwara,	Keiichi	Okano,	Yasuyuki	Suzuki,	Masayuki	Murota,	Yoshitaka	Ikeda,	Makoto	Oryu,	Mohamed	AboEllail,	Tsutomu	Masaki",Non-OADS,/arxiv_data1/oa_pdf/14/f4/WJG-23-1645.PMC5340817.pdf
World  J Gastroenterol 2017; 23(9): 1645-1656  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i9/1645.htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i9.1645 INTRODUCTION Conventional endoscopic therapy-resistant gastroin - testina diseases have traditionally required invasive  surgery.,Non-OADS,/arxiv_data1/oa_pdf/14/f4/WJG-23-1645.PMC5340817.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/14/f4/WJG-23-1645.PMC5340817.pdf
"Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1657 1657 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1657-1665  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Usefulness of a novel slim type FlushKnife-BT over  conventional FlushKnife-BT in esophageal endoscopic  submucosal dissectionObservational Study Yoshiko	Ohara,	Takashi	Toyonaga,	Namiko	Hoshi,	Shinwa	Tanaka,	Shinichi	Baba,	Hiroshi	Takihara,	 Fumiaki	Kawara,	Tsukasa	Ishida,	Yoshinori	Morita,	Eiji	Umegaki,	Takeshi	Azuma",Non-OADS,/arxiv_data1/oa_pdf/7f/50/WJG-23-1657.PMC5340818.pdf
World J Gastroenterol  2017; 23(9): 1657-1665  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i9/1657.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1657INTRODUCTION Endoscopic submucosal dissection (ESD) is a standard  treatment for early-stage tumors in the digestive  tract[1-6].,Non-OADS,/arxiv_data1/oa_pdf/7f/50/WJG-23-1657.PMC5340818.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/7f/50/WJG-23-1657.PMC5340818.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Jian-Bo Gao,  Professor, Department of  Radiology, The First Affiliated Hospital of Zhengzhou University,  No.",Non-OADS,/arxiv_data1/oa_pdf/d3/9a/WJG-23-1666.PMC5340819.pdf
"Correlations of nIC with MVD,  VEGF, and clinical-pathological features were analyzed.Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1666 1666 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1666-1675  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Spectral computed tomography in advanced gastric  cancer: Can iodine concentration non-invasively assess  angiogenesis?Prospective Study Xiao-Hua Chen, Ke Ren, Pan Liang, Ya-Ru Chai, Kui-Sheng Chen, Jian-Bo Gao",Non-OADS,/arxiv_data1/oa_pdf/d3/9a/WJG-23-1666.PMC5340819.pdf
"World J  Gastroenterol  2017; 23(9): 1666-1675  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i9/1666.htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i9.1666 INTRODUCTION Despite a recent decrease, gastric cancer (GC) remains  the most common cancer and is the third leading  cause of cancer-related death globally[1].",Non-OADS,/arxiv_data1/oa_pdf/d3/9a/WJG-23-1666.PMC5340819.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/d3/9a/WJG-23-1666.PMC5340819.pdf
"The	creators 	of	 these 	websites 	were: 	universities 	and	research 	centers 	 (n	=	25,	30%), 	foundations 	and	associations 	(n	=	15,	 18%), 	commercial 	and	pharmaceutical 	companies 	(n	=	Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1676 1676 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1676-1696  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) EVIDENCE-BASED MEDICINE Inflammatory bowel disease: An evaluation of health  information on the internet Samy	A	Azer,	Thekra	I	AlOlayan,	Malak	A	AlGhamdi,	Malak	A	AlSanea",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"World J Gastroenterol  2017; 23(9): 1676-1696   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i9/1676.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1676 INTRODUCTION Inflammatory bowel disease (IBD) refers to two  chronic inflammatory disorders, Crohn’s disease and  ulcerative colitis.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
This information about each website  was collected using the following online meter:  http://whois.domaintools.com/.,OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
In this research  we have used the electronic system available at:  http://www.readabilityformulas.com/free-readability- formula-tests.php.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Website title,  OrganisationURL Authority/ownership,  state, countryYear  createdLast  updatedNumber  of pagesNumber of  tablesNumber  of imagesNumber of  illustrations 1 Inflammatory  Bowel Disease  (IBD), Mayo Clinichttp://www.mayoclinic.org/ diseases-conditions/inflammatory- bowel-disease/basics/definition/ con-20034908Mayo Foundation for  Medical Education  and Research,  Arizona, United  States1997 04 Feb 2014 11 0 0 0 2 Inflammatory  Bowel Disease  Health Center,  WebMdhttp://www.webmd.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/ibd-crohns-disease/WebMD, Inc.,  Georgia, United  States.1998 06 Sep 2013 2 0 3 0 3 Inflammatory  Bowel Disease  (IBD), Center for  Disease Control and  Prevention (CDC)http://www.cdc.gov/ibd/ Centers for Disease  Control and  Prevention (CDC),  Georgia, United  States.1999 04 Sep 2014 3 0 1 1 4 Inflammatory  Bowel Disease,  NHS Choiceshttp://www.nhs.uk/conditions/ inflammatory-bowel-disease/ pages/introduction.aspxNHS England,  Wakefield, United  Kingdom.1996 29 Apr 2013 2 0 0 0 5 What are Crohn's  and Colitis?",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Crohn's and Colitis  Foundation http://www.ccfa.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/what-are-crohns-and-colitis/Crohns  and  Colitis  Foundation of  America, New York,  United States.1996 14 Apr 2014 1 0 1 0 6 Inflammatory  Bowel Disease,  KidsHealthhttp://kidshealth.org/parent/ medical/digestive/ibd.htmlKids Health  Organisaion,  The Nemours  Foundation, Orlando,  United States.1995 27 Jan 2015 4 0 1 0 7 Inflammatory  Bowel  Disease (IBD).",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"FamilyDoctorhttp://familydoctor.org/ familydoctor/en/diseases- conditions/inflammatory-bowel- disease.htmlAmerican Academy  of Family Physicians,  New Jersey, United  States.1998 22 Jan 2015 7 0 0 0 8 Inflammatory  Bowel Disease,  Healthlinehttp://www.healthline.com/ health/inflammatory-bowel- disease#Overview1Healthline,  California, United  States.2004 29 Nov  20116 0 0 0 9 Crohn's and Colitis,  Australiahttps://www.crohnsandcolitis.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com.au/about-crohns-colitis/ inflammatory-bowel-disease/Crohn's  and  Colitis  Australia, Victoria,  Australia.2009 24 Jul 2014 3 0 1 0 10 Crohn's and Colitis  UKhttp://www.crohnsandcolitis.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"2010 13 Nov  20142 0 1 0 11 Inflammatory  Bowel Disease  (IBD) (Intestinal  Problems of IBD),  MedicineNethttp://www.medicinenet.com/infla mmatory_bowel_disease_intestinal_ problems/article.htmMedicine.Net.com,  WebMed Network,  New York, United  States.1995 6 Sep 2013 12 0 27 0 12 Inflammatory  Bowel Disease  Center,  Cedars-Sinaihttp://www.cedars-sinai.edu/ Patients/Programs-and-Services/ Inflammatory-Bowel-Disease- Center/Cedars-Sinai Medical  Center, California,  United States.1992 5 Jul 2013 2 0 0 0 13 Inflammatory  Bowel Diseases  Symptoms and  Treatment:  Livesciencehttp://www.livescience.com/39880- inflammatory-bowel-disease.htmlTanya Lewis,  LiveScience  Contributor, New  York, United States.2001 10 Apr 2014 11 0 1 0 14 Inflammatory  Bowel Diseases  Program, Penn  Medicine.orghttp://www.pennmedicine.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/gastroenterology/patient-care/ gi-diseases/inflammatory-bowel- disease-ibd/Penn Medicine,  Pennsylvania,  United Stats.2003 6 Nov 2014 4 0 0 0 15 Inflammatory  Bowel Diseases  Support Groups,  IBDsupport.orghttp://www.ibdsupport.org/ IBD support.org,  Utah, United States.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"2011 30 May  20142 0 0 0 16 Inflammatory  Bowel Disease  (IBD), ABC Health  and wellbeinghttp://www.abc.net.au/health/ library/stories/2012/02/22/343568 8.htmAustralian  Broadcasting  Corporation, NSW,  Australia.2001 3 Dec 2014 4 0 1 0Azer	SA	 et	al.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"1682 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.com17 Inflammatory  Bowel Disease  (IBD), GIKidshttp://www.gikids.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"2009 11 Jun 2013 2 0 1 0 18 Inflammatory  Bowel Disease,  Vitamin D Councilhttps://www.vitamindcouncil.org/ health-conditions/inflammatory- bowel-disease/The Vitamin D  Council, California,  United States.2007 17 Jun 2011 6 0 0 0 19 Inflammatory  Bowel Disease  Symptoms and  Diagnosis, Seattle  children'shttp://www.seattlechildrens.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Ctr, Washington,  United States.1993 23 Apr 2014 2 0 0 0 20 Crohn's Disease,  Patient.co.ukhttp://www.patient.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"co.uk/health/crohns-disease-leafletPatient, Patient  information  Publications, Leeds,  United Kingdom.1997 05 Mar  20138 0 0 1 21 Patient Information  Crohn Disease  (Beyond and the  Basics), Uptodatehttp://www.uptodate.com/ contents/crohn-disease-beyond-the- basicsUpToDate, Wolters  Kluwer Health,  Illinois, United  States.1998 29 Jul 2014 5 0 0 0 22 Crohn's Disease,  Centre for digestive  diseaseshttp://www.cdd.com.au/pages/ disease_info/crohns_disease.htmlThe Centre for  Digestive Diseases,  NSW, Australia.08 Jul 2013 4 0 0 0 23 Crohn's Disease,  Patients: British  Society for  Gastroenterology http://www.bsg.org.uk/patients/ general/crohn-s-disease.htmlBritish Society of  Gastroenterology,  London, United  Kingdom.1996 05 Aug  20146 0 0 0 24 Crohn's Disease,  Bupahttp://www.bupa.co.uk/health- information/directory/c/crohns- diseaseThe British  United Provident  Association Ltd,  London, United  Kingdom1996 16 Jun 2014 6 0 0 1 25 Crohn's Disease,  University of  Maryland Medical  Centerhttp://umm.edu/health/medical/ reports/articles/crohns-diseaseUniversity of  Maryland Medical  Center, Maryland,  United States1996 19 Sep 2013 20 0 0 0 26 Crohn's Disease,  Symptoms,  Diagnosis,  Treatment,  Southern Crosshttps://www.southerncross.co.nz/ AboutTheGroup/HealthResources/ MedicalLibrary/tabid/178/vw/1/ ItemID/523/Crohns-disease- symptoms-diagnosis-treatment.aspxSouthern Cross  Healthcare Group;  Auckland, New  Zealand.1998 01 Feb 2015 5 0 0 0 27 Crohn's Disease,  American family  physician http://www.aafp.org/ afp/2011/1215/p1379.htmlAmerican Academy  of Family Physicians,  Kansas, United States1995 02 Jul 2014 2 0 0 0 28 What is Crohn's   Disease?",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
MNThttp://www.medicalnewstoday.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/articles/151620.phpChristian Nordquist,  MNT, Sussex, United  Kingdom.2003 02 Jan 2014 7 0 0 0 29 Crohn's Disease,  Netdoctorhttp://www.netdoctor.co.uk/ diseases/facts/crohnsdisease.htmNetDoctor.co.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Ltd,  London, United  Kingdom.1998 24 Aug  20147 0 1 0 30 Crohn's Disease,  UCSF medical  centerhttp://www.ucsfhealth.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/conditions/crohns_disease/University of  California San  Francisco Medical  Center, California,  United States.2000 04 Jan 2012 2 0 0 0 31 Crohn's Disease  Symptoms and  Treatment, US.news  Wellnesshttp://health.usnews.com/ health-news/health-wellness/ articles/2013/08/03/crohns- disease-symptoms-and-treatmentGuido Zanni, US  News, New York,  United States,1995 22 Jan 2015 3 0 0 0 32 What are the  treatments for  Crohn's disease?",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Beth Israel  Deaconess Medical  Center http://www.bidmc.org/Centers- and-Departments/Departments/ Digestive-Disease-Center/ Inflammatory-Bowel-Disease- Program/Crohns-Disease/What- are-the-treatments-for-Crohns- disease.aspxBeth Israel Deaconess  Medical Center,  Massachusetts,  United States.2002 16 Mar  200615 0 4 1Azer	SA	 et	al.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"http://www.crohnsandme.com/ crohns-information/crohns-disease- diagnosis.aspxUCB Multinational  Biopharmaceutical  Company, Brussels,  Belgium2005 29 Apr 2014 9 1 1 1 34 Understanding  Crohn's Disease,  Crohn's and Colitis.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
http://www.crohnsandcolitisinfo.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/Crohns/What-is-Crohns- DiseaseCrohn's  and  Colitis,  Illinois, United States2011 02 Oct 2014 8 0 1 1 35 Learning About  Crohn's Disease,  National Human  Genome Research  Institutehttp://www.genome.gov/25521854 National Human  Genome Research  Institute,  Massachusetts,  United States27 Sep 2011 2 0 0 0 36 Crohn's Disease,  UPMC Life  Changing Medicine http://www.upmc.com/services/ digestive-disorders-center/services/ ibd/conditions/pages/crohns- disease.aspxUPMC Digestive  Disorders Center,  UPMC Presbyterian,  Pennsylvania, United  States1999 04 Mar  20143 0 0 0 37 Crohn's Disease,  Cincinnati  Children'shttp://www.cincinnatichildrens.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/health/c/crohns/Cincinnati Children's  Hospital Medical  Center, Ohio, United  States1998 15 may  20124 0 1 0 38 Crohn's Disease,  Cleveland clinichttp://my.clevelandclinic.org/ health/diseases_conditions/hic_Infl ammatory_Bowel_Disease_IBD_Qan dA/hic_Crohns_DiseaseThe Cleveland Clinic  Foundation, Ohio,  United States1998 02 Jan 2015 2 0 0 0 39 Treatment  of Crohn's  Disease, UNC  Multidisciplinary  Center for IBD  Research and  Treatment http://www.med.unc.edu/ gi/specialties/ibd/about-ibd/ treatment-of-ibd-1/treatment-of- crohns-diseaseUNC, School of  Medicine, North  Carolina, United  States1986 07 Mar  20139 0 9 10 40 Crohn's Disease,  Emedicine healthhttp://www.emedicinehealth.com/ crohn_disease/article_em.htmEMedicine.com Inc,  WebMD Network,  Georgia, United  States2003 06 Sep 2013 10 0 0 1 41 Understanding  Crohn's Disease  and Ulcerative  Colitis.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Australian  Gastroenterology  Institute.http://www.nevdgp.org.au/info/ gastro/crohns.htmAustralian  Gastroenterology  Institute, Digestive  Health Foundation,  New South Wales,  Australia02 Jun 2014 3 0 0 0 42 Crohn's Disease,  Health Centershttp://www.drweil.com/drw/u/ ART00339/Crohns-Disease.htmlWeil's Foundation,  Arizona, United  States1999 16 Jan 2012 3 0 1 0 43 Crohn's Disease-  An Overview, the  Royal Children's  Hospital Melbourne http://www.rch.org.au/kidsinfo/ fact_sheets/Crohns_Disease_an_ove rview/The Royal Children's  Hospital Melbourne,  Victoria, Australia19 Jun 2014 3 0 0 0 44 Fighting  Inflammatory  Bowel Disease  Together, the  Irish Society for  Colitis and Crohn's  Disease http://www.iscc.ie/page.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"php?id=18&title=What%20is%20IBDThe Irish Society for  Colitis  and  Crohn's   Disease, Dublin,  United Kingdom2000 05 Jan 2014 4 0 10 1 45 Crohn's Disease  Diagnosis, New  health guidehttp://www.newhealthguide.org/ Crohn%27s-Disease-Diagnosis.htmlNew Health Guide,  United States2013 10 Feb 15.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"3 0 1 0 46 Crohn's Disease,  HealthDay.http://consumer.healthday.com/ encyclopedia/digestive-health-14/ digestion-health-news-200/crohn-s- disease-644392.htmlHealthDay, New  York, United States2002 15 Apr 2014 4 0 0 0 47 Ulcerative Colitis,  Wikipediahttp://en.wikipedia.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/wiki/Ulcerative_colitisWikimedia  Foundation, Inc,  California, United  States2001 08 May  201214 6 6 1 48 Living with UC, Do  You Know Your  Treatment Options?http://www.livingwithuc.ca/ Janssen Inc., Canada 2010, May 2014 8 4 0 2Azer	SA	 et	al.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Everyday  Healthhttp://www.everydayhealth.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
News  Medicalhttp://www.news-medical.net/ health/What-is-Ulcerative-Colitis.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"aspxThe AZO Network,  New South Wales,  Australia2004 26 Feb 2015 2 0 0 0 51 Crohn's Disease and  Ulcerative Colitis,  Better Health  Channelhttp://www.betterhealth.vic.gov.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/diseases/ulcerative-colitis/Jackson  Gastroenterology  Ltd, Central  Pennsylvania,  Pennsylvania, United  States1997 07 April  20143 0 0 3 53 Ulcerative Colitis,  Crohn's and Colitis  Canadahttp://www.crohnsandcolitis.ca/ site/c.dtJRL9NUJmL4H/b.9012449/ k.C223/Ulcerative_Colitis.htmCrohn's  and  Colitis,  Canada2008 19 Dec 2013 12 0 0 1 54 Ulcerative Colitis,  Healthgradeshttp://www.healthgrades.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/conditions/ulcerative-colitisHealthGrades, Inc,  Colorado, United  States1999 08 May  20144 0 0 0 55 Information  for Those with  Ulcerative Colitis,  Colitis UKhttp://www.ulcerativecolitis.org.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"uk/Colitis UK,  Buckinghamshire,  United Kingdom2005 20 Oct 2013 10 0 0 0 56 Colitis and Chronic  Ulcerative Colitis,  Virginia Masonhttps://www.virginiamason.org/ ColitisandChronicUlcerativeColitisVirginia Mason  Medical Center,  Washington, United  States1998 07 May  20083 0 0 0 57 Ulcerative Colitis,  GastroNethttp://www.gastro.net.au/ diseases/ulcerativecolitis.htmlGastroNet Australia  Pty Ltd, Canberra,  Australia2009 12 May  20145 2 4 5 58 Ulcerative Colitis,  Ulcerative Colitis  Net.http://www.ulcerativecolitis.net/ Serovera, Florida,  United States2000 28 Feb 2014 9 3 1 0 59 Inflammatory  Bowel Disease, Lab  Tests Onlinehttp://labtestsonline.org/ understanding/conditions/ inflammatory-bowelAmerican  Association  for Clinical  Chemistry (AACC),  Washington, DC,  United States2001 08 Nov  20103 3 0 2 60 Inflammatory  Bowel Disease  Fact Sheet,  Womenshealth.govhttp://www.womenshealth.gov/ publications/our-publications/fact- sheet/inflammatory-bowel-disease.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"htmlWomenshealth.gov,  the US Department of  Health and Human  Services1995 29 Nov  20143 0 0 3 61 Inflammatory  Bowel Disease  (IBD), Innerbodyhttp://www.innerbody.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/diseases-conditions/ibdInnerBody,  California, United  States1996 02 Oct 2012 5 2 3 4 62 Inflammatory  Bowel  Disease (IBD),  Rightdiagnosishttp://www.rightdiagnosis.com/i/ inflammatory_bowel_disease/intro.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com,  United States2005 11 Jul 2013 2 1 5 0 63 Inflammatory  Bowel Disease,  Lifescript.comhttp://www.lifescript.com/ health/centers/digestive/ related_conditions/inflammatory_b owel_disease.aspxLifeScript, California,  United States1999 05 May  20141 5 2 1 64 Inflammatory  Bowel Disease  (IBD), MUSC  Healthhttp://www.ddc.musc.edu/public/ symptomsDiseases/diseases/ smallBowel/IBD.htmlDigestive Disease  Center, The Medical  University of South  Carolina, South  Carolina, United  States1990 21 May  20131 1 1 0 65 Inflammatory  Bowel Disease  (IBD): Ulcerative  Colitis, Crohn's   Disease, New  York-Presbyterian  Digestive Diseases.http://nyp.org/services/digestive/ ibd.htmlNewYork- Presbyterian  Hospital, New York,  United States1998 24 Aug  20071 2 0 0Azer	SA	 et	al.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"http://www.humanillnesses.com/ original/Her-Kid/Inflammatory- Bowel-Disease.htmlHuman Diseases  and   Conditions Forum,  United States2006 16 Oct 2013 2 3 1 0 67 Facts About Crohn's   Disease, US.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Food and Drug  Administration http://www.fda.gov/ ForConsumers/ConsumerUpdates/ ucm107358.htmUS Food and Drug  Administration, The  US Department of  Health  and  Human  Services, Maryland,  United States1997 14 Oct 2014 1 3 2 1 68 Crohn's Disease  Symptoms and  warning Signs,  SymptomFindhttp://www.symptomfind.com/ diseases-conditions/crohns-disease- symptoms-warning-signs/Symptom.Find.Com.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"United States2008 21 Jun 2014 3 2 1 2 69 Crohn's Disease- At a Glance,  SixPartsWater.Orghttp://www.sixpartswater.org/ knowledge-centre/crohns-disease/ glanceSixPartsWater.Org,  United Kingdom2007 02 Oct 2012 2 1 3 0 70 Ulcerative Colitis,  eMedTVhttp://colitis.emedtv.com/ ulcerative-colitis/ulcerative-colitis.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"htmleMedTV,  Washington, United  States2005 07 May  20143 0 5 2 71 Crohn's Disease,  Department of  Surgery, University  of California.http://colorectal.surgery.ucsf.edu/ conditions--procedures/crohns- disease.aspxDepartment of  Surgery, University  of California,  California, United  States1986 10 Oct 2013 1 1 4 1 72 Crohn's Disease, the  National Institute  of Diabetes and  Digestive and  Kidney Diseases http://www.niddk.nih.gov/ health-information/health-topics/ digestive-diseases/crohns-disease/ Pages/facts.aspx The National  Institutes of Diabetes  and Digestive and  Kidney Diseases,  NIDDK, Maryland,  United States2002 20 Jul 2014 1 1 2 0 73 Crohn's Disease,  Patient Education  Centerhttp://www.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/articles/crohns-disease/Patient Education  Center, Harvard  Medical School,  Harvard Medical  Publications,  Massachusetts,  United States2003 20 Jun 2014 2 0 3 0 74 Crohn's Disease  Information, alot  healthhttp://health.alot.com/conditions/ crohns-disease-information--163Alot Health.Com,  Arkansas, United  States1994 15 Aug  20143 1 1 1 75 Crohn's Disease,  Diagnose-me.Comhttp://www.diagnose-me.com/ symptoms-of/crohns-disease.htmlDiagnose-me.Com,  Hawaii, United States2002 21 Jan 2014 1 3 4 1 76 Crohns Disease  Information: Is  Colon Cleansing  the Answer,  Colon Cleanse  Informationhttp://www.colon-cleanse- information.com/crohns-disease- information.htmlColon-Cleanse- Information.Com,  MKR Concepts,  Oregon, United  States2007 11 Nov  20143 0 5 0 77 Crohn's Disease or  Regional Enteritis,  MD India.http://www.medindia.net/ patients/patientinfo/Crohns- Disease.htmMedindia4u.com Pvt.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Ltd, Chennai, India2000 21 Nov  20145 0 1 0 78 Crohn's Disease  Information,  Digestive Disordershttp://www.articleinsider.com/ health-and-fitness/digestive- disorders/crohns-disease- informationDigestive Disorders,  United States2003 03 Sep 2014 2 1 2 1 79 Inflammatory  Bowel Disease,  Patient Center,  American College  of Gastroenterologyhttp://patients.gi.org/topics/ inflammatory-bowel-disease/Patient Center,  American College of  Gastroenterology,  Maryland, United  States1996 16 May  20134 3 1 2 80 Crohn's Disease: Symptoms,  Diagnosis and  Treatment,  Disabled World.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Com http://www.disabled-world.com/ health/digestive/crohns-disease/Disabled World.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Com, New York,  United States2004 29 Oct 2012 1 3 4 1 81 Crohn's Disease,  Nutritionist  Resourcehttp://www.nutritionist-resource.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"1686 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.com82 Crohn's Disease:  Symptoms,  Diagnosis and  Treatment,  verywell.comhttp://seniorhealth.about.com/cs/ digestivetract/a/crohns_2.htmVerywell.com part  of about.com, Inc.,  United States1999 10 Feb 14 6 0 4 0 83 Ulcerative Colitis,  Halyard Surgical.http://www.ulcerative-colitis.org/ Halyard Surgical,  New South Wales,  Australia2003 7 Nov 14 2 0 6 1 84 Ulcerative Colitis  Overview, Health  Communities.com http://www.healthcommunities.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Website title,  OrganisationURL Accuracy scores Readability scores The DISCERN Score  (mean ± SD)The HONcode score  (Out of 100)*The Flesch-Kincaid  Grade Level IndexThe Coleman-Liau  Readability Index 1 Inflammatory Bowel  Disease (IBD), Mayo  Clinichttp://www.mayoclinic.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/diseases-conditions/ inflammatory-bowel-disease/ basics/definition/con-2003490865.0 ± 1.0   0.86* 13.1 ± 0.0 15.0 ± 0.0 2 Inflammatory Bowel  Disease Health Center,  WebMdhttp://www.webmd.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/ibd-crohns-disease/41.3 ± 1.1   0.70* 10.5 ± 3.2 13.3 ± 2.5 3 Inflammatory Bowel  Disease (IBD), Center  for Disease Control and  Prevention (CDC)http://www.cdc.gov/ibd/ 28.7 ± 0.6 0.90 10.9 ± 2.7 13.3 ± 0.6 4 Inflammatory Bowel  Disease, NHS Choiceshttp://www.nhs.uk/conditions/ inflammatory-bowel-disease/ pages/introduction.aspx53.7 ± 0.6 0.63 12.2 ± 1.6 12.3 ± 1.5 5 What are Crohn's and  Colitis?",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Crohn's and  Colitis Foundationhttp://www.ccfa.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/what-are-crohns-and-colitis/50.3 ± 0.6 0.81 16.2 ± 9.3 13.7 ± 0.6 6 Inflammatory Bowel  Disease, KidsHealthhttp://kidshealth.org/parent/ medical/digestive/ibd.html50.7 ± 0.6 0.45 12.0 ± 0.7 11.7 ± 0.6 7 Inflammatory Bowel  Disease (IBD).",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"FamilyDoctorhttp://familydoctor.org/ familydoctor/en/diseases- conditions/inflammatory-bowel- disease.html45.0 ± 1.0   0.63*   9.6 ± 1.4 10.7 ± 0.6 8 Inflammatory Bowel  Disease, Healthlinehttp://www.healthline.com/ health/inflammatory-bowel- disease#Overview141.0 ± 1.0   0.59*   8.7 ± 0.6 11.7 ± 0.6 9 Crohn's and Colitis,  Australiahttps://www.crohnsandcolitis.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
com.au/about-crohns-colitis/ inflammatory-bowel-disease/41.7 ± 0.6 0.34 13.6 ± 3.2 13.0 ± 1.0 10 Crohn's and Colitis UK http://www.crohnsandcolitis.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org.uk/information-and-support/ information-about-ibd/what-is- IBD60.7 ± 0.6 0.45 10.4 ± 1.6 10.3 ± 3.1 11 Inflammatory  Bowel Disease (IBD)  (Intestinal Problems of  IBD), MedicineNethttp://www.medicinenet.com/ inflammatory_bowel_disease_inte stinal_problems/article.htm57.3 ± 1.5   0.75* 13.3 ± 1.5 14.3 ± 1.5 12 Inflammatory Bowel  Disease Center,  Cedars-Sinaihttp://www.cedars-sinai.edu/ Patients/Programs-and-Services/ Inflammatory-Bowel-Disease- Center/25.7 ± 1.1 0.27 13.1 ± 2.9 14.0 ± 3.6 13 Inflammatory Bowel  Diseases Symptoms and  Treatment: Livesciencehttp://www.livescience.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/39880-inflammatory-bowel- disease.html39.3 ± 0.6 0.27 11.1 ± 1.4 11.3 ± 1.5 14 Inflammatory Bowel  Diseases Program, Penn  Medicine.orghttp://www.pennmedicine.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"orghttp://www.ibdsupport.org/ 52.0 ± 1.7   0.61* 12.8 ± 3.7 13.0 ± 3.6 16 Inflammatory Bowel  Disease (IBD), ABC  Health and wellbeinghttp://www.abc.net.au/health/ library/stories/2012/02/22/3435 688.htm34.0 ± 0.0 0.45 11.1 ± 0.3 11.3 ± 0.6 17 Inflammatory Bowel  Disease (IBD), GIKidshttp://www.gikids.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/content/7/en/IBD31.0 ± 0.0 0.52 12.5 ± 0.3 12.7 ± 0.6 18 Inflammatory Bowel  Disease, Vitamin D  Councilhttps://www.vitamindcouncil.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/health-conditions/ inflammatory-bowel-disease/31.3 ± 1.1 0.43   11.0 ± 10.4 10.7 ± 1.5 19 Inflammatory Bowel  Disease Symptoms  and Diagnosis, Seattle  children'shttp://www.seattlechildrens.org/ medical-conditions/digestive- gastrointestinal-conditions/ibd- symptoms/37.3 ± 0.6 0.43  8.9 ± 1.0 11.0 ± 1.0 20 Crohn's Disease,  Patient.co.ukhttp://www.patient.co.uk/ health/crohns-disease-leaflet55.7 ± 1.5   0.59*   8.5 ± 2.0 10.0 ± 1.7 21 Patient Information  Crohn's Disease  (Beyond and the  Basics), Uptodatehttp://www.uptodate.com/ contents/crohn-disease-beyond- the-basics36.7 ± 1.1 0.70 11.2 ± 1.9 12.3 ± 0.6 22 Crohn's Disease, Centre  for digestive diseaseshttp://www.cdd.com.au/pages/ disease_info/crohns_disease.html34.7 ± 0.6 0.52 12.0 ± 0.6 14.3 ± 1.1 23 Crohn's Disease,  Patients: British Society  for Gastroenterologyhttp://www.bsg.org.uk/ patients/general/crohn-s-disease.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"html49.7 ± 0.6 0.56 11.3 ± 1.7 10.7 ± 1.1 24 Crohn's Disease, Bupa http://www.bupa.co.uk/health- information/directory/c/crohns- disease52.0 ± 0.0   0.77*   8.2 ± 0.5   9.0 ± 1.7 25 Crohn's Disease,  University of Maryland  Medical Centerhttp://umm.edu/health/ medical/reports/articles/crohns- disease64.7 ± 1.5 0.81 15.3 ± 4.8 15.0 ± 1.0 26 Crohn's Disease,  Symptoms, Diagnosis,  Treatment, Southern  Crosshttps://www.southerncross.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"co.nz/AboutTheGroup/ HealthResources/ MedicalLibrary/tabid/178/ vw/1/ItemID/523/Crohns- disease-symptoms-diagnosis- treatment.aspx42.7 ± 0.6 0.40 13.8 ± 0.3 13.7 ± 0.6 27 Crohn's Disease,  American family  physicianhttp://www.aafp.org/ afp/2011/1215/p1379.html42.3 ± 1.1 0.18   9.0 ± 2.9 12.3 ± 4.2 28 What is Crohn's  Disease?",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
MNThttp://www.medicalnewstoday.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/articles/151620.php45.7 ± 1.5   0.50* 11.2 ± 2.1 10.7 ± 1.5 29 Crohn's Disease,  Netdoctorhttp://www.netdoctor.co.uk/ diseases/facts/crohnsdisease.htm43.0 ± 0.0 0.59 10.0 ± 1.6 12.3 ± 1.5 30 Crohn's Disease, UCSF  medical centerhttp://www.ucsfhealth.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/conditions/crohns_disease/41.0 ± 1.0 0.40 11.4 ± 0.5 11.3 ± 0.6 31 Crohn's Disease  Symptoms and  Treatment, US.news  Wellnesshttp://health.usnews.com/ health-news/health-wellness/ articles/2013/08/03/crohns- disease-symptoms-and-treatment48.3 ± 0.6 0.50   6.7 ± 0.8 12.3 ± 2.5 32 What are the treatments  for Crohn's disease?",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Beth Israel Deaconess  Medical Centerhttp://www.bidmc.org/ Centers-and-Departments/ Departments/Digestive-Disease- Center/Inflammatory-Bowel- Disease-Program/Crohns- Disease/What-are-the-treatments- for-Crohns-disease.aspx41.7 ± 1.5 0.59 14.3 ± 2.2 14.3 ± 1.1 33 Diagnosing Crohn's,  Crohn's and Me.http://www.crohnsandme.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/crohns-information/crohns- disease-diagnosis.aspx43.3 ± 1.1 0.27 13.6 ± 1.1 12.7 ± 2.5 34 Understanding Crohn's   Disease, Crohn' and  Colitis.http://www.crohnsandcolitisinfo.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/Crohns/What-is-Crohns- Disease41.7 ± 0.6 0.45 12.4 ± 2.0 12.0 ± 2.6 35 Learning About  Crohn's Disease,  National Human Genome  Research Institutehttp://www.genome.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"1688 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.com36 Crohn's Disease,  UPMC Life Changing  Medicinehttp://www.upmc.com/ services/digestive-disorders- center/services/ibd/conditions/ pages/crohns-disease.aspx44.3 ± 0.6 0.27 20.3 ± 9.5 15.0 ± 2.0 37 Crohn's Disease,  Cincinnati Children'shttp://www.cincinnatichildrens.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/health/c/crohns/44.7 ± 0.6 0.40   9.3 ± 1.1 10.7 ± 0.6 38 Crohn's Disease,  Cleveland clinichttp://my.clevelandclinic.org/ health/diseases_conditions/hic_I nflammatory_Bowel_Disease_IBD _QandA/hic_Crohns_Disease26.3 ± 1.1   0.50* 12.9 ± 1.2 12.3 ± 2.3 39 Treatment of Crohn's   Disease, UNC  Multidisciplinary  Center for IBD Research  and Treatmenthttp://www.med.unc.edu/ gi/specialties/ibd/about-ibd/ treatment-of-ibd-1/treatment-of- crohns-disease42.3 ± 0.6 0.45 12.3 ± 0.5 13.3 ± 0.6 40 Crohn's Disease,  Emedicine healthhttp://www.emedicinehealth.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Australian  Gastroenterology  Institute.http://www.nevdgp.org.au/ info/gastro/crohns.htm42.3 ± 1.1 0.27 10.4 ± 0.7 11.3 ± 0.6 42 Crohn's Disease, Health  Centershttp://www.drweil.com/drw/u/ ART00339/Crohns-Disease.html37.0 ± 0.0 0.50 11.9 ± 1.1 12.7 ± 1.5 43 Crohn's Disease- An  Overview, the Royal  Children's Hospital  Melbournehttp://www.rch.org.au/ kidsinfo/fact_sheets/Crohns_Dise ase_an_overview/33.7 ± 1.1 0.50 7.7 ± 2.0 11.3 ± 1.5 44 Fighting Inflammatory  Bowel Disease  Together, the Irish  Society for Colitis and  Crohn's Diseasehttp://www.iscc.ie/page.php?i d=18&title=What%20is%20IBD37.7 ± 0.6 0.40 11.6 ± 1.4 10.7 ± 0.6 45 Crohn's Disease  Diagnosis, New health  guidehttp://www.newhealthguide.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/Crohn%27s-Disease- Diagnosis.html18.3 ± 0.6 0.65 13.5 ± 0.7 13.7 ± 1.1 46 Crohn's Disease,  HealthDay.http://consumer.healthday.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"html61.0 ± 1.0   0.86* 10.9 ± 1.4 12.0 ± 0.0 47 Ulcerative Colitis,  Wikipediahttp://en.wikipedia.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/wiki/Ulcerative_colitis54.0 ± 0.0 0.63 15.2 ± 2.1 14.0 ± 2.6 48 Living with UC, Do  You Know Your  Treatment Options?http://www.livingwithuc.ca/ 44.3 ± 1.1 0.68 12.2 ± 1.6 11.3 ± 2.3 49 What Is Ulcerative  Colitis?",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Everyday  Healthhttp://www.everydayhealth.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
News Medicalhttp://www.news-medical.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"net/health/What-is-Ulcerative- Colitis.aspx46.0 ± 1.0 0.59 11.9 ± 0.2 13.0 ± 1.0 51 Crohn's Disease and  Ulcerative Colitis,  Better Health Channelhttp://www.betterhealth.vic.gov.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/diseases/ulcerative-colitis/52.3 ± 0.6 0.36 10.6 ± 1.4 11.7 ± 2.1 53 Ulcerative Colitis,  Crohn's and Colitis  Canadahttp://www.crohnsandcolitis.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"ca/site/c.dtJRL9NUJmL4H/ b.9012449/k.C223/ Ulcerative_Colitis.htm19.7 ± 0.6 0.31   9.2 ± 1.8 10.0 ± 1.0 54 Ulcerative Colitis,  Healthgradeshttp://www.healthgrades.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/conditions/ulcerative-colitis52.7 ± 1.1 0.68 14.5 ± 3.5 14.0 ± 1.0 55 Information for Those  with Ulcerative Colitis,  Colitis UKhttp://www.ulcerativecolitis.org.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"1689 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.com56 Colitis and Chronic  Ulcerative Colitis,  Virginia Masonhttps://www.virginiamason.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/ColitisandChronicUlcerative Colitis40.7 ± 0.6 0.31 16.7 ± 3.9 15.0 ± 2.0 57 Ulcerative Colitis,  GastroNethttp://www.gastro.net.au/ diseases/ulcerativecolitis.html26.7 ± 0.6 0.60 13.1 ± 1.1 13.3 ± 2.3 58 Ulcerative Colitis,  Ulcerative Colitis Net.http://www.ulcerativecolitis.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"net/41.3 ± 0.6 0.30 11.4 ± 3.3 12.0 ± 2.0 59 Inflammatory Bowel  Disease, Lab Tests  Onlinehttp://labtestsonline.org/ understanding/conditions/ inflammatory-bowel38.3 ± 0.6   0.32* 13.0 ± 0.7 12.0 ± 1.0 60 Inflammatory Bowel  Disease Fact Sheet,  Womenshealth.govhttp://www.womenshealth.gov/ publications/our-publications/ fact-sheet/inflammatory-bowel- disease.html55.7 ± 1.5 0.40   8.8 ± 0.7 10.0 ± 1.0 61 Inflammatory Bowel  Disease (IBD),  Innerbodyhttp://www.innerbody.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/diseases-conditions/ibd39.0 ± 1.0 0.25 17.2 ± 5.7 16.7 ± 1.5 62 Inflammatory Bowel  Disease (IBD),  Rightdiagnosishttp://www.rightdiagnosis.com/ i/inflammatory_bowel_disease/ intro.htm38.0 ± 1.0 0.33 15.9 ± 4.1 15.7 ± 2.1 63 Inflammatory Bowel  Disease, Lifescript.comhttp://www.lifescript.com/ health/centers/digestive/ related_conditions/inflammatory _bowel_disease.aspx32.0 ± 1.0 0.50 15.1 ± 2.8 12.7 ± 1.5 64 Inflammatory Bowel  Disease (IBD), MUSC  Healthhttp://www.ddc.musc.edu/ public/symptomsDiseases/ diseases/smallBowel/IBD.html22.7 ± 1.1 0.27 14.2 ± 2.2 15.7 ± 2.9 65 Inflammatory Bowel  Disease (IBD):  Ulcerative Colitis,  Crohn's Disease, New  York-Presbyterian  Digestive Diseaseshttp://nyp.org/services/ digestive/ibd.html32.3 ± 0.6 0.27 13.2 ± 0.5 12.7 ± 0.6 66 Inflammatory Bowel  Disease, Human  Diseases and  Conditions Forum.http://www.humanillnesses.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Food and  Drug Administrationhttp://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"htm34.7 ± 2.1 0.36 10.6 ± 2.6 13.7 ± 2.1 68 Crohn's Disease  Symptoms and warning  Signs, SymptomFindhttp://www.symptomfind.com/ diseases-conditions/crohns- disease-symptoms-warning- signs/26.0 ± 1.0   0.26* 10.0 ± 1.9 13.7 ± 2.3 69 Crohn's Disease-At a  Glance, SixPartsWater.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Orghttp://www.sixpartswater.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/knowledge-centre/crohns- disease/glance39.7 ± 0.6 0.15 18.3 ± 3.4 12.7 ± 0.6 70 Ulcerative Colitis,  eMedTVhttp://colitis.emedtv.com/ ulcerative-colitis/ulcerative- colitis.html55.3 ± 0.6   0.32* 12.1 ± 0.8 11.0 ± 2.0 71 Crohn's Disease,  Department of  Surgery, University of  California.http://colorectal.surgery.ucsf.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"edu/conditions--procedures/ ulcerative-colitis.aspx51.0 ± 1.0 0.73 12.4 ± 0.8 12.3 ± 2.5 72 Crohn's Disease, the  National Institute of  Diabetes and Digestive  and Kidney Diseaseshttp://www.niddk.nih.gov/ health-information/health-topics/ digestive-diseases/crohns- disease/Pages/facts.aspx68.3 ± 1.2 0.95 13.6 ± 3.9 13.7 ± 5.5 73 Crohn's Disease, Patient  Education Centerhttp://www.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/articles/crohns-disease/38.0 ± 1.0 0.30 8.9 ± 0.8 12.3 ± 1.5 74 Crohn's Disease  Information, alot healthhttp://health.alot.com/ conditions/crohns-disease- information--16332.3 ± 0.6 0.22 10.4 ± 1.5 12.0 ± 2.6 75 Crohn's Disease,  Diagnose-me.Comhttp://www.diagnose-me.com/ symptoms-of/crohns-disease.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Further analysis revealed that there was no  1690 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.com76 Crohns Disease  Information: Is  Colon Cleansing the  Answer, Colon Cleanse  Informationhttp://www.colon-cleanse- information.com/crohns-disease- information.html35.7 ± 2.5 0.36 13.2 ± 0.5 14.7 ± 1.5 77 Crohn's Disease or  Regional Enteritis, MD  India.http://www.medindia.net/ patients/patientinfo/Crohns- Disease.htm46.3 ± 1.1 0.54 11.8 ± 1.3 14.0 ± 2.6 78 Crohn's Disease  Information, Digestive  Disordershttp://www.articleinsider.com/ health-and-fitness/digestive- disorders/crohns-disease- information33.3 ± 0.6 0.60 10.2 ± 0.6 12.3 ± 0.6 79 Inflammatory Bowel  Disease, Patient Center,  American College of  Gastroenterologyhttp://patients.gi.org/topics/ inflammatory-bowel-disease/58.3 ± 1.2 0.80 12.7 ± 1.3 13.0 ± 1.0 80 Crohn's Disease: Symptoms, Diagnosis  and Treatment,  Disabled World.Comhttp://www.disabled-world.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"com/health/digestive/crohns- disease/26.3 ± 2.3 0.19 8.6 ± 0.6 12.00 ± 1.73 81 Crohn's Disease,  Nutritionist Resourcehttp://www.nutritionist-resource.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"html39.3 ± 0.6 0.57 10.2 ± 2.6 11.3 ± 1.1 82 Crohn's Disease:  Symptoms, Diagnosis  and Treatment,  verywell.comhttp://seniorhealth.about.com/ cs/digestivetract/a/crohns_2.htm44.3 ± 1.5 0.37 12.6 ± 0.7 11.0 ± 1.0 83 Ulcerative Colitis,  Halyard Surgical.http://www.ulcerative-colitis.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"org/51.7 ± 1.5 0.25 12.1 ± 0.6 12.7 ± 2.5 84 Ulcerative Colitis  Overview, Health  Communities.comhttp://www.healthcommunities.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Available from: URL:  http://www.pewinternet.org/2005/05/17/health-information-online/ 8 Azer SA .,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Available from: URL:  https://www.ebizmba.com/articles/search-engines 10 Schreuders EH , Grobbee EJ, Kuipers EJ, Spaander MC,  Veldhuyzen van Zanten SJ.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Available from: URL:  http://www.discern.org.uk/discern.pdf 15 Health on the net foundation (HON) .,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Available from: URL: https://www.healthonnet.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Available from: URL:  https://www.hon.ch/HONcode/Webmasters/HON_CCE_en.htm 17 Certificate of compliance.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Available  from: URL: http://www.healthonnet.org/HONcode/Conduct.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"Available from:  URL: http://www.nlm.nih.gov/medlineplus/etr.html 23 Kutner M , Greenberg E, Jin Y , Paulsen C. The health literacy of  America’s adults: results from the 2003 National Assessment of  Adult Literacy.",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Available from: URL: http://nces.ed.gov/pubsearch/pubsinfo.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
Available from: URL: http://www.pifonline.org.,Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/6a/af/WJG-23-1676.PMC5340820.pdf
"The efficacy  of antidiabetic treatment in improving the response to Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1697 1697 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1697-1711  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) SYSTEMATIC REVIEWS Diabetes mellitus, insulin resistance and hepatitis C virus  infection: A contemporary review Anne-Claire Desbois, Patrice Cacoub",Non-OADS,/arxiv_data1/oa_pdf/39/1f/WJG-23-1697.PMC5340821.pdf
World  J Gastroenterol 2017; 23(9): 1697-1711  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i9/1697.htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i9.1697 INTRODUCTION Hepatitis C virus (HCV) infection is a major health  problem.,Non-OADS,/arxiv_data1/oa_pdf/39/1f/WJG-23-1697.PMC5340821.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/39/1f/WJG-23-1697.PMC5340821.pdf
"Core tip: This	is	a	review 	of	58	published 	articles 	on	 presacral 	venous 	plexus 	injury 	during 	the	mobilization 	Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1712 1712 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1712-1719  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) SYSTEMATIC REVIEWS Presacral venous bleeding during mobilization in rectal  cancer Jose	Enrique	Casal	Núñez,	Vincenzo	Vigorita,	Alejandro	Ruano	Poblador,	Ana	María	Gay	Fernández,	 Maria	Ángeles	Toscano	Novella,	Nieves	Cáceres	Alvarado,	Lucinda	Pérez	Dominguez",Non-OADS,/arxiv_data1/oa_pdf/64/42/WJG-23-1712.PMC5340822.pdf
World J Gastroenterol  2017; 23(9): 1712-1719   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i9/1712.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1712 INTRODUCTION Presacral venous plexus injury during the mobiliza - tion of the rectum is one of the most frequent intra-   operative complications during rectal cancer surgery[1].,Non-OADS,/arxiv_data1/oa_pdf/64/42/WJG-23-1712.PMC5340822.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/64/42/WJG-23-1712.PMC5340822.pdf
"Based 	on	our	findings, 	Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1720 1720 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1720-1724  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) CASE REPORT Gastrointestinal stromal tumor of the stomach with axillary  lymph node metastasis: A case report Naoki	Kubo,	Nobumichi	Takeuchi",Non-OADS,/arxiv_data1/oa_pdf/47/4e/WJG-23-1720.PMC5340823.pdf
"World J Gastroenterol 2017; 23(9): 1720-1724  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i9/1720.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.i9.1720 INTRODUCTION Gastrointestinal stromal tumors (GISTs) are the most  common type of gastrointestinal mesenchymal tumor ,  although GIST only accounts for approximately 1% of  gastric malignancies[1].",Non-OADS,/arxiv_data1/oa_pdf/47/4e/WJG-23-1720.PMC5340823.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/47/4e/WJG-23-1720.PMC5340823.pdf
"Key words: Leiomyosarcoma; 	Chemotherapy; 	Multiple 	 liver	tumors; 	Liver	metastasis; 	AdenocarcinomaSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i9.1725 1725 March 7, 2017 |Volume 23 |Issue 9 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 7; 23(9): 1725-1734  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) CASE REPORT Synchronous coexistence of liver metastases from cecal  leiomyosarcoma and rectal adenocarcinoma: A case report Hideki	Aoki,	Takashi	Arata,	Masashi	Utsumi,	Yutaka	Mushiake,	Tomoyoshi	Kunitomo,	Isao	Yasuhara,	 Fumitaka	Taniguchi,	Koh	Katsuda,	Kohji	Tanakaya,	Hitoshi	Takeuchi,	Rie	Yamasaki",Non-OADS,/arxiv_data1/oa_pdf/cc/fb/WJG-23-1725.PMC5340824.pdf
"World  J Gastroenterol  2017; 23(9): 1725-1734  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i9/1725.htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i9.1725 INTRODUCTION Since the appearance of gastrointestinal stromal tumor  as a distinctly defined entity, the diagnosis of intestinal  leiomyosarcoma has not been common.",Non-OADS,/arxiv_data1/oa_pdf/cc/fb/WJG-23-1725.PMC5340824.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  9",Non-OADS,/arxiv_data1/oa_pdf/cc/fb/WJG-23-1725.PMC5340824.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/99/1a/13318_2016_Article_345.PMC5340825.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.258 A. Suszka-S ´witek et al.",Non-OADS,/arxiv_data1/oa_pdf/3a/42/13318_2016_Article_342.PMC5340827.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/60/17/13318_2016_Article_346.PMC5340830.pdf
http://www.nice.org.uk/guidance/CG72 .,Non-OADS,/arxiv_data1/oa_pdf/60/17/13318_2016_Article_346.PMC5340830.pdf
http://www.lakemedelsverket.,Non-OADS,/arxiv_data1/oa_pdf/60/17/13318_2016_Article_346.PMC5340830.pdf
http://www.lakemedelsverket.,Non-OADS,/arxiv_data1/oa_pdf/60/17/13318_2016_Article_346.PMC5340830.pdf
https://www.qbtech.,Non-OADS,/arxiv_data1/oa_pdf/60/17/13318_2016_Article_346.PMC5340830.pdf
/C210)http://www.tovatest.,Non-OADS,/arxiv_data1/oa_pdf/60/17/13318_2016_Article_346.PMC5340830.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/51/88/40256_2016_Article_197.PMC5340834.pdf
"van Kuilenburg have no conﬂicts of interest that are relevant to the content of this review.Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4c/76/40262_2016_Article_450.PMC5340837.pdf
"[ 12] under the terms of the Creative Commons Attribution-NonCommer-cial 4.0 International License [ http://creativecommons.org/licenses/ by-nc/4.0/ ]).BID twice daily, IDegAsp insulin degludec/insulin aspart, ODonce daily, SDsingle dose, SSsteady state, T1DM type 1 diabetes mellitusInsulin Degludec/Insulin Aspart Pharmacological Properties and Clinical Implications 347",Non-OADS,/arxiv_data1/oa_pdf/dc/25/40262_2016_Article_455.PMC5340839.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.Insulin Degludec/Insulin Aspart Pharmacological Properties and Clinical Implications 351",Non-OADS,/arxiv_data1/oa_pdf/dc/25/40262_2016_Article_455.PMC5340839.pdf
2012. http://www.fda.gov/ downloads/AdvisoryCommittees/CommitteesMeetingMaterials/ Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM327017.pdf .,OADS,/arxiv_data1/oa_pdf/dc/25/40262_2016_Article_455.PMC5340839.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/94/94/40256_2016_Article_200.PMC5340840.pdf
"Available at: http://www.fda.gov/ohrms/dockets/ac/ 05/brieﬁng/2005-4090b1-01.htm104 D. J. Angiolillo, S. M. Weisman",Non-OADS,/arxiv_data1/oa_pdf/94/94/40256_2016_Article_200.PMC5340840.pdf
Available at: http://www.fda.gov/do wnloads/Advisory Committees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisory Committee/UCM383180.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/94/94/40256_2016_Article_200.PMC5340840.pdf
Available at:http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM3864 52.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/94/94/40256_2016_Article_200.PMC5340840.pdf
Available at: http://www.fda.gov/downloads/AdvisoryCommittees/Committees MeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM386446.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/94/94/40256_2016_Article_200.PMC5340840.pdf
Available at: http://www.fda.gov/downloads/ Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatients andProviders/UCM161282.pdf .,Non-OADS,/arxiv_data1/oa_pdf/94/94/40256_2016_Article_200.PMC5340840.pdf
2015. http://www.escardio.org/The-ESC/Press- Ofﬁce/Press-releases/Last-5-years/scot-study-quells-concerns-about- nsaid-safety .,Non-OADS,/arxiv_data1/oa_pdf/94/94/40256_2016_Article_200.PMC5340840.pdf
Available at:https://clinicaltrials.gov/ct2/show/NCT00346216 .,Non-OADS,/arxiv_data1/oa_pdf/94/94/40256_2016_Article_200.PMC5340840.pdf
Available at: http://www.fda.gov/downloads/AdvisoryCommittees/Committees MeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM386446.pdf.,Non-OADS,/arxiv_data1/oa_pdf/94/94/40256_2016_Article_200.PMC5340840.pdf
Available at: http://www.fda.gov/downloads/Advisory Committees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisory Committee/UCM383180.pdf.,Non-OADS,/arxiv_data1/oa_pdf/94/94/40256_2016_Article_200.PMC5340840.pdf
"Advances in Dermatology and Allergology 1, February / 201728Original paper  Address for correspondence: Dr. Ahu Yorulmaz, Department of Dermatology, Ankara Numune Research and Education Hospital,  Samanpazari, Altindag, 06100 Ankara, Turkey, phone: +90 3125084000, e-mail: ahuyor@gmail.com Received: 16.11.2015, accepted: 3.12.2015.A study of dermoscopic features of nail psoriasis Ahu Yorulmaz, Ferda Artuz Department of Dermatology, Ankara Numune Research and Education Hospital, Ankara, Turkey Adv Dermatol Allergol 2017; XXXIV (1): 28–35 DOI: https://doi.org/10.5114/ada.2017.65618 Abstract Introduction: Dermoscopy is a non-invasive imaging method that enables the evaluation of pigmented and non- pigmented skin lesions.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/PDIA-34-29330.PMC5340855.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
http://dx.doi.org/10.1016/j.epidem.2017.02.005 1755-4365/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"Eighteenth  Session  of the  Joint  Action  Forum,  Available:  http://www.who.int/apoc/about/structure/ jaf/Final  Communique  JAF  18  English  ﬁnal  with  annexes.pdf .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"8,  e2953, http://dx.doi.org/10.1371/journal.pntd.0002953) .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"8,  310–322,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"68, 263–313,  http://dx.doi.org/10.1016/S0065-308X(08)00611-8 .",OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"28, 161–171,  http://dx.doi.org/10.1016/j.pt.2012.02.004 .",OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"6, e1548, http://dx.doi.org/10.1371/journal.pntd.0001548 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"94,  247–341,  http://dx.doi.org/10.1016/bs.apar.2016.08.003 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"102,  13–17,  http://dx.doi.org/10.1179/ 136485908x337427 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"PLoS  One  9,  e115886, http://dx.doi.org/10.1371/journal.pone.0115886 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"8,  e2759, http://dx.doi.org/10.1371/journal.pntd.0002759 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"Parasites  Vectors  6,  289,  http://dx.doi.org/10.1186/1756- 3305-6-289 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"3,  e497,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"62,  1338–1347, http://dx.doi.org/10.1093/cid/ciw144 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"87, 1–31,  http://dx.doi.org/10.1016/bs.apar.2014.12.001 .",OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"Lancet  360, 203–210, http://dx.doi.org/10.1016/S0140-6736(02)09456-4 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"Vectors  9,  388,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"89,  51–57,  http://dx.doi.org/10.4269/ajtmh.13- 0112 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"111,  2217–2221,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"2013,  420928, http://dx.doi.org/10.1155/2013/420928 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"89,  293–300,  http://dx.doi.org/10.4269/ajtmh.13-0037 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"90,  1159–1166, http://dx.doi.org/10.4269/ajtmh.13-0501 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"9,  e0003664, http://dx.doi.org/10.1371/journal.pntd.0003664 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"166,  96–105,  http://dx.doi.org/10.1016/j.actatropica.2016.11.003 .",OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"6,  272–286,  http://dx.doi.org/10.1016/j.ijpddr.",OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"Vectors 7,  511,  http://dx.doi.org/10.1186/s13071-014-0511-9 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"9,  e0003688,  http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"Ending  the  neglect  and reaching 2020  goals,  Available  at:  http://unitingtocombatntds.org/downloads/ press/ntd  event  london  declaration  on  ntds.pdf .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"11,  e0005314,  http://dx.doi.org/10.1371/ journal.pntd.0005314 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"8,  e2821,  http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"15,  e0004328,  http://dx.doi.org/10.1371/journal.pntd.",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"9,  e0003922,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"Parasites  Vectors  5,  28,  http://dx.doi.org/10.1186/ 1756-3305-5-28 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"Parasites  Vectors  5,  66,  http://dx.doi.org/ 10.1186/s40249-016-0160-7 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"6, e1825, http://dx.doi.org/10.1371/journal.pntd.0001825 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"7,  e2169,  http://dx.doi.org/10.1371/journal.pntd.0002169 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"Dis  59,  923–932,  http://dx.doi.org/10.1093/cid/ciu467 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"9,  e0003938,  http://dx.doi.org/ 10.1371/journal.pntd.0003938 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"Vectors  8,  167,  http://dx.doi.org/10.1186/s13071-015-0779-4 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"60,  1199–1207,  http://dx.doi.org/ 10.1093/cid/ciu1152 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"Vectors  8, http://dx.doi.org/10.1186/s13071-015-0817-2 .",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"20,  258–259,  http://dx.doi.org/10.3109/09286586.2013.",Non-OADS,/arxiv_data1/oa_pdf/70/56/main.PMC5340858.pdf
"Once bound, the complex can regulate mRNA gene expression 12Joint first authors Corresponding author: marc.friedlander@scilifelab.seArticle is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.059725.",Non-OADS,/arxiv_data1/oa_pdf/a3/b6/433.PMC5340907.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 4.0 International),as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS RNA 23:433 –445; Published by Cold Spring Harbor Laboratory Press for the RNA Society 433",Non-OADS,/arxiv_data1/oa_pdf/a3/b6/433.PMC5340907.pdf
The called rat and pig reads were trimmed withthe command line: fastx_trimmer -f 1 -l 36 and low-quality readsdiscarded with fastx_artifacts_filter using the options -q 10 -p 50(http://hannonlab.cshl.edu/fastx_toolkit/).,Non-OADS,/arxiv_data1/oa_pdf/a3/b6/433.PMC5340907.pdf
"Furthermore, the processed sequence data fromhuman tissue and body fluid in the form of fasta files can be down-loaded from https://figshare.com/s/36e1c536a573011e4248.",OADS,/arxiv_data1/oa_pdf/a3/b6/433.PMC5340907.pdf
Corresponding author: t.m.breit@uva.nlArticle is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.059642.,Non-OADS,/arxiv_data1/oa_pdf/0f/05/446.PMC5340908.pdf
"This article, published in RNA, is available under a Creative Commons License (Attribution-NonCommercial 4.0 International),as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 446 RNA 23:446 –456; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/0f/05/446.PMC5340908.pdf
MATERIALS AND METHODS Biological materials Zebrafish Adult zebrafish (strain ABTL) were handled in compliance with lo- cal animal welfare regulations and maintained according to standardprotocols (http://zfin.org).,Non-OADS,/arxiv_data1/oa_pdf/0f/05/446.PMC5340908.pdf
"A participation in cytoplasmic polyadenylation Corresponding authors: ukuehn@biochemtech.uni-halle.de, ewahle@ biochemtech.uni-halle.de Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.057026.",Non-OADS,/arxiv_data1/oa_pdf/ed/83/473.PMC5340911.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT RNA 23:473 –482; Published by Cold Spring Harbor Laboratory Press for the RNA Society 473",Non-OADS,/arxiv_data1/oa_pdf/ed/83/473.PMC5340911.pdf
"For these reasons there is always a requirement for the development of new chemical probing methods to study Corresponding authors: aihm@fudan.edu.cn, drchen@fudan.edu.cn Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.",Non-OADS,/arxiv_data1/oa_pdf/90/e5/483.PMC5340912.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/90/e5/483.PMC5340912.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT RNA 23:483 –492; Published by Cold Spring Harbor Laboratory Press for the RNA Society 483",Non-OADS,/arxiv_data1/oa_pdf/90/e5/483.PMC5340912.pdf
Material Safety Data Sheet information isavailable at http://www.sigmaaldrich.com.,OADS,/arxiv_data1/oa_pdf/90/e5/483.PMC5340912.pdf
2002) wasdownloaded from: (http://pharmacy.uky.edu/research-innovation-and-discovery/faculty-labs/tsodikov-laboratory/software) and wasused to analyze the accessibility of the nucleotides within theM-box RNA in the presence of manganese (PDB:3PDR).,OADS,/arxiv_data1/oa_pdf/90/e5/483.PMC5340912.pdf
Corresponding author: shaowinwang@nhri.org.twArticle is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.059766.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/493.PMC5340913.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/4a/b1/493.PMC5340913.pdf
Adapter sequences were removedand reads were mapped to NONCODE V3.0 (http://www.noncode.org/) by Cuffcompare.,OADS,/arxiv_data1/oa_pdf/4a/b1/493.PMC5340913.pdf
Ribosomal RNA data were removed byTophat (https://ccb.jhu.edu/software/tophat/index.shtml).,OADS,/arxiv_data1/oa_pdf/4a/b1/493.PMC5340913.pdf
NovelncRNA prediction is performed by CPC (http://cpc.cbi.pku.edu.cn/).,OADS,/arxiv_data1/oa_pdf/4a/b1/493.PMC5340913.pdf
Differential expression is analyzed by Cufflinks (http://cole-trapnell-lab.github.io/cufflinks/).,OADS,/arxiv_data1/oa_pdf/4a/b1/493.PMC5340913.pdf
harvard.edu Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.058859.,Non-OADS,/arxiv_data1/oa_pdf/21/ab/504.PMC5340914.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/21/ab/504.PMC5340914.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/21/ab/504.PMC5340914.pdf
"Reads were sorted according to the barcode sequence in their 5 ′adaptor, and then adaptor sequences were trimmed by FASTX- Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/).",OADS,/arxiv_data1/oa_pdf/21/ab/504.PMC5340914.pdf
"Despite remarkably different molecular pathways of Piwi-interacting (pi) RNA biogenesis and Piwi RNP mechanisms of action, diverse organisms require Piwi/piRNA-dependent transposon silencing during sexual repro- duction (Weick and Miska 2014; Gebert and Rosenkranz Corresponding author: kcollins@berkeley.edu Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.060012.",Non-OADS,/arxiv_data1/oa_pdf/1c/f8/530.PMC5340916.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/1c/f8/530.PMC5340916.pdf
"The six libraries yielded an average of 4.9 million reads (high: CU428-starving, 5.9 million; low: SB1969-conjugating, 2.8 million).Reads that passed the internal Solexa filters had their adaptorsequences trimmed using fastq-mcf (https://expressionanalysis.github.io/ea-utils/) with the following parameters: -L 30, -k 0.Reads were then mapped to the 2008 assembly of the Tetrahymena macronuclear genome (Coyne et al.",OADS,/arxiv_data1/oa_pdf/1c/f8/530.PMC5340916.pdf
2008) and the v2 assembly of theTetrahymena micronuclear genome (http://www.broadinstitute.,OADS,/arxiv_data1/oa_pdf/1c/f8/530.PMC5340916.pdf
"2Present address: Stowers Institute for Medical Research, Kansas City, MO 64110, USA 3Present address: Green Technology Research Institute, CPC Corporation, Kaohsiung, Taiwan 812, Republic of China Corresponding author: mbscc@ccvax.sinica.edu.twArticle is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.059204.",Non-OADS,/arxiv_data1/oa_pdf/92/0c/546.PMC5340917.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/92/0c/546.PMC5340917.pdf
"After 12 months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/92/0c/546.PMC5340917.pdf
"nc886 is a ubiquitously expressed, cyto-solic noncoding RNA that was found to interact with PKR Corresponding author: gconn@emory.edu Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.060269.",Non-OADS,/arxiv_data1/oa_pdf/15/89/557.PMC5340918.pdf
116.© 2017 Calderon and Conn This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/15/89/557.PMC5340918.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/15/89/557.PMC5340918.pdf
"Therefore, reactivation or reexpression of p53 will likely have a therapeutic benefit in treating many cancers 3Present address: PMV Pharmaceuticals, Inc., Cedar Brook Corporate Center, Cranbury, New Jersey 08512, USA Corresponding author: wfriesen@ptcbio.comArticle is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.060236.",Non-OADS,/arxiv_data1/oa_pdf/86/1a/567.PMC5340919.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/86/1a/567.PMC5340919.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/86/1a/567.PMC5340919.pdf
"Thus, it has been hypothesized that ykkC is involved in the Corresponding author: ailong.ke@cornell.edu Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.060186.",OADS,/arxiv_data1/oa_pdf/11/61/578.PMC5340920.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/11/61/578.PMC5340920.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/11/61/578.PMC5340920.pdf
"In comparison 1Present address: ArcherDX, Boulder, CO 80301, USA 2Present address: Oregon Health and Sciences University, Portland, OR 97239, USA Corresponding author: abarkan@uoregon.eduArticle is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.",OADS,/arxiv_data1/oa_pdf/2b/23/586.PMC5340921.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/2b/23/586.PMC5340921.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/2b/23/586.PMC5340921.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.206805.116.© 2017 Macia et al.",OADS,/arxiv_data1/oa_pdf/3b/52/335.PMC5340962.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/3b/52/335.PMC5340962.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Research 27:335 –348 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/17; www.genome.org Genome Research 335 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/3b/52/335.PMC5340962.pdf
Data access Bisulfite Sanger sequencing traces from this study have beensubmitted to the NCBI GenBank (https://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/3b/52/335.PMC5340962.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.207597.116.© 2017 Pavlic ̌ev et al.",OADS,/arxiv_data1/oa_pdf/13/b2/349.PMC5340963.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/13/b2/349.PMC5340963.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Research 27:349 –361 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/17; www.genome.org Genome Research 349 www.genome.org",OADS,/arxiv_data1/oa_pdf/13/b2/349.PMC5340963.pdf
"Of over 400 GPCRs in the IUPHAR data set (http://www.guidetopharmacology.org), 116 are expressed >2 TPM in at least one of our cells, most in a cell-type –specific manner.",Non-OADS,/arxiv_data1/oa_pdf/13/b2/349.PMC5340963.pdf
"S7 for fragment lengths and mapped reads) using Bowtie, and assessed for abundance by eXpress (http:// www.rnaexpress.org) (see also http://bio.math.berkeley.edu/ eXpress/index.html; Roberts and Pachter 2013).",OADS,/arxiv_data1/oa_pdf/13/b2/349.PMC5340963.pdf
Analysis Single-cell transcriptomes The resulting transcriptomes were hierarchically clustered and subsequently analyzed for specific marker expression using AltAnalyze with default settings (http://www.altanalyze.org; Emig et al.,OADS,/arxiv_data1/oa_pdf/13/b2/349.PMC5340963.pdf
Downstream analyses included the characteriza- tion of the cluster-specific gene expression with GO-terms (using GO Elite from Gladstone Institutes: http://www.genmapp.org/go_elite/) to determine cell-type identities of the clusters.,OADS,/arxiv_data1/oa_pdf/13/b2/349.PMC5340963.pdf
The ligand-recep- tor relationships are based on data from two databases (Supplemental Table S5 ; http://www.guidetopharmacology.org; http://dip.doe-mbi.ucla.edu/dip/DLRP.cgi).,OADS,/arxiv_data1/oa_pdf/13/b2/349.PMC5340963.pdf
2014; https://cran.r-project.org/web/packages/circlize/) to script interaction plots with arrows connecting the ligands and corresponding receptors.,OADS,/arxiv_data1/oa_pdf/13/b2/349.PMC5340963.pdf
Data access Raw and processed data from this study have been submitted to the NCBI Gene Expression Omnibus (GEO; https://www.ncbi.,OADS,/arxiv_data1/oa_pdf/13/b2/349.PMC5340963.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.209924.116.© 2017 Blumberg et al.",OADS,/arxiv_data1/oa_pdf/d0/31/362.PMC5340964.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d0/31/362.PMC5340964.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Research 362 Genome Research 27:362 –373 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/17; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/d0/31/362.PMC5340964.pdf
"Because GRO-seq and PRO-seq data sequence cDNA generated from nascent RNA ex-tracts, we first BLAST searched our identified mtDNA reads against the entire Homo sapiens RefSeq RNA database (https://blast.ncbi.",OADS,/arxiv_data1/oa_pdf/d0/31/362.PMC5340964.pdf
SRA files were converted into FASTQ format using sratoolkit (http://www.ncbi.nlm.nih.gov/ Traces/sra/?view=toolkit_doc).,OADS,/arxiv_data1/oa_pdf/d0/31/362.PMC5340964.pdf
The sequencing adaptors were trimmed by Trim-galore (http://www.bioinformatics.babraham.,Non-OADS,/arxiv_data1/oa_pdf/d0/31/362.PMC5340964.pdf
DNase-seq FASTQ files of the CD4 +and IMR90 cell lines were downloaded from the Roadmap Epigenomics Consortium website (http://egg2.wustl.edu/roadmap/web_portal/index.html) (Roadmap Epigenomics Consortium 2015).,OADS,/arxiv_data1/oa_pdf/d0/31/362.PMC5340964.pdf
NUMTs identification NUMTs diagnosis was performed in three steps: (1) BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi) screen (Wheeler et al.,OADS,/arxiv_data1/oa_pdf/d0/31/362.PMC5340964.pdf
"To this end, we employed CLC Genomics Workbench (https://www.qiagenbioinformatics.com/) to PRO-seq data fromtwo species ( D. melanogaster andC.",OADS,/arxiv_data1/oa_pdf/d0/31/362.PMC5340964.pdf
"Data access The raw and processed sequencing files from this study (PRO-seq data from CD4+T-cells) and BED-graph files have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/), under accession numbers GSE85337 and GSE85747, respectively.",OADS,/arxiv_data1/oa_pdf/d0/31/362.PMC5340964.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.208900.116.© 2017 Roden et al.",OADS,/arxiv_data1/oa_pdf/1b/bc/374.PMC5340965.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/1b/bc/374.PMC5340965.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/ by-nc/4.0/.Research 374 Genome Research 27:374 –384 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/17; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/1b/bc/374.PMC5340965.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.212563.116.© 2017 Ma et al.",OADS,/arxiv_data1/oa_pdf/2c/7f/385.PMC5340966.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date(see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/2c/7f/385.PMC5340966.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/ by-nc/4.0/.Research 27:385 –392 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/17; www.genome.org Genome Research 385 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/2c/7f/385.PMC5340966.pdf
"Methods LCL cell culture and m6A-seq library preparation The human and chimpanzee LCLs were ordered from Coriell (https://www.coriell.org), and three rhesus LCLs were kindly provided by Dr. Eric Vallender from the New England Primate Research Center.",Non-OADS,/arxiv_data1/oa_pdf/2c/7f/385.PMC5340966.pdf
The parameters were estimated via ML us- ing R package nlme (http://cran.r-project.org/web/packages/nlme/ index.html).,OADS,/arxiv_data1/oa_pdf/2c/7f/385.PMC5340966.pdf
Data access The m6A-seq data from this study have been submitted in the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/2c/7f/385.PMC5340966.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.207613.116.© 2017 Safra et al.",OADS,/arxiv_data1/oa_pdf/ca/58/393.PMC5340967.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ca/58/393.PMC5340967.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Research 27:393 –406 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/17; www.genome.org Genome Research 393 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/ca/58/393.PMC5340967.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.219089.116.",OADS,/arxiv_data1/oa_pdf/e1/57/419.PMC5340969.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.Research 27:419 –426 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/17; www.genome.org Genome Research 419 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/e1/57/419.PMC5340969.pdf
"Data access The whole-genome sequencing and deep sequencing data from this study have been submitted to the NCBI Sequence Read Archive (SRA; https://www.ncbi.nlm.nih.gov/sra) under accession numbers SRX2487860, SRX1801343, and SRX1801344.",OADS,/arxiv_data1/oa_pdf/e1/57/419.PMC5340969.pdf
Competing interest statement The authors declare competing financial interests: Details accom- pany the full-text HTML version of the paper at http://genome.cshlp.org/.,Non-OADS,/arxiv_data1/oa_pdf/e1/57/419.PMC5340969.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.212175.116.This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/7e/b1/427.PMC5340970.pdf
"After six months, it is available under aCreative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.Research 27:427 –439 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/17; www.genome.org Genome Research 427 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/7e/b1/427.PMC5340970.pdf
"Regions of enriched tags known as “hotspots ”(i.e., peaks) were determined using the algorithms and methods previ- ously described with minor modification (http://sourceforge.net/ projects/dnase2hotspots) (Baek et al.",OADS,/arxiv_data1/oa_pdf/7e/b1/427.PMC5340970.pdf
"Motif analysis, genome annotation, and binned genomic distance analysis Analyses were performed using HOMER (http://homer.salk.edu/ homer/) (Heinz et al.",OADS,/arxiv_data1/oa_pdf/7e/b1/427.PMC5340970.pdf
Data access All high-throughput sequencing data from this study are summa-rized in Supplemental Table S6 and have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/7e/b1/427.PMC5340970.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.211169.116.© 2017 Goldstein et al.",OADS,/arxiv_data1/oa_pdf/a8/01/462.PMC5340973.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a8/01/462.PMC5340973.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/ by-nc/4.0/.Research 462 Genome Research 27:462 –470 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/17; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/a8/01/462.PMC5340973.pdf
to the WS220 (WormBase; http://www.wormbase.org) genome with Bowtie (Langmead et al.,OADS,/arxiv_data1/oa_pdf/a8/01/462.PMC5340973.pdf
Data access The sequence data from this study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE83133.,OADS,/arxiv_data1/oa_pdf/a8/01/462.PMC5340973.pdf
Sanger se- quencing traces from this study have been submitted to the Trace Archive (https://trace.ncbi.nlm.nih.gov/Traces/trace.cgi) un- der TI numbers 2344111651 –2344112080.,OADS,/arxiv_data1/oa_pdf/a8/01/462.PMC5340973.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.214619.116.© 2017 Maheshwari et al.",OADS,/arxiv_data1/oa_pdf/b6/dd/471.PMC5340974.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/b6/dd/471.PMC5340974.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Research 27:471 –478 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/17; www.genome.org Genome Research 471 www.genome.org",OADS,/arxiv_data1/oa_pdf/b6/dd/471.PMC5340974.pdf
"Illumina sequencing and data processing Library construction was performed using the KAPA Hyper Prep kitas described in the manual (https://www.kapabiosystems.com/), with the only exception that five PCR cycles post-adaptor ligation libraries were size-selected for mononucleosomes, i.e., 200 –400 bp using BluePippin (Sage Science) ( Supplemental Fig.",Non-OADS,/arxiv_data1/oa_pdf/b6/dd/471.PMC5340974.pdf
Allprep script (https://github.com/Comai-Lab/allprep).,Non-OADS,/arxiv_data1/oa_pdf/b6/dd/471.PMC5340974.pdf
Paired reads were merged using SeqPrep (https://github.com/jstjohn/ SeqPrep) with parameters –q 30 (quality) and –L 35 (minimum merged pair length).,OADS,/arxiv_data1/oa_pdf/b6/dd/471.PMC5340974.pdf
Cluster analysis LASTZ (http://www.bx.psu.edu/~rsharris/lastz/) (Harris 2007) was used to identify CEN180 repeats within the assembled TAIR10 ge- nome and PacBio contigs (Kim et al.,OADS,/arxiv_data1/oa_pdf/b6/dd/471.PMC5340974.pdf
Data access Raw FASTQ data as well as processed peak and bigWig files from this study have been submitted to the NCBI Gene Expression Omnibus (GEO; https://www.ncbi.nlm.nih.gov/geo/) under acces-sion number GSE88907.,OADS,/arxiv_data1/oa_pdf/b6/dd/471.PMC5340974.pdf
Scripts and details of the analysis meth- ods are available in the Supplemental Material and can also be accessed at http://doi.org/10.5281/zenodo.160186 and https:// zenodo.org/record/180498 (Allprep).,OADS,/arxiv_data1/oa_pdf/b6/dd/471.PMC5340974.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.212803.116.© 2017 Zhan et al.",OADS,/arxiv_data1/oa_pdf/f0/9e/479.PMC5340975.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/f0/9e/479.PMC5340975.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Method 27:479 –490 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/17; www.genome.org Genome Research 479 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/f0/9e/479.PMC5340975.pdf
CaTCH is provided as an R package at https://github.com/ zhanyinx/CaTCH_R (source code can be found in Supplemental Methods ).,OADS,/arxiv_data1/oa_pdf/f0/9e/479.PMC5340975.pdf
S4d ).Data access The sequencing data from this study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/f0/9e/479.PMC5340975.pdf
CaTCH is provided as an R package at https://github.com/zhanyinx/CaTCH_R.,Non-OADS,/arxiv_data1/oa_pdf/f0/9e/479.PMC5340975.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Nabil Eid, Junior Associate Pro - fessor,  Division of Life Sciences, Department of Anatomy  and Cell Biology, Osaka Medical College, 2-7 Daigaku-machi,  Takatsuki, Osaka 569-8686, Japan.",Non-OADS,/arxiv_data1/oa_pdf/15/0c/WJH-9-349.PMC5340990.pdf
Parkin in cancer: Mitophagy-related/unrelated Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4254/wjh.v9.i7.349World J Hepatol   2017  March 8; 9(7): 349-351 ISSN 1948-5182 (online),Non-OADS,/arxiv_data1/oa_pdf/15/0c/WJH-9-349.PMC5340990.pdf
World J Hepatol  2017; 9(7): 349-351  Available from:  URL:  http://www.wjgnet.co m/1948-5182 /full/v9/i7/349.,Non-OADS,/arxiv_data1/oa_pdf/15/0c/WJH-9-349.PMC5340990.pdf
htm   DOI: http://dx.doi.org/10.4254/wjh.v9.i7.,OADS,/arxiv_data1/oa_pdf/15/0c/WJH-9-349.PMC5340990.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/15/0c/WJH-9-349.PMC5340990.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Cecilia Binda, MD,  Internal Medicine,  Gastroenterology and Hepatology, Catholic University Sacred  Heart of Rome, Agostino Gemelli Hospital, Largo Agostino  Gemelli 8, 00168 Rome, Italy.",Non-OADS,/arxiv_data1/oa_pdf/5f/d9/WJH-9-352.PMC5340991.pdf
Key words:  Direct acting antivirals; Hepatitis C; Liver  transplantation; Liver fibrosis; Cirrhosis; Hepatocellular  carcinomaSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4254/wjh.v9.i7.352World J Hepatol   2017  March 8; 9(7): 352-367 ISSN 1948-5182 (online),Non-OADS,/arxiv_data1/oa_pdf/5f/d9/WJH-9-352.PMC5340991.pdf
Future of  liver disease in the era of direct acting antivirals for the treatment  of hepatitis C. World J Hepatol  2017; 9(7): 352-367  Available  from: URL:  http://www.wjgnet.co m/1948-5182 /full/v9/i7/352.,Non-OADS,/arxiv_data1/oa_pdf/5f/d9/WJH-9-352.PMC5340991.pdf
htm  DOI: http://dx.doi.org/10.4254/wjh.v9.i7.,OADS,/arxiv_data1/oa_pdf/5f/d9/WJH-9-352.PMC5340991.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/5f/d9/WJH-9-352.PMC5340991.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Preeyanat Vongchan, PhD,  Department  of Medical Technology, Faculty of Associated Medical Sciences,  Chiang Mai University, 239 Huay Kaew Road, Muang District,  Chiang Mai 50200, Thailand.",Non-OADS,/arxiv_data1/oa_pdf/93/5d/WJH-9-368.PMC5340992.pdf
Data from amino acid analysis  was aligned with glypican-3 ( https://www.ebi.ac.uk/ Tools/msa/clustalo /).,OADS,/arxiv_data1/oa_pdf/93/5d/WJH-9-368.PMC5340992.pdf
RESULTS Monoclonal antibody 1E4-1D9 reacted with an HSPG  isolated from human liver and a band of 67 kD was  Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4254/wjh.v9.i7.368World J Hepatol   2017  March 8; 9(7): 368-384 © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/93/5d/WJH-9-368.PMC5340992.pdf
World J Hepatol  2017; 9(7): 368-384  Available  from: URL:  http://www.wjgnet.co m/1948-5182 /full/v9/i7/368.,Non-OADS,/arxiv_data1/oa_pdf/93/5d/WJH-9-368.PMC5340992.pdf
"htm  DOI: http://dx.doi.org/10.4254/wjh.v9.i7.368 INTRODUCTION Hepatocellular carcinoma (HCC) is the fifth most common  cancer worldwide and the third most common cause of  cancer-related deaths[1,2].",Non-OADS,/arxiv_data1/oa_pdf/93/5d/WJH-9-368.PMC5340992.pdf
Alignment of  gi30722350 ( https://blast.ncbi.nlm.nih.gov/Blast.cg i)  demonstrated that it was matched to all FYVE containing  protein with 99.7% matched to FYCO-1 (data not shown).,OADS,/arxiv_data1/oa_pdf/93/5d/WJH-9-368.PMC5340992.pdf
"program: https://www.ebi.ac.uk/Tools/msa/clustalo/ Figure 4  Band of approximately 135 kD precipitated by mAb 1E4-1D9 was analyzed by LC-MS.  A: Prediction of glycosylation sites and transmembrane region  in hypothetical protein sequence gi60219551 was predicted by TMHMMM software; B: Number of cysteine was determined from all 1378 amino acid sequence,  yellow highlight are N-glycosylation sites, green letter are cysteine, blue letter are glycosylation sites; C: Sequence of gi60219551 was aligned with glypican-3 based  on the reliable program on website: https://blast.ncbi.nlm.nih.gov/Blast.cgi.Vongchan P  et al.",OADS,/arxiv_data1/oa_pdf/93/5d/WJH-9-368.PMC5340992.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/93/5d/WJH-9-368.PMC5340992.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Kathleen E Corey, MD, MPH, MMSc,  Department of Medicine, Gastrointestinal Unit, Massachusetts  General Hospital, Harvard Medical School, 25 Shattuck St,  Boston, MA 02115, United States.",Non-OADS,/arxiv_data1/oa_pdf/9a/76/WJH-9-385.PMC5340993.pdf
"kcorey@partners.or g Telephone:  +1-617-7240274 Fax:  +1-617-7245997 Received:  July 12, 2016 Peer-review started:  July 13, 2016 First decision:  December 13, 2016 Revised:  December 20, 2016 Accepted:  February 8, 2017 Article in press:  February 13, 2017 Published online:  March 8, 2017 Abstract AIM To identify risk factors associated with hepatocellular Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4254/wjh.v9.i7.385World J Hepatol   2017  March 8; 9(7): 385-390 © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/9a/76/WJH-9-385.PMC5340993.pdf
World J Hepatol   2017; 9(7): 385-390  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/9a/76/WJH-9-385.PMC5340993.pdf
com/ 1948-5182 /full/v9/i7/385.htm  DOI: http://dx.doi.org/10.4254/ wjh.v9.i7.385INTRODUCTION The burden of nonalcoholic fatty liver disease (NAFLD)  is substantial.,Non-OADS,/arxiv_data1/oa_pdf/9a/76/WJH-9-385.PMC5340993.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/9a/76/WJH-9-385.PMC5340993.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Neeta K Venepalli, MD, MBA, Assistant  Professor  of Hematology and Oncology, Department of Medicine,  Section of Hematology/Oncology, University of Illinois at Chicago,  840 South Wood Street, 820-E CSB, Chicago, IL 60612,  United States.",Non-OADS,/arxiv_data1/oa_pdf/c8/3b/WJH-9-391.PMC5340994.pdf
OS analyses were performed using Kaplan-Meier Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4254/wjh.v9.i7.391World J Hepatol   2017  March 8; 9(7): 391-400 ISSN 1948-5182 (online),Non-OADS,/arxiv_data1/oa_pdf/c8/3b/WJH-9-391.PMC5340994.pdf
World J Hepatol  2017;  9(7): 391-400  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/c8/3b/WJH-9-391.PMC5340994.pdf
"com/ 1948-5182 /full/v9/i7/391.htm  DOI: http://dx.doi.org/10.4254/ wjh.v9.i7.391 INTRODUCTION Hepatocellular carcinoma (HCC) is the sixth most common  malignancy worldwide and the third leading cause of  cancer related mortality[1,2].",Non-OADS,/arxiv_data1/oa_pdf/c8/3b/WJH-9-391.PMC5340994.pdf
Available from: URL: http://globocan.iarc.,Non-OADS,/arxiv_data1/oa_pdf/c8/3b/WJH-9-391.PMC5340994.pdf
"Available from:  URL: http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf 6 El-Serag HB , Lau M, Eschbach K, Davila J, Goodwin J. Epide - miology of hepatocellular carcinoma in Hispanics in the United  States.",OADS,/arxiv_data1/oa_pdf/c8/3b/WJH-9-391.PMC5340994.pdf
"Available from: URL: https://www.sciencedaily.com/ releases/2013/12/131209084147.htm 29 Flores YN , Yee HF, Leng M, Escarce JJ, Bastani R, Salmerón  J, Morales LS.",Non-OADS,/arxiv_data1/oa_pdf/c8/3b/WJH-9-391.PMC5340994.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c8/3b/WJH-9-391.PMC5340994.pdf
"Details can be found at https://clinicaltrials.gov/ct2/show/ NCT0242184 8.Informed consent statement:  All study participants, or their  legal guardians, provided written consent prior to study enrollment.",Non-OADS,/arxiv_data1/oa_pdf/fe/2a/WJH-9-401.PMC5340995.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Giliane Belarmino,  Department of  Gastroenterology, Surgical Division, Faculdade de Medicina da  Universidade de São Paulo, Avenida Dr. Arnaldo, 455, Cerqueira  César,  Sao Paulo 05403-000, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/fe/2a/WJH-9-401.PMC5340995.pdf
"giliane85@hotmail.com   Telephone:  +55-11-30617459 Fax:  +55-11-30617459 Received:  July 30, 2016 Peer-review started:  August 2, 2016 First decision:  September 8, 2016 Revised:  December 22, 2016 Accepted:  January 11, 2017 Article in press:  January 14, 2017 Published online:  March 8, 2017 Abstract AIM To evaluate the prognostic value of the phase angle (PA) Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4254/wjh.v9.i7.401World J Hepatol   2017  March 8; 9(7): 401-408 ISSN 1948-5182 (online)",Non-OADS,/arxiv_data1/oa_pdf/fe/2a/WJH-9-401.PMC5340995.pdf
"htm  DOI: http://dx.doi.org/10.4254/ wjh.v9.i7.401 INTRODUCTION Liver transplantation (LT) is the best option for patients  with advanced cirrhosis, but its clinical application is often  limited by the low availability of organ donors, risk of  organ rejection, and implied high cost[1,2].",Non-OADS,/arxiv_data1/oa_pdf/fe/2a/WJH-9-401.PMC5340995.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/fe/2a/WJH-9-401.PMC5340995.pdf
"20 Nobel Media AB 2014, http://www.nobelprize.org/ nobel_prizes/chemistry/laureates/2015/press.html, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0b/d2/SC-008-C6SC03502G.PMC5341205.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/8c/main.PMC5341260.pdf
http://dx.doi.org/10.1016/j.rbms.2015.04.0052405-6618/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/93/8c/main.PMC5341260.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/8c/main.PMC5341260.pdf
Supplementary data Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.rbms.2015.04.005 .,OADS,/arxiv_data1/oa_pdf/93/8c/main.PMC5341260.pdf
"The primers were designed for the selected  SNPs using the Primer3 online tool, (http://www.bioinfo.",OADS,/arxiv_data1/oa_pdf/a8/36/AIAN-20-5.PMC5341267.pdf
Available from: http://www.omim.org/ entry/53500.,Non-OADS,/arxiv_data1/oa_pdf/36/51/AIAN-20-78.PMC5341278.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/66/main.PMC5341284.pdf
http://dx.doi.org/10.1016/j.rbms.2015.04.003 2405-6618/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/53/66/main.PMC5341284.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/66/main.PMC5341284.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.rbms.2015.04.003 .,OADS,/arxiv_data1/oa_pdf/53/66/main.PMC5341284.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/67/main.PMC5341285.pdf
http://dx.doi.org/10.1016/j.rbms.2015.04.0012405-6618 © 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/67/main.PMC5341285.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/67/main.PMC5341285.pdf
Supplementary data Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.rbms.2015.04.001 .,OADS,/arxiv_data1/oa_pdf/b3/67/main.PMC5341285.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
http://dx.doi.org/10.1016/j.rbms.2015.04.006 2405-6618 © 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
"For comparison of monetary values of historic sums with today ’s values, the web site http://www.thisismoney.co.",Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
His arc-welding innovations (http://www.lincolnelectric.com/en-us/Pages/default.aspx ) are described as having transformed many industries and were critical to America's war efforts.,Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
"KTSF, which is owned by the Lincoln Broadcasting Figure 1 (a) Muriel Harris (courtesy of John Fallows, who has copyright), and (b) Lillian Lincoln Howell (from her obituary at http://hosting-19478.tributes.com /obituary/show/Lillian-Lincoln- Howell-101686506 ).67 The Oldham Notebooks: Sources of support and patterns of expenditure",Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
"In this return, Howell is described as Chief Executive Officer and one of three directors withbrother David and son Lincoln ( http://990s.foundationcenter.",Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.rbms.2015.04.006 .,OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
2 at http://www.pomona.edu/Magazine/PCMsp05/DEtommorrow3.shtml.,Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
"San Francisco Chronicle, Page A-23 April 22nd, and at http://sfgate.com/cgi-bin/article.cgi?f=/c/a/ 2003/04/22/ED137939.DTL.69 The Oldham Notebooks: Sources of support and patterns of expenditure",Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
http://www.sfgate.,Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
http://www.arizonafoothillsmagazine.,Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
http://www.tvnewscheck.,Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
com/article/78994/ktsf-owner-lillian-lincoln-howell-dies-at-93 http://www.sfexaminer.com/sanfrancisco/ktsf-owner-lillian- lincoln-howell-who-steered-programming-toward-diverse-languages-dies/Content?oid=2896805 http://hosting-19478.tributes.com/ obituary/show/Lillian-Lincoln-Howell-101686506.,Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
"http://www.consumeraction.or g/press/articles/consumer_ action_anniversary_and_awards/.70 MH Johnson, K Elder",Non-OADS,/arxiv_data1/oa_pdf/e0/55/main.PMC5341286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e0/ce/main.PMC5341287.pdf
http://dx.doi.org/10.1016/j.rbms.2015.04.0042405-6618 © 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/ce/main.PMC5341287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e0/ce/main.PMC5341287.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.rbms.2015.04.004 .,OADS,/arxiv_data1/oa_pdf/e0/ce/main.PMC5341287.pdf
This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/8e/main.PMC5341289.pdf
http://dx.doi.org/10.1016/j.rbms.2015.04.0022405-6618/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/22/8e/main.PMC5341289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/8e/main.PMC5341289.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.rbms.2015.04.002 .,OADS,/arxiv_data1/oa_pdf/22/8e/main.PMC5341289.pdf
Available FREE in open access from:  http://www.clinicalimagingscience.,Non-OADS,/arxiv_data1/oa_pdf/dd/9d/JCIS-7-8.PMC5341301.pdf
Available FREE in open access from:  http://www.clinicalimagingscience.,Non-OADS,/arxiv_data1/oa_pdf/29/a0/JCIS-7-6.PMC5341302.pdf
Available FREE in open access from:  http://www.clinicalimagingscience.,Non-OADS,/arxiv_data1/oa_pdf/92/45/JCIS-7-9.PMC5341303.pdf
Available FREE in open access from:  http://www.clinicalimagingscience.,Non-OADS,/arxiv_data1/oa_pdf/0e/d7/JCIS-7-7.PMC5341304.pdf
"Cooperation and partnership with a patients’  association: a VHL disease patients’ association,  named “Hotto Chain”, was established in Japan in  2003 (http://www.vhl-japan.org/).",Non-OADS,/arxiv_data1/oa_pdf/6f/4e/nmc-57-0059.PMC5341341.pdf
"(national Society of genetic Counselors (2005),  http://nsgc.org/p/cm/ld/fid=386) Patients diagnosed with VHL disease should be  regularly followed-up, and their families need to recognize their own risk of VHL disease onset.",Non-OADS,/arxiv_data1/oa_pdf/6f/4e/nmc-57-0059.PMC5341341.pdf
"the number of patients with mmD who received the designated disease treatment in Japan was 17,436 in 2014 (http://www.nanbyou.or.jp/entry/209).",Non-OADS,/arxiv_data1/oa_pdf/c4/75/nmc-57-0066.PMC5341342.pdf
"notably, Japan agency for medical research and Development (amED) was established to facilitate clinical trials and development of thera - pies for intractable diseases including rare diseases such as mmD (http://www.amed.go.jp/).",Non-OADS,/arxiv_data1/oa_pdf/c4/75/nmc-57-0066.PMC5341342.pdf
"thus, in support of these national initiatives, establishing a rare disease registry will further advance clinical research as well as facilitate the development of orphan drugs (http://www.eucerd.eu/).",Non-OADS,/arxiv_data1/oa_pdf/c4/75/nmc-57-0066.PMC5341342.pdf
"14) JmDr can be introduced at a  global academic meeting such as the International moyamoya meeting, which is held biannually (http://www.moyamoya2015.com/).",Non-OADS,/arxiv_data1/oa_pdf/c4/75/nmc-57-0066.PMC5341342.pdf
"In 2012, the International rare disease research consortium (IrDirc) was established to generate funding to accelerate research for develop - ment of novel therapies and diagnosis (http://www.irdirc.org/).",Non-OADS,/arxiv_data1/oa_pdf/c4/75/nmc-57-0066.PMC5341342.pdf
"Part of the data items will be employed from the stroke version of (cDE) proposed by nInDs (nIn https://commondataelements.ninds.nih.gov/#page=Default), which will ensure that our disease registry meets with the international standards and will facilitate international co-oper - ation.18) It is also important to utilize the data  from the past as well as ongoing clinical research; therefore, data items collected in Jam, amorE and cosmo-Japan studies will be included in the registry, which will enable continuous follow-up of the patients who participated in these studies.",Non-OADS,/arxiv_data1/oa_pdf/c4/75/nmc-57-0066.PMC5341342.pdf
"Leading Causes of Death r eports, National and  regional, 1999–2013, 2015. http://webappa.cdc.",Non-OADS,/arxiv_data1/oa_pdf/34/7e/nmc-57-0082.PMC5341344.pdf
"Atlanta,  Centers for Disease Control and Prevention, National Center for injury Prevention and Control, 2004. https://www.cdc.gov/traumaticbraininjury/tbi_ed.html Access 2015.9.22  3) injury Prevention and Control: Traumatic Brain injury,  Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/34/7e/nmc-57-0082.PMC5341344.pdf
"http://www.cdc.gov/traumaticbraininjury/data/dist_hosp.html Access 2015.9.22  4) injury Prevention and Control: Traumatic Brain injury,  Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/34/7e/nmc-57-0082.PMC5341344.pdf
"http://www.cdc.gov/traumaticbraininjury/data/dist_death.html Access 2015.9.22  5) Keenan  HT, Runyan  DK, Marshall  SW, Nocera MA,  Merten DF, Sinal SH: A population-based study of  inflicted traumatic brain injury in young children.",Non-OADS,/arxiv_data1/oa_pdf/34/7e/nmc-57-0082.PMC5341344.pdf
"Palliative care for children How to treat children with a serious disease  has long been a topic in the field of pediatrics.1)  a guideline working group for children’s terminal  care in the ethical committee of the Japan Pediatric society produced a document called, “Guideline for the discussion of medical care for children with serious disease” in april 2012 (http://www.jpeds.or.jp/uploads/files/saisin_120808.pdf).",Non-OADS,/arxiv_data1/oa_pdf/79/48/nmc-57-0101.PMC5341346.pdf
This amendment made the legal process in these cases faster and much less complicated than in previous cases (http://www.gov-online.go.jp/useful/article/201203/1.html).,Non-OADS,/arxiv_data1/oa_pdf/79/48/nmc-57-0101.PMC5341346.pdf
"Fragmentation, label- ing, and hybridization to the GeneChip S. pombe Tiling 1.0FR Arrays (Affymetrix) were performed by the Affymetrix core facilityat Karolinska Institutet (BEA) according to standard protocols(http://www.affymetrix.com).",OADS,/arxiv_data1/oa_pdf/1d/7a/EMBR-17-753.PMC5341516.pdf
"For microarray analysis, RNA was treated according to the Affy- metrix total RNA labeling protocol (http://www.affymetrix.com)and hybridized to GeneChip S. pombe Tiling 1.0FR Arrays (Affyme- trix) by the Affymetrix core facility at Karolinska Institutet (BEA).In all cases, two or three biological replicates were hybridizedseparately.",OADS,/arxiv_data1/oa_pdf/1d/7a/EMBR-17-753.PMC5341516.pdf
"Data analysis was performed in R(http://www.r-project.org) using the Bioconductor (http://www.bioconductor.org) packages “affy”, “affxparser”, and “preprocessCore”with standard parameters.",OADS,/arxiv_data1/oa_pdf/1d/7a/EMBR-17-753.PMC5341516.pdf
Signals activated by Piezo1 and  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/32/nihms852563.PMC5341576.pdf
").7Co-first author SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven figures, one table, and four movies and can be  found with this article online at http://dx.doi.org/10.1016/j.celrep.2016.04.035 .",Non-OADS,/arxiv_data1/oa_pdf/e8/32/nihms852563.PMC5341576.pdf
"The primary machinery of this mechanism resides in a 26S proteasomal complex, where target proteins meet their http://dx.doi.org/10.1016/j.bbrep.2017.01.013 Received 19 September 2016; Received in revised form 24 January 2017; Accepted 31 January 2017⁎Correspondence to: Department of Pharmaceutical Sciences, 69 North Eagleville Rd, Unit 3092, Storrs, CT 06269-3092.",Non-OADS,/arxiv_data1/oa_pdf/19/96/main.PMC5341616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/96/main.PMC5341616.pdf
"Statistics were calculated in R(https://www.r-project.org/, in the public domain).",OADS,/arxiv_data1/oa_pdf/70/fd/i1552-5783-58-2-1346.PMC5341621.pdf
Available at: https://www.osapublishing.org/ abstract.cfm?uri ¼josaa-24-7-1842.,Non-OADS,/arxiv_data1/oa_pdf/95/4c/i1552-5783-58-2-1323.PMC5341623.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/23/9b/357.PMC5341718.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/41/5c/359.PMC5341719.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/3f/d3/364.PMC5341720.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7a/ed/370.PMC5341721.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b7/c7/381.PMC5341722.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f6/d6/387.PMC5341723.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/5d/11/396.PMC5341724.pdf
The specific targeted sites of  CRISP/Cas9 were selected based on the ChopChop web tool  (https://chopchop.rc.fas.harvard.edu; Montague et al.,OADS,/arxiv_data1/oa_pdf/5d/11/396.PMC5341724.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7e/4c/411.PMC5341725.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/20/e4/429.PMC5341726.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4b/36/440.PMC5341727.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/39/f0/452.PMC5341728.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7d/25/463.PMC5341729.pdf
"Compiled binary distributions, source code, and a detailed guide to  using this software tool is provided in the Supplemental Material  and are available at https://github.com/NanoSPD/NanoSPD.",OADS,/arxiv_data1/oa_pdf/7d/25/463.PMC5341729.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/98/59/476.PMC5341730.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/26/3c/488.PMC5341731.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4e/main.PMC5341737.pdf
The data that do exist show http://dx.doi.org/10.1016/j.vaccine.2017.01.080 0264-410X/ /C2112017 The Authors.,OADS,/arxiv_data1/oa_pdf/dd/4e/main.PMC5341737.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).qInformed consent was obtained from the study participants.,Non-OADS,/arxiv_data1/oa_pdf/dd/4e/main.PMC5341737.pdf
"Published with license by Taylor & Francis Group, LLC © CNRS This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.PLANT SIGNALING & BEHAVIOR 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
"2, e1282022 (5 pages)http://dx.doi.org/10.1080/15592324.2017.1282022",Non-OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
ORCID Yvon Jaillais http://orcid.org/0000-0003-4923-883X References 1.,Non-OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Nat Rev Mol Cell Biol 2008; 9:99-111; PMID:18216767; http://dx.doi.org/10.1038/nrm2328 2.,OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Science 2006; 313:347-51; PMID:16857939; http://dx.doi.org/10.1126/science.1129551 4.,Non-OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Science 2006; 314:1458-61; PMID:17095657; http://dx.doi.org/10.1126/science.1134389 5.,OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Dev Cell 2012; 23:886-95; PMID:23153485; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Dev Cell 2016; 39:139-53; PMID:27780039; http://dx.doi.org/10.1016/j.devcel.2016.09.030 7.,OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Cell 2010; 143:966-77; PMID:21145462; http://dx.doi.org/ 10.1016/j.cell.2010.11.028 8.,OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Plants 2016; 2:16089; PMID:27322096; http://dx.doi.org/10.1038/ nplants.2016.89 9.,OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Science 2012; 337:727- 30; PMID:22722250; http://dx.doi.org/10.1126/science.1222483 10.,Non-OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Science 2008; 319:210-13; PMID:18187657; http://dx.doi.org/10.1126/science.1152066 11.,OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Methods Mol Biol 2016; 1376:175-94; PMID:26552684; http://dx.doi.org/10.1007/978-1-4939-3170-5_15 12.,Non-OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Nat Rev Mol Cell Biol 2012; 13:463- 70; PMID:22722608; http://dx.doi.org/10.1038/nrm3379 13.,OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Physiol Rev 2013; 93:1019-37; PMID:23899561; http://dx.doi.org/10.1152/physrev.00028.2012 14.,Non-OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Annu Rev Biophys 2010;39:407-27; PMID:20192774; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
J Cell Biol 2009; 185:917-28; PMID:19487458; http://dx.doi.org/10.1083/jcb.200903020 16.,Non-OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
A multi-colour/multi-af ﬁnity marker set to visualize phosphoinositide dynamics in Arabidopsis.Plant J 2014; 77:322-37; PMID:24147788; http://dx.doi.org/10.1111/tpj.12358 18.,OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
AnalBiochem 2008; 378:197-201; PMID:18466755; http://dx.doi.org/ 10.1016/j.ab.2008.03.052 19.,OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
New Phytol 2014; 203:483-94; PMID:24750036; http://dx.doi.org/10.1111/nph.12814 20.,Non-OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
Development 2016; 143(24):4687-700; PMID:27836964; http://dx.doi.org/10.1242/dev.137117PLANT SIGNALING & BEHAVIOR e1282022-5,OADS,/arxiv_data1/oa_pdf/86/e4/kpsb-12-02-1282022.PMC5341768.pdf
"Published with license by Taylor & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"1, 53 –58 http://dx.doi.org/10.1080/19490976.2016.1270810",Non-OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Nat Commun 2015; 6:7577;PMID:26154811; http://dx.doi.org/10.1038/ncomms8577 [3] Butto LF, Haller D. Dysbiosis in intestinal in ﬂammation: Cause or consequence.",Non-OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Gastroenterology2016; 150:S578; http://dx.doi.org/10.1016/S0016-5085(16)31978-3 [5] Ocvirk S, Sava IG, Lengfelder I, Lagkouvardos I, Steck N, Roh JH, et al.",Non-OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"PLoS Pathog 2015; 11:e1004911; PMID:26067254;http://dx.doi.org/10.1371/journal.ppat.1004911 [6] Butt /C19o LF, Schaubeck M, Haller D. Mechanisms of microbe-host-interaction in Crohn ’s Disease: Dysbiosis vs. Pathobiont selection.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Frontiers Immunol 2015; 6:555; http://dx.doi.org/10.3389/mmu.2015.00555 [7] Wehkamp J, Stange EF.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Paneth ’s disease J Crohns Colitis 2010; 4:523-31; PMID:21122555; http://dx.doi.org/10.1016/j.crohns.2010.05.010 [8] Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, AndersonCA, et al.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
Nature 2012; 491:119-24; PMID:23128233; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Nat Genet 2015; 47:979-86;PMID:26192919; http://dx.doi.org/10.1038/ng.3359 [10] Kaser A, Adolph TE, Blumberg RS.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Semin Immunopa-thol 2013; 35:307-19; PMID:23588234; http://dx.doi.org/10.1007/s00281-013-0377-5 [11] Adolph TE, Tomczak MF, Niederreiter L, Ko HJ, Bock J, Martinez-Naves E, Glickman JN, Tschurtschenthaler M,Hartwig J, Hosomi S, et al.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Science 2005; 307:731-4; PMID:15692051; http://dx.doi.org/10.1126/science.1104911 [14] Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, Kishi C, Kc W, Carrero JA, Hunt S, et al.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Nature 2008; 456:259-63; PMID:18849966; http://dx.doi.org/10.1038/nature07416[15] Liu B, Gulati AS, Cantillana V, Henry SC, Schmidt EA, Daniell X, Grossniklaus E, Schoenborn AA, Sartor RB,Taylor GA. Irgm1-de ﬁcient mice exhibit Paneth cell abnormalities and increased susceptibility to acute intes-tinal in ﬂammation.",Non-OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Am J Physiol Gastrointest Liver Physiol 2013; 305:G573-84; PMID:23989005; http://dx.doi.org/10.1152/ajpgi.00071.2013 [16] Kaser A, Lee AH, Franke A, Glickman JN, Zeissig S, Tilg H, Nieuwenhuis EE, Higgins DE, Schreiber S, GlimcherLH, et al.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Cell 2008; 134:743-56; PMID:18775308; http://dx.doi.org/10.1016/j.cell.2008.07.021 [17] Simms LA, Doecke JD, Walsh MD, Huang N, Fowler E V ,R a d f o r d - S m i t hG L .R educed alpha-defensin expression is associated with in ﬂammation and not NOD2 mutation status in ileal Crohn ’sd i s e a s e .G u t 2008; 57:903-10; PMID:18305068; http://dx.doi.org/10.1136/gut.2007.142588 [18] Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, Ohmura M, Naka K, Hosokawa K, Ikeda Y, et al.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Nat Med 2006; 12:446-51; PMID:16565722; http://dx.doi.org/10.1038/ nm1388 [19] Johansson ME, Hansson GC.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Nat Rev Immunol 2016; 16(10):639-49; PMID:27498766; http://dx.doi.org/10.1038/nri.2016.88 [20] Johansson ME, Jakobsson HE, Holmen-Larsson J, Schutte A, Ermund A, Rodriguez-Pineiro AM, Arike L, Wising C, Svensson F, B €ackhed F, et al.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Cell Host & Microbe 2015;18:582-92; PMID:26526499; http://dx.doi.org/10.1016/j.chom.2015.10.007 [21] Hansen CH, Nielsen DS, Kverka M, Zakostelska Z, Kli- mesova K, Hudcovic T, Tlaskalova-Hogenova H, HansenAK.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"PLoS One 2012; 7:e34043; PMID:22479515; http://dx.doi.org/10.1371/journal.pone.0034043 [22] Arrieta MC, Walter J, Finlay BB.",Non-OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Cell HostMicrobe 2016; 19:575-8; PMID:27173924; http://dx.doi.org/10.1016/j.chom.2016.04.014 [23] Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy E B ,R e a d i n gN C ,V i l l a b l a n c aE J ,W a n gS ,M o r aJ R ,e ta l .G u t immune maturation depends on colonization with a host-speciﬁc microbiota.",Non-OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Cell 2012; 149:1578-93; PMID:22726443; http://dx.doi.org/10.1016/j.cell.2012.04.037 [24] Rawls JF, Mahowald MA, Ley RE, Gordon JI.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
Cell2006; 127:423-33; PMID:17055441; http://dx.doi.org/ 10.1016/j.cell.2006.08.043GUT MICROBES 57,OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Nat Commun 2015;6:8292; PMID:26392213; http://dx.doi.org/10.1038/ncomms9292 [26] Mashukova A, Wald FA, Salas PJ.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Mol Cell Biol 2011; 31:756-65; PMID:21135124;http://dx.doi.org/10.1128/MCB.00811-10[27] Sha S, Liang J, Chen M, Xu B, Liang C, Wei N, Wu K. Systematic review: faecal microbiota transplantationtherapy for digestive and nondigestive disorders in adultsand children.",Non-OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Aliment Pharmacol Ther 2014; 39:1003-32;PMID:24641570; http://dx.doi.org/10.1111/apt.12699 [28] Paramsothy S, Kamm M, Walsh A, van den Boaerde J, Samuel D, Leong R, et al.",OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Multi donor intense faecal micro- biota transplantation is an effective treatment for resistant ulcerative colitis: A randomised Placebo-Controlled trial.Gastroenterology 2016; 150, Issue 4, Supplement 1; S122-S123; http://dx.doi.org/10.1016/S0016-5085(16)30517-058 L. F. BUTT /C19O AND D. HALLER",Non-OADS,/arxiv_data1/oa_pdf/47/75/kgmi-08-01-1270810.PMC5341912.pdf
"Available from  https://www.sisben.gov.co/Dooris, M. (2004).",Non-OADS,/arxiv_data1/oa_pdf/6a/22/10.1177_2333393616681392.PMC5342281.pdf
"Retrieved from http://www.medellincomovamos.org/pobreza-y-desigualdad Moffat, T. (2010).",Non-OADS,/arxiv_data1/oa_pdf/6a/22/10.1177_2333393616681392.PMC5342281.pdf
"Retrieved from http://www.who.int/dietphysicalactivity/child-hood/en/ Author Biographies Patricia Olaya-Contreras, RN, MSc in Reproductive  Epidemiology, PhD, is a guest researcher at Unit for Health promo-tion Research, University of southern Denmark, and associate pro- fessor at the Institute of Health and Care Sciences, University of  Gothenburg, Diana-Carolina Ocampo, RN, MSc in Collective Health, is a doc- toral student at the University Andina Simon Bolivar, Ecuador.Eva Ladekjær Larsen, anthropologist, PhD, is associate professor  at Unit for Health Promotion Research, University of Southern Denmark.",Non-OADS,/arxiv_data1/oa_pdf/6a/22/10.1177_2333393616681392.PMC5342281.pdf
"Retrieved  from http://www.cihc.ca/files/CIHC_IPCompetencies_Feb1-210.pdf Conrad, D. (2004).",OADS,/arxiv_data1/oa_pdf/d1/8c/10.1177_2333393614565186.PMC5342284.pdf
"Retrieved from http://www.ualberta.ca/~iiqm/backissues/3_1/ pdf/conrad.pdf Derrida, J.",Non-OADS,/arxiv_data1/oa_pdf/d1/8c/10.1177_2333393614565186.PMC5342284.pdf
"Retrieved from http://www.clas.ufl.edu/ users/burt/inc.pdf Diamond, D. (2007).",Non-OADS,/arxiv_data1/oa_pdf/d1/8c/10.1177_2333393614565186.PMC5342284.pdf
"Retrieved from http://www.aacn  .nche.edu/education-resources/ipecreport.pdf Jackson, A. Y.",Non-OADS,/arxiv_data1/oa_pdf/d1/8c/10.1177_2333393614565186.PMC5342284.pdf
"Retrieved from http://www.qualitative -research.net/index.php/fqs/article/view/2108/3670 Tong, A., Sainsbury, P., & Craig, J.",OADS,/arxiv_data1/oa_pdf/d1/8c/10.1177_2333393614565186.PMC5342284.pdf
"Retrieved from http://www.who.int/hrh/resources/transf_  scaling_hpet/en/ Author Biography Susan C. Sommerfeldt, PhD, RN, is a faculty lecturer in the  Faculty of Nursing at the University of Alberta in Edmonton, Alberta, Canada.",Non-OADS,/arxiv_data1/oa_pdf/d1/8c/10.1177_2333393614565186.PMC5342284.pdf
"Available  from http://nej.sagepub.com Comrie, R. W. (2012).",Non-OADS,/arxiv_data1/oa_pdf/2c/b4/10.1177_2333393615625996.PMC5342286.pdf
"Available  from http://nej.sagepub.com Cummings, C. L. (2011).",Non-OADS,/arxiv_data1/oa_pdf/2c/b4/10.1177_2333393615625996.PMC5342286.pdf
"Available from http://www.thefreedictionary.com Gaudine, A., LeFort, S. M., Lamb, M., & Thorne, L. (2011).",Non-OADS,/arxiv_data1/oa_pdf/2c/b4/10.1177_2333393615625996.PMC5342286.pdf
"Retrieved from http://onlinelibrary.wiley.com/jour- nal/10.1111/(ISSN)1478-5153 McGibbon, E., Peter, E., & Gallop, R. (2010).",Non-OADS,/arxiv_data1/oa_pdf/2c/b4/10.1177_2333393615625996.PMC5342286.pdf
"Retrieved from http://dspace.nwu.ac.za/handle/10394/4005 Price, A. M. (2013).",OADS,/arxiv_data1/oa_pdf/2c/b4/10.1177_2333393615625996.PMC5342286.pdf
"Available from http://ccn.aacnjournals.org Scribante, J., & Bhagwanjee, S. (2007).",Non-OADS,/arxiv_data1/oa_pdf/2c/b4/10.1177_2333393615625996.PMC5342286.pdf
"Available  from http://www.ajcconline.org Stievano, A., De Marinis, M. G., Russo, M. T., Rocco, G., &  Alvaro, R. (2012).",Non-OADS,/arxiv_data1/oa_pdf/2c/b4/10.1177_2333393615625996.PMC5342286.pdf
"Available from http://ujdigispace.uj.ac.za/handle/10210/5370 Tschannen, D., & Kalisch, B. J.",Non-OADS,/arxiv_data1/oa_pdf/2c/b4/10.1177_2333393615625996.PMC5342286.pdf
"Available from http://ccn.aac- njournals.org Urden, L. D., Stacy, K. M., & Lough, M. E. (2006).",Non-OADS,/arxiv_data1/oa_pdf/2c/b4/10.1177_2333393615625996.PMC5342286.pdf
"Retrieved from http://www.who.int/whr/2006/en/ Author Biographies Suegnèt Scholtz, RN, DCur, is a student of nursing science,  University of Johannesburg, Johannesburg, South Africa.",Non-OADS,/arxiv_data1/oa_pdf/2c/b4/10.1177_2333393615625996.PMC5342286.pdf
"Retrieved from  http://www.caringforkids.cps.ca/handouts/breastfeeding Dietrich Leurer, M., & Misskey, E. (2015).",Non-OADS,/arxiv_data1/oa_pdf/5a/68/10.1177_2333393615611654.PMC5342287.pdf
Retrieved from http://www.statcan.gc.ca/pub/82-624-x/2013001/ article/11879-eng.pdf Government of Canada.,Non-OADS,/arxiv_data1/oa_pdf/5a/68/10.1177_2333393615611654.PMC5342287.pdf
"Retrieved from http://www.statcan.gc.ca/tables-tab-leaux/sum-som/l01/cst01/famil108a-eng.htm Hamilton, A. E. (2015).",OADS,/arxiv_data1/oa_pdf/5a/68/10.1177_2333393615611654.PMC5342287.pdf
"Retrieved from http://apps.who.int/iris/bitstream/10665/43623/1/9789241595230_eng.pdf Ip, S., Chung, M., Raman, G., Chew, P., Magula, N., DeVine, D.,  .",OADS,/arxiv_data1/oa_pdf/5a/68/10.1177_2333393615611654.PMC5342287.pdf
"Retrieved from http://archive.ahrq.gov/ downloads/pub/evidence/pdf/brfout/brfout.pdf Locke, A.",OADS,/arxiv_data1/oa_pdf/5a/68/10.1177_2333393615611654.PMC5342287.pdf
"Retrieved  from http://www.hscic.gov.uk/catalogue/PUB08694/Infant- Feeding-Survey-2010-Consolidated-Report.pdf McCann, M. F., Baydar, N., & Williams, R. L. (2007).",Non-OADS,/arxiv_data1/oa_pdf/5a/68/10.1177_2333393615611654.PMC5342287.pdf
"Retrieved from http://www.cdc.gov/breastfeeding/ pdf/2013breastfeedingreportcard.pdf Neergaard, M. A., Olesen, F., Andersen, R. S., & Sondergaard, J.",Non-OADS,/arxiv_data1/oa_pdf/5a/68/10.1177_2333393615611654.PMC5342287.pdf
"Retrieved from http://www.unicef.org.uk/Documents/Baby_Friendly/Research/Preventing_disease_sav-ing_resources.pdf Sandelowski, M. (2000).",Non-OADS,/arxiv_data1/oa_pdf/5a/68/10.1177_2333393615611654.PMC5342287.pdf
"Retrieved  from http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-240X Sandelowski, M. (2010).",Non-OADS,/arxiv_data1/oa_pdf/5a/68/10.1177_2333393615611654.PMC5342287.pdf
"Retrieved from http://apps.who.int/iris/bitstream/10665/149018/1/WHO_NMH_NHD_14.2_eng.pdf Author Biographies Marie Dietrich Leurer, RN, PhD, is an assistant professor in the College of Nursing (South Saskatchewan Campus), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.",Non-OADS,/arxiv_data1/oa_pdf/5a/68/10.1177_2333393615611654.PMC5342287.pdf
"Retrieved from  http://www.diabetes.org/diabetes-basics/symptoms/?loc=db- slabnav Bell, R., Bertoni, A., Calles, J., Hairston, K., Hunter, J., Mount,  D., & Whitt-Glover, M. (2010).",Non-OADS,/arxiv_data1/oa_pdf/0a/cb/10.1177_2333393615610576.PMC5342290.pdf
"Retrieved  from http://www.cdc.gov/diabetes/statistics/esrd/fig5.htm Chesla, C. A., Fisher, L., Mullan, J. T., Skaff, M. M., Gardiner,  P., Chun, K., & Kantner, R. (2004).",OADS,/arxiv_data1/oa_pdf/0a/cb/10.1177_2333393615610576.PMC5342290.pdf
"Retrieved from http://diabetes.niddk.nih.gov/dm/pubs/america/index.aspx Newton, R. L., Jr., Griffith, D. M., Kearney, W. B., & Bennett, G.  G. (2014).",Non-OADS,/arxiv_data1/oa_pdf/0a/cb/10.1177_2333393615610576.PMC5342290.pdf
"Retrieved January 31, 2014, from http://images.alfresco.advan star.com/alfresco_images/HealthCare/2013/10/08/fba7fd87-f56c-40f8-89b5-f16859909d5b/hct1010_ezine.pdf.",Non-OADS,/arxiv_data1/oa_pdf/09/a0/10.1177_2333393614565185.PMC5342292.pdf
"Retrieved from http://www.bumc.bu.edu/irb/irb- guidance/ Brown, A. S., Disler, S., Burns, L., Carlson, A., Davis, A., Kurian,  C., .",Non-OADS,/arxiv_data1/oa_pdf/81/b5/10.1177_2333393616676154.PMC5342293.pdf
"Retrieved from http://www.cdc.gov/asthma/most_recent_data.htm#modalIdString_CDCTable_0 Clark, N. M., Lachance, L. L., Benedict, M. B., Doctor, L. J.,  Gilmore, L., Kelly, C. S., .",OADS,/arxiv_data1/oa_pdf/81/b5/10.1177_2333393616676154.PMC5342293.pdf
"Retrieved from http://www.cityofboston.gov/Images_Documents/sanitary- code_tcm3-35385.pdf Messer, L. C., Laraia, B.",Non-OADS,/arxiv_data1/oa_pdf/81/b5/10.1177_2333393616676154.PMC5342293.pdf
"Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24683937 Rumchev, K., Spickett, J., Bulsara, M., Phillips, M., & Stick, S.  (2004).",OADS,/arxiv_data1/oa_pdf/81/b5/10.1177_2333393616676154.PMC5342293.pdf
"Retrieved from http://www.ncbi.nlm.nih.gov/ pubmed/8648037 Shani, Z., Scott, R. G., Schofield, L. S., Johnson, J. H., Williams,  E. R., Hampton, J., & Ramprasad, V. (2015).",OADS,/arxiv_data1/oa_pdf/81/b5/10.1177_2333393616676154.PMC5342293.pdf
"Retrived July 13,  2015 at http://www.wma.net/en/30publications/10policies/ b3/17c.pdf Yalom, I.",Non-OADS,/arxiv_data1/oa_pdf/9a/72/10.1177_2333393615595965.PMC5342296.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8d/c7/lctt-8-001.PMC5342609.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8d/c7/lctt-8-001.PMC5342609.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Lung Cancer: Targets and Therapy 2017:8 1–11Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  1 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S105678Pembrolizumab in the treatment of metastatic  non-small-cell lung cancer: patient selection and  perspectives Ashwin Somasundaram   Timothy F Burns Division of Hematology/Oncology,   Department of Medicine, University of Pittsburgh Cancer Institute,  Pittsburgh, PA, USAAbstract:  Lung cancer is the leading killer of both men and women in the US, and the 5-year  survival remains poor.",Non-OADS,/arxiv_data1/oa_pdf/8d/c7/lctt-8-001.PMC5342609.pdf
"Antigen-presenting cells (APCs) recognize cancer cells Correspondence: Timothy F Burns   Division of Hematology/Oncology,  Department of Medicine, University of Pittsburgh, Hillman Cancer Center Research Pavilion, Office: Suite 2.18e Lab: 2.7, 5117 Centre Avenue, Pittsburgh, PA 15213, USA Tel +1 412 864 7859   Fax +1 412 623 7768   Email burnstf@upmc.eduJournal name: Lung Cancer: Targets and Therapy Article Designation: REVIEWY ear: 2017V olume: 8Running head verso: Somasundaram and BurnsRunning head recto: Pembrolizumab in NSCLCDOI: http://dx.doi.org/10.2147/LCTT.S105678",Non-OADS,/arxiv_data1/oa_pdf/8d/c7/lctt-8-001.PMC5342609.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02007070.,Non-OADS,/arxiv_data1/oa_pdf/8d/c7/lctt-8-001.PMC5342609.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01840579.,Non-OADS,/arxiv_data1/oa_pdf/8d/c7/lctt-8-001.PMC5342609.pdf
Available from: https://clinicaltri-als.gov/ct2/show/NCT02775435.,Non-OADS,/arxiv_data1/oa_pdf/8d/c7/lctt-8-001.PMC5342609.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02578680.,Non-OADS,/arxiv_data1/oa_pdf/8d/c7/lctt-8-001.PMC5342609.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02504372.,Non-OADS,/arxiv_data1/oa_pdf/8d/c7/lctt-8-001.PMC5342609.pdf
"Lung Cancer: Targets and Therapy 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/lung-cancer-targets--therapy-journalLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/8d/c7/lctt-8-001.PMC5342609.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from   published authors.Dovepress 11 Pembrolizumab in NSCLC  28.,Non-OADS,/arxiv_data1/oa_pdf/8d/c7/lctt-8-001.PMC5342609.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/14/04/ndt-13-697.PMC5342610.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 697–706Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  697OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13210 8 Influence of CFH gene on symptom severity  of schizophrenia chen Zhang1 Qinyu lv1 Weixing Fan2 Wei Tang3 Zhenghui Yi1 1Schizophrenia Program, Shanghai  Mental Health Center, Shanghai Jiao  T ong University School of Medicine,   Shanghai, 2Department of Psychiatry,   Jinhua Second Hospital, Jinhua,   3Department of Psychiatry, Wenzhou  Kanging Hospital, Wenzhou, People’s  Republic of ChinaObjective:  Recent advances have provided compelling evidence for the role of excessive  complement activity in the pathophysiology of schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/14/04/ndt-13-697.PMC5342610.pdf
"Family, twin and adoption studies have demonstrated that schizophrenia is a familiar  disorder with a complex mode of inheritance, and its heritability reaches upward of  80%.4,5 Hence, understanding the genetics involved in schizophrenia seems to provide correspondence: chen Zhang;  Zhenghui Yi Schizophrenia Program, Shanghai Mental  Health Center, Shanghai Jiao Tong  University School of Medicine, 600  Wan Ping Nan Road, Shanghai 200030,  People’s Republic of China email zhangchen645@gmail.co m;  yizhenghui1971@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Zhang et al Running head recto: CFH and schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S132108",Non-OADS,/arxiv_data1/oa_pdf/14/04/ndt-13-697.PMC5342610.pdf
"Neuropsychiatric Disease and Treatment 2017:13submit your manuscript | www.dovepress.co m Dove press Dove press 699CFH and schizophrenia whether CFH  is differentially expressed in brain between  patients with schizophrenia and healthy controls, using  SZDB database ( http://www.szdb.org /), a newly developed  comprehensive resource for schizophrenia research.25 SNP selection In our recent studies,14,26 we performed an extensive analysis  of SNPs in CFH  and selected a total of 11 SNPs with 80%  coverage of the gene.",Non-OADS,/arxiv_data1/oa_pdf/14/04/ndt-13-697.PMC5342610.pdf
"The 11 SNPs were detected using multiplex poly - merase chain reaction and the SNaPshot assay, while details  have been described in our previous work.14,26 Psychiatric Genomics Consortium data  analysis To further validate the association between the studied SNPs  and schizophrenia, we extracted the schizophrenia genetic  association data from the Psychiatric Genomics Consortium  (PGC; http://www.broadinstitute.org/mpg/ricopili /) database30  and reanalyzed the data set as an independent sample.",OADS,/arxiv_data1/oa_pdf/14/04/ndt-13-697.PMC5342610.pdf
"Brain eQTL analysis for risk SNPs The brain eQTL analysis was performed using the brain eQTL  database ( http://caprica.genetics.kcl.ac.uk/BRAINEAC /), a  large exon-specific eQTL data set covering 10 human brain  regions.",OADS,/arxiv_data1/oa_pdf/14/04/ndt-13-697.PMC5342610.pdf
Hardy–Weinberg equilibrium testing  and allele and genotype frequency analysis were conducted  using SHEsis ( http://analysis.bio-x.c n).32 The pairwise  linkage disequilibrium (LD) analysis for all pairs of SNPs  was applied to detect the inter-marker relationship in case– control samples.,OADS,/arxiv_data1/oa_pdf/14/04/ndt-13-697.PMC5342610.pdf
Data were extracted from the SZDB   (http://www.szdb.org /).,OADS,/arxiv_data1/oa_pdf/14/04/ndt-13-697.PMC5342610.pdf
Data were extracted from the BRAINEAC  database ( http://caprica.genetics.kcl.ac.uk/BRAINEAC /).,OADS,/arxiv_data1/oa_pdf/14/04/ndt-13-697.PMC5342610.pdf
Note:  Data from the Psychiatric Genomics Consortium (PGC; http://www.broadinstitute.org/mpg/ricopili /) database.,OADS,/arxiv_data1/oa_pdf/14/04/ndt-13-697.PMC5342610.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/14/04/ndt-13-697.PMC5342610.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/04/ndt-13-697.PMC5342610.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d8/ca/lctt-8-013.PMC5342611.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d8/ca/lctt-8-013.PMC5342611.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Lung Cancer: Targets and Therapy 2017:8 13–19Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  13 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S104207Spotlight on necitumumab in the treatment of  non-small-cell lung carcinoma Manish K Thakur Antoinette J Wozniak Department of Oncology, Karmanos  Cancer Center, Detroit, MI, USAAbstract: The treatment options for metastatic non-small-cell lung cancer (NSCLC) have  expanded dramatically in the last 10 years with the discovery of newer drugs and targeted therapy.",Non-OADS,/arxiv_data1/oa_pdf/d8/ca/lctt-8-013.PMC5342611.pdf
"11Correspondence: Antoinette J Wozniak Department of Oncology, Karmanos Cancer Center, 4100 John R, Detroit, MI 48201, USAEmail wozniakt@karmanos.orgJournal name: Lung Cancer: Targets and Therapy Article Designation: REVIEWY ear: 2017V olume: 8Running head verso: Thakur and WozniakRunning head recto: Necitumumab in the treatment of NSCLCDOI: http://dx.doi.org/10.2147/LCTT.S104207",Non-OADS,/arxiv_data1/oa_pdf/d8/ca/lctt-8-013.PMC5342611.pdf
"Lung Cancer: Targets and Therapy 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/lung-cancer-targets--therapy-journalLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/d8/ca/lctt-8-013.PMC5342611.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from   published authors.Dovepress 19 Necitumumab in the treatment of NSCLC,Non-OADS,/arxiv_data1/oa_pdf/d8/ca/lctt-8-013.PMC5342611.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c6/b4/ndt-13-667.PMC5342612.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 667–683Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  667OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11969 4 effects of a structured 20-session slow-cortical- potential-based neurofeedback program  on attentional performance in children and  adolescents with attention-deficit hyperactivity  disorder: retrospective analysis of an open-label  pilot-approach and 6-month follow-up Johanna s albrecht,1–3 sarah  Bubenzer-Busch,1,2 anne  gallien,1,4 eva lotte Knospe,1,2  Tilman J gaber,1,2,5 Florian D  Zepf1,2,6,7 1clinic for child and adolescent Psychiatry,   Psychosomatics and Psychotherapy,   rWTh aachen University, aachen, 2Jara  Translational Brain Medicine, aachen &   Jülich, 3center for Pediatrics and  adolescent Medicine elisabeth hospital  rheydt, Mönchengladbach, 4clinic for  Neurology, Medical center city region  aachen, Würselen, 5Neuro care group,   Munich, germany; 6centre and Discipline  of child and adolescent Psychiatry,   Psychosomatics and Psychotherapy, school  of Paediatrics and child health & school  of Psychiatry and clinical Neurosciences,   Faculty of Medicine, Dentistry and health  sciences, The University of Western  australia, 7Department of health in  Western australia, specialised child  and adolescent Mental health services,   Perth,  Wa, australiaObjective:  The aim of this approach was to conduct a structured electroencephalography-based  neurofeedback training program for children and adolescents with attention-deficit hyperactivity  disorder (ADHD) using slow cortical potentials with an intensive first (almost daily sessions)  and second phase of training (two sessions per week) and to assess aspects of attentional  performance.",Non-OADS,/arxiv_data1/oa_pdf/c6/b4/ndt-13-667.PMC5342612.pdf
"Keywords:  SCP, neurofeedback, ADHD, children, adolescents, attentioncorrespondence: Florian D Zepf centre and Discipline of child and adolescent  Psychiatry, Psychosomatics and Psychotherapy,  The University of Western australia,  35 stirling highway (M561), crawley, Perth,  Wa 6009, australia email florian.zepf@uwa.edu.a u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Albrecht et al Running head recto: Effects of a structured 20-session SCP-based neurofeedback program DOI: http://dx.doi.org/10.2147/NDT.S119694",Non-OADS,/arxiv_data1/oa_pdf/c6/b4/ndt-13-667.PMC5342612.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c6/b4/ndt-13-667.PMC5342612.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/b4/ndt-13-667.PMC5342612.pdf
Or use: http://youtu.be/lzT-b6CQPe 0Video abstract,Non-OADS,/arxiv_data1/oa_pdf/c6/b4/ndt-13-667.PMC5342612.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8b/61/ndt-13-653.PMC5342613.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 653–665Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  653OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12827 8 risk of recurrent overdose associated with  prescribing patterns of psychotropic medications  after nonfatal overdose Yasuyuki Okumura1 Daisuke Nishi2 1research Department, institute  for health economics and Policy,   association for health economics  research and social insurance and  Welfare, T okyo, 2Department of  Mental health Policy and evaluation,   National institute of Mental health,   National center of Neurology and  Psychiatry, Kodaira, JapanObjective:  We aimed to estimate risk of recurrent overdose associated with psychosocial  assessment by psychiatrists during hospitalization for nonfatal overdose and prescribing patterns  of psychotropic medications after discharge.",Non-OADS,/arxiv_data1/oa_pdf/8b/61/ndt-13-653.PMC5342613.pdf
"Some studies found a  protective effect of psychosocial assessment on recurrent self-harm,5–10 but others failed correspondence: Yasuyuki Okumura research Department, institute for  health economics and Policy, association  for health economics research and  social insurance and Welfare, 11 Toyo  Kaiji Building 2F, 1-5-11 Nishishimbashi,  Minato-ku, Tokyo 105-0003, Japan Tel +81 3 3506 8529 email yokumura@blue.zero.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Okumura and Nishi Running head recto: Risk of recurrent overdose with benzodiazepines DOI: http://dx.doi.org/10.2147/NDT.S128278",Non-OADS,/arxiv_data1/oa_pdf/8b/61/ndt-13-653.PMC5342613.pdf
"Available from: http://www.mhlw.go.jp/ stf/shingi/2r9852000002ss9z-att/2r9852000002ssfg.pd f. Accessed  February 17, 2016.",Non-OADS,/arxiv_data1/oa_pdf/8b/61/ndt-13-653.PMC5342613.pdf
Available from: http://www.stat.,OADS,/arxiv_data1/oa_pdf/8b/61/ndt-13-653.PMC5342613.pdf
"Available from: http://www.ipss.go.jp/s-info/e/ ssj2014/PDF/ssj2014.pd f. Accessed January 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/8b/61/ndt-13-653.PMC5342613.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8b/61/ndt-13-653.PMC5342613.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/61/ndt-13-653.PMC5342613.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7b/e0/lctt-8-021.PMC5342614.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7b/e0/lctt-8-021.PMC5342614.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Lung Cancer: Targets and Therapy 2017:8 21–30Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  21 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S124301Trajectory of chemotherapy for patients  with EGFR wild-type advanced pulmonary  adenocarcinoma: a single-institution  retrospective study Seigo Minami Y oshitaka Ogata Shouichi Ihara Suguru YamamotoKiyoshi Komuta Department of Respiratory Medicine,   Osaka Police Hospital, Osaka, JapanBackground:  Pulmonary adenocarcinoma, recently benefited by new cytotoxic and molecularly  targeted drugs, has been classified by driver mutations, such as EGFR mutations.",Non-OADS,/arxiv_data1/oa_pdf/7b/e0/lctt-8-021.PMC5342614.pdf
"1Correspondence: Seigo Minami Department of Respiratory Medicine, Osaka Police Hospital, 10-31 Kitayama-cho, Tennoji-ku, Osaka 543-0035, JapanTel +81 6 6771 6051Fax +81 6 6771 2838Email seigominami@oph.gr.jpJournal name: Lung Cancer: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Minami et alRunning head recto: Chemotherapy trajectory in EGFR adenocarcinomaDOI: http://dx.doi.org/10.2147/LCTT.S124301",Non-OADS,/arxiv_data1/oa_pdf/7b/e0/lctt-8-021.PMC5342614.pdf
"Lung Cancer: Targets and Therapy 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/lung-cancer-targets--therapy-journalLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/7b/e0/lctt-8-021.PMC5342614.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from   published authors.Dovepress 30 Minami et al 194 Ad, no driver mutation, diagnosed from June 2007 until March 2015 at Osaka Police Hospital 148 received first-line chemotherapy 37 dead 8 unknown and transferred to other hospital s 1 alive28 at our hospital 7 at other hospitals 2 at home121 PD 27 no confirmation of PD 12 dead without PD 6 proceeded to other treatment without PD 6 transferred to other hospitals without PD 3 remain not to progress after first-line     chemotherapy 89 received second-line chemotherapy 48 received third-line chemotherapy 30 received fourth-line chemotherapy9 no confirmation of PD 5 dead without PD 2 proceeded to other treatment without PD 1 transferred to other hospital without PD 1 remain not to progress after third-line     chemotherapy39 PD73 PD 16 no confirmation of PD 7 proceeded to other treatment without PD 5 dead without PD 3 remain not to progress after second-line     chemotherapy 1 transferred to other hospitals without PD46 did not receive chemotherapy Figure S1 Patient flowchart.",Non-OADS,/arxiv_data1/oa_pdf/7b/e0/lctt-8-021.PMC5342614.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5d/07/ndt-13-685.PMC5342615.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 685–695Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  685OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13026 9 Efficacy and safety of oxcarbazepine in the  treatment of children with epilepsy: a meta- analysis of randomized controlled trials hua geng Chengzhong Wang Department of Pediatrics, Maternal  and child health hospital of  Yancheng, Yancheng city, People’s  Republic of ChinaBackground:  To assess the efficacy and safety of oxcarbazepine (OXC) in the treatment of  children with epilepsy.",Non-OADS,/arxiv_data1/oa_pdf/5d/07/ndt-13-685.PMC5342615.pdf
"Oxcarbazepine (OXC) is a new AED that is used for epilepsy treatment, both  in adults and in pediatric patients.6–8 It was developed in an attempt to improve the Correspondence: Chengzhong Wang Department of Pediatrics, Maternal  and child health hospital of Yancheng,  Yancheng city, Jiangsu Province, 224002,  People’s Republic of China email wangmengzh@sohu.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Geng and Wang Running head recto: Oxcarbazepine in children with epilepsy DOI: http://dx.doi.org/10.2147/NDT.S130269",Non-OADS,/arxiv_data1/oa_pdf/5d/07/ndt-13-685.PMC5342615.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/5d/07/ndt-13-685.PMC5342615.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/07/ndt-13-685.PMC5342615.pdf
"Retrieved from http://www.observatorisdmkindonesia.org/./3.-Indonesia Lincoln, Y. S., & Guba, E. G. (1985).",Non-OADS,/arxiv_data1/oa_pdf/e6/94/10.1177_2333393616651766.PMC5342631.pdf
"Retrieved from http://www.folkhalsomyn- digheten.se/amnesomraden/livsvillkor-och-levnadsvanor/ psykisk-halsa/nulage-psykisk-halsa/ Nicolaisen, M., & Thorsen, K. (2014).",OADS,/arxiv_data1/oa_pdf/e6/94/10.1177_2333393616651766.PMC5342631.pdf
"Retrieved from https://www.regjeringen.no/globalassets/upload/kd/vedlegg/uh/rammeplaner/helse/ram- meplan_sykepleierutdanning_08.pdf Reboussin, B.",OADS,/arxiv_data1/oa_pdf/e6/94/10.1177_2333393616651766.PMC5342631.pdf
"Retrieved from http://www.vexen.co.uk/countries/scandinavia.html Wang, F., Liu, J., Liu, L., Wang, F., Ma, Z., Gao, D., .",Non-OADS,/arxiv_data1/oa_pdf/e6/94/10.1177_2333393616651766.PMC5342631.pdf
Retrieved from http://www.who.int/healthpromotion/milestones/en/ World Health Organisation.,Non-OADS,/arxiv_data1/oa_pdf/e6/94/10.1177_2333393616651766.PMC5342631.pdf
Retrieved from http://apps.who.int/gho/data/view.main.680?lang=en World Medical Association.,OADS,/arxiv_data1/oa_pdf/e6/94/10.1177_2333393616651766.PMC5342631.pdf
"Retrieved from http://www.wma.net/en/20activities/10e thics/10helsinki/ Yamagishi, T. Z., Hashimoto, H., Cook, K. S., Kiyonari, T.,  Shinada, M., Mifune, N., .",OADS,/arxiv_data1/oa_pdf/e6/94/10.1177_2333393616651766.PMC5342631.pdf
Retrieved from  http://data.unaids.org/pub/EpiReport/2006/2006_EpiUpdate_ en.pdf Joint United Nations Programme on HIV/AIDS.,OADS,/arxiv_data1/oa_pdf/42/d3/10.1177_2333393616650082.PMC5342635.pdf
Retrieved from http://www.unaids.org/globalreport/Global_report.htm Joint United Nations Programme on HIV/AIDS.,Non-OADS,/arxiv_data1/oa_pdf/42/d3/10.1177_2333393616650082.PMC5342635.pdf
Retrieved from http://www.unaidsmena.org/Egypt/en/countries-regions/page/582 Joint United Nations Programme on HIV/AIDS.,Non-OADS,/arxiv_data1/oa_pdf/42/d3/10.1177_2333393616650082.PMC5342635.pdf
"Retrieved from http://www.unaids.org/sites/default/files/country/documents//LBN_narrative_report_2014.pdf Kalaajieh, W. K. (2000).",Non-OADS,/arxiv_data1/oa_pdf/42/d3/10.1177_2333393616650082.PMC5342635.pdf
"Retrieved from  http://www.unaids.org/sites/default/files/en/dataanalysis/ knowyourresponse/countryprogressreports/2014countries/ LBN_narrative_report_2014.pdf Obermeyer, C. M. (2006).",OADS,/arxiv_data1/oa_pdf/42/d3/10.1177_2333393616650082.PMC5342635.pdf
Retrieved from http://www.dailystar.,Non-OADS,/arxiv_data1/oa_pdf/42/d3/10.1177_2333393616650082.PMC5342635.pdf
"Retrieved from https://secure.cihi.ca/free_products/ntr_head_injuries_2006_e.pdf *Carter, B.",OADS,/arxiv_data1/oa_pdf/22/8d/10.1177_2333393615614307.PMC5342636.pdf
"Retrieved from http://goo.gl/AQ8ghL Hartman, L. R., Duncanson, M., Farahat, S. M., & Lindsay, S.  (2015).",Non-OADS,/arxiv_data1/oa_pdf/22/8d/10.1177_2333393615614307.PMC5342636.pdf
"Retrieved from http://obia.ca/wp-content/uploads/2013/01/ImpactReportOnline-Dec2012.pdf *Plotts, C., & Jantz, P. (2012).",OADS,/arxiv_data1/oa_pdf/22/8d/10.1177_2333393615614307.PMC5342636.pdf
"Available from http://oed.com Pazargadi, M., Fereidooni Moghadam, M., Fallahi Khoshknab, M.,  Alijani Renani, H., & Molazem, Z.",Non-OADS,/arxiv_data1/oa_pdf/a8/bb/10.1177_2333393616630465.PMC5342637.pdf
Retrieved from http://www.crec.co.uk/docs/Trustworthypaper.,Non-OADS,/arxiv_data1/oa_pdf/a8/bb/10.1177_2333393616630465.PMC5342637.pdf
"Retrieved from http://health.usnews.com/best-hospitals/area/ut/intermountain-medical-center-6870141 Von Dietze, E., & Orb, A.",Non-OADS,/arxiv_data1/oa_pdf/c3/6e/10.1177_2333393616650081.PMC5342640.pdf
Retrieved from  http://planipolis.iiep.unesco.org/upload/Kenya/KenyaNationalHumanDevelopmentReport2009.pdf International Diabetes Federation.,Non-OADS,/arxiv_data1/oa_pdf/37/16/10.1177_2333393616641825.PMC5342641.pdf
"Retrieved from  http://www.idf.org/membership/afr/kenya Joo, J. Y.",Non-OADS,/arxiv_data1/oa_pdf/37/16/10.1177_2333393616641825.PMC5342641.pdf
"Retrieved from http://www.knbs.or.ke/index.php?option=com_phocadownload&view=categories&Itemid=599 Keter, L. K., & Mutiso, P. C. (2012).",OADS,/arxiv_data1/oa_pdf/37/16/10.1177_2333393616641825.PMC5342641.pdf
"Retrieved from http://www.cdc.gov/violenceprevention/overview/social-eco-logicalmodel.html Chacko, L. R., & Chacko, S. A.",Non-OADS,/arxiv_data1/oa_pdf/8c/c4/10.1177_2333393615622176.PMC5342642.pdf
Retrieved from http://www.co.clatsop.or.us/sites/default/files/fileattachments/public_health/page/691/clatsop_assessment_2013.pdf Community Health Advocacy and Resource Team.,Non-OADS,/arxiv_data1/oa_pdf/8c/c4/10.1177_2333393615622176.PMC5342642.pdf
"Retrieved from http://www.clatsopchart.org/?page_id=629 Crider, K. S., Bailey, L. B., & Berry, R. J.",Non-OADS,/arxiv_data1/oa_pdf/8c/c4/10.1177_2333393615622176.PMC5342642.pdf
"Retrieved from http://hpp.sagepub.com/content/11/5/629.long Thornton, L. E., Jeffery, R. W., & Crawford, D. A.",Non-OADS,/arxiv_data1/oa_pdf/8c/c4/10.1177_2333393615622176.PMC5342642.pdf
"Retrieved from http://quickfacts.census.gov/qfd/states/41/41007.html Valera, P., Gallin, J., Schuk, D., & Davis, N. (2009).",OADS,/arxiv_data1/oa_pdf/8c/c4/10.1177_2333393615622176.PMC5342642.pdf
"Retrieved  from http://www.brasil.gov.br/observatoriocrack/cuidado/out- ros-centros-atencao-psicossocial.html Castel, R. (1991).",OADS,/arxiv_data1/oa_pdf/88/dd/10.1177_2333393616670442.PMC5342643.pdf
"Notes 1.  http://www.soziologie.de/en/gsa/ethik-kommission/code-of- ethics.html, retrieved on 05/10/2015.",Non-OADS,/arxiv_data1/oa_pdf/90/21/10.1177_2333393616630466.PMC5342644.pdf
The specialty of oncology was officially recognized when The American Society of Clinical Oncology (ASCO) was founded in 1964 by seven cancer physicians to increase cancer treatment efforts and counteract the stigma associated with the incurable disease (http://www.cancer - progress.net/asco50).,Non-OADS,/arxiv_data1/oa_pdf/4a/eb/10.1177_2333393615585972.PMC5342645.pdf
"As reported by Malone (2002, p.105), 1990 Tobacco industry letters documented a quotation by a com-pany executive reporting “if mobilized, nurses could easily become formidable opponents for the tobacco industry.” This testimonial in addition to nursing being the largest and most respected profession in the United States, the conse-quences of such activism could be positively enormous (http://www.gallup.com/poll/1654/Honesty-Ethics-Professions.aspx).",Non-OADS,/arxiv_data1/oa_pdf/4a/eb/10.1177_2333393615585972.PMC5342645.pdf
"Retrieved from http://www.cancerprogress.net/asco50 Amos, A., & Haglund, M. (2000).",OADS,/arxiv_data1/oa_pdf/4a/eb/10.1177_2333393615585972.PMC5342645.pdf
"Supplemental Material The Chinese translation of the article is available at http://gqn.sage pub.com/content/by/supplemental-data References Ågård, A. S., Egerod, I., Tønnesen, E., & Lomborg, K. (2012).",Non-OADS,/arxiv_data1/oa_pdf/5f/be/10.1177_2333393616631677.PMC5342646.pdf
"Retrieved from http://www.jointcommission.org/sentinel_event_alert_issue_40_behav- iors_that_undermine_a_culture_of_safety/ Kivimaki, M., Elovainio, M., & Vahtera, J.",OADS,/arxiv_data1/oa_pdf/56/c3/10.1177_2333393616641002.PMC5342647.pdf
"Retrieved from http://www.archives.gov/education/ lessons/worksheets/ Patton, M. Q.",Non-OADS,/arxiv_data1/oa_pdf/56/c3/10.1177_2333393616641002.PMC5342647.pdf
Retrieved from http://www.who.int/healthpromotion/Milestones_Health_Promotion_05022010.pdf?ua=1World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/76/3e/10.1177_2333393615580305.PMC5342648.pdf
"Retrieved from http://apps.who.int/iris/bitstream/10665/63698/1/WHO_HPR_ HEP_4ICHP_BR_97.4_eng.pdf?ua=1 Wullink, M., Widdershoven, G., van Schrojenstein Lantman-de  Valk, H., Metsemakers, J., & Dinant, G. J.",OADS,/arxiv_data1/oa_pdf/76/3e/10.1177_2333393615580305.PMC5342648.pdf
Retrieved from https://www.midwives.org.au/midwifery-phi-losophy,Non-OADS,/arxiv_data1/oa_pdf/1c/5f/10.1177_2333393616675029.PMC5342651.pdf
"Retrieved from http://www.internationalmidwives.org/who-we-are/vision-mission Lazarus, E. (1988).",Non-OADS,/arxiv_data1/oa_pdf/1c/5f/10.1177_2333393616675029.PMC5342651.pdf
"Retrieved from http://tinyurl.com/jzks7xp Davies, C. (1998).",Non-OADS,/arxiv_data1/oa_pdf/60/a3/10.1177_2333393616632126.PMC5342652.pdf
Retrieved from https://www.ednet.ns.ca/earlyyears/docu- ments/Early%20Years_Discussion%20Paper_EN.pdf Nova Scotia.,Non-OADS,/arxiv_data1/oa_pdf/60/a3/10.1177_2333393616632126.PMC5342652.pdf
Retrieved from http://www.phac-aspc.gc.ca/ph-sp/determi-nants/index-eng.php Public Health Agency of Canada.,Non-OADS,/arxiv_data1/oa_pdf/60/a3/10.1177_2333393616632126.PMC5342652.pdf
"Retrieved from http://www.phac-aspc.gc.ca/rhs-ssg/phi- isp-2013-eng.php Scott, J.",OADS,/arxiv_data1/oa_pdf/60/a3/10.1177_2333393616632126.PMC5342652.pdf
"The data were imported into Skyline software (https://skyline.ms/project/home/software/Skyline/begin.view) for peak integration and exportedinto Excel for ratio calculation of analyte to internal standard, where applicable.",OADS,/arxiv_data1/oa_pdf/4a/5c/1602096.PMC5342653.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602096/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/4a/5c/1602096.PMC5342653.pdf
R package version 6.0-57 (2015); https://cran.r-project.org/web/packages/caret/index.html.,Non-OADS,/arxiv_data1/oa_pdf/4a/5c/1602096.PMC5342653.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1601314/DC1Supplementary Textfig.,Non-OADS,/arxiv_data1/oa_pdf/7e/d3/1601314.PMC5342654.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602467/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/d4/52/1602467.PMC5342655.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602183/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/7c/81/1602183.PMC5342656.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602258/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/5a/5b/1602258.PMC5342657.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1601298/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/94/14/1601298.PMC5342658.pdf
Retrieved from  http://www.aacn.nche.edu/media-relations/fact-sheets/nurs- ing-workforce American Association of Colleges of Nursing.,Non-OADS,/arxiv_data1/oa_pdf/14/9e/10.1177_2333393615614306.PMC5342820.pdf
Retrieved from http://www.aacn.nche.edu/aacn-publications/white-papers/RN-BSN-White-Paper.pdf American Association of Colleges of Nursing.,Non-OADS,/arxiv_data1/oa_pdf/14/9e/10.1177_2333393615614306.PMC5342820.pdf
Retrieved from http://www.aacn.nche.edu/aacn-publications/position/joint-statement-academic-progression The American Nurses Association.,OADS,/arxiv_data1/oa_pdf/14/9e/10.1177_2333393615614306.PMC5342820.pdf
"Retrieved from http://www.eric.ed.gov/ERICWebPortal/detail?accno=ED021059 Birks, M., Chapman, Y., & Francis, K. (2008).",OADS,/arxiv_data1/oa_pdf/14/9e/10.1177_2333393615614306.PMC5342820.pdf
Retrieved from http://www.rntobsn.org/faq/ Future of Nursing Campaign for Action.,Non-OADS,/arxiv_data1/oa_pdf/14/9e/10.1177_2333393615614306.PMC5342820.pdf
"Retrieved from http://campaignforaction.org/dashboard Hooper, J., McEwen, M., & Mancini, M. (2013).",Non-OADS,/arxiv_data1/oa_pdf/14/9e/10.1177_2333393615614306.PMC5342820.pdf
Available from  http://www.journalnursingregulation.com/ The Institute of Medicine.,Non-OADS,/arxiv_data1/oa_pdf/14/9e/10.1177_2333393615614306.PMC5342820.pdf
"Retrieved from http://www.iom.edu/Reports/2010/The-Future-of-Nursing-Leading-Change-Advancing-Health.aspx/ John, D. (2010).",Non-OADS,/arxiv_data1/oa_pdf/14/9e/10.1177_2333393615614306.PMC5342820.pdf
"Retrieved from http://www.nysna.org/nursing-practice/journal-new-york-state-nurses-association#.VIH-icl5VZ8 Kumm, S., Godfrey, N., Martin, D., Tucci, M., Muenks, M., &  Spaeth, T. (2014).",Non-OADS,/arxiv_data1/oa_pdf/14/9e/10.1177_2333393615614306.PMC5342820.pdf
"Retrieved from http://www.who.int/respiratory/publica-tions/crd_country_level/en/ Anderson, W. G., Kools, S., & Lyndon, A.",OADS,/arxiv_data1/oa_pdf/39/8c/10.1177_2333393616638977.PMC5342844.pdf
"Retrieved from https://www.lunge.dk/sites/default/files/argumenter_for_en_national_lungeplan_19_april_2013.pdf Bjørg, C. (2008).",OADS,/arxiv_data1/oa_pdf/39/8c/10.1177_2333393616638977.PMC5342844.pdf
"Retrieved from http://sundhedsstyrelsen.dk/publ/Publ2007/CFF/KOL/KOLanbefalinger.pdf Blumer, H. (1969).",OADS,/arxiv_data1/oa_pdf/39/8c/10.1177_2333393616638977.PMC5342844.pdf
Retrieved from http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.,Non-OADS,/arxiv_data1/oa_pdf/39/8c/10.1177_2333393616638977.PMC5342844.pdf
"Retrieved from  http://www.icn.ch/who-we-are/code-of-ethics-for-nurses/ Karakurt, P., & Ünsal, A.",Non-OADS,/arxiv_data1/oa_pdf/39/8c/10.1177_2333393616638977.PMC5342844.pdf
"Retrieved  from  http://www.who.int/respiratory/publications/crd_strat- egy/en/ Author Biographies Lone Birgitte Skov Jensen, RN, MNSc, is a PhD student at  Department of Education, University of Aarhus, and assistant pro-fessor at the Nursing School UCC Hillerød, the Regional Capital,  Denmark.",Non-OADS,/arxiv_data1/oa_pdf/39/8c/10.1177_2333393616638977.PMC5342844.pdf
"Safety Science, 41(10),   837-859. doi: http://dx.doi.org/10.1016/S0925-7535(02)00036-X Drach-Zahavy, A., Goldblatt, H., & Maizel, A.",OADS,/arxiv_data1/oa_pdf/3b/c9/10.1177_2333393615592390.PMC5342847.pdf
"Available from http://www.jointcommission.org/ Klein, G. A., Moon, B., & Hoffman, R. (2006).",Non-OADS,/arxiv_data1/oa_pdf/3b/c9/10.1177_2333393615592390.PMC5342847.pdf
"Available  from https://www.e-education.psu.edu/drupal6/files/sgam/Kleine_10.1.1.104.8963[1].pdf Kohn, L. T., Corrigan, J. M., & Donaldson, M. S. (2000).",Non-OADS,/arxiv_data1/oa_pdf/3b/c9/10.1177_2333393615592390.PMC5342847.pdf
"Marine Policy, 42(0), 85-90. doi: http://dx.doi.org/10.1016/ j.marpol.2013.02.007 Walter, S. R., Li, L., Dunsmuir, W. T. M., & Westbrook, J. I.",OADS,/arxiv_data1/oa_pdf/3b/c9/10.1177_2333393615592390.PMC5342847.pdf
The original version of the figure can be found at http://journals.sagepub.com/doi/suppl/10.1177/2333393616683073Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/11/11/10.1177_2333393616683073.PMC5342849.pdf
"Retrieved  from http://www.census2011.co.in/census/state/rajasthan.html Cohen, S. (2012).",Non-OADS,/arxiv_data1/oa_pdf/11/11/10.1177_2333393616683073.PMC5342849.pdf
"Retrieved from http://archive.financialex- press.com/news/centre-plans-ban-on-open-retail-sale-of-abor- tion-pills/1001260 Duggal, R., & Ramachandran, V. (2004).",Non-OADS,/arxiv_data1/oa_pdf/11/11/10.1177_2333393616683073.PMC5342849.pdf
"Retrieved from http://nej.sagepub.com/con- tent/early/2016/06/08/0969733016652449.long Appelbaum, P., & Grisso, T. (2001).",Non-OADS,/arxiv_data1/oa_pdf/de/47/10.1177_2333393616671076.PMC5342852.pdf
Retrieved from http://www.bclaws.ca/EPLibraries/bclaws_new/document/ID/freeside/00_96181_01 BC Ministry of Health and Ministry Responsible for Seniors.,Non-OADS,/arxiv_data1/oa_pdf/de/47/10.1177_2333393616671076.PMC5342852.pdf
"Retrieved from http://www.patienttalk.info/psinfopatients03.htm Kapp, M., & Mossman, D. (1996).",OADS,/arxiv_data1/oa_pdf/de/47/10.1177_2333393616671076.PMC5342852.pdf
"Retrieved from http://ecite.utas.edu.au/59139 Green, J.",OADS,/arxiv_data1/oa_pdf/b7/fe/10.1177_2333393614565181.PMC5342853.pdf
"Retrieved from http://ssrn.com/abstract=2062200 Malacrida, C. (2002).",OADS,/arxiv_data1/oa_pdf/b7/fe/10.1177_2333393614565181.PMC5342853.pdf
Retrieved from http://www.biomedcentral.,OADS,/arxiv_data1/oa_pdf/ce/38/10.1177_2333393616680902.PMC5342855.pdf
Retrieved from http://www.ers.usda.gov/topics/ food-nutrition-assistance/food-security-in-the-us/definitions- of-food-security.aspx U.S. Department of Agriculture and U.S. Department of Health  and Human Services.,Non-OADS,/arxiv_data1/oa_pdf/ce/38/10.1177_2333393616680902.PMC5342855.pdf
Retrieved  from http://www.theasa.org/ethics/guidelines.shtml European Endometriosis Alliance.,Non-OADS,/arxiv_data1/oa_pdf/e3/7d/10.1177_2333393616651351.PMC5342857.pdf
"Retrieved  from http://www.endometriosis.org/news/general/historic-deci- sion-for-womens-health-made-by-european-comission/  Evans, S., Moalem-Taylor, G., & Tracey, D. J.",Non-OADS,/arxiv_data1/oa_pdf/e3/7d/10.1177_2333393616651351.PMC5342857.pdf
"Retrieved from http://www.icn.ch/images/stories/documents/about/icncode_english.pdf Jackson, J.",Non-OADS,/arxiv_data1/oa_pdf/e3/7d/10.1177_2333393616651351.PMC5342857.pdf
"Retrieved from  http://www.amazon.com/Information-Worlds-Technology-Behavior-Internet/dp/041599778X Jeon, Y.-H. (2004).",OADS,/arxiv_data1/oa_pdf/f7/af/10.1177_2333393616680967.PMC5342858.pdf
"Retrieved from http://riskybusiness.web.unc.edu/files/2015/01/Health-Behavior-and-Health-Education.pdf#page=503 Savolainen, R. (1995).",Non-OADS,/arxiv_data1/oa_pdf/f7/af/10.1177_2333393616680967.PMC5342858.pdf
"Retrieved from http://journals.lww.com/aacnadvancedcriticalcare/Abstract/2004/07000/Quality_of_Life_Issues_in_Patients_With.13.aspx Spindler, H., Johansen, J.",Non-OADS,/arxiv_data1/oa_pdf/09/3d/10.1177_2333393616674810.PMC5342860.pdf
"Retrieved from http://www.socialstyrelsen.se/ nationalguidelines/nationalguidelinesformethodsofpre- ventingdisease Redman, B. K. (2007).",Non-OADS,/arxiv_data1/oa_pdf/24/6f/10.1177_2333393615599168.PMC5342863.pdf
Retrieved from http://www.vgregion.se/upload/Regionkanslierna/VG%20Prim%c3%a4rv%c3%a5rd/KoK/Krav%20och%20 kvalitetsbok%202013.pdf SFS.,OADS,/arxiv_data1/oa_pdf/24/6f/10.1177_2333393615599168.PMC5342863.pdf
Retrieved  from http://www.riksdagen.se/sv/Dokument-Lagar/Lagar/ Svenskforfattningssamling/Lag-2003460-om-etikprovning_sfs-2003-460/ SFS.,OADS,/arxiv_data1/oa_pdf/24/6f/10.1177_2333393615599168.PMC5342863.pdf
Retrieved from http://www.socialstyrelsen.se/publika-tioner2012/2012-2-9 SFS.,Non-OADS,/arxiv_data1/oa_pdf/24/6f/10.1177_2333393615599168.PMC5342863.pdf
Retrieved from https://lagen.nu/2010:659 SFS.,OADS,/arxiv_data1/oa_pdf/24/6f/10.1177_2333393615599168.PMC5342863.pdf
Retrieved from  http://www.riksdagen.se/sv/Dokument-Lagar/Lagar/ Svenskforfattningssamling/sfs_sfs-2014-821/ SOSFS.,Non-OADS,/arxiv_data1/oa_pdf/24/6f/10.1177_2333393615599168.PMC5342863.pdf
"Retrieved from http://www.socialstyrelsen.se/publika- tioner2012/2012-6-532011-9 Tomey, A. M. (2009).",Non-OADS,/arxiv_data1/oa_pdf/24/6f/10.1177_2333393615599168.PMC5342863.pdf
Retrieved from http://www.who.int/whr/2008/en/ index.html World Medical Association.,Non-OADS,/arxiv_data1/oa_pdf/24/6f/10.1177_2333393615599168.PMC5342863.pdf
"Retrieved from  http://www.cdc.gov/violenceprevention/pdf/ipvbook-a.pdf Reviere, S. L., Farber, E. W., Twomey, H., Okun, A., Jackson,  E., Zanville, H., & Kaslow, N. J.",Non-OADS,/arxiv_data1/oa_pdf/09/33/10.1177_2333393614565182.PMC5342865.pdf
"Retrieved from https://www.ncjrs.gov/pdffiles1/ nij/181867.pdf Tubbs, C. Y.",OADS,/arxiv_data1/oa_pdf/09/33/10.1177_2333393614565182.PMC5342865.pdf
"E-mail: hm_kim@kaist.ac.kr https://doi.org/10.5483/BMBRep.2017.50.2.011Received 21 January 2017Keywords: CD14, Innate immunity, LBP , LPS transfer, Single-mole- cule fluorescence analysis, TLR4/MD2, Transmission electron mi-croscopy Abbreviations:  CD14, cluster of differentiation 14; LBP , LPS-bind- ing protein; LPS, lipopolysaccharide; MD2, myeloid differentiationfactor 2; TEM, transmission electron microscopy; TLR4, Toll-like receptor 4 Perspective to:  Je-Kyung Ryu and Soo Jin Kim et al.",Non-OADS,/arxiv_data1/oa_pdf/7a/50/bmb-50-055.PMC5342866.pdf
Dynamic LPS transfer cascade to TLR4/MD2 complex Soo Jin Kim and Ho Min Kim 56 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/7a/50/bmb-50-055.PMC5342866.pdf
"Dynamic LPS transfer cascade to TLR4/MD2 complex Soo Jin Kim and Ho Min Kim 57 http://bmbreports.org BMB Reportselectrostatic repulsion between LBP D311 and CD14  N-termini, LBP retains its binding to LPS micelles and recruits another CD14.",Non-OADS,/arxiv_data1/oa_pdf/7a/50/bmb-50-055.PMC5342866.pdf
"E-mail: jhkim@korea.ac.kr https://doi.org/10.5483/BMBRep.2017.50.2.012Received 21 January 2017Keywords: Liver fibrosis, MFGE8, MSC, Secretome Abbreviations:  ECM, Extracellular matrix; HSCs, Hepatic stellate  cells; MFGE8, Milk fat globule-EGF factor 8; MSCs, Mesenchymal stem cells; TGF , Transforming growth factor beta; UCMSCs,  Umbilical cord-derived MSCs Perspective to:  Su Yeon An, Yu Jin Jang et al.",Non-OADS,/arxiv_data1/oa_pdf/99/36/bmb-50-058.PMC5342867.pdf
59 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/99/36/bmb-50-058.PMC5342867.pdf
"Tel: +858-246-0452; Fax: +858-822-4717;  E-mail: wju@ucsd.edu https://doi.org/10.5483/BMBRep.2017.50.2.200Received 1 December 2016Keywords: Adenylyl cyclases, cAMP , Glaucoma, Optic nerve head  astrocyte, Retinal ganglion cells ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Role of cyclic AMP in the eye with glaucoma Myoung Sup Shim1, Keun-Young Kim2 & Won-Kyu Ju1,* 1Hamilton Glaucoma Center and Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, La Jolla, C A  92037, 2Center for Research on Biological Systems, National Center for Microscopy and Imaging Research and Department of  Neuroscience, University of California San Diego, La Jolla, CA 92093, USA Glaucoma is characterized by a slow and progressive  degeneration of the optic nerve, including retinal ganglion cell (RGC) axons in the optic nerve head (ONH), leading to visual  impairment.",Non-OADS,/arxiv_data1/oa_pdf/d8/d2/bmb-50-060.PMC5342868.pdf
"61 http://bmbreports.org BMB ReportsACs have been thought of as potential drug targets in many  neurodegenerative disorders, including glaucoma (23, 24).",Non-OADS,/arxiv_data1/oa_pdf/d8/d2/bmb-50-060.PMC5342868.pdf
"62 BMB Reports http://bmbreports.orgDrug target Subtype GPCR type ACs type Available drugs Drug typeMechanisms of  action  Inflow -ARs  (2, 52)1G q - Apraclonidine Agonists Decrease inflow 2G i tmAC Brimonidine -ARs  (2, 152)1G s tmAC Timolol, betaxol, 2G s and G i tmAC   carteolol and levobunolol Blockers Decrease inflow 3G s tmAC CA (2, 63) - sAC?",Non-OADS,/arxiv_data1/oa_pdf/d8/d2/bmb-50-060.PMC5342868.pdf
"63 http://bmbreports.org BMB Reportseffects by binding to ten known prostaglandin receptors, such  as types I, E and F, which are GPCRs linking to various G   subunits, including G s, Gi, and G q.",Non-OADS,/arxiv_data1/oa_pdf/d8/d2/bmb-50-060.PMC5342868.pdf
64 BMB Reports http://bmbreports.org109).,OADS,/arxiv_data1/oa_pdf/d8/d2/bmb-50-060.PMC5342868.pdf
65 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/d8/d2/bmb-50-060.PMC5342868.pdf
"66 BMB Reports http://bmbreports.orgstrategies to understand aqueous humor dynamics and IOP  regulation, and to enhance the survival of RGC and its axon, as well as ONH astrocytes in glaucoma and other optic  neuropathies.",Non-OADS,/arxiv_data1/oa_pdf/d8/d2/bmb-50-060.PMC5342868.pdf
67 http://bmbreports.org BMB Reports33.,Non-OADS,/arxiv_data1/oa_pdf/d8/d2/bmb-50-060.PMC5342868.pdf
68 BMB Reports http://bmbreports.orgBestrophin 2 is expressed in human non-pigmented  ciliary epithelium but not retinal pigment epithelium.,Non-OADS,/arxiv_data1/oa_pdf/d8/d2/bmb-50-060.PMC5342868.pdf
"69 http://bmbreports.org BMB ReportsExp Ophthalmol 37, 718-729 103.",Non-OADS,/arxiv_data1/oa_pdf/d8/d2/bmb-50-060.PMC5342868.pdf
70 BMB Reports http://bmbreports.orgreceptor desensitization.,Non-OADS,/arxiv_data1/oa_pdf/d8/d2/bmb-50-060.PMC5342868.pdf
"Tel: +82-31-219-7803; Fax: +82-31-219-  7802; E-mail: j5mo@ajou.ac.kr https://doi.org/10.5483/BMBRep.2017.50.2.199Received 23 November 2016Keywords: YAP , TAZ, Hippo pathway, Mechanical cues, GPCR,  Nutrient ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The role of extracellular biophysical cues in modulating the  Hippo-YAP pathway Jung-Soon Mo * Genomic Instability Research Center (GIRC), Ajou University School of Medicine, Suwon 16499, Korea The Hippo signaling pathway plays an essential role in  adult-tissue homeostasis and organ-size control.",Non-OADS,/arxiv_data1/oa_pdf/5c/66/bmb-50-071.PMC5342869.pdf
Regulation of Hippo-YAP pathway by extracellular cues Jung-Soon Mo 72 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/5c/66/bmb-50-071.PMC5342869.pdf
Regulation of Hippo-YAP pathway by extracellular cues Jung-Soon Mo 73 http://bmbreports.org BMB Reportscytoskeleton is responsible for the transduction of mechanical  stress in cells.,Non-OADS,/arxiv_data1/oa_pdf/5c/66/bmb-50-071.PMC5342869.pdf
"Regulation of Hippo-YAP pathway by extracellular cues Jung-Soon Mo 74 BMB Reports http://bmbreports.orgdependent regulation of the differentiation of mesenchymal  stem cells (MSCs) into cancer-associated fibroblasts, CAFs.",Non-OADS,/arxiv_data1/oa_pdf/5c/66/bmb-50-071.PMC5342869.pdf
Regulation of Hippo-YAP pathway by extracellular cues Jung-Soon Mo 75 http://bmbreports.org BMB Reportspathway is reported to drive YAP activation and its target-  genes expression in perivascular epithelioid cell tumors and glioblastomas (84-86).,Non-OADS,/arxiv_data1/oa_pdf/5c/66/bmb-50-071.PMC5342869.pdf
Regulation of Hippo-YAP pathway by extracellular cues Jung-Soon Mo 76 BMB Reports http://bmbreports.org7.,Non-OADS,/arxiv_data1/oa_pdf/5c/66/bmb-50-071.PMC5342869.pdf
Regulation of Hippo-YAP pathway by extracellular cues Jung-Soon Mo 77 http://bmbreports.org BMB Reportscorneal epithelial cells in mice deficient for destrin (actin  depolymerizing factor).,Non-OADS,/arxiv_data1/oa_pdf/5c/66/bmb-50-071.PMC5342869.pdf
Regulation of Hippo-YAP pathway by extracellular cues Jung-Soon Mo 78 BMB Reports http://bmbreports.orginduces AMPK-mediated regulation of YAP and the Hippo  pathway.,Non-OADS,/arxiv_data1/oa_pdf/5c/66/bmb-50-071.PMC5342869.pdf
"https://doi.org/10.5483/BMBRep.2017.50.2.101Received 16 June 2016, Revised 1 July 2016,  Accepted 14 October 2016 Keywords: Adipose-derived mesenchymal stem cells, Chronic ob- structive pulmonary disease, Regeneration, Spheroid cultures ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Human adipose-derived mesenchymal stem cell spheroids  improve recovery in a mouse model of elastase-induced emphysema Ryeon Jin Cho1,#, You-Sun Kim1,2,#, Ji-Young Kim2 & Yeon-Mok Oh1,2,3,* 1University of Ulsan College of Medicine, Seoul 05505, 2Asan Institute for Life Science, Seoul 05505, 3Department of Pulmonary and  Critical Care Medicine, and Clinical Research Center for Chronic Obstructive Airway Disease, Asan Medical Center, Seoul 05505, Korea Emphysema, a pathologic component of the chronic  obstructive pulmonary disease, causes irreversible destruction of lung.",Non-OADS,/arxiv_data1/oa_pdf/c0/5c/bmb-50-079.PMC5342870.pdf
80 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c0/5c/bmb-50-079.PMC5342870.pdf
81 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/c0/5c/bmb-50-079.PMC5342870.pdf
"82 BMB Reports http://bmbreports.orgDISCUSSION In the current study, we examined if spheroid ASCs showed  improved therapeutic efficacy in a mouse elastase-induced  model of emphysema.",Non-OADS,/arxiv_data1/oa_pdf/c0/5c/bmb-50-079.PMC5342870.pdf
"83 http://bmbreports.org BMB Reportsdiameter of 300 m were coated with 70% (v/v) ethanol,  followed by PBS and 3% (W/V) BSA to prevent cell attachment.",Non-OADS,/arxiv_data1/oa_pdf/c0/5c/bmb-50-079.PMC5342870.pdf
84 BMB Reports http://bmbreports.orgmice.,OADS,/arxiv_data1/oa_pdf/c0/5c/bmb-50-079.PMC5342870.pdf
"https://doi.org/10.5483/BMBRep.2017.50.2.150Received 25 August 2016, Revised 23 September 2016,  Accepted 18 November 2016 Keywords: Anti-inflammatory, Cytopermeability, Heparin Binding  Domain, Superoxide dismutase 3, Zinc (II) ion ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Zinc(II) ion promotes anti-inflammatory effects of rhSOD3  by increasing cellular association Younghwa Kim1,#, Yoon-Jae Jeon2,#, Kang Ryu3 & Tae-Yoon Kim2,* 1Department of Emergency Medical Technology, Kyungil University, Gyeongsan 38428, 2Laboratory of Dermato-Immunology, Catholic  Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul 06591, 3RNS BIO, Seoul 04784, Korea Recently, we demonstrated that superoxide dismutase 3  (SOD3) is a strong candidate for biomedicine.",Non-OADS,/arxiv_data1/oa_pdf/2d/81/bmb-50-085.PMC5342871.pdf
86 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/2d/81/bmb-50-085.PMC5342871.pdf
87 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/2d/81/bmb-50-085.PMC5342871.pdf
88 BMB Reports http://bmbreports.orgassociation via HBD of rhSOD3.,OADS,/arxiv_data1/oa_pdf/2d/81/bmb-50-085.PMC5342871.pdf
"89 http://bmbreports.org BMB Reportswere analyzed by western blot analysis, using anti-p-STAT3,  p-STAT3, GAPDH (Santa Cruz Biotechnology, CA, USA) and anti- hSOD3 (AbCam, Cambridge, UK) antibodies.",OADS,/arxiv_data1/oa_pdf/2d/81/bmb-50-085.PMC5342871.pdf
90 BMB Reports http://bmbreports.orgNordestgaard BG (2006) Genetically increased antioxidative  protection and decreased chronic obstructive pulmonary disease.,Non-OADS,/arxiv_data1/oa_pdf/2d/81/bmb-50-085.PMC5342871.pdf
"https://doi.org/10.5483/BMBRep.2017.50.2.188Received 10 November 2016, Revised 2 December 2016,  Accepted 13 December 2016 Keywords: APAP , Keap1, Nrf2, Oxidative stress, Verapamil ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The hypertension drug, verapamil,  activates Nrf2 by promoting  p62-dependent autophagic Keap1 degradation and prevents acetaminophen-induced cytotoxicity Da Hyun Lee1,2,#, Jeong Su Park1,#, Yu Seol Lee1, Su Haeng Sung1, Yong-ho Lee3 & Soo Han Bae1,* 1Severance Biomedical Science Institute, Yonsei Biomedical Re search Institute, Yonsei University College of Medicine, 2Brain Korea 21  PLUS Project for Medical Science, Yonsei University, 3Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei  University College of Medicine, Seoul 03722, Korea Nuclear factor erythroid 2-related factor 2 (Nrf2) provides a  cellular defense against oxidative stress by inducing the expression of antioxidant and detoxification enzymes.",Non-OADS,/arxiv_data1/oa_pdf/52/f7/bmb-50-091.PMC5342872.pdf
92 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/52/f7/bmb-50-091.PMC5342872.pdf
93 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/52/f7/bmb-50-091.PMC5342872.pdf
94 BMB Reports http://bmbreports.orgreported that p62 phosphorylation (p-S351) activates the Nrf2  pathway (21).,OADS,/arxiv_data1/oa_pdf/52/f7/bmb-50-091.PMC5342872.pdf
"95 http://bmbreports.org BMB Reportscommonly used as an analgesic and antipyretic drug (33);  however, it induces hepatotoxicity when taken in overdose (15).",Non-OADS,/arxiv_data1/oa_pdf/52/f7/bmb-50-091.PMC5342872.pdf
96 BMB Reports http://bmbreports.orgof Keap1.,Non-OADS,/arxiv_data1/oa_pdf/52/f7/bmb-50-091.PMC5342872.pdf
"Tel: +82-2-740-8686; Fax: +82-2-765-  8656; E-mail: hhbkim@snu.ac.kr https://doi.org/10.5483/BMBRep.2017.50.2.170Received 7 October 2016, Revised 31 October 2016,  Accepted 20 December 2016 Keywords: Inflammation, Mineralization, NF- B, Osteoblast, S100A4 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Extracellular S100A4 negatively regulates osteoblast function  by activating the NF- B pathway Haemin Kim, Yong Deok Lee, Min Kyung Kim, Jun-Oh Kwon, Min-Kyoung Song, Zang Hee Lee & Hong-Hee Kim * Department of Cell and Developmental Biology, BK21 Program and DRI, School of Dentistry, Seoul National University, Seoul 03080 ,  Korea Patients with inflammatory bone disease or cancer exhibit an  increased risk of fractures and delayed bone healing.",Non-OADS,/arxiv_data1/oa_pdf/2c/2b/bmb-50-097.PMC5342873.pdf
98 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/2c/2b/bmb-50-097.PMC5342873.pdf
99 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/2c/2b/bmb-50-097.PMC5342873.pdf
100 BMB Reports http://bmbreports.orgformation by osteoblasts.,Non-OADS,/arxiv_data1/oa_pdf/2c/2b/bmb-50-097.PMC5342873.pdf
"101 http://bmbreports.org BMB Reportsreal-time PCR analysis were as follows: Runx2  forward, 5’-  CGCACGACAACCGCACCA-3’; Runx2 reverse, 5’-CAGCACG  GAGCACAGGAAGTT-3’; Bglap forward, 5’-CCGGGAGCAG  TGTGAGCTTA-3’; Bglap reverse, 5’-TAGATGCGTTTGTAGG  CGGTC-3’; Hprt (hypoxanthine-guanine phosphoribosyltrans- ferase) forward, 5’-CCTAAGATGAGCGCAAGTTGAA-3’; Hprt  reverse, 5’- CCACAGGGACTAGAACACCTGCTAA-3’.",Non-OADS,/arxiv_data1/oa_pdf/2c/2b/bmb-50-097.PMC5342873.pdf
102 BMB Reports http://bmbreports.org8.,Non-OADS,/arxiv_data1/oa_pdf/2c/2b/bmb-50-097.PMC5342873.pdf
"Tel: +82-33-250-8831; Fax: +82-33-244-  3286; E-mail: ymkim@kangwon.ac.kr https://doi.org/10.5483/BMBRep.2017.50.2.220Received 19 December 2016, Revised 29 December 2016,  Accepted 13 January 2017 Keywords: HO-1/CO, NF- B, Osteoclastogenesis, RANKL ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Heme oxygenase-1 (HO-1)/carbon monoxide (CO) axis  suppresses RANKL-induced osteoclastic differentiation by inhibiting redox-sensitive NF- B activation Sun-Uk Bak1, Suji Kim1, Hae-Jun Hwang1, Jung-A Yun1, Wan-Sung Kim1, Moo-Ho Won2, Ji-Yoon Kim3, Kwon-Soo Ha1,  Young-Guen Kwon4 & Young-Myeong Kim1,* Departments of 1Molecular and Cellular Biochemistry and 2Neurobiology, School of Medicine, Kangwon National University, Chuncheon  24341, 3Department of Anesthesiology and Pain Medi cine, Hanyang University Hospital, Seoul 04763, 4Department of Biochemistry,  College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Korea Heme oxygenase (HO-1) catalyzes heme to carbon monoxide  (CO), biliverdin/bilirubin, and iron and is known to prevent the pathogenesis of several human diseases.",Non-OADS,/arxiv_data1/oa_pdf/71/c2/bmb-50-103.PMC5342874.pdf
104 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/71/c2/bmb-50-103.PMC5342874.pdf
105 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/71/c2/bmb-50-103.PMC5342874.pdf
106 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/71/c2/bmb-50-103.PMC5342874.pdf
107 http://bmbreports.org BMB Reportsbiological functions (12).,OADS,/arxiv_data1/oa_pdf/71/c2/bmb-50-103.PMC5342874.pdf
"108 BMB Reports http://bmbreports.orgabsence of CORM-2 for 20 min using DCFH-DA, as previously  described (24).",OADS,/arxiv_data1/oa_pdf/71/c2/bmb-50-103.PMC5342874.pdf
"Complications refer to unexpected events  that may occur even after adequate treatment, such as postop-EDITORIAL Young-Kyun Kim Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul  National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu,  Seongnam 13620, Korea TEL: +82-31-787-7541   FAX: +82-31-787-4068 E-mail: kyk0505@snubh.org ORCID: http://orcid.org/0000-0002-7268-3870    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCMalpractice and complications Young-Kyun Kim, D.D.S., Ph.D.",Non-OADS,/arxiv_data1/oa_pdf/ac/c8/jkaoms-43-1.PMC5342966.pdf
https://doi.org/10.5125/jkaoms.2017.43.1.1 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/ac/c8/jkaoms-43-1.PMC5342966.pdf
"It is known that a certain amount of bisphosphonate ORIGINAL ARTICLE Uk-Kyu Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan  National University, 49 Busandaehak-ro, Mulgeum-eup, Yangsan 50612, Korea TEL: +82-55-360-5100   FAX: +82-55-360-5104 E-mail: kuksjs@pusan.ac.kr ORCID: http://orcid.org/0000-0003-1251-7843    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCRelationship between disease stage and renal function in   bisphosphonate-related osteonecrosis of the jaw Yun-Ho Kim1, Han-Kyul Park1, Na-Rae Choi1, Seong-Won Kim1, Gyoo-Cheon Kim2,   Dae-Seok Hwang1, Yong-Deok Kim1, Sang-Hun Shin1, Uk-Kyu Kim1 Departments of 1Oral and Maxillofacial Surgery and 2Oral Anatomy, School of Dentistry, Pusan National University,   Yangsan, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2017;43:16-22) Objectives:  Bisphosphonate is the primary cause of bisphosphonate-related osteonecrosis of the jaw (BRONJ).",Non-OADS,/arxiv_data1/oa_pdf/86/23/jkaoms-43-16.PMC5342967.pdf
https://doi.org/10.5125/jkaoms.2017.43.1.16 pISSN 2234-7550 ·eISSN 2234-5930 This study was supported by a 2015 Clinical Research Grant of Pusan National University Dental Hospital.,Non-OADS,/arxiv_data1/oa_pdf/86/23/jkaoms-43-16.PMC5342967.pdf
"ORCID Yun-Ho Kim, http://orcid.org/0000-0002-3533-6693 Han-Kyul Park, http://orcid.org/0000-0002-6695-9156 Na-Rae Choi, http://orcid.org/0000-0002-5251-0825 Seong-Won Kim, http://orcid.org/0000-0002-9994-5121 Gyoo-Cheon Kim, http://orcid.org/0000-0003-3568-3529 Dae-Seok Hwang, http://orcid.org/0000-0001-6899-1769 Yong-Deok Kim, http://orcid.org/0000-0002-5807-7487 Sang-Hun Shin, http://orcid.org/0000-0002-0467-6206 Uk-Kyu Kim, http://orcid.org/0000-0003-1251-7843 References 1.",Non-OADS,/arxiv_data1/oa_pdf/86/23/jkaoms-43-16.PMC5342967.pdf
Available  from: https://en.wikipedia.org/wiki/Renal_function.,Non-OADS,/arxiv_data1/oa_pdf/86/23/jkaoms-43-16.PMC5342967.pdf
Available from: http://www.fda.gov/downloads/AdvisoryCommittees/Committees-MeetingMaterials/Drugs/DrugSafetyandRiskManagementAdviso-ryCommittee/UCM270958.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/23/jkaoms-43-16.PMC5342967.pdf
"Recently, the ORIGINAL ARTICLE Su-Gwan Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun  University, 303 Pilmun-daero, Dong-gu, Gwangju 61452, Korea TEL: +82-62-220-3815   FAX: +82-62-228-7316 E-mail: sgckim@chosun.ac.kr ORCID: http://orcid.org/0000-0002-0424-9984    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCComparative study of postoperative stability between conventional  orthognathic surgery and a surgery-first orthognathic approach after  bilateral sagittal split ramus osteotomy for skeletal class III correction Deuk-Hyun Mah, Su-Gwan Kim, Ji-Su Oh, Jae-Seek You, Seo-Yun Jung, Won-Gi Kim, Kyung-Hwan Yu Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University, Gwangju, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2017;43:23-28) Objectives:  The purpose of this study is to compare the postoperative stability of conventional orthognathic surgery to a surgery-first orthognathic ap- proach after bilateral sagittal split ramus osteotomy (BSSRO).",Non-OADS,/arxiv_data1/oa_pdf/fe/d9/jkaoms-43-23.PMC5342968.pdf
"https://doi.org/10.5125/jkaoms.2017.43.1.23 pISSN 2234-7550 ·eISSN 2234-5930 This study was supported by research fund from Chosun University, 2016.",OADS,/arxiv_data1/oa_pdf/fe/d9/jkaoms-43-23.PMC5342968.pdf
"J Korean Assoc Oral Maxillofac Surg 2017;43:23-28 28ORCID Deuk-Hyun Mah, http://orcid.org/0000-0003-3530-2466 Su-Gwan Kim, http://orcid.org/0000-0002-0424-9984 Ji-Su Oh, http://orcid.org/0000-0002-8369-5025 Jae-Seek You, http://orcid.org/0000-0001-7638-9583 Seo-Yun Jung, http://orcid.org/0000-0002-4745-1939 Won-Gi Kim, http://orcid.org/0000-0003-3060-7746 Kyung-Hwan Yu, http://orcid.org/0000-0003-2902-8931 References 1.",Non-OADS,/arxiv_data1/oa_pdf/fe/d9/jkaoms-43-23.PMC5342968.pdf
"Box 27, Sunyani, Brong Ahafo, Ghana TEL: +233-249-681-906    E-mail: smin5@snu.ac.kr ORCID: http://orcid.org/0000-0002-6916-0489    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCOral manifestations and their correlation to baseline CD4 count of   HIV/AIDS patients in Ghana Paul Frimpong1, Emmanuel Kofi Amponsah1, Jacob Abebrese2, Soung Min Kim1,3 1Oral and Maxillofacial Microvascular Reconstruction LAB,   2Department of Ear, Nose and Throat, Brong Ahafo Regional Hospital, Sunyani, Ghana,   3Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2017;43:29-36) Objectives:  Acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus  (HIV).",Non-OADS,/arxiv_data1/oa_pdf/b2/5b/jkaoms-43-29.PMC5342969.pdf
"https://doi.org/10.5125/jkaoms.2017.43.1.29 pISSN 2234-7550 ·eISSN 2234-5930 This research was supported by the International Research & Development Program of the National Research Foundation of Korea (NRF) funded  by the Ministry of Science, ICT & Future Planning (2016K1A3A9A01913024).",OADS,/arxiv_data1/oa_pdf/b2/5b/jkaoms-43-29.PMC5342969.pdf
"ORCID Paul Frimpong, http://orcid.org/0000-0002-1647-2155 Emmanuel Kofi Amponsah, http://orcid.org/0000-0002- 0720-3025  Jacob Abebrese, http://orcid.org/0000-0003-1125-5482 Soung Min Kim, http://orcid.org/0000-0002-6916-0489References 1.",Non-OADS,/arxiv_data1/oa_pdf/b2/5b/jkaoms-43-29.PMC5342969.pdf
Available from: http://www.ghanaids.gov.gh/gac1/aids_info.php.,Non-OADS,/arxiv_data1/oa_pdf/b2/5b/jkaoms-43-29.PMC5342969.pdf
Avail - able from: http://www.unaids.org/en/resources/documents/2014/JC2681_2014-Global-Plan-progress.,Non-OADS,/arxiv_data1/oa_pdf/b2/5b/jkaoms-43-29.PMC5342969.pdf
Available from: http://www.unaids.org/en/resources/documents/2014/20141201_Paris_declara- tion.,Non-OADS,/arxiv_data1/oa_pdf/b2/5b/jkaoms-43-29.PMC5342969.pdf
"Kim  et al.2 investigated the rate of complications among 418 INVITED REVIEW ARTICLE Young-Kyun Kim Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul  National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu,  Seongnam 13620, Korea TEL: +82-31-787-7541   FAX: +82-31-787-4068 E-mail: kyk0505@snubh.org ORCID: http://orcid.org/0000-0002-7268-3870    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCComplications associated with orthognathic surgery Young-Kyun Kim, D.D.S., Ph.D.",Non-OADS,/arxiv_data1/oa_pdf/a7/ed/jkaoms-43-3.PMC5342970.pdf
https://doi.org/10.5125/jkaoms.2017.43.1.3 pISSN 2234-7550 ·eISSN 2234-5930,Non-OADS,/arxiv_data1/oa_pdf/a7/ed/jkaoms-43-3.PMC5342970.pdf
"The management of angle fracture is  difficult because of its thin cross-sectional area and its attach-ORIGINAL ARTICLE Sang-Jun Park Department of Oral and Maxillofacial Surgery, Inje University Busan Paik  Hospital, 75 Bokji-ro, Busanjin-gu, Busan 47392, Korea TEL: +82-51-890-6369   FAX: +82-51-896-6675 E-mail: ds5nki@hanmail.net ORCID: http://orcid.org/0000-0002-6444-7560    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCEvaluation of postoperative complications according to treatment of  third molars in mandibular angle fracture Hye-Youn Lim, Tae-Young Jung, Sang-Jun Park Department of Oral and Maxillofacial Surgery, Inje University Busan Paik Hospital, Busan, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2017;43:37-41) Objectives:  The aim of this study was to evaluate the implication of third molars in postoperative complications of mandibular angle fracture with  open reduction and internal fixation (ORIF).",Non-OADS,/arxiv_data1/oa_pdf/e1/5c/jkaoms-43-37.PMC5342971.pdf
https://doi.org/10.5125/jkaoms.2017.43.1.37 pISSN 2234-7550 ·eISSN 2234-5930,Non-OADS,/arxiv_data1/oa_pdf/e1/5c/jkaoms-43-37.PMC5342971.pdf
"ORCID Hye-Youn Lim, http://orcid.org/0000-0001-5846-3794 Tae-Young Jung, http://orcid.org/0000-0001-7131-358X Sang-Jun Park, http://orcid.org/0000-0002-6444-7560References 1.",Non-OADS,/arxiv_data1/oa_pdf/e1/5c/jkaoms-43-37.PMC5342971.pdf
"Sergio Olate Department of Oral and Maxillofacial Surgery, Universidad de La Frontera,  Claro Solar 115, 4to Piso, Oficina 20, Temuco 4780000, Chile TEL: +56-45-2400968   FAX: +56-45-2325000 E-mail: sergio.olate@ufrontera.cl ORCID: http://orcid.org/0000-0001-8153-0676    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCChemosis as complication in transconjunctival approach for orbital trauma Sergio Olate1,2, Celso Palmieri Jr.3, Márcio de Moraes4 1Department of Oral and Maxillofacial Surgery, Universidad de La Frontera,   2Center for Research in Biomedical Sciences, Universidad Autónoma de Chile, Temuco, Chile,   3Department of Oral and Maxillofacial Surgery, Louisiana State University, Shreveport, LA, USA,   4Deparment of Oral Diagnosis, State University of Campinas, Piracicaba, Brazil Abstract  (J Korean Assoc Oral Maxillofac Surg 2017;43:42-45) The aim of this report was to discuss a complication resulting from a transconjunctival approach to treating an orbital fracture.",Non-OADS,/arxiv_data1/oa_pdf/d1/15/jkaoms-43-42.PMC5342972.pdf
https://doi.org/10.5125/jkaoms.2017.43.1.42 pISSN 2234-7550 ·eISSN 2234-5930SPECIAL ARTICLES ASSOCIATED   WITH COMPLICATIONS,Non-OADS,/arxiv_data1/oa_pdf/d1/15/jkaoms-43-42.PMC5342972.pdf
"ORCID Sergio Olate, http://orcid.org/0000-0001-8153-0676 Celso Palmieri Jr., http://orcid.org/0000-0002-4683-564X Márcio de Moraes, http://orcid.org/0000-0002-5229-5723 References 1.",Non-OADS,/arxiv_data1/oa_pdf/d1/15/jkaoms-43-42.PMC5342972.pdf
"The shape of the mandibular angle is important in  determining the impression of the face; therefore, the square- shaped face of Asians may cause a negative impact aestheti- Yoon-Sic Han Department of Oral and Maxillofacial Surgery, Section of Dentistry, SMG- SNU Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061,  Korea TEL: +82-2-870-2495   FAX: +82-2-831-0714 E-mail: hanomfs@gmail.com ORCID: http://orcid.org/0000-0001-8060-5330    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCThe postoperative trismus, nerve injury and secondary angle formation  after partial masseter muscle resection combined with   mandibular angle reduction: a case report Jeong-Hwan Kim1,2, Seong-Un Lim1, Ki-Su Jin1, Ho Lee1,2, Yoon-Sic Han1,2 1Department of Oral and Maxillofacial Surgery, Section of Dentistry, SMG-SNU Boramae Medical Center,   2Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul National University, Seoul, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2017;43:46-48) A patient, who underwent partial masseter muscle resection and mandibular angle reduction at a plastic surgery clinic, visited this hospital with major  complaints of trismus and dysesthesia.",Non-OADS,/arxiv_data1/oa_pdf/d7/e3/jkaoms-43-46.PMC5342973.pdf
https://doi.org/10.5125/jkaoms.2017.43.1.46 pISSN 2234-7550 ·eISSN 2234-5930SPECIAL ARTICLES ASSOCIATED   WITH COMPLICATIONS,Non-OADS,/arxiv_data1/oa_pdf/d7/e3/jkaoms-43-46.PMC5342973.pdf
"ORCID Jeong-Hwan Kim, http://orcid.org/0000-0003-1424-5802 Seong-Un Lim, http://orcid.org/0000-0002-6112-1768 Ki-Su Jin, http://orcid.org/0000-0002-4055-3131 Ho Lee, http://orcid.org/0000-0002-0413-2954 Yoon-Sic Han, http://orcid.org/0000-0001-8060-5330 References 1.",Non-OADS,/arxiv_data1/oa_pdf/d7/e3/jkaoms-43-46.PMC5342973.pdf
"Difficulty  Sang-Woon Lee Department of Dentistry, Gangneung Asan Hospital, University of Ulsan  College of Medicine, 38 Bangdong-gil, Sacheon-myeon, Gangneung 25440,  Korea TEL: +82-33-610-3391   FAX: +82-33-610-4960 E-mail: sangwoone@hanmail.net ORCID: http://orcid.org/0000-0002-0904-9391    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCIatrogenic subcutaneous cervicofacial emphysema with  pneumomediastinum after class V restoration Sang-Woon Lee1, Yoon-Hyuk Huh2, Min-Sang Cha1 1Department of Dentistry, Gangneung Asan Hospital, University of Ulsan College of Medicine,   2Department of Prosthodontics and Research Institute of Oral Science, Gangneung-Wonju National University, Gangneung, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2017;43:49-52) Subcutaneous facial emphysema after dental treatment is an uncommon complication caused by the invasion of high-pressure air; in severe cases, it  can spread to the neck, mediastinum, and thorax, resulting in cervical emphysema, pneumomediastinum, and pneumothorax.",Non-OADS,/arxiv_data1/oa_pdf/5b/bd/jkaoms-43-49.PMC5342974.pdf
https://doi.org/10.5125/jkaoms.2017.43.1.49 pISSN 2234-7550 ·eISSN 2234-5930SPECIAL ARTICLES ASSOCIATED   WITH COMPLICATIONS,Non-OADS,/arxiv_data1/oa_pdf/5b/bd/jkaoms-43-49.PMC5342974.pdf
"ORCID Sang-Woon Lee, http://orcid.org/0000-0002-0904-9391 Yoon-Hyuk Huh, http://orcid.org/0000-0003-4072-5199 Min-Sang Cha, http://orcid.org/0000-0003-1695-0142 References 1.",Non-OADS,/arxiv_data1/oa_pdf/5b/bd/jkaoms-43-49.PMC5342974.pdf
"Ho Lee Department of Oral and Maxillofacial Surgery, Section of Dentistry, SMG- SNU Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061,  Korea TEL: +82-2-870-2496   FAX: +82-2-831-0714 E-mail: neo0224@gmail.com ORCID: http://orcid.org/0000-0002-0413-2954    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCMalocclusion after open reduction of midfacial fracture: a case report Seong-Un Lim1, Ki-Su Jin1, Yoon-Sic Han1,2, Ho Lee1,2 1Department of Oral and Maxillofacial Surgery, Section of Dentistry, SMG-SNU Boramae Medical Center,   2Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul National University, Seoul, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2017;43:53-56) Malocclusion is a serious complication of open reduction surgery for facial fractures.",Non-OADS,/arxiv_data1/oa_pdf/59/06/jkaoms-43-53.PMC5342975.pdf
https://doi.org/10.5125/jkaoms.2017.43.1.53 pISSN 2234-7550 ·eISSN 2234-5930SPECIAL ARTICLES ASSOCIATED   WITH COMPLICATIONS,Non-OADS,/arxiv_data1/oa_pdf/59/06/jkaoms-43-53.PMC5342975.pdf
"ORCID Seong-Un Lim, http://orcid.org/0000-0002-6112-1768 Ki-Su Jin, http://orcid.org/0000-0002-4055-3131 Yoon-Sic Han, http://orcid.org/0000-0001-8060-5330 Ho Lee, http://orcid.org/0000-0002-0413-2954 References 1.",Non-OADS,/arxiv_data1/oa_pdf/59/06/jkaoms-43-53.PMC5342975.pdf
"Mortality is considerably higher (up to 70% of cases)  Serena Cocca Department of ENT, General Hospital of Siena, University of Siena, Viale  Bracci, 14, Siena 53100, Italy TEL: +39-3201525334   FAX: +39-0577585771 E-mail: mailarticoli@libero.it ORCID: http://orcid.org/0000-0003-3485-9967    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCStevens-Johnson syndrome and abuse of anabolic steroids Serena Cocca1, Massimo Viviano2 Departments of  1ENT and 2Dentistry, General Hospital of Siena, University of Siena, Siena, Italy Abstract  (J Korean Assoc Oral Maxillofac Surg 2017;43:57-60) Stevens-Johnson syndrome (SJS) is characterized by mucocutaneous tenderness and typical hemorrhagic erosions, erythema and epidermal detachment  presenting as blisters and areas of denuded skin.",Non-OADS,/arxiv_data1/oa_pdf/bb/4d/jkaoms-43-57.PMC5342976.pdf
https://doi.org/10.5125/jkaoms.2017.43.1.57 pISSN 2234-7550 ·eISSN 2234-5930SPECIAL ARTICLES ASSOCIATED   WITH COMPLICATIONS,Non-OADS,/arxiv_data1/oa_pdf/bb/4d/jkaoms-43-57.PMC5342976.pdf
"ORCID Serena Cocca, http://orcid.org/0000-0003-3485-9967 Massimo Viviano, http://orcid.org/0000-0002-9405-731X References 1.",Non-OADS,/arxiv_data1/oa_pdf/bb/4d/jkaoms-43-57.PMC5342976.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Chironomid larvaeBacterial species16s rRNA geneSanger sequencing MEGA 7 software Phylogenetic tree 1.,Non-OADS,/arxiv_data1/oa_pdf/34/10/main.PMC5342978.pdf
http://dx.doi.org/10.1016/j.gdata.2017.03.001 2213-5960/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/34/10/main.PMC5342978.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/10/main.PMC5342978.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/12/main.PMC5342979.pdf
Abdominal  computed tomography (CT)  showed  a  high  density  of  bowel  ﬂuid  in  the  dis- http://dx.doi.org/10.1016/j.ijscr.2017.02.037 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/66/12/main.PMC5342979.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.01.010,OADS,/arxiv_data1/oa_pdf/39/d7/main.PMC5342980.pdf
Adverse events were recorded and graded on the basis of the CTCAE v4.2 ( http://ctep.cancer.gov/reporting/ctc.html ).,Non-OADS,/arxiv_data1/oa_pdf/39/d7/main.PMC5342980.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/fc/main.PMC5342981.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.02.045 2049-0801/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/85/fc/main.PMC5342981.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/1c/main.PMC5342982.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.02.053 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/1b/1c/main.PMC5342982.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/b2/main.PMC5342983.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.02.044 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/af/b2/main.PMC5342983.pdf
"109 (4) (1995) 353e357, http://dx.doi.org/10.1017/S0022215100130130 .",Non-OADS,/arxiv_data1/oa_pdf/af/b2/main.PMC5342983.pdf
"67 (S1) (2014) 67 e73, http://dx.doi.org/10.1007/s12070-014-0765-8 .",Non-OADS,/arxiv_data1/oa_pdf/af/b2/main.PMC5342983.pdf
"31 (1) (2013) 356 e360, http://dx.doi.org/ 10.4067/S0717-95022013000100055 .",Non-OADS,/arxiv_data1/oa_pdf/af/b2/main.PMC5342983.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/c5/main.PMC5342984.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/c5/main.PMC5342984.pdf
http://dx.doi.org/10.1016/j.eucr.2017.02.005Urology Case Reports 12 (2017) 26 e27,Non-OADS,/arxiv_data1/oa_pdf/d5/c5/main.PMC5342984.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/bd/main.PMC5342985.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/bd/main.PMC5342985.pdf
http://dx.doi.org/10.1016/j.eucr.2017.02.003Urology Case Reports 12 (2017) 28 e30,Non-OADS,/arxiv_data1/oa_pdf/07/bd/main.PMC5342985.pdf
http://dx.doi.org/10.3109/21681805.2013.777365 .P u b M e dP M I D : 23495792.,Non-OADS,/arxiv_data1/oa_pdf/07/bd/main.PMC5342985.pdf
http://dx.doi.org/10.1111/j.1464- 410X.2008.08168.x .,Non-OADS,/arxiv_data1/oa_pdf/07/bd/main.PMC5342985.pdf
http://dx.doi.org/10.1016/j.juro.2012.03.126 .,OADS,/arxiv_data1/oa_pdf/07/bd/main.PMC5342985.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/d2/main.PMC5342986.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2017.02.001 2211-3207/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/d2/main.PMC5342986.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.01.006,OADS,/arxiv_data1/oa_pdf/3e/28/main.PMC5342987.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.0072211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
http://dx.doi.org/10.1007/s12603-016-0695-0 .,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
Urban Health 86:5. http://dx.doi.org/ 10.1007/s11524-009-9390-3 .,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
http://www.nola.gov/city/fresh-food-retailers-initiative/ .,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
10:120206. http://dx.doi.org/10.5888/ pcd10.120206 .,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
https://www.acf.hhs.gov/ocs/programs/community- economic-development/healthy-food- ﬁnancing .,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
http://dx.doi.org/10.1097/PHH.0000000000000412 .,OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
10:73. http://dx.doi.org/10.1186/1479-5868-10-73 .,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
BMC Public Health 13:45. http://dx.doi.org/10.1186/1471-2458-13-45 .109 J. Gustat et al.,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
12:45. http://dx.doi.org/10.1186/1475-2891-12-45 .,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
"BMC Public Health 16:872. http://dx.doi.org/ 10.1186/s12889-016-3499-6 .Uglem, S., Stea, T.H., Frolich, W., et al., 2011.",Non-OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
A BMC Public Health 11:343. http://dx.doi.org/10.1186/1471-2458-11-343 .,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/main.PMC5342997.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.02.005 2213-0071/ ©2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/3c/3d/main.PMC5342998.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 184 e187,Non-OADS,/arxiv_data1/oa_pdf/3c/3d/main.PMC5342998.pdf
http://dx.doi.org/10.1016/j.nicl.2017.01.023 2213-1582/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/50/ee/main.PMC5342999.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/ee/main.PMC5342999.pdf
This is an ope n access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/ee/main.PMC5342999.pdf
Further study details are provided at the NCT-clinical trials website: https://clinicaltrials.gov/ct2/show/ NCT00875654?term=ISIS+stroke+stem+cells&rank=1 .,Non-OADS,/arxiv_data1/oa_pdf/50/ee/main.PMC5342999.pdf
"Intensity outliers were de- tected using ART ( https://www.nitrc.org/projects/artifact_detect ), with an interscan movement threshold of 1 mm, and a global interscan signal intensity threshold of 3 SD relative to the session mean.",OADS,/arxiv_data1/oa_pdf/50/ee/main.PMC5342999.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/7b/main.PMC5343000.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.02.014 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/7b/main.PMC5343000.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 176 e178,Non-OADS,/arxiv_data1/oa_pdf/5e/7b/main.PMC5343000.pdf
"Avalaible at, http://www.scielo.org.mx/scielo.php?script ¼sci_ arttext &pid¼S1405-99402005000200009 &lng¼es.",Non-OADS,/arxiv_data1/oa_pdf/5e/7b/main.PMC5343000.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/7e/main.PMC5343001.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.02.015 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/7e/main.PMC5343001.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 188 e191,Non-OADS,/arxiv_data1/oa_pdf/90/7e/main.PMC5343001.pdf
"Thus it is perhaps not surpris- ing that activity of adipose tissue mitochondria seems to be especiallyimportant for the maintenance of whole-body metabolic health, http://dx.doi.org/10.1016/j.redox.2017.02.011 Received 2 February 2017; Accepted 13 February 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/0f/e1/main.PMC5343002.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/e1/main.PMC5343002.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2017.02.011 .,OADS,/arxiv_data1/oa_pdf/0f/e1/main.PMC5343002.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):145-152 145Korean J Physiol Pharmacol 2017;21(2):145-152 https://doi.org/10.4196/kjpp.2017.21.2.145 Author contributions: A.S.A.,Non-OADS,/arxiv_data1/oa_pdf/70/0b/kjpp-21-145.PMC5343047.pdf
"146 https://doi.org/10.4196/kjpp.2017.21.2.145 Korean J Physiol Pharmacol 2017;21(2):145-152Aulakh AS et al Although, the mechanisms involved in mediating RIPC- induced cardioprotective effects have not been fully elucidated,  yet there have been two theories of RIPC-induced cardio - protective effects viz.",Non-OADS,/arxiv_data1/oa_pdf/70/0b/kjpp-21-145.PMC5343047.pdf
148 https://doi.org/10.4196/kjpp.2017.21.2.145 Korean J Physiol Pharmacol 2017;21(2):145-152Aulakh AS et al induced cardioprotection and pretreatment with S-nitroso-N- acetylpenicillamine (SNAP) abrogated the cardioprotective effect of dialysate.,Non-OADS,/arxiv_data1/oa_pdf/70/0b/kjpp-21-145.PMC5343047.pdf
150 https://doi.org/10.4196/kjpp.2017.21.2.145 Korean J Physiol Pharmacol 2017;21(2):145-152Aulakh AS et al CLINICAL  IMPLICATIONS  OF RIPC RIPC treatment strategy is a major breakthrough in the  cardiovascular field that has been translated into the clinical  settings [2].,Non-OADS,/arxiv_data1/oa_pdf/70/0b/kjpp-21-145.PMC5343047.pdf
"152 https://doi.org/10.4196/kjpp.2017.21.2.145 Korean J Physiol Pharmacol 2017;21(2):145-152Aulakh AS et al DP, Hoole SP.",Non-OADS,/arxiv_data1/oa_pdf/70/0b/kjpp-21-145.PMC5343047.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):153-160 153Korean J Physiol Pharmacol 2017;21(2):153-160 https://doi.org/10.4196/kjpp.2017.21.2.153 Author contributions: H.J.K.,Non-OADS,/arxiv_data1/oa_pdf/4c/58/kjpp-21-153.PMC5343048.pdf
154 https://doi.org/10.4196/kjpp.2017.21.2.153 Korean J Physiol Pharmacol 2017;21(2):153-160Lee MJ et al stem cells (hUCB-MSCs) are preferred for clinical application  because they have a higher number of mesenchymal progenitor cells per unit volume and are less carcinogenic [9-11] .,Non-OADS,/arxiv_data1/oa_pdf/4c/58/kjpp-21-153.PMC5343048.pdf
"156 https://doi.org/10.4196/kjpp.2017.21.2.153 Korean J Physiol Pharmacol 2017;21(2):153-160Lee MJ et al RESUL TS hUCB-MSCs decreased mechanical threshold in all  three neuropathic pain models, with long-lasting  antinociception in SNI model  Compared to the baseline value, mechanical threshold was  decreased maximally 14 days after peripheral nerve injury in  all neuropathic pain models ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/4c/58/kjpp-21-153.PMC5343048.pdf
"158 https://doi.org/10.4196/kjpp.2017.21.2.153 Korean J Physiol Pharmacol 2017;21(2):153-160Lee MJ et al various pharmacological agents have been used to attenuate  neuropathic pain, including N-methyl-D-aspartate receptor antagonists, gamma-aminobutyric acid agonists, opioid agonists, anticonvulsants [30].",Non-OADS,/arxiv_data1/oa_pdf/4c/58/kjpp-21-153.PMC5343048.pdf
160 https://doi.org/10.4196/kjpp.2017.21.2.153 Korean J Physiol Pharmacol 2017;21(2):153-160Lee MJ et al allodynia and hyperalgesia after sciatic nerve constriction.,Non-OADS,/arxiv_data1/oa_pdf/4c/58/kjpp-21-153.PMC5343048.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):161-168 161Korean J Physiol Pharmacol 2017;21(2):161-168 https://doi.org/10.4196/kjpp.2017.21.2.161 Author contributions: E.B.K., S.H.N., B.R.A., S.R.Y., J.Y.L.",Non-OADS,/arxiv_data1/oa_pdf/a3/4b/kjpp-21-161.PMC5343049.pdf
162 https://doi.org/10.4196/kjpp.2017.21.2.161 Korean J Physiol Pharmacol 2017;21(2):161-168Kim E et al and are therefore able to induce the onset of angiogenesis and  apoptosis through crosstalk with ECs in pathological conditions such as cancer and hyperglycemia [1] .,Non-OADS,/arxiv_data1/oa_pdf/a3/4b/kjpp-21-161.PMC5343049.pdf
164 https://doi.org/10.4196/kjpp.2017.21.2.161 Korean J Physiol Pharmacol 2017;21(2):161-168Kim E et al RESUL TS Phenotypic and functional identification of human  PVCs derived from human UCs PVCs were isolated and cultured from vessels of umbilical  cords by a non-enzymatic isolation method [11].,Non-OADS,/arxiv_data1/oa_pdf/a3/4b/kjpp-21-161.PMC5343049.pdf
166 https://doi.org/10.4196/kjpp.2017.21.2.161 Korean J Physiol Pharmacol 2017;21(2):161-168Kim E et al antibody on the proliferation of A549 cells ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/a3/4b/kjpp-21-161.PMC5343049.pdf
168 https://doi.org/10.4196/kjpp.2017.21.2.161 Korean J Physiol Pharmacol 2017;21(2):161-168Kim E et al 29.,Non-OADS,/arxiv_data1/oa_pdf/a3/4b/kjpp-21-161.PMC5343049.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):169-177 169Korean J Physiol Pharmacol 2017;21(2):169-177 https://doi.org/10.4196/kjpp.2017.21.2.169 Author contributions: Conception and design of study: K.J.K., K.W.S.",Non-OADS,/arxiv_data1/oa_pdf/50/c1/kjpp-21-169.PMC5343050.pdf
"170 https://doi.org/10.4196/kjpp.2017.21.2.169 Korean J Physiol Pharmacol 2017;21(2):169-177Kim KJ et al schizophrenia, depression and anxiety [3,7] .",Non-OADS,/arxiv_data1/oa_pdf/50/c1/kjpp-21-169.PMC5343050.pdf
172 https://doi.org/10.4196/kjpp.2017.21.2.169 Korean J Physiol Pharmacol 2017;21(2):169-177Kim KJ et al results suggest that the inhibitory action of lamotrigine on 5-HT3  receptors resulted from the blockade of the channel activation  process.,Non-OADS,/arxiv_data1/oa_pdf/50/c1/kjpp-21-169.PMC5343050.pdf
"174 https://doi.org/10.4196/kjpp.2017.21.2.169 Korean J Physiol Pharmacol 2017;21(2):169-177Kim KJ et al 1961.9±100.9 msec (n=8, p<0.05, paired t-test).",Non-OADS,/arxiv_data1/oa_pdf/50/c1/kjpp-21-169.PMC5343050.pdf
176 https://doi.org/10.4196/kjpp.2017.21.2.169 Korean J Physiol Pharmacol 2017;21(2):169-177Kim KJ et al blocking through an open channel blocker.,Non-OADS,/arxiv_data1/oa_pdf/50/c1/kjpp-21-169.PMC5343050.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):179-188 179Korean J Physiol Pharmacol 2017;21(2):179-188 https://doi.org/10.4196/kjpp.2017.21.2.179 Author contributions: J.H.K.,Non-OADS,/arxiv_data1/oa_pdf/2b/b0/kjpp-21-179.PMC5343051.pdf
"180 https://doi.org/10.4196/kjpp.2017.21.2.179 Korean J Physiol Pharmacol 2017;21(2):179-188Kim JH et al brain and plays a specific role in memory, thought, attention,  perception, and language [11] .",Non-OADS,/arxiv_data1/oa_pdf/2b/b0/kjpp-21-179.PMC5343051.pdf
"182 https://doi.org/10.4196/kjpp.2017.21.2.179 Korean J Physiol Pharmacol 2017;21(2):179-188Kim JH et al LC3B-II and Beclin1 protein is significantly up- regulated in the cerebral cortex but not in the  brainstem To validate the transcriptional level of autophagy, we examined  the expressional level of the autophagy proteins LC3B-II and  Beclin1, which are crucial for the formation of autophagosomes in response to environmental stress [23] .",Non-OADS,/arxiv_data1/oa_pdf/2b/b0/kjpp-21-179.PMC5343051.pdf
184 https://doi.org/10.4196/kjpp.2017.21.2.179 Korean J Physiol Pharmacol 2017;21(2):179-188Kim JH et al we further examined whether more autophagic structures  accumulate in cerebral cortical neurons or brainstem neurons in response to 4 weeks of RF-EMF exposure using TEM.,Non-OADS,/arxiv_data1/oa_pdf/2b/b0/kjpp-21-179.PMC5343051.pdf
"186 https://doi.org/10.4196/kjpp.2017.21.2.179 Korean J Physiol Pharmacol 2017;21(2):179-188Kim JH et al lipids to the phagophore [25,26] .",Non-OADS,/arxiv_data1/oa_pdf/2b/b0/kjpp-21-179.PMC5343051.pdf
188 https://doi.org/10.4196/kjpp.2017.21.2.179 Korean J Physiol Pharmacol 2017;21(2):179-188Kim JH et al ethics.,Non-OADS,/arxiv_data1/oa_pdf/2b/b0/kjpp-21-179.PMC5343051.pdf
Available from: http://www.encyclopedia.com/doc/1O128-brainstem.html.,Non-OADS,/arxiv_data1/oa_pdf/2b/b0/kjpp-21-179.PMC5343051.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):189-195 189Korean J Physiol Pharmacol 2017;21(2):189-195 https://doi.org/10.4196/kjpp.2017.21.2.189 Author contributions: Conception and design: L.J.E., L.J.S.",Non-OADS,/arxiv_data1/oa_pdf/38/58/kjpp-21-189.PMC5343052.pdf
"190 https://doi.org/10.4196/kjpp.2017.21.2.189 Korean J Physiol Pharmacol 2017;21(2):189-195Lee JH et al secretion, increases soluble mucin secretion, and upregulates the  expression of membrane-associated mucins [5] .",Non-OADS,/arxiv_data1/oa_pdf/38/58/kjpp-21-189.PMC5343052.pdf
"Mean distances between original and migrated wound edges of three separate samples per treatment were determined using an image analysis system (Image J 1.33o; available by ftp at zippy.nimh.nih.gov/ or at http://rsb.info.nih.gov/nih-imageJ; developed by Wayne Rasband, National Institute of Health, Bethesda, MD, USA), and percentage wound closures in response to diquafosol and HA were compared.",OADS,/arxiv_data1/oa_pdf/38/58/kjpp-21-189.PMC5343052.pdf
192 https://doi.org/10.4196/kjpp.2017.21.2.189 Korean J Physiol Pharmacol 2017;21(2):189-195Lee JH et al it should be noted the ideal range for extracellular fluid has been  reported to be 4.3 to 4.6 mEq/L [11] .,Non-OADS,/arxiv_data1/oa_pdf/38/58/kjpp-21-189.PMC5343052.pdf
194 https://doi.org/10.4196/kjpp.2017.21.2.189 Korean J Physiol Pharmacol 2017;21(2):189-195Lee JH et al at concentrations over 2000 mM [23].,Non-OADS,/arxiv_data1/oa_pdf/38/58/kjpp-21-189.PMC5343052.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):197-204 197Korean J Physiol Pharmacol 2017;21(2):197-204 https://doi.org/10.4196/kjpp.2017.21.2.197 Author contributions: D.G.K.,Non-OADS,/arxiv_data1/oa_pdf/f8/e8/kjpp-21-197.PMC5343053.pdf
"198 https://doi.org/10.4196/kjpp.2017.21.2.197 Korean J Physiol Pharmacol 2017;21(2):197-204Kang DG et al patients [3,4].",Non-OADS,/arxiv_data1/oa_pdf/f8/e8/kjpp-21-197.PMC5343053.pdf
200 https://doi.org/10.4196/kjpp.2017.21.2.197 Korean J Physiol Pharmacol 2017;21(2):197-204Kang DG et al and the 100 mM oleanolic acid plus IL-1 b group received a 30  mL injection of 20 ng IL-1 b in sterile PBS into the right knee  joint.,Non-OADS,/arxiv_data1/oa_pdf/f8/e8/kjpp-21-197.PMC5343053.pdf
"202 https://doi.org/10.4196/kjpp.2017.21.2.197 Korean J Physiol Pharmacol 2017;21(2):197-204Kang DG et al Effect of oleanolic acid on MMP-3 production in vivo To examine whether oleanolic acid shows the potential effect  in vivo , we examined the effect of intraarticular injection of  oleanolic acid into the knee joint of rats on IL-1 b-stimulated  production of MMP-3 from articular cartilage tissues.",Non-OADS,/arxiv_data1/oa_pdf/f8/e8/kjpp-21-197.PMC5343053.pdf
204 https://doi.org/10.4196/kjpp.2017.21.2.197 Korean J Physiol Pharmacol 2017;21(2):197-204Kang DG et al AJ.,Non-OADS,/arxiv_data1/oa_pdf/f8/e8/kjpp-21-197.PMC5343053.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):205-213 205Korean J Physiol Pharmacol 2017;21(2):205-213 https://doi.org/10.4196/kjpp.2017.21.2.205 Author contributions: L.T.N., A.R.S., and S.J.",Non-OADS,/arxiv_data1/oa_pdf/eb/5d/kjpp-21-205.PMC5343054.pdf
206 https://doi.org/10.4196/kjpp.2017.21.2.205 Korean J Physiol Pharmacol 2017;21(2):205-213Nguyen LT et al cells and improvement in cancer relapse.,Non-OADS,/arxiv_data1/oa_pdf/eb/5d/kjpp-21-205.PMC5343054.pdf
"208 https://doi.org/10.4196/kjpp.2017.21.2.205 Korean J Physiol Pharmacol 2017;21(2):205-213Nguyen LT et al mM) for 24 h, 48 h and 72 h and cell viability was determined by  MTT assay.",OADS,/arxiv_data1/oa_pdf/eb/5d/kjpp-21-205.PMC5343054.pdf
210 https://doi.org/10.4196/kjpp.2017.21.2.205 Korean J Physiol Pharmacol 2017;21(2):205-213Nguyen LT et al pathways.,Non-OADS,/arxiv_data1/oa_pdf/eb/5d/kjpp-21-205.PMC5343054.pdf
"212 https://doi.org/10.4196/kjpp.2017.21.2.205 Korean J Physiol Pharmacol 2017;21(2):205-213Nguyen LT et al Foxo3a activity in quercetin treatment, our study found that JNK  was a possible signaling pathway involved in induction of Foxo3a activity in quercetin-treated breast cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/eb/5d/kjpp-21-205.PMC5343054.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):215-223 215Korean J Physiol Pharmacol 2017;21(2):215-223 https://doi.org/10.4196/kjpp.2017.21.2.215 Author contributions: J.E.H., J.H.C., I.S.C.",Non-OADS,/arxiv_data1/oa_pdf/2f/90/kjpp-21-215.PMC5343055.pdf
"216 https://doi.org/10.4196/kjpp.2017.21.2.215 Korean J Physiol Pharmacol 2017;21(2):215-223Han JE et al acid A (GABAA) receptors are modulated by an acidic pH [8,10] ,  suggesting that local and systemic changes in the extracellular pH  may affect basic functions, including neuronal excitability.",Non-OADS,/arxiv_data1/oa_pdf/2f/90/kjpp-21-215.PMC5343055.pdf
"218 https://doi.org/10.4196/kjpp.2017.21.2.215 Korean J Physiol Pharmacol 2017;21(2):215-223Han JE et al are provided as the mean±standard error of the mean (SEM),  except where indicated, using values normalized to the control.",OADS,/arxiv_data1/oa_pdf/2f/90/kjpp-21-215.PMC5343055.pdf
220 https://doi.org/10.4196/kjpp.2017.21.2.215 Korean J Physiol Pharmacol 2017;21(2):215-223Han JE et al solution also changed both the I~V and G~V relationships.,Non-OADS,/arxiv_data1/oa_pdf/2f/90/kjpp-21-215.PMC5343055.pdf
"222 https://doi.org/10.4196/kjpp.2017.21.2.215 Korean J Physiol Pharmacol 2017;21(2):215-223Han JE et al in shifts in both voltage dependence and channel conductance  [32,49,50] .",OADS,/arxiv_data1/oa_pdf/2f/90/kjpp-21-215.PMC5343055.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):225-232 225Korean J Physiol Pharmacol 2017;21(2):225-232 https://doi.org/10.4196/kjpp.2017.21.2.225 Author contributions: S.E.S., H.L.",Non-OADS,/arxiv_data1/oa_pdf/e4/48/kjpp-21-225.PMC5343056.pdf
"226 https://doi.org/10.4196/kjpp.2017.21.2.225 Korean J Physiol Pharmacol 2017;21(2):225-232Shin SE et al induces strong membrane depolarization [9,10] .",Non-OADS,/arxiv_data1/oa_pdf/e4/48/kjpp-21-225.PMC5343056.pdf
228 https://doi.org/10.4196/kjpp.2017.21.2.225 Korean J Physiol Pharmacol 2017;21(2):225-232Shin SE et al We also investigated the influence of nortriptyline on steady- state inactivation curves.,OADS,/arxiv_data1/oa_pdf/e4/48/kjpp-21-225.PMC5343056.pdf
230 https://doi.org/10.4196/kjpp.2017.21.2.225 Korean J Physiol Pharmacol 2017;21(2):225-232Shin SE et al channels is independent of serotonin uptake inhibition.,Non-OADS,/arxiv_data1/oa_pdf/e4/48/kjpp-21-225.PMC5343056.pdf
232 https://doi.org/10.4196/kjpp.2017.21.2.225 Korean J Physiol Pharmacol 2017;21(2):225-232Shin SE et al by parent drug and not by 10-hydroxymetabolites.,Non-OADS,/arxiv_data1/oa_pdf/e4/48/kjpp-21-225.PMC5343056.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):233-239 233Korean J Physiol Pharmacol 2017;21(2):233-239 https://doi.org/10.4196/kjpp.2017.21.2.233 Author contributions: M.N.Y.,Non-OADS,/arxiv_data1/oa_pdf/73/2b/kjpp-21-233.PMC5343057.pdf
"234 https://doi.org/10.4196/kjpp.2017.21.2.233 Korean J Physiol Pharmacol 2017;21(2):233-239Yoon MN et al Pancreatic acinar cells synthesize and secrete a variety of  digestive enzyme, tightly regulated by intracellular repetitive  Ca2+ oscillation [19,20] .",Non-OADS,/arxiv_data1/oa_pdf/73/2b/kjpp-21-233.PMC5343057.pdf
"236 https://doi.org/10.4196/kjpp.2017.21.2.233 Korean J Physiol Pharmacol 2017;21(2):233-239Yoon MN et al mg/ml or 1,4-dithiothreitol (DTT) at 2 mM with CCh completely  prevented the effects of H2O2 (i.e., the additional elevation of  intracellular Ca2+ levels and the termination of Ca2+ oscillation)  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/73/2b/kjpp-21-233.PMC5343057.pdf
"238 https://doi.org/10.4196/kjpp.2017.21.2.233 Korean J Physiol Pharmacol 2017;21(2):233-239Yoon MN et al potential (TRP) channels, such as TRPC3, TRPM2, TRPM7, and  TRPPA1 are also known to sensitive to ROS [36] .",Non-OADS,/arxiv_data1/oa_pdf/73/2b/kjpp-21-233.PMC5343057.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):241-249 241Korean J Physiol Pharmacol 2017;21(2):241-249 https://doi.org/10.4196/kjpp.2017.21.2.241 Author contributions: T.D.W., J.H.K., D.K.Y., and K.P .L.",Non-OADS,/arxiv_data1/oa_pdf/71/98/kjpp-21-241.PMC5343058.pdf
"242 https://doi.org/10.4196/kjpp.2017.21.2.241 Korean J Physiol Pharmacol 2017;21(2):241-249Wijerathne TD et al activated directly by intracellular alkalinization and progesterone,  mSlo3, which mediates a weakly outwardly rectifying K+  conductance in sperm known as KSper, can sense pH or Ca2+ and  set the membrane potential in a way that favors Catsper-mediated Ca 2+ influx.",Non-OADS,/arxiv_data1/oa_pdf/71/98/kjpp-21-241.PMC5343058.pdf
244 https://doi.org/10.4196/kjpp.2017.21.2.241 Korean J Physiol Pharmacol 2017;21(2):241-249Wijerathne TD et al and hLRRC52 at a 1:1 ratio resulted in a 147±14.56 pA/pF (n=30)  current at +116 mV that displayed the characteristic step-current shape of hSlo3+hLRRC52 currents ( Fig.,OADS,/arxiv_data1/oa_pdf/71/98/kjpp-21-241.PMC5343058.pdf
246 https://doi.org/10.4196/kjpp.2017.21.2.241 Korean J Physiol Pharmacol 2017;21(2):241-249Wijerathne TD et al the pharmacological properties of this current is beneficial for  understanding the molecular nature of the sperm K+ channel.,Non-OADS,/arxiv_data1/oa_pdf/71/98/kjpp-21-241.PMC5343058.pdf
"248 https://doi.org/10.4196/kjpp.2017.21.2.241 Korean J Physiol Pharmacol 2017;21(2):241-249Wijerathne TD et al Our data show that 10 mM LDD175 dramatically shifted the  half-activation voltage of rSlo1 to a hyperpolarized potential,  whereas this concentration of LDD175 had no significant effect on hSlo3 at pH 7.3 or pH 8.0 in the absence of Ca 2+.",Non-OADS,/arxiv_data1/oa_pdf/71/98/kjpp-21-241.PMC5343058.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):251-257 251Korean J Physiol Pharmacol 2017;21(2):251-257 https://doi.org/10.4196/kjpp.2017.21.2.251 Author contributions:  S.W.K.,Non-OADS,/arxiv_data1/oa_pdf/cf/18/kjpp-21-251.PMC5343059.pdf
"252 https://doi.org/10.4196/kjpp.2017.21.2.251 Korean J Physiol Pharmacol 2017;21(2):251-257Kang SW et al inhibitor of IK,n, as IK,n is not reported to develop before P6 in  mice OHCs [5].",Non-OADS,/arxiv_data1/oa_pdf/cf/18/kjpp-21-251.PMC5343059.pdf
"254 https://doi.org/10.4196/kjpp.2017.21.2.251 Korean J Physiol Pharmacol 2017;21(2):251-257Kang SW et al 8 cells, the currents were reduced to 93.6±1.4% (n=8, 1 mM) and  90.5±2.7% (n=8, 10 mM) ( Fig.",OADS,/arxiv_data1/oa_pdf/cf/18/kjpp-21-251.PMC5343059.pdf
"256 https://doi.org/10.4196/kjpp.2017.21.2.251 Korean J Physiol Pharmacol 2017;21(2):251-257Kang SW et al by Marcotti and Kros in developing mice OHCs [5] , it is not in  line with our results because KCNQ4 is known to be relatively  insensitive to TEA [19,20] .",Non-OADS,/arxiv_data1/oa_pdf/cf/18/kjpp-21-251.PMC5343059.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):259-265 259Korean J Physiol Pharmacol 2017;21(2):259-265 https://doi.org/10.4196/kjpp.2017.21.2.259 Author contributions: Y.S.Y.,Non-OADS,/arxiv_data1/oa_pdf/eb/6d/kjpp-21-259.PMC5343060.pdf
260 https://doi.org/10.4196/kjpp.2017.21.2.259 Korean J Physiol Pharmacol 2017;21(2):259-265Yang YS et al regulate excitability in most neurons even though they are  inhibitory.,OADS,/arxiv_data1/oa_pdf/eb/6d/kjpp-21-259.PMC5343060.pdf
"262 https://doi.org/10.4196/kjpp.2017.21.2.259 Korean J Physiol Pharmacol 2017;21(2):259-265Yang YS et al influx, we also tested if it might participate in IDR upregulation  resulted from Ca2+ influx via VDCCs.",OADS,/arxiv_data1/oa_pdf/eb/6d/kjpp-21-259.PMC5343060.pdf
"264 https://doi.org/10.4196/kjpp.2017.21.2.259 Korean J Physiol Pharmacol 2017;21(2):259-265Yang YS et al These pathogenic outcomes are likely due to the hyperexcitability  of neurons during development, as IDR channels are targeted by  cellular signaling pathways of various growth factors in young brain [24].",Non-OADS,/arxiv_data1/oa_pdf/eb/6d/kjpp-21-259.PMC5343060.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):267-273 267Korean J Physiol Pharmacol 2017;21(2):267-273 https://doi.org/10.4196/kjpp.2017.21.2.267 Author contributions: S.J.P .,Non-OADS,/arxiv_data1/oa_pdf/ed/ad/kjpp-21-267.PMC5343061.pdf
268 https://doi.org/10.4196/kjpp.2017.21.2.267 Korean J Physiol Pharmacol 2017;21(2):267-273Park SJ et al in a dose-dependent manner by ionizing radiation (IR) [7] .,Non-OADS,/arxiv_data1/oa_pdf/ed/ad/kjpp-21-267.PMC5343061.pdf
"270 https://doi.org/10.4196/kjpp.2017.21.2.267 Korean J Physiol Pharmacol 2017;21(2):267-273Park SJ et al Overexpression of PIG3 enhances tumorigenicity in  colon cancer cells To investigate whether PIG3 could be involved in cancer  cell tumorigenicity, we constructed a pEGFP-N1 vector ex - pressing the full-length PIG3 gene.",Non-OADS,/arxiv_data1/oa_pdf/ed/ad/kjpp-21-267.PMC5343061.pdf
"272 https://doi.org/10.4196/kjpp.2017.21.2.267 Korean J Physiol Pharmacol 2017;21(2):267-273Park SJ et al of the tumors derived from control and PIG3 shRNA-HCT116  cells were 1.7±0.06 g and 0.5±0.12 g, respectively ( Fig.",OADS,/arxiv_data1/oa_pdf/ed/ad/kjpp-21-267.PMC5343061.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):275 275Korean J Physiol Pharmacol 2017;21(2):275 https://doi.org/10.4196/kjpp.2017.21.2.275 Erratum to:  Korean J Physiol Pharmacol 2017;21(1):19-26 https://doi.org/10.4196/kjpp.2017.21.1.19 Due to an oversight of the editorial team, the original version of this article contained an error in the list of authors.",Non-OADS,/arxiv_data1/oa_pdf/77/89/kjpp-21-275.PMC5343062.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(2):277 277Korean J Physiol Pharmacol 2017;21(2):277 https://doi.org/10.4196/kjpp.2017.21.2.277 Retraction notice to:  Korean J Physiol Pharmacol 2016;20(4):325-332 https://doi.org/10.4196/kjpp.2016.20.4.325 It was brought to the Editors-in-Chief’s attention that there were significant similarities between this paper and previously published  articles.,Non-OADS,/arxiv_data1/oa_pdf/65/2d/kjpp-21-277.PMC5343063.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
Nationella riktlinjer fo ¨r diabetesva ˚rden 2010 – Sto¨df o¨r styrning och ledning 2010. http://www.socialstyrelsen.,Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
Global guideline for type 2 diabetes 2012. https://www.idf.org/global-guideline-type-2- diabetes-2012 .,Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
"A ˚rsrapport, 2013 a ˚rs resultat 2013. https://www.ndr.nu/pdfs/Arsrapport_NDR_2013.pdf .A c c e s - sed 22 Dec 2016.246 A˚.",Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
General guidelines for economic evaluations from the Pharmaceutical Beneﬁts Board (LFNAR 2003:2) 2003. http://www.tlv.se/Upload/ English/Guidelines-for-economic-evaluations-LFNAR-2003-2.,Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
https://clinicaltrials.gov/ct2/show/ results/NCT01045447?term=NCT01045447&rank=1 .,Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
2013. http://www.tlv.se/upload/beslut_2013/bes130618-tresiba.,Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
2015. http://www.socialstyrelsen.se/Lists/ Artikelkatalog/Attachments/19687/2015-2-1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
2016. http://viss.nu/Handlaggning/ Vardprogram/Endokrina-organ/Diabetes/ .,Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
http://www.scb.se/en_/Finding-statistics/Statistics-by-subject-area/ Prices-and-Consumption/Consumer-Price-Index/Consumer-Price-Index-CPI/Aktuell-Pong/33779/Consumer-Price-Index-CPI/33907/ .,Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
http://www.tlv.se/beslut/ .,Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
http://www.scb.se/en_/Finding-st atistics/Statistics-by-subject- area/Labour-market/Wages-salaries-and-labour-costs/Salary-structures-whole-economy/Aktuell-Pong/14374/149087/ .,Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
"Presented at the AmericanDiabetes Association 74nd Annual Scientiﬁc Sessions, SanFrancisco; 13-17 June 2014. http://ada.scientiﬁcposters.com/ epsAbstractADA.cfm?id=8 , 2014.",OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
NICE DSU Technical support document 1: introduction to evidence synthesis for decision making 2012. http://www.nicedsu.org.uk/ TSD1%20Introduction.ﬁnal.08.05.12.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
2015. https://www.iqwig.de/ download/IQWiG_General_Methods_Version_%204-2.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
Choices in methods for eco- nomic evaluation 2012. http://www.has-sante.fr/portail/upload/ docs/application/pdf/2012-10/choices_in_methods_for_economic_evaluation.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
Swedish krona historic exchange rates look-up 2016. http://www.x-rates.com/historical/?from=SEK&amount=1&date=2016-11-24 .,OADS,/arxiv_data1/oa_pdf/8b/18/40258_2016_Article_301.PMC5343072.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c5/c0/40258_2016_Article_288.PMC5343076.pdf
Avail- able from: http://www3.weforum.org/docs/WEF_Harvard_HE_ GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c5/c0/40258_2016_Article_288.PMC5343076.pdf
Available from: http://ec.europa.eu/economy_ﬁnance/publications/economic_paper/ 2012/pdf/ecp_461_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c5/c0/40258_2016_Article_288.PMC5343076.pdf
Avail- able from: http://www.kwf.nl/sitecollectiondocuments/sck% 20rapport%20toegankelijkheid%20van%20dure%20kankergeneesmiddelen.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c5/c0/40258_2016_Article_288.PMC5343076.pdf
Available from: https://www.england.nhs.uk/wp-content/uploads/2013/04/ cdf-sop.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c5/c0/40258_2016_Article_288.PMC5343076.pdf
Available from: https://www.zorginstituutnederland.nl/binaries/ content/documents/zinl-www/documenten/publicaties/rapporten-en-standpunten/2015/1506-kosteneffectiviteit-in-de-praktijk/1506- kosteneffectiviteit-in-de-praktijk/Kosteneffectiviteit ?in?de?,Non-OADS,/arxiv_data1/oa_pdf/c5/c0/40258_2016_Article_288.PMC5343076.pdf
Available from: http://www.kbs-frb.,Non-OADS,/arxiv_data1/oa_pdf/c5/c0/40258_2016_Article_288.PMC5343076.pdf
Available from: http://www.nice.org.uk/Media/Default/About/ what-we-do/NICE-guidance/NI CE-technology-appraisals/VBA- TA-Methods-Guide-for-Consultation.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c5/c0/40258_2016_Article_288.PMC5343076.pdf
Available from: http://www.eepru.org.uk/EEPRU%20VBP% 20survey%20DP.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c5/c0/40258_2016_Article_288.PMC5343076.pdf
Available from: http://www.discapnet.es/ SiteCollectionDocuments/Dis capnet/Documentos/Legislacion/ en_0221.htm .,Non-OADS,/arxiv_data1/oa_pdf/c5/c0/40258_2016_Article_288.PMC5343076.pdf
"3.1 Availability and Use of EQ-5D InstrumentsThe position in 2016 with respect to translations, as detailed on the EuroQol website ( http://www.euroqol.org ), is 176 EQ-5D-3L and 138 EQ-5D-5L language versions.",Non-OADS,/arxiv_data1/oa_pdf/5f/84/40258_2017_Article_310.PMC5343080.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5f/84/40258_2017_Article_310.PMC5343080.pdf
27.http://www.euroqol.org/eq-5d-publications/5l-valuation.html .,Non-OADS,/arxiv_data1/oa_pdf/5f/84/40258_2017_Article_310.PMC5343080.pdf
2014. http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/5f/84/40258_2017_Article_310.PMC5343080.pdf
NICE guidelines for hepatitis C are currently being developed and will be published in September 2016 (https://www.nice.org.uk/guida nce/indevelopment/gid-cg wave0666 ).,Non-OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
The comparators were TE (also referred to as Fibroscan) ( http://www.myliverexam.com/en/lexamen- ﬁbroscan.html ) and the index test of LB.,OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
2015. https://www.nice.org.uk/ about/what-we-do/our-programmes/nice-guidance/nice-medical- technologies-evaluation-programme .,Non-OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
2015. https://www.nice.org.uk/guidance/mtg27/ .,Non-OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
2012. http://www.britishliver trust.org.uk/liver-information/liver-conditions/hepatitis-b/ .A c c e s - sed 1 Jun 2016.,Non-OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
Hepatitis C. 2015. http://www.nhs.uk/conditions/ Hepatitis-C/Pages/Introduction.aspx .,Non-OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
2015. https://www.nice.org.uk/news/press-and-media/ nice-recommends-new-treatment-options-for-hepatitis-c .,Non-OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
2013. https://www.nice.org.uk/guidance/cg165 .,Non-OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
http://clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
http://clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
http://clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
2009. http://nhscep.useconnect.co.uk/CEPProducts/ Catalogue.aspx .,Non-OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
2013. https://www.gov.uk/government/publications/nhs-reference-costs- 2012-to-2013 .,Non-OADS,/arxiv_data1/oa_pdf/de/b9/40258_2016_Article_277.PMC5343083.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2017.01.001 1008-1275/ ©2017 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/5b/7e/main.PMC5343090.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 18 e19,Non-OADS,/arxiv_data1/oa_pdf/5b/7e/main.PMC5343090.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/88/main.PMC5343091.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.04.008 1008-1275/ ©2017 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/19/88/main.PMC5343091.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 59 e62,Non-OADS,/arxiv_data1/oa_pdf/19/88/main.PMC5343091.pdf
http://dx.doi.org/10.3928/ 01477447-20131021-15 .,Non-OADS,/arxiv_data1/oa_pdf/19/88/main.PMC5343091.pdf
"http://dx.doi.org/10.4103/ 0019-5413.114907 .4.Mehta JA, Bain GI.",Non-OADS,/arxiv_data1/oa_pdf/19/88/main.PMC5343091.pdf
http://dx.doi.org/10.4055/cios.2015.7.2.241 .,Non-OADS,/arxiv_data1/oa_pdf/19/88/main.PMC5343091.pdf
2011;12:130. http://dx.doi.org/10.1186/1471-2474-12-130 .,Non-OADS,/arxiv_data1/oa_pdf/19/88/main.PMC5343091.pdf
http://dx.doi.org/10.5704/MOJ.1303.010 .,Non-OADS,/arxiv_data1/oa_pdf/19/88/main.PMC5343091.pdf
http://dx.doi.org/10.1016/ j.jse.2011.04.033 .,OADS,/arxiv_data1/oa_pdf/19/88/main.PMC5343091.pdf
http://dx.doi.org/10.4103/0019-5413.111500 .,Non-OADS,/arxiv_data1/oa_pdf/19/88/main.PMC5343091.pdf
http://dx.doi.org/10.1302/ 0301-620X.92B5.23067 .,Non-OADS,/arxiv_data1/oa_pdf/19/88/main.PMC5343091.pdf
http://dx.doi.org/10.1007/s10195-014-0331-x .G.,Non-OADS,/arxiv_data1/oa_pdf/19/88/main.PMC5343091.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/29/main.PMC5343092.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.11.002 1008-1275/ ©2017 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/cc/29/main.PMC5343092.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 9 e13,Non-OADS,/arxiv_data1/oa_pdf/cc/29/main.PMC5343092.pdf
2015;2015:943839. http://dx.doi.org/ 10.1155/2015/943839 .,Non-OADS,/arxiv_data1/oa_pdf/cc/29/main.PMC5343092.pdf
http://dx.doi.org/10.1007/s00381-009-0939-y .,Non-OADS,/arxiv_data1/oa_pdf/cc/29/main.PMC5343092.pdf
http://dx.doi.org/10.1016/ j.tripleo.2009.05.023 .,OADS,/arxiv_data1/oa_pdf/cc/29/main.PMC5343092.pdf
2014;4:9 e18.http://dx.doi.org/ 10.4103/2231-0746.133065 .,Non-OADS,/arxiv_data1/oa_pdf/cc/29/main.PMC5343092.pdf
http://dx.doi.org/10.1007/s00266-011-9853-2 .,Non-OADS,/arxiv_data1/oa_pdf/cc/29/main.PMC5343092.pdf
http://dx.doi.org/10.1097/SCS.0b013e3182326f2c .,Non-OADS,/arxiv_data1/oa_pdf/cc/29/main.PMC5343092.pdf
http://dx.doi.org/ 10.1016/j.jcms.2010.01.005 .,OADS,/arxiv_data1/oa_pdf/cc/29/main.PMC5343092.pdf
http://dx.doi.org/10.1016/ j.jfma.2016.01.003 .,OADS,/arxiv_data1/oa_pdf/cc/29/main.PMC5343092.pdf
http://dx.doi.org/10.1016/ j.joms.2016.01.010 .,OADS,/arxiv_data1/oa_pdf/cc/29/main.PMC5343092.pdf
http://dx.doi.org/10.1097/ 01.prs.0000436523.79293.64 .,Non-OADS,/arxiv_data1/oa_pdf/cc/29/main.PMC5343092.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.10.003 1008-1275/ ©2017 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 34 e38,Non-OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
http://dx.doi.org/10.1016/j.neuchi.2014.02.012 .,OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
http://dx.doi.org/10.1055/s-0030-1254145 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
http://dx.doi.org/10.1007/s00701-012-1432-z .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
http://dx.doi.org/ 10.1007/s00264-016-3177-4 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
2016;143:90 e94.http://dx.doi.org/10.1016/j.clineuro.,OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
2011;20:58 e64.http://dx.doi.org/10.1007/s00586- 010-1493-8 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
http://dx.doi.org/ 10.1016/j.ijsu.2016.01.034 .,OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
http://dx.doi.org/10.1097/BRS.0000000000000990 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
http://dx.doi.org/10.1007/s00701-013-1828-4 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
http://dx.doi.org/10.1097/PHM.0000000000000296 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
http://dx.doi.org/10.3109/ 02688697.2011.650739 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
http://dx.doi.org/10.1016/ j.ijsu.2014.02.015 .Y.,OADS,/arxiv_data1/oa_pdf/4d/19/main.PMC5343093.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/95/main.PMC5343094.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.05.003 1008-1275/ ©2017 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/76/95/main.PMC5343094.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 45 e48,Non-OADS,/arxiv_data1/oa_pdf/76/95/main.PMC5343094.pdf
http://dx.doi.org/10.2106/JBJS.H.00034 .4.Neer II CS.,OADS,/arxiv_data1/oa_pdf/76/95/main.PMC5343094.pdf
http://dx.doi.org/10.1016/j.jse.2009.11.056 .,OADS,/arxiv_data1/oa_pdf/76/95/main.PMC5343094.pdf
http://dx.doi.org/10.1016/j.injury.2008.07.021 .,OADS,/arxiv_data1/oa_pdf/76/95/main.PMC5343094.pdf
http://dx.doi.org/10.1007/s00402-010-1196-y .,Non-OADS,/arxiv_data1/oa_pdf/76/95/main.PMC5343094.pdf
http://dx.doi.org/10.1016/j.jse.2012.08.022 .,OADS,/arxiv_data1/oa_pdf/76/95/main.PMC5343094.pdf
http://dx.doi.org/10.1007/s00264-014-2340-z .,Non-OADS,/arxiv_data1/oa_pdf/76/95/main.PMC5343094.pdf
2014;5:65 e73.http://dx.doi.org/10.1016/j.jcot.2014.05.007 .,OADS,/arxiv_data1/oa_pdf/76/95/main.PMC5343094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/d1/main.PMC5343095.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.05.004 1008-1275/ ©2017 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/cd/d1/main.PMC5343095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 1 e3,Non-OADS,/arxiv_data1/oa_pdf/cd/d1/main.PMC5343095.pdf
http://dx.doi.org/10.1074/jbc.M800850200 .,Non-OADS,/arxiv_data1/oa_pdf/cd/d1/main.PMC5343095.pdf
http://dx.doi.org/10.1097/SCS.0b013e3181f502fa .,Non-OADS,/arxiv_data1/oa_pdf/cd/d1/main.PMC5343095.pdf
http://dx.doi.org/10.1097/SCS.0b013e31824dbdd4 .,Non-OADS,/arxiv_data1/oa_pdf/cd/d1/main.PMC5343095.pdf
http://dx.doi.org/10.1159/ 000149907 .,Non-OADS,/arxiv_data1/oa_pdf/cd/d1/main.PMC5343095.pdf
http://dx.doi.org/10.1007/s00586-009-1179-2 .,Non-OADS,/arxiv_data1/oa_pdf/cd/d1/main.PMC5343095.pdf
http://dx.doi.org/10.2106/ JBJS.I.01763 .,Non-OADS,/arxiv_data1/oa_pdf/cd/d1/main.PMC5343095.pdf
http://dx.doi.org/10.1016/j.injury.2015.07.013 .,OADS,/arxiv_data1/oa_pdf/cd/d1/main.PMC5343095.pdf
http://dx.doi.org/ 10.4055/cios.2011.3.3.230 .,Non-OADS,/arxiv_data1/oa_pdf/cd/d1/main.PMC5343095.pdf
http://dx.doi.org/10.1111/clr.12568 .,Non-OADS,/arxiv_data1/oa_pdf/cd/d1/main.PMC5343095.pdf
http://dx.doi.org/10.1371/journal.pone.0050378 .,Non-OADS,/arxiv_data1/oa_pdf/cd/d1/main.PMC5343095.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.02.005 1008-1275/ ©2017 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 49 e51,Non-OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
http://dx.doi.org/ 10.1093/ije/dyn189 .,OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
http://dx.doi.org/10.1371/ journal.pone.0096743 .,Non-OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
http://dx.doi.org/10.1016/j.ajem.2014.09.023 .,OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
2012;13: 87.http://dx.doi.org/10.1186/1745-6215-13-87 .,Non-OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
http://dx.doi.org/10.1111/ijs.12132 .,Non-OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
2013;13:20. http://dx.doi.org/10.1186/ 1471-227X-13-20 .,Non-OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
http://dx.doi.org/10.1007/s12028-012-9681-5 .,Non-OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
http://dx.doi.org/10.1089/neu.2015.4039 .,Non-OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
http://dx.doi.org/10.1016/S0140-6736(11)60396-6 .,OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
http://dx.doi.org/10.1016/ j.annemergmed.2013.08.028 .,OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
2015;33:458. http://dx.doi.org/10.1016/ j.ajem.2014.11.009 .,OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
http://dx.doi.org/10.1136/ bmj.e5839 .A.,Non-OADS,/arxiv_data1/oa_pdf/13/84/main.PMC5343096.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/d0/main.PMC5343097.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.03.007 1008-1275/ ©2017 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/c0/d0/main.PMC5343097.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 39 e44,Non-OADS,/arxiv_data1/oa_pdf/c0/d0/main.PMC5343097.pdf
"http://dx.doi.org/ 10.1016/j.injury.2008.08.011 .4.Roldan JC, Jepsen S, Miller J, et al.",OADS,/arxiv_data1/oa_pdf/c0/d0/main.PMC5343097.pdf
http://dx.doi.org/10.1097/BOT.0b013e318172cea5 .,Non-OADS,/arxiv_data1/oa_pdf/c0/d0/main.PMC5343097.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.10.005 1008-1275/ ©2017 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 14 e17,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
http://dx.doi.org/10.1016/0266-4356(91)90192-8 .,OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
http://dx.doi.org/10.1097/00006534-200108000-00006 .,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
http://dx.doi.org/10.1016/ S0266-4356(96)90007-8 .,OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
http://dx.doi.org/ 10.1097/TA.0b013e3181492f41 .,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
http://dx.doi.org/10.1016/0020-1383(94)90184-8 .,OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
http://dx.doi.org/10.1136/emermed-2013-202804 .,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
http://dx.doi.org/ 10.1007/s00068-010-0038-5 .,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
http://dx.doi.org/10.1016/S1079-2104(98)90146-9 .,OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
http://dx.doi.org/10.1016/j.joms.2009.04.117 .,OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
2010;43:42 e48.http://dx.doi.org/10.4103/0970- 0358.63959 .,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
2016;2016:3608602. http://dx.doi.org/10.1155/ 2016/3608602 .,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
2016;27:6. http://dx.doi.org/10.1097/SCS.0000000000002280 .15.,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
2014;2014:982104. http://dx.doi.org/10.1155/2014/982104 .,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
http://dx.doi.org/10.1097/SCS.0000000000000830 .,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
2013;2013:452750. http://dx.doi.org/10.1155/2013/452750 .,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
2000;371:10 e27.http://dx.doi.org/10.1097/00003086- 200002000-00003 .,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
http://dx.doi.org/10.4161/org.23306 .,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
http://dx.doi.org/10.1016/j.injury.2005.07.029 .,OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
http://dx.doi.org/10.1517/14712598.2010.481669 .,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
2012;6:51 e55.http://dx.doi.org/10.2174/1874210601206010051 .,Non-OADS,/arxiv_data1/oa_pdf/34/ae/main.PMC5343098.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.10.002 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 20 e26,Non-OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.1016/j.aap.2016.02.002 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.1016/S0001-4575(99)00014-7 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.3141/ 2281-16 .,Non-OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
TRB Paper 03 e2331 http://citeseerx.ist.psu.edu/viewdoc/summary?doi ¼10.1.,Non-OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.1016/ j.aap.2005.04.004 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/ 10.1016/j.aap.2007.02.001 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.1016/j.aap.2010.09.006 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.1016/ j.aap.2014.02.014 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.1016/ 0001-4575(96)00009-7 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.1016/S0001-4575(02) 00135-5 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
2005. http://dx.doi.org/10.4271/2005-01-0944 .,Non-OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.1016/j.aap.2008.03.010 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/ 10.1016/j.jsr.2003.05.009 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.1016/ S0001-4575(03)00012-5 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.1016/j.aap.2006.05.002 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.1016/ j.aap.2015.09.005 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.1016/S0001-4575(01)00009-4 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/ 10.1139/l94-090 .,Non-OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.3141/2386-11 .,Non-OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
http://dx.doi.org/10.1016/ j.jsr.2014.12.001 .,OADS,/arxiv_data1/oa_pdf/ed/06/main.PMC5343099.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/main.PMC5343100.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.12.015 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/main.PMC5343100.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 56 e58,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/main.PMC5343100.pdf
http://dx.doi.org/10.1097/TA.0b013e31822cf359 .,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/main.PMC5343100.pdf
http://dx.doi.org/10.1097/TA.0b013e31829e20e3 .,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/main.PMC5343100.pdf
http://dx.doi.org/10.4068/cmj.2011.47.2.134 .,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/main.PMC5343100.pdf
"2012;26. http://dx.doi.org/10.1016/ j.avsg.2012.04.012 , 1129.e13-6.",OADS,/arxiv_data1/oa_pdf/b3/0c/main.PMC5343100.pdf
2013;14:58 e62.http://dx.doi.org/10.12659/AJCR.883808 .,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/main.PMC5343100.pdf
http://dx.doi.org/10.1097/ SLA.0b013e3181e3375a .,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/main.PMC5343100.pdf
http://dx.doi.org/10.1016/j.jvs.2005.05.010 .A.,OADS,/arxiv_data1/oa_pdf/b3/0c/main.PMC5343100.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/3d/main.PMC5343101.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.10.006 1008-1275/ ©2017 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/85/3d/main.PMC5343101.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 27 e33,Non-OADS,/arxiv_data1/oa_pdf/85/3d/main.PMC5343101.pdf
World Health Organization; 2013. http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/85/3d/main.PMC5343101.pdf
Tehran; 2013. https://www.amar.,Non-OADS,/arxiv_data1/oa_pdf/85/3d/main.PMC5343101.pdf
Available at: http://www-nrd.nhtsa.dot.gov/ Pubs/812124.pdf .,Non-OADS,/arxiv_data1/oa_pdf/85/3d/main.PMC5343101.pdf
2011;42:90 e96.http://dx.doi.org/10.1016/j.injury.2010.08.040 .,OADS,/arxiv_data1/oa_pdf/85/3d/main.PMC5343101.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/1b/main.PMC5343102.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.05.002 1008-1275/ ©2017 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/01/1b/main.PMC5343102.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 52 e55,Non-OADS,/arxiv_data1/oa_pdf/01/1b/main.PMC5343102.pdf
http://dx.doi.org/10.1007/s10140-012-1063-y .,Non-OADS,/arxiv_data1/oa_pdf/01/1b/main.PMC5343102.pdf
http://dx.doi.org/10.2214/AJR.11.7973 .,Non-OADS,/arxiv_data1/oa_pdf/01/1b/main.PMC5343102.pdf
2012;19:53 e60.http://dx.doi.org/10.1007/ s10140-011-0989-9 .,Non-OADS,/arxiv_data1/oa_pdf/01/1b/main.PMC5343102.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.11.003 1008-1275/ ©2017 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 20 (2017) 4 e8,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
http://dx.doi.org/10.1097/ SCS.0000000000001789 .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
http://dx.doi.org/10.1016/j.ijom.2015.11.022 .,OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
2014;9:13. http://dx.doi.org/ 10.1186/1749-7922-9-13 .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
2017;66:3 e4.http://dx.doi.org/10.1007/s00101-016-0252-6 .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
http://dx.doi.org/10.1016/ j.surge.2013.07.001 .,OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
http://dx.doi.org/10.1097/SCS.0000000000002338 .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
http://dx.doi.org/10.1016/ j.clinimag.2012.11.002 .,OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
http://dx.doi.org/10.1055/s-0032-1322535 .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
2013;8:32. http://dx.doi.org/10.1186/1749-7922-8-32 .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
http://dx.doi.org/10.3390/ ijms15023088 .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
2013;2013:760205. http://dx.doi.org/10.1155/2013/760205 .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
http://dx.doi.org/ 10.1016/j.jcms.2013.05.005 .,OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
2008;3:32. http://dx.doi.org/10.1186/1749-7922-3-32 .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
2009;35:61 e66.http://dx.doi.org/10.1007/s00068-008-8013-0 .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
http://dx.doi.org/ 10.1016/S0020-1383(14)70014-2 .,OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
2015;16:215. http://dx.doi.org/10.1186/s13063-015-0733-y .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
http://dx.doi.org/10.1007/s00268-013- 2226-z .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/main.PMC5343103.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.09.004 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/8c/05/main.PMC5343108.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/05/main.PMC5343108.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.08.006 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/7d/4b/main.PMC5343109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/4b/main.PMC5343109.pdf
Available from: http://dx.doi.org/10.1007/ s00706-016-1694-x .,Non-OADS,/arxiv_data1/oa_pdf/7d/4b/main.PMC5343109.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.11.002 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/eb/31/main.PMC5343110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/31/main.PMC5343110.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.10.002 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/d7/61/main.PMC5343111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/61/main.PMC5343111.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.07.001 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/df/45/main.PMC5343112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/45/main.PMC5343112.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.11.005 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/d2/cc/main.PMC5343113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/cc/main.PMC5343113.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.11.006 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/49/d9/main.PMC5343114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/d9/main.PMC5343114.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.07.005 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/98/dd/main.PMC5343115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/dd/main.PMC5343115.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.06.012 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/01/b5/main.PMC5343116.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/b5/main.PMC5343116.pdf
Bioinformatic analysis Open reading frames (ORFs) were determined using NCBI online tools ( http://www.ncbi.nlm.nih.gov/gorf/gorf.html ).,OADS,/arxiv_data1/oa_pdf/01/b5/main.PMC5343116.pdf
"The physical and chemical parameters, such as molecular mass (MW), theoretical pIand stability of the deduced amino acids were predicted by ProtParam software online ( http://web.expasy.org/protparam/ ), while conserved domains of both SgSQS and SgCAS were identi ﬁed by ScanProsite ( http://www.ebi.ac.uk/Tools/pfa/iprscan/ ).",OADS,/arxiv_data1/oa_pdf/01/b5/main.PMC5343116.pdf
"The signal peptide, subcellular localization and transmembrane regions were identi ﬁed using SignalP4.1 Server ( http://www.cbs.dtu.dk/services/ SignalP/ ), PSORT ( http://wolfpsort.org/ ) and TMHMM Server v. 2.0 ( http://www.cbs.dtu.dk/services/TMHMM/ ).",OADS,/arxiv_data1/oa_pdf/01/b5/main.PMC5343116.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.10.001 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/e6/be/main.PMC5343117.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/be/main.PMC5343117.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.06.003 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/25/0e/main.PMC5343118.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/0e/main.PMC5343118.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/88/main.PMC5343151.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.12.002 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/d4/ec/main.PMC5343154.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/ec/main.PMC5343154.pdf
"Capsulatus (ADE87147), Aquifex aeolicus (O67625), and E. coli (NP_414570) were aligned with Clustal Omega ( http://www.ebi.ac.",Non-OADS,/arxiv_data1/oa_pdf/d4/ec/main.PMC5343154.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.12.001 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/82/27/main.PMC5343163.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/27/main.PMC5343163.pdf
"Exhaustive literature search in NCBI PubMed, Google, Bing, and CNKI ( http://cnki.net/ ) has been performed to outline the progress of Anemone research during the last three decades.",OADS,/arxiv_data1/oa_pdf/82/27/main.PMC5343163.pdf
The root and leaves ofAnemone canadensis was one of the most highly esteemed medicines of the Omaha and Ponca Indians ( http://plants.for9.net/ edible-and-medicinal-plants ).,Non-OADS,/arxiv_data1/oa_pdf/82/27/main.PMC5343163.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/8e/main.PMC5343165.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.08.004 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/7a/b1/main.PMC5343191.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/b1/main.PMC5343191.pdf
T HIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE ( http://creativecommons.o rg/licenses/by-nc-nd/4.0/ ).ISSN 2452-302X http://dx.doi.org/10.1016/j.jacbts.2016.10.006,Non-OADS,/arxiv_data1/oa_pdf/9e/90/main.PMC5343290.pdf
This is an open access article under the CC BY-NC-NDlicense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/90/main.PMC5343290.pdf
"http://doi.org/10.1183/20734735.001617  Breathe | March 2017 | Volume 13 | No 1 11 Continuing professional  development: introducing the ERS International Certificate  in Respiratory Sleep Medicinesharon.mitchell@ersnet.org Sharon Mitchell1, Renata L. Riha2, Gernot Rohde3,4, Anita K. Simonds5 and the ERS Education Sleep Working Group6 1ERS Education, European Respiratory Society, Lausanne, Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/06/fa/EDU-0016-2017.PMC5343602.pdf
"Organised in a modular format, this continuing  professional development programme in respiratory sleep will provide learners with the opportunity to  @ ERSpublications Certification of specialists in respiratory sleep medicine for the purposes of continuing professional development http://ow.ly/4uX9309g3HsCite as: Mitchell S, Riha RL, Rohde G, et al.",Non-OADS,/arxiv_data1/oa_pdf/06/fa/EDU-0016-2017.PMC5343602.pdf
http://doi.org/10.1183/20734735.001717  Breathe | March 2017 | Volume 13 | No 1 3 Cite as: Riha RL.,Non-OADS,/arxiv_data1/oa_pdf/8a/c4/EDU-0017-2017.PMC5343603.pdf
@ ERSpublications The March issue of Breathe looks at psychological comorbidity of respiratory illness   http://ow.ly/ZlPd3094gKlWelcome to the March issue of Breathe!,Non-OADS,/arxiv_data1/oa_pdf/8a/c4/EDU-0017-2017.PMC5343603.pdf
"International Journal of Preventive Medicine 2017, 8:8 http://www.ijpvmjournal.net/content/8/1/8INTRODUCTION Somatic complaints are physical symptoms of which  presence, severity or consequences cannot be explained  by any detectable physical disorder.",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/IJPVM-8-8.PMC5343604.pdf
"International Journal of Preventive Medicine 2017, 8:8 http://www.ijpvmjournal.net/content/8/1/8the FactMixtAnalysis package in the free Software  Environment for Statistical Computing R. Factor means  were allowed to be free across classes while factor loadings  were restricted to be equal.",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/IJPVM-8-8.PMC5343604.pdf
"International Journal of Preventive Medicine 2017, 8:8 http://www.ijpvmjournal.net/content/8/1/8Comparison of mean somatic complaints profiles  across the different categories of demographic  and lifestyle characteristics As shown in Table  2, means of four somatic complaints  profiles for females, individuals with educational level  of under diploma, obese and inactive participants were  significantly greater than others ( P < 0.05).",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/IJPVM-8-8.PMC5343604.pdf
"International Journal of Preventive Medicine 2017, 8:8 http://www.ijpvmjournal.net/content/8/1/8classes, respectively, were physically inactive and  moderately inactive, suggesting marginally higher levels  inactivity among population belong to high psychological  somatic complaints profile class ( P < 0.1).",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/IJPVM-8-8.PMC5343604.pdf
"International Journal of Preventive Medicine 2017, 8:8 http://www.ijpvmjournal.net/content/8/1/8of somatic complaints between different populations  using clustering, factor analysis or LCA[10‑12,19] For  instance, in the Fink et al.’s study, three latent factors,  i.e., “cardiopulmonary,” “musculoskeletal/pain,” and  “gastrointestinal” using factor analyses was extracted.",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/IJPVM-8-8.PMC5343604.pdf
"International Journal of Preventive Medicine 2017, 8:8 http://www.ijpvmjournal.net/content/8/1/8We are grateful to thank all staff of IUMS (MUI) who  kindly participated in our study and staff of Public  Relations Unit, and other authorities of IUMS for their  excellent cooperation.",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/IJPVM-8-8.PMC5343604.pdf
Available from: https://www.ncbi.nlm.nih.gov/ books/NBK51962/.,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/IJPVM-8-8.PMC5343604.pdf
Available  at:https://www.uptodate.com/contents/inflammation‑in‑renal ‑ insufficiency.,Non-OADS,/arxiv_data1/oa_pdf/82/9b/ABR-6-13.PMC5343607.pdf
Available from: http://www.krueger.ca/downloads/skincancer.,Non-OADS,/arxiv_data1/oa_pdf/a1/db/ABR-6-14.PMC5343608.pdf
"International Journal of Preventive Medicine 2017, 8:10 http://www.ijpvmjournal.net/content/8/1/10this intervention.",Non-OADS,/arxiv_data1/oa_pdf/0b/9d/IJPVM-8-10.PMC5343609.pdf
"International Journal of Preventive Medicine 2017, 8:10 http://www.ijpvmjournal.net/content/8/1/10Dietary information was collected by 3‑day food records  and an average of 3‑day calorie intake was calculated by  nutritionist 4 software (First Databank, Hearst Corp, San  Bruno, CA, USA).",Non-OADS,/arxiv_data1/oa_pdf/0b/9d/IJPVM-8-10.PMC5343609.pdf
"International Journal of Preventive Medicine 2017, 8:10 http://www.ijpvmjournal.net/content/8/1/10in intervention group ( P < 0.001).",Non-OADS,/arxiv_data1/oa_pdf/0b/9d/IJPVM-8-10.PMC5343609.pdf
"International Journal of Preventive Medicine 2017, 8:10 http://www.ijpvmjournal.net/content/8/1/10for LBM.",Non-OADS,/arxiv_data1/oa_pdf/0b/9d/IJPVM-8-10.PMC5343609.pdf
"International Journal of Preventive Medicine 2017, 8:10 http://www.ijpvmjournal.net/content/8/1/10disease.",Non-OADS,/arxiv_data1/oa_pdf/0b/9d/IJPVM-8-10.PMC5343609.pdf
"International Journal of Preventive Medicine 2017, 8:7 http://www.ijpvmjournal.net/content/8/1/7COC.",Non-OADS,/arxiv_data1/oa_pdf/98/68/IJPVM-8-7.PMC5343610.pdf
"International Journal of Preventive Medicine 2017, 8:7 http://www.ijpvmjournal.net/content/8/1/7calculated as 710 considering an effect size of 7%.",Non-OADS,/arxiv_data1/oa_pdf/98/68/IJPVM-8-7.PMC5343610.pdf
"International Journal of Preventive Medicine 2017, 8:7 http://www.ijpvmjournal.net/content/8/1/7Table 2: Characteristics of respondents in Fars and Mazandaran provinces Respondent Item Amount or n (%) P Fars ( n=87) Mazandaran ( n=54) FPs ( n=141) Age (year) 47.2±8.6 45.9±8.5 0.4 Experience (year) Mean of working as GP 15.9±7.3 13.2±0.6 0.04 Mean of working as FP 3±6.4 2.5±1.1 <0.001 Gender Male 59 (68) 34 (63) 0.5 Female 28 (32) 20 (37) Employment status Employed by the state 13 (15) 11 (20) 0.3 Independent/self‑employed 36 (41) 21 (39) Contract with insurance organization 21 (24) 15 (28) Contract with medical university 17 (20) 7 (13) Postgraduate training or retraining course Completed the postgraduate training 1 (1) 3 (6) 0.5 Still following postgraduate training 9 (10) 1 (2) Completed a retraining program 16 (18) 8 (14) No training 61 (71) 42 (78) Area of employment Private practice 37 (43) 36 (67) 0.7 Private clinics 21 (24) 7 (13) Public health center 29 (33) 11 (20) Respondent Item Fars ( n=431) Mazandaran ( n=279) P Patients ( n=710) Age (year) 37.1±17 39.4±12.7 0.05 Gender Male 111 (26) 113 (40.5) <0.001 Female 320 (74) 166 (59.5) Education Literate/primary school 35 (10) 24 (11) 0.3 Secondary school 27 (7.5) 45 (21) High school 126 (35) 53 (25) Higher education/university 171 (47.5) 91 (43) Occupation In school 52 (12) 9 (3) 0.5 Unable to work 7 (1.5) 2 (0.5) Employee 174 (40.5) 142 (51) Retired 29 (6.5) 14 (5) Looking for job 36 (8.5) 15 (5.5) Other 133 (31) 97 (35) Living situation Alone 21 (5) 7 (2.5) 0.001 With parents 102 (23.5) 33 (12) With husband/wife 94 (22) 74 (26.5) With family (include children) 194 (45) 162 (58) Other 20 (4.5) 3 (1) Variables were expressed as mean±SD and frequency (%).",Non-OADS,/arxiv_data1/oa_pdf/98/68/IJPVM-8-7.PMC5343610.pdf
"International Journal of Preventive Medicine 2017, 8:7 http://www.ijpvmjournal.net/content/8/1/7Table 3: Availability and use of clinical information and computers by family physicians Topics Fars ( n=87), n (%) Mazandaran ( n=54), n (%) Total ( n=141), n (%) P* Keeping patients’ medical records Routinely of all patient contacts 33 (61.1) 11 (12.6) 44 (31.2) <0.001 Unless it is too busy 4 (7.4) 29 (33.3) 33 (23.4) For frequent patients only 0 10 (11.5) 10 (7.1) Except for minor or trivial complaints and illnesses 13 (24.1) 20 (23) 33 (23.4) Not keeping 4 (7.4) 17 (19.5) 21 (14.9) Having software program for medical records With appropriate capability 17 (31.5) 18 (20.7) 35 (24.8) 0.2 With poor capability 14 (25.9) 31 (35.6) 45 (31.9) Not having (not need) 23 (42.6) 38 (43.6) 61 (43.3) Using the computer for Booking appointments 3 (3.4) 0 3 (1.5) 0.003 Writing bills/financial administration 4 (4.5) 7 (6.1) 11 (5.4) Prescription of medicines 8 (9) 3 (2.6) 11 (5.4) Keeping medical records 32 (36) 45 (39.1) 77 (37.7) Writing referral letters 3 (3.4) 3 (2.6) 6 (2.9) Searching information 39 (43.8) 50 (43.5) 89 (43.6) Not using 0 7 (6.1) 7 (3.4) Easy to generate a list of patients by diagnosis or  health risk31 (57.4) 9 (10.3) 40 (28.4) <0.001 Referral letters for all or most referred patients to  specialists48 (90.6) 72 (86.7) 120 (88.2) 0.4 Medical feedback (almost) always from specialists 42 (79.2) 38 (43.7) 80 (57) 0.001 Values were expressed as frequency (%).",Non-OADS,/arxiv_data1/oa_pdf/98/68/IJPVM-8-7.PMC5343610.pdf
"International Journal of Preventive Medicine 2017, 8:7 http://www.ijpvmjournal.net/content/8/1/7Longitudinal continuity Because the FPP has been introduced recently (2013) in  the two provinces, length of registration time with an FP  was a relatively short time.",Non-OADS,/arxiv_data1/oa_pdf/98/68/IJPVM-8-7.PMC5343610.pdf
"International Journal of Preventive Medicine 2017, 8:7 http://www.ijpvmjournal.net/content/8/1/7Many surveyors have been making great efforts to show  the importance of interpersonal COC.",Non-OADS,/arxiv_data1/oa_pdf/98/68/IJPVM-8-7.PMC5343610.pdf
"International Journal of Preventive Medicine 2017, 8:7 http://www.ijpvmjournal.net/content/8/1/74.",Non-OADS,/arxiv_data1/oa_pdf/98/68/IJPVM-8-7.PMC5343610.pdf
: Housekeeping genes for hypoxia‑treated cells2 Advanced Biomedical Research | 2017Materials and Methods Microarray data reanalysis Microarray data were downloaded from gene expression  omnibus (GEO) database at http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/49/83/ABR-6-15.PMC5343613.pdf
"Data analysis For choosing the most s table  HKG, raw cycle threshold  values were analyzed with ref Finder at cotton expressed  sequence tag database available at http://www.leonxie.com/ referencegene.php.",OADS,/arxiv_data1/oa_pdf/49/83/ABR-6-15.PMC5343613.pdf
"International Journal of Preventive Medicine 2017, 8:9 http://www.ijpvmjournal.net/content/8/1/9in developing countries with roughly half of those deaths  occurring prematurely to persons younger than 70 years  of age.",Non-OADS,/arxiv_data1/oa_pdf/cc/de/IJPVM-8-9.PMC5343616.pdf
"International Journal of Preventive Medicine 2017, 8:9 http://www.ijpvmjournal.net/content/8/1/9activities, respectively), along with P14 and P15 (days and  time of moderate‑intensity sports, fitness, or recreational  activities, respectively) were considered.",Non-OADS,/arxiv_data1/oa_pdf/cc/de/IJPVM-8-9.PMC5343616.pdf
"International Journal of Preventive Medicine 2017, 8:9 http://www.ijpvmjournal.net/content/8/1/9relationship of age and gender with the number of  F&V servings consumed per day; in higher ages, the  proportion  of people consuming ≥5  servings of F&V per  day decreased ( P = 0.001).",Non-OADS,/arxiv_data1/oa_pdf/cc/de/IJPVM-8-9.PMC5343616.pdf
"International Journal of Preventive Medicine 2017, 8:9 http://www.ijpvmjournal.net/content/8/1/9DISCUSSION The present cross‑sectional study showed that males  had a higher prevalence than females for having  3–5 RFs (20.4% vs. 6.6%), using tobacco (13.3% vs. 0.6%),  engaging in high PA (27.4% vs. 15.1%), and having  diabetes (3.5%  vs. 2.1%) while having ≥5  servings of F&V per day was higher in female than male employees (47.8%  vs. 72.1%).",Non-OADS,/arxiv_data1/oa_pdf/cc/de/IJPVM-8-9.PMC5343616.pdf
"International Journal of Preventive Medicine 2017, 8:9 http://www.ijpvmjournal.net/content/8/1/9counterparts (24.6%).",Non-OADS,/arxiv_data1/oa_pdf/cc/de/IJPVM-8-9.PMC5343616.pdf
"International Journal of Preventive Medicine 2017, 8:9 http://www.ijpvmjournal.net/content/8/1/9Financial support and sponsorship Nil.",Non-OADS,/arxiv_data1/oa_pdf/cc/de/IJPVM-8-9.PMC5343616.pdf
Available from:  http://www.who.int/nmh/events/ncd_action_plan/en/.,OADS,/arxiv_data1/oa_pdf/cc/de/IJPVM-8-9.PMC5343616.pdf
Available from: http://www.who.int/gho/ncd/ mortality_morbidity/en/.,Non-OADS,/arxiv_data1/oa_pdf/cc/de/IJPVM-8-9.PMC5343616.pdf
Available from: http://www.who.int/nmh/publications/ncd‑profiles‑2014/ en/.,OADS,/arxiv_data1/oa_pdf/cc/de/IJPVM-8-9.PMC5343616.pdf
Available from:  http://www.who.int/chp/steps/saint_kitts_and_nevis/en/.,Non-OADS,/arxiv_data1/oa_pdf/cc/de/IJPVM-8-9.PMC5343616.pdf
Available from:  http://www.who.int/chp/steps/GPAQ/en/.,OADS,/arxiv_data1/oa_pdf/cc/de/IJPVM-8-9.PMC5343616.pdf
Available from: http://www.who.int/tobacco/surveillance/ policy/country_profile/en/.,Non-OADS,/arxiv_data1/oa_pdf/cc/de/IJPVM-8-9.PMC5343616.pdf
Available from: http://www.screening.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/d1/f7/AMS-6-172.PMC5343623.pdf
http://meps.ahrq.gov/mepsweb/ data_files/ publications/st368/stat368.pdf.,OADS,/arxiv_data1/oa_pdf/48/fd/AMS-6-260.PMC5343638.pdf
Available  from: https://books.google.co.in/books?id=RT8rAwAAQBAJ&dq=htt ps://books.google.co.in/books/about/PDQ_Oral_Disease.&source=gbs_ navlinks_s.,Non-OADS,/arxiv_data1/oa_pdf/44/7d/AMS-6-300.PMC5343646.pdf
Available at: http://www.un.org/en/development/desa/news/ population/2015‑report.html [last accessed on 2016 Aug 08].,Non-OADS,/arxiv_data1/oa_pdf/39/ac/JISPCD-7-41.PMC5343682.pdf
Available at: http://www.nytimes.com/2010/07/31/ health/31 patient.html [last accessed on 2016 Aug 09].,Non-OADS,/arxiv_data1/oa_pdf/39/ac/JISPCD-7-41.PMC5343682.pdf
Available at: http://guntur.nic.in/geography.,Non-OADS,/arxiv_data1/oa_pdf/39/ac/JISPCD-7-41.PMC5343682.pdf
"http://doi.org/10.1183/20734735.014916  Breathe | March 2017 | Volume 13 | No 1 33 Obstructive sleep apnoea (OSA) is a condition characterised by repetitive, intermittent partial  or complete collapse/obstruction of the upper airway during sleep.",Non-OADS,/arxiv_data1/oa_pdf/b1/c9/EDU-0149-2016.PMC5343728.pdf
"@ ERSpublications OSA patients should be assessed for Type D personality to determine likely CPAP compliance   http://ow.ly/DIbb309cMPHCite as: Maschauer EL, Fairley DM, Riha RL.",Non-OADS,/arxiv_data1/oa_pdf/b1/c9/EDU-0149-2016.PMC5343728.pdf
http://doi.org/10.1183/20734735.017516  Breathe | March 2017 | Volume 13 | No 1 5 Cite as: Yankulov A. ERS  clinical fellowship report.,Non-OADS,/arxiv_data1/oa_pdf/11/6b/EDU-0175-2016.PMC5343729.pdf
"I am grateful to all my mentors in the field of lung transplantation: A. Haverich, G. Warnecke, I. Tudorache, C. Kuhn, ERS clinical fellowship report @ ERSpublications An ERS clinical fellowship is an excellent opportunity to discover and develop a new field in your medical career http://ow.ly/WmiY306uzUM",Non-OADS,/arxiv_data1/oa_pdf/11/6b/EDU-0175-2016.PMC5343729.pdf
http://doi.org/10.1183/20734735.018516  Breathe | March 2017 | Volume 13 | No 1 59 Cite as: Spanevello A.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/EDU-0185-2016.PMC5343730.pdf
Its mission is the progression and dissemination of knowledge  @ ERSpublications Meet ERS Assembly 5: airway diseases http://ow.ly/M4ou306WbrQMeet the Assemblies,Non-OADS,/arxiv_data1/oa_pdf/90/9f/EDU-0185-2016.PMC5343730.pdf
"http://doi.org/10.1183/20734735.019016  Breathe | March 2017 | Volume 13 | No 1 7 Cite as: Ambosino N, Fatnic E.  Comprehensive management of ventilator-dependent patients: course report.",Non-OADS,/arxiv_data1/oa_pdf/53/ae/EDU-0190-2016.PMC5343731.pdf
"@ ERSpublications ERS hosted a postgraduate course on comprehensive management of ventilator-dependent patients in Barcelona, Spain http://ow.ly/jYzL306W0l6J.",Non-OADS,/arxiv_data1/oa_pdf/53/ae/EDU-0190-2016.PMC5343731.pdf
"http://doi.org/10.1183/20734735.019716  Breathe | March 2017 | Volume 13 | No 1 45 @CoughingAndyRAndy.Robson@nhslothian.scot.nhs.uk Andrew Robson NHS Lothian Respiratory Physiology Service, Western General Hospital, Edinburgh, UK.",Non-OADS,/arxiv_data1/oa_pdf/3c/47/EDU-0197-2016.PMC5343732.pdf
"Dyspnoea, hyperventilation and  functional cough: a guide to which tests help sort them out @ ERSpublications Methods that can be used to investigate dyspnoea in a newly referred patient   http://ow.ly/EsQW307U9hdCite as: Robson A. Dyspnoea, hyperventilation and functional cough: which tests help to sort them out?",Non-OADS,/arxiv_data1/oa_pdf/3c/47/EDU-0197-2016.PMC5343732.pdf
"http://doi.org/10.1183/20734735.019816  Breathe | March 2017 | Volume 13 | No 1 51 Cite as: Bos LD, Langer D,  Flood E. New ECMC members.",Non-OADS,/arxiv_data1/oa_pdf/b5/2d/EDU-0198-2016.PMC5343733.pdf
@ ERSpublications A message from the new chair of the @ERStalk ECMC http://ow.ly/QmaL307YkcxEarly Career Forum,Non-OADS,/arxiv_data1/oa_pdf/b5/2d/EDU-0198-2016.PMC5343733.pdf
http://doi.org/10.1183/20734735.020016  Breathe | March 2017 | Volume 13 | No 1 9 Cite as: Franssen FME.,Non-OADS,/arxiv_data1/oa_pdf/04/03/EDU-0200-2016.PMC5343734.pdf
@ ERSpublications A recap of the first Breathe online journal club by @fritsfranssen http://ow.ly/5uXX308xAG1,Non-OADS,/arxiv_data1/oa_pdf/04/03/EDU-0200-2016.PMC5343734.pdf
"Catch  up at http://ers.adobeconnect.com/p56j4rsbeqb To register for the next Breathe journal club, please complete the form at https://goo.gl/forms/rcR5jtg2sqkttph12",Non-OADS,/arxiv_data1/oa_pdf/04/03/EDU-0200-2016.PMC5343734.pdf
"http://doi.org/10.1183/20734735.131116  Breathe | March 2017 | Volume 13 | No 1 61 Maria R. Bonsignore is Head of the ERS Clinical Physiology, Sleep and Pulmonary  Circulation Assembly, and an Associate Professor at DiBiMIS, University of Palermo, Palermo, Italy.",Non-OADS,/arxiv_data1/oa_pdf/c1/ba/EDU-1311-2016.PMC5343735.pdf
"@ ERSpublications Maria Bonsignore, Head of ERS Assembly 4, gives an insight into her life   http://ow.ly/bt1W3062QhoConfidences de Salon",Non-OADS,/arxiv_data1/oa_pdf/c1/ba/EDU-1311-2016.PMC5343735.pdf
http://doi.org/10.1183/20734735.131216  Breathe | March 2017 | Volume 13 | No 1 55 Case 2 A 62-year-old male presents with chest pain.,Non-OADS,/arxiv_data1/oa_pdf/3d/69/EDU-1312-2016.PMC5343736.pdf
"http://doi.org/10.1183/20734735.131316  Breathe | March 2017 | Volume 13 | No 1 53 Hot topics from the Assemblies Prevalence of pulmonary embolism in patients  with syncope: findings from the Pulmonary Embolism in Syncope Italian Trial (PESIT) Authors: Prandoni P, Lensing AW, Prins MH, et al.",Non-OADS,/arxiv_data1/oa_pdf/a8/e5/EDU-1313-2016.PMC5343737.pdf
http://doi.org/10.1183/20734735.015216  Breathe | March 2017 | Volume 13 | No 1 23 Summary Involuntary cough without an identified underlying organic reason has been given various names  and recommended treatments.,Non-OADS,/arxiv_data1/oa_pdf/83/b8/EDU-0152-2016.PMC5344044.pdf
"@ ERSpublications Diagnosis of the functional disorder called habit cough can be readily made by the unique clinical characteristics http://ow.ly/Al5B3094oxjCite as: Weinberger M, Lockshin B.",Non-OADS,/arxiv_data1/oa_pdf/83/b8/EDU-0152-2016.PMC5344044.pdf
"http://doi.org/10.1183/20734735.019316  Breathe | March 2017 | Volume 13 | No 1 15 Initially described as hysteria and then Munchausen’s stridor, we now recognise vocal cord  dysfunction as several disorders.",Non-OADS,/arxiv_data1/oa_pdf/0b/d6/EDU-0193-2016.PMC5344045.pdf
"While asthma had been a common misdiagnosis for Vocal cord dysfunction: a functional cause of  respiratory distress @ ERSpublications VCD has several clinical and physiological phenotypes, which should be individually identified   http://ow.ly/orfb309fMxhCite as: Weinberger M, Doshi D. Vocal cord dysfunction: a functional cause of respiratory distress.",Non-OADS,/arxiv_data1/oa_pdf/0b/d6/EDU-0193-2016.PMC5344045.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000600002Consolidating in the present, with an eye to  the future Rogerio Souza Disciplina de Pneumologia, Instituto do Coração (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo (SP) Brasil.",Non-OADS,/arxiv_data1/oa_pdf/03/00/1806-3713-jbpneu-42-06-00399.PMC5344084.pdf
2015;41(2):110-23.  https://doi.org/10.1590/S1806-37132015000004474 3.,Non-OADS,/arxiv_data1/oa_pdf/03/00/1806-3713-jbpneu-42-06-00399.PMC5344084.pdf
2014;40(5):528-34. https://doi.org/10.1590/S1806- 37132014000500009 4.,Non-OADS,/arxiv_data1/oa_pdf/03/00/1806-3713-jbpneu-42-06-00399.PMC5344084.pdf
2014;40(6):609-16.  https://doi.org/10.1590/S1806-37132014000600004 5.,Non-OADS,/arxiv_data1/oa_pdf/03/00/1806-3713-jbpneu-42-06-00399.PMC5344084.pdf
2014;40(5):564-72. https://doi.org/10.1590/S1806- 37132014000500013 6.,Non-OADS,/arxiv_data1/oa_pdf/03/00/1806-3713-jbpneu-42-06-00399.PMC5344084.pdf
2015;41(2):124-32. https://doi.org/10.1590/S1806- 371320150000045267.,Non-OADS,/arxiv_data1/oa_pdf/03/00/1806-3713-jbpneu-42-06-00399.PMC5344084.pdf
2015;41(5):410-4. https://doi.org/10.1590/S1806- 37132015000004493 9.,Non-OADS,/arxiv_data1/oa_pdf/03/00/1806-3713-jbpneu-42-06-00399.PMC5344084.pdf
2014;40(2):164-70. https://doi.org/10.1590/S1806- 37132014000200010 10.,Non-OADS,/arxiv_data1/oa_pdf/03/00/1806-3713-jbpneu-42-06-00399.PMC5344084.pdf
2015;41(6):539- 46. https://doi.org/10.1590/S1806-37562015000000056 11.,Non-OADS,/arxiv_data1/oa_pdf/03/00/1806-3713-jbpneu-42-06-00399.PMC5344084.pdf
2015;41(5):454-66. https://doi.org/10.1590/S1806- 37132015000000152 12.,Non-OADS,/arxiv_data1/oa_pdf/03/00/1806-3713-jbpneu-42-06-00399.PMC5344084.pdf
2015;41(3):264-74. https://doi.org/10.1590/ S1806-37132015000004479 13.,Non-OADS,/arxiv_data1/oa_pdf/03/00/1806-3713-jbpneu-42-06-00399.PMC5344084.pdf
2015;41(1):1-2. https://doi.org/10.1590/S1806- 37132015000100001 400 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/03/00/1806-3713-jbpneu-42-06-00399.PMC5344084.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000600001The JBP and sleep medicine Pedro Rodrigues Genta1 1.,Non-OADS,/arxiv_data1/oa_pdf/85/96/1806-3713-jbpneu-42-06-00401.PMC5344085.pdf
2016:42(1):48-54. https://doi.org/10.1590/S1806-37562016000000012 3.,Non-OADS,/arxiv_data1/oa_pdf/85/96/1806-3713-jbpneu-42-06-00401.PMC5344085.pdf
2016:42(5):362- 366. https://doi.org/10.1590/S1806-37562016000000015 4.,Non-OADS,/arxiv_data1/oa_pdf/85/96/1806-3713-jbpneu-42-06-00401.PMC5344085.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000354Developing research questions that make a  difference Cecilia Maria Patino1,2, Juliana Carvalho Ferreira2,3 1.",Non-OADS,/arxiv_data1/oa_pdf/e1/54/1806-3713-jbpneu-42-06-00403.PMC5344087.pdf
2010;10:11. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/54/1806-3713-jbpneu-42-06-00403.PMC5344087.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562015000000320ABSTRACT Objective:  To evaluate the effects of positive expiratory pressure (PEP) on pulmonary  epithelial membrane permeability in healthy subjects.,Non-OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
http://dx.doi.org/10.1152/ ajpregu.00459.2009 2.,Non-OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
2005;85(3):811-44. http://dx.doi.org/10.1152/ physrev.00022.2004 3.,Non-OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
http://dx.doi.org/10.1152/ ajpregu.00444.2012 4.,Non-OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
http://dx.doi.org/10.1016/j.ccm.2006.06.007 5.,OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
1997;24(1):81-7. http://dx.doi.org/10.1007/ BF01728316 6.,Non-OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
2011;25(8):554-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
2009;27(1):20-4. http://dx.doi.org/10.1007/s11604-008- 0288-x 8.,Non-OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
2013;27(7):592-9. http://dx.doi.org/10.1007/s12149-013-0722-8 9.,Non-OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
1986;89(6):774-81. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
2013;107(8):1178-85. http://dx.doi.org/10.1016/j.rmed.2013.03.020 14.,OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
2007;33(4):397- 406. http://dx.doi.org/10.1590/S1806-37132007000400008 16.,Non-OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
2007;156(3):340-4. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
2012;11(99):16519-24. http://dx.doi.org/10.5897/AJB12.2563 19.,Non-OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
2005;99(4):1402- 11. http://dx.doi.org/10.1152/japplphysiol.01165.2004 25.,Non-OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
1998;113(2):459-66. http://dx.doi.org/10.1378/ chest.113.2.459 408 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/da/1c/1806-3713-jbpneu-42-06-00404.PMC5344088.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000054ABSTRACT Objective:  To investigate the reported cases of tuberculosis and of tuberculosis-HIV  co-infection in Brazil between 2002 and 2012.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2015;16(1):57-63. http://dx.doi.org/10.1038/ni.3048 3.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
"2003;163(9):1009-21. http://dx.doi.org/10.1001/archinte.163.9.1009 5. de Carvalho LG, Buani AZ, Zöllner MS, Scherma AP.",Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2006;32(5):424-9. http://dx.doi.org/10.1590/S1806- 37132006000500009 6.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2013;39(3):357-64. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2002;35(1):51-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2011;11:351.  http://dx.doi.org/10.1186/1471-2334-11-351 13.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
Cien  Saude Col. 2011;16(11):4503-12. http://dx.doi.org/10.1590/S1413- 81232011001200023 14.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2015;48 Suppl  1:63-9. http://dx.doi.org/10.1590/0037-8682-0055-2014 15.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2012;92(1):18-30.  http://dx.doi.org/10.1016/j.tube.2011.08.004 16.,OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2015;19(11):1305-11. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2001;35(1):81-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
"2013;21(2):507-14. http://dx.doi.org/10.1590/ S0104-11692013000200006 24. do Prado TN, Miranda AE, de Souza FM, Dias Edos S, Sousa LK,  Arakaki-Sanchez D, et al.",OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2014;14:415. http://dx.doi.org/10.1186/1471- 2334-14-415 25.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2016;110(3):199-206. http://dx.doi.org/10.1093/trstmh/trw011 26.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2016;14:41.  http://dx.doi.org/10.1186/s12916-016-0584-8 27.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2013;12:61. http://dx.doi.org/10.1186/1475-9276-12-61 28.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2014;18(10):1149-58. http://dx.doi.org/10.5588/ijtld.13.0889 29.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2015;129(6):783-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2007;15(5):936-41. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2014;43(4):1114-22. http://dx.doi.org/10.1093/ije/dyu044 34.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2013;17(3):345-7. http://dx.doi.org/10.5588/ijtld.12.0123 35.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2014;44(1):251-4. http://dx.doi.org/10.1183/09031936.00205413 36.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2014;68(3):259-63.  http://dx.doi.org/10.1016/j.jinf.2013.09.034 37.,OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
2013;39(2):221-5. http://dx.doi.org/10.1590/S1806- 37132013000200014 422 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/db/37/1806-3713-jbpneu-42-06-00416.PMC5344089.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562015000600006ABSTRACT Objective:  To describe orofacial muscle function in patients with severe asthma.,Non-OADS,/arxiv_data1/oa_pdf/8a/90/1806-3713-jbpneu-42-06-00423.PMC5344090.pdf
Available from: http://ginasthma.org/wp-content/ uploads/2016/01/GINA_Pocket_2015.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/8a/90/1806-3713-jbpneu-42-06-00423.PMC5344090.pdf
1999;116(6):1646-52. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/90/1806-3713-jbpneu-42-06-00423.PMC5344090.pdf
2010;28(4):249-59. http://dx.doi.org/10.1179/crn.2010.033 5.,Non-OADS,/arxiv_data1/oa_pdf/8a/90/1806-3713-jbpneu-42-06-00423.PMC5344090.pdf
2009;75(2):268- 74. http://dx.doi.org/10.1016/S1808-8694(15)30789-8 7.,Non-OADS,/arxiv_data1/oa_pdf/8a/90/1806-3713-jbpneu-42-06-00423.PMC5344090.pdf
2012;17(2):171-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/90/1806-3713-jbpneu-42-06-00423.PMC5344090.pdf
2014;43(4):1216. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/90/1806-3713-jbpneu-42-06-00423.PMC5344090.pdf
2009;123(1):96-102. http://dx.doi.org/10.1017/S002221510800323X 12.,Non-OADS,/arxiv_data1/oa_pdf/8a/90/1806-3713-jbpneu-42-06-00423.PMC5344090.pdf
2008;34(10):756-63. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/90/1806-3713-jbpneu-42-06-00423.PMC5344090.pdf
2008;10(4):513-9. http://dx.doi.org/10.1590/S1516- 18462008000400011 15.,Non-OADS,/arxiv_data1/oa_pdf/8a/90/1806-3713-jbpneu-42-06-00423.PMC5344090.pdf
2007;25(2):65-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/90/1806-3713-jbpneu-42-06-00423.PMC5344090.pdf
"2006;43(4):307-9. http://dx.doi.org/10.1080/02770900600623305 18. da Cunha DA, da Silva HJ, Nascimento GK, da Silva EG, da Cunha  RA, Régis RM, et al, Analysis of the masticatory process of  asthmatic children: Clinical and electromyographic research.",Non-OADS,/arxiv_data1/oa_pdf/8a/90/1806-3713-jbpneu-42-06-00423.PMC5344090.pdf
2012;14(1):114-21. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/90/1806-3713-jbpneu-42-06-00423.PMC5344090.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562015000000301ABSTRACT Objective:  To translate the Perme Intensive Care Unit Mobility Score and the ICU Mobility  Scale (IMS) into Portuguese, creating versions that are cross-culturally adapted for use  in Brazil, and to determine the interobserver agreement and reliability for both versions.",Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
They are  available online at http://www.jornaldepneumologia.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2009;373(9678):1874-82. http://dx.doi.org/10.1016/ S0140-6736(09)60658-92.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2008;36(8):2238-43. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2010;91(4):536-42. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2011;91(7):1109-15. http://dx.doi.org/10.2522/ptj.20100369 6.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2015;19:127. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
http://dx.doi.org/10.1016/j.jcrc.2014.01.019 8.,OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2014;43(1):19-24. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2012;92(12):1536-45. http://dx.doi.org/10.2522/ptj.20110412 12.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2014;10(1):41-9.  http://dx.doi.org/10.14797/mdcj-10-1-4113.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2008;126(4):215- 9. http://dx.doi.org/10.1590/S1516-31802008000400003 14.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2000;25(24):3186-91. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2005;8(2):94-104. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2007;23(1):1-20. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2015;41(3):225-30. http://dx.doi.org/10.1590/ S1806-37132015000004338 20.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
http://dx.doi.org/10.1186/cc12835 21.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2007;60(1):34-42.  http://dx.doi.org/10.1016/j.jclinepi.2006.03.012  434 J Bras Pneumol.,OADS,/arxiv_data1/oa_pdf/40/a6/1806-3713-jbpneu-42-06-00429.PMC5344091.pdf
2016;42(6):435-439 435 ORIGINAL ARTICLEhttp://dx.doi.org/10.1590/S1806-3756201 5000000029,Non-OADS,/arxiv_data1/oa_pdf/e6/c3/1806-3713-jbpneu-42-06-00435.PMC5344092.pdf
2008;246(3):697-722. http://dx.doi.org/10.1148/ radiol.24620707122.,OADS,/arxiv_data1/oa_pdf/e6/c3/1806-3713-jbpneu-42-06-00435.PMC5344092.pdf
1985;157(3):611-4. http://dx.doi.org/10.1148/ 438 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/e6/c3/1806-3713-jbpneu-42-06-00435.PMC5344092.pdf
2005;78(933):862- 5. http://dx.doi.org/10.1259/bjr/77712845 4.,Non-OADS,/arxiv_data1/oa_pdf/e6/c3/1806-3713-jbpneu-42-06-00435.PMC5344092.pdf
2008;44(7):386-92. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/c3/1806-3713-jbpneu-42-06-00435.PMC5344092.pdf
2012;2012:485-91. http://dx.doi.org/10.1182/ asheducation-2012.1.485 8.,Non-OADS,/arxiv_data1/oa_pdf/e6/c3/1806-3713-jbpneu-42-06-00435.PMC5344092.pdf
2008;46(12):1813- 21. http://dx.doi.org/10.1086/588660 9.,Non-OADS,/arxiv_data1/oa_pdf/e6/c3/1806-3713-jbpneu-42-06-00435.PMC5344092.pdf
2005;185(3):608-15. http://dx.doi.org/10.2214/ ajr.185.3.01850608 11.,Non-OADS,/arxiv_data1/oa_pdf/e6/c3/1806-3713-jbpneu-42-06-00435.PMC5344092.pdf
1994;106(4):1156-61. http://dx.doi.org/10.1378/chest.106.4.1156 12.,Non-OADS,/arxiv_data1/oa_pdf/e6/c3/1806-3713-jbpneu-42-06-00435.PMC5344092.pdf
2012;142(6):1469- 73. http://dx.doi.org/10.1378/chest.12-0114 14.,Non-OADS,/arxiv_data1/oa_pdf/e6/c3/1806-3713-jbpneu-42-06-00435.PMC5344092.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000098ABSTRACT To assess the impact that educational interventions to improve inhaler techniques have  on the clinical and functional control of asthma and COPD, we evaluated 44 participants  before and after such an intervention.",Non-OADS,/arxiv_data1/oa_pdf/46/18/1806-3713-jbpneu-42-06-00440.PMC5344093.pdf
2003;16(3):249-54. https://doi.org/10.1089/089426803769017613 2.,Non-OADS,/arxiv_data1/oa_pdf/46/18/1806-3713-jbpneu-42-06-00440.PMC5344093.pdf
2008;102(4):593- 604. https://doi.org/10.1016/j.rmed.2007.11.003 3.,Non-OADS,/arxiv_data1/oa_pdf/46/18/1806-3713-jbpneu-42-06-00440.PMC5344093.pdf
2011;105(12):1815-22. https://doi.org/10.1016/j.rmed.2011.07.004 4.,Non-OADS,/arxiv_data1/oa_pdf/46/18/1806-3713-jbpneu-42-06-00440.PMC5344093.pdf
2015;28(6):702-7. https://doi.org/10.20344/amp.5905 5.,Non-OADS,/arxiv_data1/oa_pdf/46/18/1806-3713-jbpneu-42-06-00440.PMC5344093.pdf
2016;22(3):163-6. https://doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/18/1806-3713-jbpneu-42-06-00440.PMC5344093.pdf
2012;27(10):1317-25. https://doi.org/10.1007/s11606-012-2090-9 7.,Non-OADS,/arxiv_data1/oa_pdf/46/18/1806-3713-jbpneu-42-06-00440.PMC5344093.pdf
2012;13:64. https://doi.org/10.1186/1745-6215-13-64 8.,Non-OADS,/arxiv_data1/oa_pdf/46/18/1806-3713-jbpneu-42-06-00440.PMC5344093.pdf
2008;72(1):26-33. https://doi.org/10.1016/j.pec.2008.01.014 9.,OADS,/arxiv_data1/oa_pdf/46/18/1806-3713-jbpneu-42-06-00440.PMC5344093.pdf
2006;100(9):1479-94. https://doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/46/18/1806-3713-jbpneu-42-06-00440.PMC5344093.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000269ABSTRACT Objective:  To report an initial experience with a digital drainage system during the  postoperative period of pediatric thoracic surgery.,Non-OADS,/arxiv_data1/oa_pdf/9f/3b/1806-3713-jbpneu-42-06-00444.PMC5344094.pdf
2014;40(5):579-81. https://doi.org/10.1590/S1806- 37132014000500015 2.,Non-OADS,/arxiv_data1/oa_pdf/9f/3b/1806-3713-jbpneu-42-06-00444.PMC5344094.pdf
2008;86(2):396-401. https://doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/9f/3b/1806-3713-jbpneu-42-06-00444.PMC5344094.pdf
2013;21(2):129-34.  https://doi.org/10.5455/aim.2013.21.129-134 4.,Non-OADS,/arxiv_data1/oa_pdf/9f/3b/1806-3713-jbpneu-42-06-00444.PMC5344094.pdf
2010;20(3):413-20. https://doi.org/10.1016/j.thorsurg.2010.03.007 6.,OADS,/arxiv_data1/oa_pdf/9f/3b/1806-3713-jbpneu-42-06-00444.PMC5344094.pdf
https://doi.org/10.1016/j.ejcts.2010.12.027 7.,OADS,/arxiv_data1/oa_pdf/9f/3b/1806-3713-jbpneu-42-06-00444.PMC5344094.pdf
2011;13(5):490- 3; discussion 493. https://doi.org/10.1510/icvts.2011.280941 446 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/9f/3b/1806-3713-jbpneu-42-06-00444.PMC5344094.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000260ABSTRACT Objective:  To describe diagnostic and treatment aspects of hard metal lung disease  (HMLD) and to review the current literature on the topic.,Non-OADS,/arxiv_data1/oa_pdf/25/e4/1806-3713-jbpneu-42-06-00447.PMC5344095.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000050ABSTRACT Objective:  To evaluate mouthpiece ventilation (MPV) in patients with Duchenne  muscular dystrophy (DMD) who are noncompliant with noninvasive ventilation (NIV).,Non-OADS,/arxiv_data1/oa_pdf/de/1a/1806-3713-jbpneu-42-06-00453.PMC5344096.pdf
2011;105(4):625-9. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/de/1a/1806-3713-jbpneu-42-06-00453.PMC5344096.pdf
2007;4(3):167-77. http://dx.doi.org/10.1177/1479972307080697 3.,Non-OADS,/arxiv_data1/oa_pdf/de/1a/1806-3713-jbpneu-42-06-00453.PMC5344096.pdf
2012;13(8):1056-65.  http://dx.doi.org/10.1016/j.sleep.2012.05.014 4.,OADS,/arxiv_data1/oa_pdf/de/1a/1806-3713-jbpneu-42-06-00453.PMC5344096.pdf
Neuromuscul Disord 2003;13(10):804-12. http://dx.doi.org/10.1016/ S0960-8966(03)00162-7 5.,OADS,/arxiv_data1/oa_pdf/de/1a/1806-3713-jbpneu-42-06-00453.PMC5344096.pdf
2014;20(4):211-8. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/de/1a/1806-3713-jbpneu-42-06-00453.PMC5344096.pdf
2011;56(6):744-50. http://dx.doi.org/10.4187/respcare.00831 8.,Non-OADS,/arxiv_data1/oa_pdf/de/1a/1806-3713-jbpneu-42-06-00453.PMC5344096.pdf
2004;170(4):456-65. http://dx.doi.org/10.1164/rccm.200307-885ST 9.,Non-OADS,/arxiv_data1/oa_pdf/de/1a/1806-3713-jbpneu-42-06-00453.PMC5344096.pdf
2002;28(3):278-84. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/1a/1806-3713-jbpneu-42-06-00453.PMC5344096.pdf
2014;59(9):1329-37. http://dx.doi.org/10.4187/ respcare.03031 456 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/de/1a/1806-3713-jbpneu-42-06-00453.PMC5344096.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000168An uncommon tomographic association:  amiodarone pulmonary toxicity and  adenocarcinoma Arthur Soares Souza Jr1,2, Gláucia Zanetti3, Edson Marchiori3 1.",Non-OADS,/arxiv_data1/oa_pdf/38/c2/1806-3713-jbpneu-42-06-00465.PMC5344098.pdf
http://dx.doi.org/10.1503/cmaj.111763 2.,Non-OADS,/arxiv_data1/oa_pdf/38/c2/1806-3713-jbpneu-42-06-00465.PMC5344098.pdf
2007;176(10):1411-3.  http://dx.doi.org/10.1503/cmaj.061102J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/38/c2/1806-3713-jbpneu-42-06-00465.PMC5344098.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000277Pulmonary fat embolism of neoplastic origin Flávia Pinto1, Miriam Menna Barreto1, Daniela Braz Parente1, Edson Marchiori1 1.",Non-OADS,/arxiv_data1/oa_pdf/62/ad/1806-3713-jbpneu-42-06-00466.PMC5344099.pdf
2014;8(4):133-5.  https://doi.org/10.1177/1753465814538690 3.,Non-OADS,/arxiv_data1/oa_pdf/62/ad/1806-3713-jbpneu-42-06-00466.PMC5344099.pdf
https://doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/ad/1806-3713-jbpneu-42-06-00466.PMC5344099.pdf
2013;269(2):615-8. https://doi.org/10.1148/radiol.13121187 5.,Non-OADS,/arxiv_data1/oa_pdf/62/ad/1806-3713-jbpneu-42-06-00466.PMC5344099.pdf
http://www.woundsin- ternational.com .,Non-OADS,/arxiv_data1/oa_pdf/bc/08/wocn-44-172.PMC5344181.pdf
http://www.woundsinternational.com .,Non-OADS,/arxiv_data1/oa_pdf/bc/08/wocn-44-172.PMC5344181.pdf
http://www.WongBakerFACES.org .,Non-OADS,/arxiv_data1/oa_pdf/bc/08/wocn-44-172.PMC5344181.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Impact of Mcl-1 overexpression in lprmice NS Anstee et al 408 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/37/d0/cdd2016125a.PMC5344201.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)HIC1-miR-23 ~ 27 ~ 24 feedback loop in breast cancer Yanbo Wang et al 432 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/97/3d/cdd2016136a.PMC5344204.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2017 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)miR-29c-5p inhibits the tumorigenesis of GBC through CPEB4 Y-J Shu et al 457 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/6d/62/cdd2016146a.PMC5344207.pdf
"O- and N-glycosylated sites were predicted using the GlycoEP server (prediction of glycosides in eukaryotic glycoproteins), 16NetNGlyc1.0 and NetOGlyc 3.1 servers available at http://www.imtech.res.in/raghava/glycoep/ and at the CBS (Center for biological sequence analysis (http://www.cbs.dtu.dk/services/NetNGlyc/ or NetO- Glyc/), respectivley.",OADS,/arxiv_data1/oa_pdf/ba/69/cdd2016150a.PMC5344210.pdf
"Representation of TRAIL-R1 and mTRAIL-R 3D structureprediction were inferred from TRAIL-R2 crystallographic structure using PHYRE2Protein Fold Recognition server, 17at http://www.sbg.bio.ic.ac.uk/phyre2.",OADS,/arxiv_data1/oa_pdf/ba/69/cdd2016150a.PMC5344210.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)N-glycosylation of TRAIL receptors F Dufour et al 510 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/ba/69/cdd2016150a.PMC5344210.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017ApoSOD1 induces Ca2+/Akt/ERK prosurvival pathway Tiziana Petrozziello et al 522 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/6c/80/cdd2016154a.PMC5344211.pdf
http://dx.doi.org/10.1016/j.idcr.2017.02.007 2214-2509/©  2017  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/bb/c3/main.PMC5344216.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  8  (2017)  22–26 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/bb/c3/main.PMC5344216.pdf
Most carbohydrate-degrading enzymes were found inContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/dibData in Brief http://dx.doi.org/10.1016/j.dib.2017.02.032 2352-3409/ &2017 The Authors.,OADS,/arxiv_data1/oa_pdf/56/af/main.PMC5344218.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).DOI of original article: http://dx.doi.org/10.1016/j.jprot.2017.01.003 nCorresponding author at: Division of Glycoscience, School of Biotechnology, Royal Institute of Technology (KTH), AlbaNova University Centre, 106 91 Stockholm, Sweden E-mail address: mckee@kth.se (L.S.",Non-OADS,/arxiv_data1/oa_pdf/56/af/main.PMC5344218.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/af/main.PMC5344218.pdf
Supporting information Transparency data associated with this article can be found in the online version at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/af/main.PMC5344218.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/ 10.1016/j.dib.2017.02.032 .,OADS,/arxiv_data1/oa_pdf/56/af/main.PMC5344218.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/5f/main.PMC5344219.pdf
She  received  oral  glycemic http://dx.doi.org/10.1016/j.ijscr.2017.02.033 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/44/5f/main.PMC5344219.pdf
"(2016),  http://dx.doi.org/10.1007/s00464-016-5376-x .",Non-OADS,/arxiv_data1/oa_pdf/44/5f/main.PMC5344219.pdf
